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Chapter 1
Molecules of map plasticity in the somatosensory cortex
Part of this chapter has been published or is under review:
Kole K. 
Experience-dependent plasticity of neurovascularization.
J Neurophysiol. 2015;114:2077–9. doi:10.1152/jn.00972.2014. 
 
and 
 
Kole, K., Scheenen, W.J.J.M., Tiesinga, P., Celikel, T. 
Molecules of map plasticity in the somatosensory cortex. 
Neurosci. Biobehav. Rev. 2017; Manuscript under review
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Abstract
Sensory maps are representations of the sensory epithelia in the central nervous system.  They 
are the products of sensory information about the environment and the neural dynamics (e.g. 
attention, motivation, expectation, experience, learning and memory) that shape functional cir-
cuits in the brain. Encoding the sensory world as maps is efficient, as map formation effectively 
groups neurons that most commonly interact with each other.  This organization decreases 
metabolic costs, reduces cable length, minimizes long-range connectivity, increases process-
ing speed without altering conduction velocity and enables topographic reorganization of the 
sensory representations. Despite the intuitive explanatory power behind sensory maps as be-
ing neuronal precursors to sensory perception, and the plasticity of sensory cortices as neural 
correlates of perceptual learning, the molecular mechanisms that regulate plasticity of sensory 
maps are not well understood. Here we perform a meta-analysis of transcriptional and trans-
lational changes during altered sensory organ use to nominate the major molecular correlates 
of experience-dependent map plasticity in the primary somatosensory cortex. We argue that 
brain plasticity is a systems-level response that involves all the major cell classes in the brain, 
from neuron and glia to non-neuronal cells including vascular epithelia, although the molecular 
pathways and temporal regulation of gene expression upon altered sensory experience depend 
on the cell-class.  Using molecular pathway analyses, we further propose a gene regulatory 
network that could couple activity-dependent changes in neurons to adaptive changes in neu-
rovasculature, and finally we show that transcriptional regulations observed in major brain 
disorders target genes that are modulated by altered sensory experience. Thus, understanding 
the molecular mechanisms of experience-dependent plasticity of sensory maps might help to 
unravel the cellular events that shape brain plasticity in health and disease. 
11
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Introduction   
Neurons along the sensory axis in the brain are responsible for the incorporation and process-
ing of inputs originating from the peripheral organs, granting the organism the ability to sense. 
As the incoming sensory information is often highly complex, the nervous system has to deal 
with a high-dimensional space in a time-varying manner.  For over a century, it has been known 
that neurons within sensory areas display so-called ‘receptive fields’ which are temporally 
varying representations of the sensory periphery in individual neurons [1].  Neurons in the 
primary visual cortex, for instance, are known to possess orientation selectivity: they respond 
strongly to visual stimuli of a given specific angle but lose their responsiveness to the same 
stimulus when it is rotated further away from their preferred angle [2]. Similarly, neurons in 
the primary auditory cortex respond preferentially to stimuli at a given frequency although 
their selectiveness diminishes as the loudness of the sound increases [3]. Sensory cortices are 
typically organized so that neurons that have similar receptive fields are located in each other’s 
vicinity thus forming sensory maps in the neocortex (Figure 1).
 
Receptive fields are not hard-wired, but adapt to ongoing changes in the statistics of the incom-
ing sensory information. This process, also known as experience-dependent plasticity (EDP), 
is believed to underlie cortical map plasticity.  Experiments across sensory modalities have 
shown as a general rule that preferential use of a sensory organ, or passive exposure to a select 
stimulus feature, results in the expansion of the sensory organ, or stimulus representation in the 
cortex (Figure 1). Synaptic and network mechanisms of EDP are increasingly well understood 
[4–7], and commonly studied in the context of changes in electrophysiological properties of 
neurons and synaptically coupled networks.  As long lasting changes in synaptic organization 
require molecular regulation in individual cells, there is a growing interest in systematic identi-
fication of molecular pathways that control EDP to mechanistically understand how experience 
alters neural networks and shapes behavior.  Here, focusing on the map plasticity in the primary 
somatosensory cortex, we review the state-of-art of molecular correlates of EDP, and perform 
a meta-analysis of transcriptional and translational changes observed upon altered whisker 
use.  We argue that experience alters gene regulation not only in neurons but in other types of 
cells in the brain, although the time-course, the dynamics (e.g. up- vs downregulation) and the 
pathways of plasticity are at least partially cell-type specific.  Linking the synaptic activation in 
neurons and the subsequent regulation of releasable molecules to changes in neurovasculature, 
we further address how systems level brain plasticity can be modulated. 
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Figure 1.  Receptive field plasticity and map reorganization across primary sensory cor-
tices in rodents. (A) Relative locations of visual, auditory and somatosensory cortices in the 
rodent brain; areal designations and locations are approximated. (B) Receptive field organiza-
tion across the three cortices. Top row: The visual cortex can be subdivided into monocular and 
binocular region. Middle row: Auditory cortical neurons have a ‘preferred frequency’. As the 
loudness of the auditory stimulus increases receptive fields are broadened, and neurons respond 
to stimuli across frequencies. Bottom row: Neurons in the somatosensory cortex are organized 
in a columnar fashion. Neurons in a column share a common principal whisker to which they 
preferentially respond. The response amplitude is reduced with increased distance between the 
principal whisker and the deflected (neighboring) whisker. (C) Cortical representations of the 
ipsilateral eye in the monocular region, a select tonal frequency and a whisker under normal 
conditions. (D) Upon sustained manipulation of sensory input (i.e. monocular deprivation [8], 
exposure to select tonal frequency[9] or whisker deprivation[10]) the sensory maps are reorga-
nized. Independent from the sensory modality, increased use of a sensory organ, or exposure to 
a specific stimulus, results in expansion of cortical representations in an experience-dependent 
manner.
 
The whisker system as a model to study neuroplasticity
Cortical representations of rodent whiskers in the barrel cortex, a subfield of the somatosensory 
cortex [11] have become one of the leading animal models to study experience-dependent plas-
ticity. They possess several distinct advantages over other models of EDP, including: (1) whis-
kers are organized in an orderly manner on the rodent’s snout, with ~32 macro vibrissae (i.e. 
whiskers) spanning across 5 rows (named A-to-E; color coded on the figurine) and 4-8 arcs, 
and topographically represented by neighboring cortical columns in the barrel cortex (Figure 
13
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1C, bottom). This discrete topographic map allows easy and reproducible identification of the 
neural circuits that are altered by differential sensory organ use. (2) just like fingers they are 
represented as somatosensory and motor maps in the cortex, but unlike fingers, whiskers can 
be reversibly deprived, providing a unique opportunity to study map reorganization during 
sensory deprivation and recovery from sensory organ loss. (3) whisker deprivation can be ap-
plied with ease and is relatively mild compared to other sensory deprivation paradigms such 
as ocular closure or digit amputation, and to some degree belongs to the rodents’ natural sen-
sory experience. Whiskers, like other hairs, undergo a hair-cycle, which results in spontaneous 
whisker loss, and rodents often pull their own whiskers while grooming and commonly barber 
each other’s whiskers during social interaction [12]. Whisker deprivation is therefore likely 
to be less stressful for experimental animals, compared to the other established deprivation 
protocols across sensory modalities. Whisker plucking or clipping also differs markedly from 
follicle ablation, ocular removal, cochlea removal, follicle lesioning or nerve severance, which 
not only irreversibly eliminate peripheral sensory input, but also lead to nerve degeneration, 
nerve regeneration and cell death, which on their own could influence neuronal responses [13, 
14]. These characteristics make the rodent whisker-to-barrel system ideally suited for the study 
of cortical EDP and as such it is widely used for this purpose.
Types of receptive field plasticity in the barrel cortex
As originally shown in the barrel cortex [15], sensory deprivation induced by transient whis-
ker trimming is sufficient to perturb receptive field organization both during development and 
in adulthood [16, 17]. The extent of plasticity depends on the nature and duration of sensory 
deprivation as well as the age of the animal.  Synaptic competition for sensory input is hy-
pothesized to be a major driving force for cortical map plasticity [10, 18] and can readily be 
introduced through a wide range of deprivation protocols. Trimming all whiskers, but one, for 
example, results in expansion of the spared whisker’s representation (Figure 2B) [19] while 
depriving all whiskers except two neighboring ones, fuses the representation of the two spared 
whiskers (Figure 2C) [20]. Other methods of deprivation range from single or multiple row 
sparing[21–23] or deprivation[24] and single whisker deprivation (Figure 2D) [25] to more 
complex deprivation protocols (e.g. chessboard pattern deprivation, where every other whisker 
is deprived[26, 27]). Independent from the type of the deprivation protocol employed, these 
studies commonly concluded that experience-dependent changes in receptive field plasticity 
can be summarized by increased representation of the spared, and decreased representation 
of the deprived whisker.  However, receptive field plasticity can also be induced by allowing 
animals to explore novel (or otherwise enriched) environments [28] (Figure 2E) or simply by 
passive whisker stimulation [29] (Figure 2F). These observations suggest that there are mul-
tiple forms of receptive field plasticity that could be modulated by contextual and top-down 
processes even in the absence of altered sensory organ use. 
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Figure 2. Known types of plasticity in the barrel cortex. Schematic representation of the 
sensory deprivation/experience condition, representative single neuron receptive fields in the 
supragranular layers of the barrel cortex, and the presumed map organization in the same lay-
ers across five different plasticity induction protocol. (A) Neurons in the barrel cortex respond 
to deflection of multiple whiskers.  The whisker that evokes the largest number of action po-
tentials is named as principal whisker, and the others are referred to as surround whiskers. In 
the absence of any whisker deprivation, perceptual training or environmental enrichment, the 
receptive field organization follows a topographical mapping where neurons in neighbouring 
cortical columns have neighbouring whiskers on the periphery as their principal whiskers. 
Neighboring whisker representations only partially overlap preserving the topographic map-
ping of the sensory periphery at the level of cortical circuits.  (B) When all whiskers, but one, 
are removed, neural responses to the spared whisker are potentiated in neighbouring barrel col-
umns[19], resulting in spared whisker representation to expand into the neighbouring cortical 
columns whose principal whiskers have been deprived. (C) Sparing two neighbouring whis-
kers causes their receptive fields to merge [20], as spared whisker representations’ increasingly 
overlap. (D) Depriving one (row of) whiskers result in neurons in the deprived cortical column 
to acquire a new principal whisker [25]; while deprived whisker representation shrinks, the 
spared surrounding whisker representations expand to drive stimulus evoked representations 
in the deprived whisker’s column.  (E) Enriched environment experience leads to sharpened 
receptive fields and whisker representations in the barrel cortex [28]. (F) Chronic (over)stim-
ulation of a single whisker results in a shrunken receptive field in neurons of the correspond-
15
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ing barrel column while the receptive fields of the non-stimulated whisker tend to broaden 
[29].   Single whisker representations are believed to expand upon non-stimulated whiskers, 
and shrink after stimulated whisker’s deflection, reflecting increased topographic precision of 
the sensory map.
The majority of the studies on receptive field plasticity (and in brain plasticity in general) have 
focused on neurons. Glial cells can be found in high numbers in the mammalian brain and 
are indispensable for proper brain function [30, 31]. Neuroglial cells include astrocytes, mi-
croglia and oligodendrocytes, which together are involved in, for example, myelination, neu-
rotransmitter recycling, response to brain damage and pathogens, and neurovascular coupling 
(also see the section on “From synaptic activity to vascular plasticity”). Glial cell morphology 
and activity can be modulated in an experience dependent manner [32–35]. For example, as-
trocytes’ morphology and abundance are altered upon environmental enrichment, while the 
number of astrocytic contacts with synapses increase [36–38].  As astro-neuronal cannabinoid 
signaling is critical for long-term depression of cortical synapses [39], sensory deprivation 
induced synaptic depression might involve both neuronal and glial processes. Both oligoden-
drocyte morphology and axonal myelination by oligodendrocytes are modulated by recent sen-
sory experience; social isolation or disruption of oligodendrocyte neuregulin signaling reduce 
axonal myelination and cognitive performance in select long-term memory paradigms [40]; 
conversely, activity-dependent myelination and oligodendrogenesis improve task performance 
[41].  Microglia are classically known to be involved in the defense against pathogens, but are 
also involved in synaptogenesis during learning and memory, and respond to sensory input by 
increasing their contact with dendritic spines and synapses [42–44].  Given their tight coupling 
to their neuronal counterparts, it is not surprising that glial cells have a preferred stimulus in the 
visual cortex [45]. Thus, (plasticity of) receptive fields are unlikely to be restricted to neurons, 
although non-neuronal plasticity in the barrel cortex is not commonly studied. 
Molecular correlates of plasticity
Studies describing the neuronal mechanisms underlying experience-dependent plasticity in the 
barrel cortex system are plentiful (see e.g [16, 19, 22, 24, 25, 46–65]). There has been, howev-
er, a surprising lack of experimental studies to unveil the molecular mechanisms that underlie 
the observed changes in neuronal responses in response to (altered) sensory experience.  Sin-
gle molecules, particularly those that had been previously shown to modulate synaptic plas-
ticity, such as the Ca2+/calmodulin-dependent protein kinase (CaMK), the transcription factor 
Cre-Response Element Binding (CREB), the growth factor Brain-derived Neurotrophic Factor 
(BDNF) and nitric oxide [66–69] have been studied in some detail, however technologies now 
allow for systematically addressing the molecular correlates of map plasticity throughout the 
transcriptome and proteome. Changes in transcripts’ abundance can be quantified through the 
use of microarrays and RNA sequencing, while the proteome can be surveyed through, for 
example, tandem mass spectrometry. These techniques provide valuable information on the 
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molecular processes and pathways that are required to establish, maintain and adapt the neural 
circuit organization in response to sensory experience. Moreover, these data can now also be 
obtained in cellular and subcellular resolution as individual cells can be sorted and their RNA 
subsequently sequenced [70].
 
Input-dependent and cell type-specific effects of brief enhanced sensory experience on barrel 
cortex transcriptome
In a pioneering study that employed microarrays to quantitatively address transcriptional regu-
lation in the barrel cortex, Vallès and colleagues studied animals upon exposure to an enriched 
environment (EEE) [71].  Adult rats in the experimental group were subjected to 30 minutes of 
EEE in a dark room filled with novel objects and toys.  The control group was kept in the dark 
for the same duration but in their own home cages.  Animals were sacrificed, either immediate-
ly after EEE or following a 4 hour period spent in their home cages, before isolation of barrel 
cortical RNA which was subjected to microarray analysis, thereby identifying EEE-induced 
changes in the transcriptome.
A common way to interpret large-scale molecular datasets is through the use of gene ontol-
ogy (GO) terms. Gene ontologies entail defined cellular components, molecular functions or 
biological processes to which genes (or rather, their protein products) contribute [72]. Gene 
ontology analyses determine whether gene sets that are differentially regulated belong to 
distinct GO terms and if their co-regulation is significant.  GO classification of the differen-
tially expressed transcripts in the Vallès et al dataset has shown that gene transcription rapidly 
changes upon EEE (Figure 3), with a time course similar to whisker deprivation-induced reg-
ulation of gene transcription [73].  The majority of transcriptional regulation after EEE can be 
linked to general cellular processes (Figure 3A), although the direction of the transcriptional 
regulation, i.e. up- vs down-regulation, depends on the sensory history; immediately after 
EEE the vast majority of differentially expressed transcripts are up-regulated (170 upregulat-
ed, 31 downregulated), whereas in the 4h group downregulated genes are more prevalent (29 
upregulated, 98 downregulated). Lack of the sustained upregulation of gene transcription in 
this group might reflect the fact that animals were returned to their home cage, i.e. an envi-
ronmentally impoverished environment, before tissue collection for a period of 4h. Expected 
reduction in the utilization of the somatosensory input to explore animals’ familiar environ-
ment might in turn diminish synaptic transmission and, consequently, the rate of metabolism, 
thus obviating upregulation of transcripts.  If an enriched environment modulates gene ex-
pression in an activity-dependent manner, one might predict that longer EEE would result in 
sustained transcript up- or downregulation lasting until the network has accommodated to the 
enhanced sensory input. 
17
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Figure 3 (previous page). Gene ontology of differentially expressed genes after exposure 
to an enriched environment (previous page).  (A) Twelve most significant GO terms based 
on the transcriptional changes after EEE in the barrel cortex (data from [71]). Transcripts are 
clustered by their respective GO term, numbers indicate p-values.  Note that most genes are 
commonly classified under multiple GO terms. (B) Relative (with respect to control condition) 
expression values of all differentially regulated transcripts at 0 or 4 hours. The color code 
denotes GO terms.  Those transcripts that appear in multiple GO terms are plotted only once; 
the cluster membership is ranked. As such only the most differentially regulated GO term is 
displayed for those transcripts that are classified under multiple GO terms.  The majority of 
transcripts (n=103) are upregulated following EEE, half of which remain upregulated in the 
4h group (upper right quadrant, n=52), the other half is downregulated (lower right quadrant, 
n=51). Only few genes have steady downregulation (lower left quadrant, n=2), or temporally 
delayed upregulation (upper left quadrant, n=6).  Thus exposure to an enriched environment 
triggers temporally varying transcriptional regulation.  The direction of change in single gene 
transcription can be used to classify transcriptional dynamics and relate it to behavioral context.
This was confirmed in a follow-up study in which rats were subjected to EEE for 28 days, after 
which only 29 genes were found to be differentially expressed, likely reflecting the ‘steady-
state’ of the cortical reorganization upon chronic alteration in incoming sensory information 
[74].
The overrepresented GO terms identified after EEE are not specific to neurons or synapses. 
They mostly represent general cellular processes such as transcription, metabolism and cell 
signaling, which suggests that after EEE, gene expression changes may not be restricted to 
(or even be most prevalent in) neurons. Although the term ‘regulation of synaptic transmis-
sion’ (which specifically refers to communication through chemical synapses) was found to 
be overrepresented, other differentially regulated genes were strongly related to blood vessel 
morphogenesis. Sustained increased neuronal activity leads to heightened energy consumption 
and thus elevates oxygen consumption [75].  Increased metabolic rate and subsequent hypoxia 
could also elevate reactive oxygen species, which have been shown to induce oxidative stress 
and ultimately neuronal death [76].  Thus overrepresentation of GO terms such as ‘response 
to oxidative stress’ and ‘blood vessel morphogenesis’ point to an important role for vascular 
endothelial cells in experience-dependent plasticity, serving to accommodate increased energy 
consumption (also see the section “From synaptic activity to vascular plasticity” below).  This 
also suggests that the transcriptomes of distinct cell types might be differentially regulated by 
EEE.  To explore the possibility, using publicly available single-cell transcriptomics data from 
experimentally naïve juvenile mouse somatosensory cortex [70], we calculated a cell enrich-
ment index (CEI).  We normalized the average copy number of each gene within each cell class 
by the total copy number across all cell classes for each gene differentially expressed in the 
Vallès dataset. We then selected transcripts that were enriched by >10% compared to others, 
which showed that most transcripts were preferentially expressed in interneurons, whereas 
astrocytes were the least represented cell class in the Valles dataset (Figure 4A). Interestingly, 
19
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Figure 4.  Cell type-specific mRNA expression profiles after exposure to an enriched en-
vironment. Genes that are preferentially expressed in a cell-type specific manner was deter-
mined using single-cell RNAseq data ([70]; see main text for details).  (A) Distribution of dif-
ferentially expressed genes 0 or 4 hours after EEE across identified cell classes. (B) Temporal 
changes in gene transcription across cell types. Pie charts represent the relative percentage of 
genes whose transcription is downregulated (in orange), upregulated (in green) or non-regu-
lated (in yellow) when the normalized transcription levels in 4h group were compared to 0h.
20
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genes that displayed the most robust expression changes in response to EEE were preferentially 
expressed not only in pyramidal cells but also in endothelial cells and microglia. 
Transcripts found mostly in astrocytes, interneurons and oligodendrocytes, by contrast, showed 
modest changes after EEE (Figure 4A, B). Comparing gene expression across 0h or 4h showed 
that the majority of transcripts were reduced in their abundance at the 4h interval across all 
cell types, often returning (close) to baseline levels (Figure 4B).  These changes were most 
diverse (albeit only marginally) in pyramidal cells (7 up-, 22 downregulated, 6 no change) 
while endothelial cells had relative abundance of genes whose transcription is upregulated 
after 4 hours (Figure 4B). Despite the fact that we calculated the CEI based on cells obtained 
from experimentally naïve juvenile mice and use it to address the plausible cellular diversity 
in adult rodents, these results argue that sensory experience might affect gene expression in 
a cell type-specific manner. If so, cellular signaling pathways upstream of differential gene 
expression are also likely to be distinct for each cell class.  A systematic analysis of the mouse 
transcriptome upon altered sensory organ use will help to unravel the cellular diversity and 
molecular pathways associated with experience-dependent plasticity. 
Extended sensory stimulation and deprivation and their effects on synaptic proteins
Transcriptional modulation by sensory experience will alter structural and functional orga-
nization of neural circuits only if the changes are reflected in the proteome. Because RNA 
translation into protein is not a linear process, and controlled by posttranscriptional regulatory 
mechanisms [77], proteomic studies will be required to mechanistically address the molec-
ular pathways associated with expression of plasticity.  Currently the only proteomics study 
available in barrel cortex was performed by Butko and colleagues [78], who either clipped or 
brushed the whisker pads of rats for a period of 30 days, starting from P4, and subsequently 
prepared synaptoneurosomes from barrel cortex.  Using  tandem mass spectrometry Butko and 
colleagues identified systematic downregulation of translation for various ion channels (e.g. 
inward rectifying potassium channels KCNJ3 and KCNJ6, calcium-activated potassium chan-
nel KCNN2), neurotransmitter receptors (e.g. AMPA and NMDA receptor subunits GluA1, 
GluA2, GLuN1, GluN2A/B), cytoskeletal proteins (e.g. Catenins) and signaling proteins (e.g. 
adenylyl cyclase, protein kinase C) in whisker deprived rats. These alterations in protein levels 
are likely to be the cause of electrophysiological changes in receptive field and sensory map 
representations. 
From synaptic activity to vascular plasticity
If brain plasticity is a systems level response to change, as argued above, there must be mo-
lecular players that could couple changes in one cell type to another.  For example, changes in 
neuronal activity might be coupled to neurovascularization, helping to control both the neural 
activity as well as the dynamics of the blood flow in an experience dependent manner [79]. 
21
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Short-term changes in local blood flow are associated with neuronal activity and modulated 
by astrocyte-mediated vasodilation, vasoconstriction [80, 81] and cholinergic signaling[82]; 
inhibitory neurons are also implicated in neurovascular coupling as specific subsets of inter-
neurons can have different effects on vascular tone [83]. They can induce vasoconstriction 
through vasoactive proteins such as neuropeptide Y and somatostatin, whereas vasodilation 
can be achieved through secretion of vasoactive intestinal polypeptide or nitric oxide (NO), a 
potent vasodilatory molecule. Dynamic modulation of the cerebrovasculature thus involves a 
wide range of neuronal and non-neuronal cell types.
 
Besides short-term adaptation, long-term effects on the neurovasculature also have been ob-
served. Already over two decades ago, in the visual cortex of young and adult rats synapto-
genesis was found to be accompanied by angiogenesis (i.e. the formation of new blood ves-
sels) following EEE [37, 84]. More recent research has shown that during a critical postnatal 
developmental period, excessive stimulation induces a reduction of blood vessel sprouting 
and endothelial proliferation in the somatosensory, auditory and motor cortices [85]. These 
anti-angiogenic effects were associated with hypoxic conditions in the corresponding over-
stimulated brain regions, which in turn was accompanied dendritic spine loss. A separate study 
[86] employed both enhanced and decreased whisker experience, and found that blood vessel 
patterning in barrel cortex was modulated as a result: vascular density and branching were 
diminished in response to whisker deprivation whereas the same metrics were enhanced upon 
whisker stimulation. These findings indicate that the organization of the neurovascular bed is 
modulated in the wake of sensory experience, and suggest that brain oxygen levels (which are 
a derivative of brain vascularization) can in fact form a limiting factor to synaptic plasticity.
 
Despite the clear demonstrations of the impact of sensory experience on the neurovasculature, 
it is currently unknown which molecular components might orchestrate experience-dependent 
blood vessel patterning in the neocortex. To identify potential cellular signaling pathways in-
volved in this process, based on the findings of Valles and colleagues, we identified ten genes 
(Cyr61, Plat, Jun, Junb, ET-1, Klf2, Pdgfb, Verge (also known as Apold1), Prkx and Rap1b), 
which could link the synaptic activation to vascularization through activity dependent modu-
lation of releasable molecules.  The products of these ten genes, discussed in detail below, are 
involved in a variety of functions that enable neurovascular plasticity ranging from induction 
of vessel sprouting and vasodilation to cell migration and alterations in cell permeability.
 
Molecules of neurovascular plasticity
Cysteine-rich angiogenic inducer 61 (Cyr61) codes for a secreted extracellular matrix (ECM) 
protein involved in processes involving cell migration, adhesion, differentiation and mitogene-
sis [87]. In cortical neurons, mechanical strain and BDNF have been shown to induce transcrip-
tional activity of Serum Response Factor (SRF), which in turn is involved in regulating Cyr61 
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promoter activity [88, 89]; A third way that Cyr61 expression could be regulated by neuronal 
activity is through muscarinic acetylcholine receptors (mAChRs) and NMDA receptors [90, 
91].
The tissue plasminogen activator (Plat) is involved in ECM degradation, a critical step in an-
giogenesis that serves to clear the way for migration of vasculature-associated cells. Its gene 
product has been shown to be secreted by vascular endothelial cells in response to fluid shear 
stress, linking its function to neuronal activity resulting in increased blood flow [92]. Mechan-
ical stretch induced expression of vascular endothelial growth factor (VEGF) and angiotensin 
(AGT) requires activation by PLAT [93]. Its gene product is also involved in mediating synap-
tic growth, increasing NMDAR-mediated Ca2+ influx and cleaving proBDNF into BDNF and 
hence also has functions related to neuronal plasticity [94–96].
 
Another secreted protein, endothelin-1 (ET-1 or EDN1) can exert its distinct functions de-
pending on the receptor it binds to. Activation of ETA receptors results in vasoconstriction [97] 
whereas ETB receptor activation leads to the secretion of the vasodilators NO (nitric oxide), 
prostacyclin and EDHF (endothelium-derived hyperpolarizing factor) from endothelial cells 
[98], and hence leads to vasodilation. ET-1 also induces expression of matrix metalloprotein-
ase 9 and hence helps to clear the ECM [99]. Consistent with its vasculature-related functions, 
hypoxia is a potent ET-1 inducer: in VECs, hypoxic conditions result in the binding of the ET-1 
promoter by hypoxia-inducible factor-1 (HIF-1), which is mediated by, among others, AP-1 
[100]. ET-1 and its receptors are found in neuronal and glial cells [101]. Interestingly, there is 
evidence that endothelin-1 can function as a neurotransmitter, which would as such strongly 
bridge neuronal activity with neurovasculature modulation [102, 103].
 
Activator protein 1 (AP-1) is a transcription factor regulating various cellular processes such as 
cell proliferation, differentiation, apoptosis, and cell migration [104, 105]. It consists of homo 
or heterodimers of Jun proteins, among which are JUN and JUNB, the transcripts of which 
were differentially expressed following EEE [71]. Inhibition of AP-1 results in reduced vascu-
lar smooth muscle cell proliferation and diminished migration and tubule formation by ECs. 
In addition, inhibited microvascular endothelial cell proliferation and was observed, as well as 
reduced vasculature formation by ECs after cerebral ischemia [106–109]. Jun and Junb have 
both been shown to be induced by increased neuronal activity and plasticity [110–112].
 
The gene product of Klf2, Lung Krüppel-like factor 2, a zinc finger transcription factor, has 
been linked to several functions in vasculature. Klf2-/- mouse embryos display normal angio-
genesis, but also necrosis of endothelial cells, as well as a reduction in ECM deposition while 
the number of differentiating smooth muscle cells and pericytes is decreased, leading to hem-
orrhaging and death [113]. Klf2 is upregulated in response to increased blood flow: indeed, in 
23
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silent heart (sih) zebrafish, which possess a non-contractile heart, expression of Klf2 in vascu-
lature is absent, showing that increased blood flow induces Klf2 expression [114]. Interesting-
ly, ET-1 was found to be under transcriptional control by KLF2 [115].
 
An upstream regulator of Klf2, Jun and JunB, Platelet-derived growth factor (PDGF) is strong-
ly linked to vascular function. The transcript coding for one of its subunits, Pdgfb, is upreg-
ulated after EEE [71]. Pdgfb-/- embryos suffer from hemorrhages, edema and aneurysms as a 
consequence of the increased blood pressure[116]. In the brain, PDGFRβ (PDGF receptor β, 
with high affinity for PDGF-B) is exclusively expressed by pericytes, which are important 
for vessel contraction, angiogenesis and maintenance of blood-brain barrier integrity [117]. 
PDGF-BB also is linked to PLAT, which it requires to induce mitogenesis and chemotaxis in 
vascular smooth muscle cells [118]; it is also involved in ECM degradation through induc-
tion of matrix metalloproteinase 2 [119]. Besides vasculature modulation, PDGF-BB was also 
found to inhibit NMDA receptors in neurons [120], but at this time it is unclear whether PDGF 
is secreted in an activity-dependent manner.
 
The product of the vascular early response gene (Verge or Apold1) accumulates at the periph-
ery of endothelial cells, where it functions to regulate cell permeability by remodeling the cells’ 
cytoskeleton, allowing substances to pass through endothelial cell layers [121]. A knockout of 
this gene is shown to exacerbate outcomes after stroke in mice [122]. Conditions inducing its 
expression has been studied in various tissues, and include hypoxia, ischemia, physical activity 
and hypertonicity [121, 123–125]). A putative mechanism linking neuronal activity to Verge 
expression entails tumor necrosis factor (TNF) and fibroblast growth factor (FGF) signaling, 
which are expressed in response to glutamate and oxygen-glucose deprivation by neurons and 
astrocytes [126, 127].
 
Intracellular signaling pathways activate cellular processes downstream of membrane recep-
tors. Prkx codes for a cAMP-dependent protein kinase involved in transcriptional regulation 
through interaction with and/or phosphorylation of its downstream targets [128]. Several 
downstream targets of PRKX are involved in vascular functions such as maintenance of blood 
vessel integrity and (inhibition of) angiogenesis [129–131]. Indeed, Prkx expression has been 
shown to be involved in vascular endothelial cell proliferation, migration, vascular-like struc-
ture formation and morphogenesis [129, 132]. The neuronal function of PRKX is has not been 
studied in detail, hence as of yet it is unknown whether its regulation can be modulated through 
increased neuronal activity.
 
Rap G proteins are members of the Ras-like GTPase family, involved in various cellular 
functions such as growth, differentiation and survival; a member of this family (Rap1b) was 
found upregulated following EEE [71]. RAP1B has been shown to exert vascular functions: 
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RAP1B-deficient mice and cultured endothelial cells display defects cell proliferation, migra-
tion, tubule formation and angiogenesis [133, 134]. Interestingly, RAP1B has been shown to in 
intracellular signaling pathways of in hippocampal LTP induction, as an inactive Rap1b mutant 
lead to reduced LTP induction [135].
 
Among these ten targets relevant to neurovascular plasticity, perhaps the most striking is the 
role of PDGF-B signaling: it can induce expression of Jun, Junb, Cyr61, Rap1b, ET-1 and Klf2, 
the latter of which has been shown to have, among others, ET-1 as a downstream regulatory 
target. ET-1, in turn, may exert its vascular functions by inducing the expression and release of 
vasodilatory or vasoconstrictory molecules. PDGF-BB-mediated induction of chemotaxis and 
mitogenesis in vascular smooth muscle cells requires PLAT, linking PDGF-B to yet another 
vasculature modulator. Because these genes are expressed in an activity-dependent manner 
(based on [71]), pathways such as these could well orchestrate blood vessel patterning to suit 
the needs of neuronal circuits [85, 86].
 
Linking synaptic activity to vasculature change through releasable molecules
The genes outlined above are shown to contribute to neurovascularization, however it is not 
known whether synaptic activity could regulate their transcription, and whether there are 
downstream protein-protein interactions that could link plasticity of synaptic communica-
tion to the organization of the neurovascular bed.  Because experience dependent plasticity 
of neural activity is the primary mechanism by which receptive fields and sensory represen-
tations in the brain reorganize, we addressed the upstream pathways that link that these genes 
to the synapse. To this end, we utilized the Ingenuity® Pathway Analysis (IPA®, Qiagen) to 
investigate the potential regulatory pathways in which the genes of interest are involved. In 
pathway reconstruction, we only included experimental data from neurons, astrocytes, endo-
thelial cells, fibroblasts, smooth muscle cells (as these three can be found in blood vessels), 
the CNS and CNS cell lines. Molecules were only included if they are expressed in these cell 
types; interactions between molecules were allowed to be indirect or direct but always filtered 
for activating relationships between receptors, kinases and transcription factors (e.g. kinases 
activating downstream transcription factors). Between transcription factors and downstream 
genes, relationships were filtered for ‘expression’ or ‘transcription’. Since we aimed to provide 
an overview of common pathways, only transcription factors that target at least two of the ten 
analyzed genes were used in pathway reconstruction. This approach yielded an overview of 
the pathways that may be activated as a result of stretch, growth factor and glutamate receptor 
stimulation (Figure 5).
 
Mechanoreceptors can be found in vasculature-related cells and astrocytes, where they can be 
activated as a result of increased blood flow, leading to an influx of calcium [136–138]. Among 
the mechanoreceptors, we find that AGTR1 and TRPc5 could modulate the activation of ElF-
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2AK2, AKT1, MAPK14, PTK2B, ERK1/2 and SRC, which in turn allow transcriptional regu-
lation of the genes of interest (Figure 5; also see [139];[140]).  In the growth factor pathway we 
included basic fibroblast growth factor (bFGF) , hepatocyte growth factor (HGF), vascular en-
dothelial growth factor (VEGF), brain derived neurotrophic factor (BDNF), and nerve growth 
factor (NGF) which show enhanced expression in an activity dependent manner in neurons 
and/or astrocytes [126, 141];[142];[143];[126, 144]. Particularly AKT1 and ERK1/2 are down-
stream of these receptors. The glutamate receptor pathways include ionotrophic,α-amino-3-hy-
droxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-Methyl-D-aspartic acid (NMDA) 
receptors, activation of which lead to influx of Ca2+, K+ and/or Na+, as well as metabotropic glu-
tamate receptors (mGluRs).  The pathway analysis showed that glutamate receptor activation 
is likely to induce activation of particularly ERK1/2 and PRKD1 kinases, leading to activation 
of CREB1 and STAT1 (Figure 5).
 
The most inclusive transcriptional regulators suggested by this “synaptic activity to neurovas-
cularization” pathway are CREB1, FOS and TP53, which together can potentially regulate all 
our genes of interest with the exception of KLF2. Fos was also found by Vallès and colleagues 
to be upregulated along with Trp53rk (TP53 regulating kinase), which increases the likelihood 
of FOS and TP53 involvement in the predicted pathways. 
Surprisingly, activating protein 1 (AP-1) was not found to have any role in any of the three 
pathways, even though two of its subunits were found to be upregulated after EEE (Jun, Junb) 
[71] and have many potential upstream transcription factors (Figure 5). This suggests that the 
role of AP-1 either lays in the regulation of genes with vasculature-unrelated functions or that 
its upstream pathway involves synaptic receptors mapped herein. Lastly, no regulators were 
found upstream of Prkx and Rap1b that fit in the obtained pathways, suggesting that there is at 
least another class of upstream regulators that could link the synaptic activity to neurovascu-
larization.
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Figure 5. Linking synaptic activation to neurovascular reorganization.  See main text for 
details.  
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From synaptic activity to synaptic disorders
As outlined above, experience-dependent plasticity is highly complex and encompasses a wide 
range of molecular and cellular processes, at least in part in a cell-type dependent manner. In-
creased neuronal activity activates intracellular signaling pathways that ultimately serve to reg-
ulate synaptic strength, gene transcription, cell metabolism, intercellular signaling, cytoskele-
tal remodeling and blood vessel patterning. Transcriptomic regulation of these processes shows 
a strong correlation with sensory input: several hours after being removed from an enriched 
environment, the transcriptome follows suit [71]. Importantly, EDP likely affects cell types dif-
ferentially, as is reflected in experience-dependent changes in the barrel cortex transcriptome. 
The complex nature of EDP suggests a certain amount of vulnerability to dysregulation due 
to genetic or environmental causes. Perturbation of molecules associated with plasticity have 
been found to result in developmental and behavioural phenotypes that closely resemble those 
observed in neurological disorders. For example, perturbation of the plasticity-related proteins 
BDNF, Neuregulin 1 or mGluR1 result in a schizophrenia-like phenotype [145–147]; sup-
pression of Pak3 expression (associated with X-linked intellectual disability) in rats disrupts 
hippocampal plasticity [148]; when synapsin 1 through 3, involved in synaptic neurotrans-
mitter release, are knocked out in mice, the animals show ASD-related phenotypes of social 
impairments [149]. Synapsin 3 is also linked to schizophrenia-like behaviour [150]; Aberrant 
phosphorylation of eukaryotic Initiation Factor 2 (eIF2) can cause memory impairments, and 
its suppression was found to reduce plasticity and memory impairments in Alzheimer’s disease 
model mice [151].
Moving beyond animal models, many genome-wide association (GWA) and population studies 
are focused on discerning the underlying genetic causes of (predispositions to) neurological 
disorders. We asked whether EDP-related transcripts and proteins identified in the studies by 
Vallès et al [71] and Butko et al [78] are differentially regulated in neurological disorders. 
Therefore we used the Disease and Gene Annotations (DGA) [152], which entails a database 
of documented relationships between genes and diseases or disorders (such as altered protein 
or mRNA levels, single-nucleotide polymorphisms and mutations). Although the transcripts 
and proteins that Butko and Vallès identified as differentially regulated hardly overlap, the dis-
orders with which they have been associated by population studies show a striking similarity, 
despite the divergent protein classes they encompass (Figure 6). This could be explained in 
part by the notion that these particular disorders are studied heavily.
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Figure 6 – Experience-dependent plasticity and select brain disorders share common mo-
lecular targets. Top: Neurological disorders associated with differentially expressed transcripts 
(A, data from [71]) or proteins (B, data from [78]) after exposure to an enriched environment; 
genes are clustered by disorder. Bottom: Protein classes of transcripts (left) or proteins (right) 
associated with neurological diseases (Based on Panther Database).
Neuronal plasticity is altered in various neurological disorders, including schizophrenia [153], 
intellectual disability [154], autism [155] and bipolar disorder [156]. Targets from both data-
sets can be linked to many of common neurological disorders including Alzheimer’s disease, 
autism spectrum disorder and schizophrenia (Figure 6). Some molecules are currently not 
known to be affected in multiple disorders, which seems to be particularly the case with tran-
scripts or proteins related to schizophrenia, while others are affected in up to seven distinct 
brain disorders. For example, GRIN2B is associated with Alzheimer’s disease [157], autism 
[158], bipolar disorder [159], Parkinson’s disease [160] and schizophrenia. Since GRIN2B 
is an NMDA receptor subunit, this observation likely reflects its central role in plasticity and 
neurological function in general. Due to the difference in sample isolation procedures in the 
studies by Vallès et al. (2011) and Butko et al. (2013), i.e. whole tissue punch vs synaptoneu-
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rosomes, respectively, the molecules linked to brain disorders also differ substantially in the 
protein classes they encompass (Figure 6). For example, cytoskeletal proteins make up a large 
portion of the disease-related targets identified by Butko et al [78] and transcription factors are 
not found, whereas the reverse is true for the targets based on Vallès et al [71].
 
An important caveat of the observations is that the links that can be established can only be as 
numerous as the observations that they are based on.  Nevertheless, complementing GWA or 
population studies with experimental evidence such as those obtained from transcriptomics or 
proteomics studies can facilitate identification of underlying causes of neurological disorders 
or understanding how symptoms during disease progression arise. Although transcriptome- 
or proteome-wide studies provide direction for research, in particular when combined with 
expression data obtained from patients, functional studies remain indispensable to fully un-
derstand the molecular bases of health and disease.  As experience-dependent plasticity and a 
large number of brain disorders involve similar transcriptional and translational targets, expe-
rience-dependent plasticity in sensory circuits could help to unravel the molecular pathways 
associated with brain disorders. 
Future directions for molecular studies of EDP 
Transcriptomic and proteomic big data have an outstanding promise to usher the field of expe-
rience-dependent plasticity to a new era where differential transcriptional regulation of genes 
are linked to neural network reorganization through large-scale molecular pathway analysis, 
causally linking molecules to network organization and ultimately to behaviour. 
 
EDP requires the interaction of the numerous different cell types that exist in the brain, from 
excitatory [24] and inhibitory [161] neurons to glia [162] and even the epithelial and muscle 
cells of blood vessels [85, 86].  A major unanswered question is how the vastly diverse cortical 
cellular population orchestrates EDP and which of the molecules that underlie it are common 
across (all) cell types and which are critical to a select few. Current technologies allow for the 
isolation of individual cells, possibly in combination with fluorescent labeling of molecularly 
defined cell classes, from which RNA [70] or (although still in need of development) proteins 
[163] can be harvested and subsequently analyzed. Using currently available datasets, it is 
possible to infer post hoc which cell types most robustly changed their transcriptomic make-up 
following sensory experience, as we have exemplified above. Nonetheless, applying single-cell 
technologies in combination with sensory experience manipulations would enable the study of 
molecules critical for EDP with unprecedented precision.
 
A further benefit would come from the collection of samples in a cortical layer-specific manner. 
Electrophysiologically, cortical lamina have since long been shown to display distinct phe-
notypes in cortical map plasticity [20], stemming from the organization of their thalamic and 
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cortical inputs and their cellular populations [164]. Cortical laminae can be readily identified 
through molecular markers, showing their distinct molecular identities [164, 165], which likely 
shows the coherence between a layer’s functional role and the molecules required to exert it. 
This stresses the importance of anatomical resolution when studying experience-dependent 
plasticity on either the electrophysiological and molecular level. Both Vallès [71] and Butko 
[78] and their colleagues have examined, through in situ hybridization or immunostainings, 
the distribution of a subset of identified targets across cortical lamina, revealing tight spatial 
restrictions on their expression in cellular populations. Such post-hoc approaches however are 
of low throughput, and future studies should strive to obtain lamina-specific tissues (much like 
[165]) and use these for subsequent processing and analysis. This will allow for a large-scale 
screening of layer-specific manifestations of experience-dependent plasticity at the molecular 
level.
The most recent transcriptome and proteome studies employ environmental enrichment or 
all-whisker stimulation or trimming, which induce homeostatic plasticity in barrel cortex. Ho-
meostatic and Hebbian plasticity work in coherence to establish cortical maps, but their mecha-
nisms differ significantly [4, 166, 167]. Alternative deprivation or stimulation methods, such as 
single-row whisker deprivation or single-whisker experience, result in electrophysiologically 
well-defined plasticity phenotypes, the molecular mechanisms of which have been poorly stud-
ied and still require elucidation. 
The ultimate goal will have to be to systematically study experience-dependent plasticity in a 
cell, cell-type, node (e.g. cortical layer) specific manner, across the many forms of experience 
(see Figure 2) and perceptual learning induced plasticity.  This will allow researchers to cre-
ate an all-inclusive molecular map of the transcriptome and proteome, that will lead to causal 
experiments to unravel the molecules that control brain plasticity.  The whisker system, with 
its modular organization along the whisker-to-barrel pathway as well as the rich behavioral 
repertoire of whisker dependent tasks (e.g. [168–171];[172, 173, 182–188, 174–181]), will 
likely lead the way.  
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Abstract
Experience-dependent plasticity (EDP) is essential for anatomical and functional maturation of 
sensory circuits during development. As described in Chapter 1, the synaptic and circuit mech-
anisms of EDP are increasingly better understood, however its molecular mechanisms remain 
largely elusive. EDP can be readily studied in the rodent barrel cortex, which processes whisker 
tactile information. Depriving select whiskers while sparing their neighbours introduces com-
petition between barrel columns, ultimately leading to weakening of intracortical feed-forward 
excitatory projections in the deprived columns; the same synapses in the neighbouring spared 
columns are potentiated. These experience-dependent, and cortical column- and layer-specific, 
alterations of synaptic strength are thought to underlie somatosensory map plasticity. Molecu-
lar mechanisms of EDP have been traditionally studied by identifying single or small subsets 
of targets along the biochemical pathways that link synaptic receptors to nuclear processes; 
Recent technological advances in large-scale analysis of gene transcription and translation 
now allow systematic observation of thousands of molecules simultaneously. Here we used 
RNA-sequencing and label-free quantitative mass spectrometry on tissues extracted from ju-
venile (P23-26) sensory deprived mouse barrel cortex in a column- and layer-specific manner. 
Samples were collected from cortical layers (L) 2/3 and L4 spanning across control, deprived, 
1st and 2nd order spared columns. High-quality RNA was purified and sequenced, yielding in 
a transcriptome-wide dataset entailing an average of 50 million paired-end reads per sample, 
75 base pairs in length. On average, 90.15% of reads could be uniquely mapped to the mm10 
reference mouse genome. Protein mass spectrometry yielded >10,000 peptides mapping to 
~5000 protein groups/sample. Of these, 4,676 were identified with high confidence and >3000 
are found across all samples. Here we provide a detailed description of our methods as well as 
an extended data quality control of the datasets, the utility of which is exemplified in Chapter 
3.  These datasets, which are publicly freely available, are the first correlated transcriptome and 
proteome data that allow mining the molecular correlates of EDP, and would lead to functional 
studies to systematically control brain plasticity. 
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Introduction
Sensory experience shapes neural circuits throughout life, although the extend of experience-de-
pendent plasticity is believed to become limited as organisms age. Changes in neural circuits, 
in turn, allow the brain to adapt to recent sensory, motor and perceptual experiences of animals 
in their ever-changing environments. The rodent barrel cortex, a subfield of the primary so-
matosensory cortex, processes sensory information originating from mystacial vibrissae (whis-
kers), which are organized as a grid of 5 rows (A-E) and 4-~6 arcs (1-~6) on the snout.  Each 
cortical “barrel column” receives majority of its sensory input from one (so called principal) 
whisker, anatomically delineating the neural circuits associated with each whisker. Taking ad-
vantage of this organizational principle, previous studies have shown that targeted deprivation 
of select whiskers results in weakening of the sensory evoked responses in synaptic projections 
originating from barrel cortical layer (L)4 and targeting L2/3 [1, 2]. In contrast, correspond-
ing projections in the neighbouring sparing whiskers’ cortical columns are strengthened [3]. 
The molecular mechanisms of EDP, however, are still largely unknown, Important molecular 
players in EDP, such as Ca2+/calmodulin-dependent protein kinase (CaMK), the transcription 
factor Cre-Response Element Binding (CREB), the secreted growth factor Brain-derived Neu-
rotrophic Factor (BDNF) and nitric oxide [4–7] have previously been discovered. Although 
single-molecule studies are indispensable to gain a mechanistic insight of molecular players 
of EDP, they are low throughput approaches, and by definition ignore many other (potentially 
key) molecules in relevant molecular pathways. Recent technological advances now allow for 
the systematic study of large numbers of molecules (in particular RNA and protein) simultane-
ously, providing a broad scope of the overall molecular make-up of a given cellular population. 
Understanding how sensory experience shapes neuronal circuits will benefit from systematic 
analysis of the transcriptome and proteome following altered sensory experience. Thanks to the 
rich history of synaptic physiological study of EDP upon whisker deprivation and the opportu-
nity to selectively sensory deprive known populations of neurons (while sparing sensory input 
to the neighbouring neuronal populations), the rodent barrel cortex is an ideally suited model 
system for this purpose. We therefore isolated cortical tissues from control animals, and ani-
mals whose C-row whiskers were deprived bilaterally. It has been already shown that this form 
of whisker deprivation powerfully shapes sensory representations, cause induction of long-
term potentiation and long-term depression, and bidirectionally control the cortical inhibitory 
tone in an experience-dependent manner [1–3, 8]. Individual barrel columns can be identified 
ex vivo, allowing us to obtain tissues from known columnar (A-E) and laminar (L2/3 or L4) 
identity, the abundances of identified RNA or protein molecules of which could subsequently 
be interrogated using high-throughput RNA-sequencing or mass-spectrometry, respectively. 
RNA is in principle a precursor to protein, but in recent years it has become increasingly clear 
that protein translation is under tight regulatory control by posttranscriptional mechanisms, 
and proteins typically have different turnover rates than RNAs [9, 10]; RNA abundances alone 
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therefore do not provide a one-to-one representation of the protein machinery, stressing the 
importance of approaching EDP from both a transcriptional and translational angle. Moreover, 
focusing on both molecules could allow for the identification of previously unknown posttran-
scriptional mechanisms that could play critical roles in experience-dependent map plasticity. 
Here, we thus provide the first correlated cortical transcriptome and proteome mapped upon 
induction of experience-dependent plasticity in freely behaving animals.  We describe in detail 
the methods we employed to 1) obtain anatomically high-resolution cortical brain tissues, 2) 
prepare and process the samples for large-scale molecular screening and 3) analyze and qual-
ity-check the resulting datasets. Both RNA and protein data were found to be of high quality, 
and will help to understand molecular mechanisms of EDP in barrel cortex, and likely other 
brain regions.
Materials and methods
Animals
All experiments were performed in accordance with the Animal Ethics Committee of the Rad-
boud University in Nijmegen, the Netherlands. Pregnant wild type mice (Charles River) were 
kept at a 12-hour light/dark cycle with access to food ad libitum. Cages were checked for 
birth daily. To induce experience-dependent plasticity, pups underwent bilateral plucking of 
their C-row whiskers under isoflurane anaesthesia at P12 (Figure 1). Control animals were not 
plucked but anaesthetized and handled similarly. After recovery pups were returned to their 
home cage. Every other day pups were checked for whisker regrowth, which were plucked if 
present. At P23-P26, pups were randomly selected from their litter for slice preparation and 
tissue collection. Samples from cortical layer (L) 4 and L2/3 were treated independently with 
their own corresponding groups of controls, deprived, 1st order spared, 2nd order spared col-
umns as detailed in Figure 1. For RNA-sequencing, each experimental condition (i.e. whisker 
deprived or control) consisted of 4 female pups; For mass spectrometry, 3 female pups were 
used in the control group whereas the deprived group consisted of 4 females. Due to
the small tissue sizes, obtaining successful LC-MS runs was technically challenging. Thus, not
all laminar samples from all cortical columns are retained for the full analysis (See
Supplemental Table 1 for the distribution of samples across groups). In addition, 10 of the 
samples were run a second time, providing 10 technical replicates.
Slice preparation and sample collection
Pups were anaesthetized using isoflurane and then perfused with ice cold carbogenated slicing 
medium (108 mM ChCl, 3 mM KCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 25 mM glucose, 1 
mM CalCl2, 6 mM MgSO4 and 3 mM Na-pyruvate). Next, pups were decapitated, after which 
the brain was quickly dissected out and 400 µm thalamocortical slices from each hemisphere 
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Figure 1. Overview of the experimental design, sample collection and data organization. 
(A) Pups were bilaterally spared or deprived of off their C-row whiskers between P12 and 
P23-P26, when acute slices were made and column- and layer-specific tissues were excised. 
(B) For RNA-sequencing, RNA was isolated, checked for integrity and purity, and subsequent-
ly sequenced. For protein mass spectrometry, proteins were denatured and purified, followed 
by on-filter digestion into tryptic peptides, which were subsequently desalted and sequenced 
on a mass spectrometer. 
 
were prepared as described before [1, 2]. Slices were transferred to 37 degrees Celsius carbo-
genated ACSF (120 mM NaCl, 3.5 mM KCl, 10 mM glucose, 2.5 mM CaCl2, 1.3 mM MgSO4, 
25 mM NaHCO3 and 1.25 mM NaH2PO4) where they were kept for 30 minutes and recov-
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ered at room temperature for another 30 minutes until tissue collection. After recovery, slices 
were placed under a Nikon Eclipse FN1 microscope. The holding chamber was continuously 
perfused with room temperature carbogenated ACSF. Due to the 55 degree cut, slices were 
obtained in which S1 barrels from specific rows (A-E) could be identified. A thin, long glass 
pipette was pulled using a Sutter instruments P-2000 pipette puller and was used to make inter-
columnar incisions from L1 to the bottom of L4 after which the slice was placed under a binoc-
ular dissection microscope where the location of specific barrel columns could now be readily 
identified by eye. A sterile 32G needle was then used to cut out L2/3 and L4 separately from 
each column. Tissue from columns A/E and B/D were pooled as they both constitute second 
and first order spared whiskers, respectively. Immediately after dissection, tissue samples were 
snap frozen in liquid nitrogen and stored at -80 degrees Celcius until further use. All tools that 
came into direct contact with brain tissue were treated using RNAseZap in order to minimize 
RNAse contamination.
RNA isolation and quality control
Tissue samples originating from the same rows and layers were pooled within each animal. 
Tissue was quickly dissolved in Qiazol (Qiagen #79306), after which RNA was isolated using 
the miRNeasy Mini kit (Qiagen #217004), DNAse treated (Thermo Scientific, #EN0521) and 
cleaned up using RNeasy MinElute kit (Qiagen #74204), all following the manufacturer’s in-
structions. Samples were then stored at -80 degrees Celcius until further processing.
 
RNA sample integrity was determined using Agilent Tapestation (High Sensitivity RNA Scre-
entape). Sample RINs ranged from 7.1 to 8.8. To further assess RNA purity and integrity, RNA 
samples were used in RT-PCR to confirm that cDNA could be produced and that a large (~1000 
bp) amplicon could be obtained. To produce cDNA, SuperScript® II Reverse Transcriptase 
(Thermo Scientific #18064014) and random hexamer primers (Roche #11034731001) were 
used. The resulting cDNA was then added to a PCR reaction mix which further consisted of 
Jumpstart Ready Mix (Sigma P2893) and exon-exon junction spanning CamKII primers (FW 
TCCAACATTGTACGCCTCCAT; RV TGTTGGTGCTGTCGGAAGAT). From all cDNA 
samples a fragment of the expected size could be amplified, suggesting that the RNA samples 
contained pure RNA of sufficient integrity. All RNA samples thus passed our quality control 
criteria and were subjected to RNA sequencing.
RNA sequencing
RNA sequencing was conducted at the Genomics Core Facility of the EMBL, Heidelberg, 
Germany. The cDNA library was generated using the non-stranded NEBNext Ultra RNA Li-
brary Preparation Kit for Illumina (New England Biolabs, catalogue #E7530), which includes 
oligo-dT bead selection of mRNA. For library enrichment, 13-14 PCR cycles were performed. 
Pooled libraries were sequenced on the Illumina NextSeq 500 instrument in a 75bp paired-end 
51
LAMINAR AND COLUMNAR TRANSCRIPTOME AND PROTEOME OF THE BARREL CORTEX
2
mode using High output flow cells.
Quantitative PCR validation
Transcripts found differentially expressed between cortical L4 and L2/3 according to RNA-se-
quencing results were selected for qPCR validation. cDNA (see RNA isolation and quali-
ty control) was used in a reaction mixture further containing Sensifast SYBR No-ROX re-
action mix (Bioline #BIO-98005) and intron-spanning primers (designed using NCBI 
Primer Blast). Primer sequences used are as follows (5’-3’): Gfap, FW GGTATCGGTCTA-
AGTTTGCA, RV TGGTAACTGGCCGACTCC; Sema3c, FW GAAGGCCTCTGATAGTC-
CGC, RV GGGAAACCCCCTCATTGGAG; Chd3, FW GCAGGTGGAGCAGAAGT-
CAT, RV GAACTCTCTCCACTTGGCCC; Plcxd2, FW CCTCACTCAGCACCCTCAAG, 
RV CTGCACACTCGTGGTGTTTG; Nrsn1, FW GGGGATTGGAGGGACAGAGT 
RV CTGCCAGGACAGTTAGTCCG; Srxn1, FW CGGTGCACAACGTACCAATC RV 
TGCTCCCAGGTACATCCTCA; Actb, FW CTGACCCTGAAGTACCCCATT, RV AGAG-
GCATACAGGGACAGCA; Ppia, FW AGCCATGGAGCGTTTTGGGTCC, RV AGCAGAT-
GGGGTAGGGACGCT. The PCR program was run on a Bioline CFX96 thermal cycler and 
started with 2 minutes 95 degrees Celcius, after which 50 cycles followed, each of which 
consisted of denaturation at 95 degrees Celcius for 5 seconds, annealing for 10 seconds at 62 
degrees Celcius, and secondary annealing at 72 degrees Celcius for 20 seconds. After cycling 
was completed, a melting protocol was performed, from 65 to 95 a 62 degrees Celcius measur-
ing fluorescence at every degree Celcius to control for product specificity.
Lysate preparation and protein digestion
Samples were prepared for mass spectrometry using the filter-aided sample preparation (FASP) 
method, as described before [11] (Figure 1B). Briefly, mouse brain tissues were homogenized 
in lysis buffer (4% w/v SDS, 100 mM Tris/HCl and 0.1 M DTT, pH 7.6) and incubated at 
95 °C for 3 min. To shear DNA and reduce sample viscosity, samples were ultrasonicated. 
Samples were then clarified by centrifugation, after which the proteins in the extract were 
precipitated using urea buffer (8M urea, 0.1 M Tris/HCl, pH 8.5) and centrifuge-filtered us-
ing 30 kDa filters (Microcon YM-30). After washing with urea buffer (pH 8.0), proteins were 
alkylated with iodoacetamide, followed by washing with ammonium bicarbonate. Trypsin 
(Promega Cat#V5280) was applied to digest the extracted proteins. The resulting peptides 
were then collected by centrifugation and desalted using C18 (Empore) StageTips. Given the 
small sample size protein yield was not determined before moving on to mass spectrometry. 
 
Mass spectrometry  
Tryptic peptides were separated on an online Easy-nLC 1000 (Thermo) using a 214 minute 
long gradient of acetonitrile (7% to 30%) followed by washes at 60%, followed by 95% ace-
tonitrile for 240 min of total data collection. Mass spectra were collected on a LTQ-Orbitrap 
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Fusion Tribrid mass spectrometer (Thermo) in data-dependent top-speed mode with dynamic 
exclusion set at 60 s.
Data processing
Raw data was analysed using MaxQuant version 1.5.1.0. with match-between-runs, label-free 
quantification and intensity based absolute quantification (iBAQ) enabled. Dependent peptides 
were enabled to perform an unbiased search against modifications on the identified peptides. 
The RefSeq protein sequence database downloaded on 28-06-2016 was used to identify pro-
teins. Identified proteins were filtered for reverse hits and common contaminants. To quantify 
protein expression in Figure 4C, we used the Proteomic Ruler approach [12].  All other pro-
cessing was performed in MATLAB or R programming languages.  
Results  
RNA sequencing data validation and quality control
Sequencing read quality was assessed using FastQC (Babraham Bioinformatics), the results of 
which were merged using MultiQC (http://multiqc.info). Results are displayed in Figure 2. Per 
base quality phred scores range from 34.80 to 35.15, indicating base call accuracies of >99.9% 
(Figure 2A). Overall 91.48-94.03% of reads had a mean phred score of 30 or above (Figure 
2B). In line with these scores, per base N content (i.e. percentage of bases that could not confi-
dently called) was very low, with a maximum value 0.053%.
Figure 2. FastQC and STAR output graphs for all samples. (A-B) Phred scores per base and 
per sequence. (C) Per sequence GC content. (D) STAR output of alignment scores.
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Reads were then mapped to the mm10 reference genome using STAR (https:// github. com/ 
alexdobin/ STAR/ releases), which uniquely mapped between 39,000,000 and 59,000,000 reads, 
constituting an average 90.15% unique map rate across samples (Figure 2D). Since the library 
preparation protocol entails a PCR enrichment step which can lead to technical duplication, 
hence an overestimation of observed transcripts, we used Seqmonk (Babraham Bioinformat-
ics) to plot the read density against the duplication levels (i.e. the percentage of duplicate reads) 
for each transcript. The obtained duplication plots showed a clear positive relation between 
read density and duplication levels (Figure 3 and Supplemental Figure 1), suggesting that 
the origin of read duplication is biological, rather than technical. Based on the above quality 
control measures we determined that our RNA-sequencing data was of sufficient quality to be 
used in downstream analyses, therefore we continued with gene expression analysis.
 
Figure 3. Overlays of duplication plot contours, showing a positive correlation between 
read density and duplication levels. Depicted contours enclose 90% of the data points. 
 
Analysis of gene expression
Using a 2 read cut-off, we identified 16,900 to 17,600 transcripts per sample (Figure 4A). Dif-
ferential gene expression analyses across groups were performed using EdgeR v3.12.1 [13, 14] 
using only genes with a read count per million (CPM) >1 in at least 4 samples (Supplementary 
Table 1 for details on the commands used). Since laminar identity is an important feature of our 
experimental setup, we assessed the relative expression of known molecular markers for L2/3 
(Cacna1h, Id2, Igfbp4, Igfn1, Mdga1, Plcxd1, Rasgrf2, Rgs8, Tle3) and L4 (Cartpt, Cyp39a1, 
Kcnh5, Kcnip2, Lmo3, Rorb, Scnn1a) [15–17] , which showed selective enrichment of the lam-
inar markers in isolated layers (Figure 4B).
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To further validate our RNA-sequencing results, we chose a subset of differentially expressed 
transcripts identified from comparisons between cortical layers on the basis of their fold chang-
es and transcript abundance according to RNA-seq. Transcripts found to be upregulated by 
RNA sequencing in L2/3 were Gfap (9.6 
fold), Sema3c (1.92 fold) and Chd3 (1.52 
fold), whereas Plcxd2 (5.02 fold), Nrsn1 
(2.01 fold) and Srxn1 (1.44 fold) were 
found more abundant in L4. Intron-span-
ning primers were designed for these 
transcripts and used with cDNA template 
(see RNA isolation and quality control) 
to assess the expression levels of these 
transcripts, together with two housekeep-
ing genes (Actb and Ppia). All targets 
showed qPCR results corresponding with 
those observed in RNA-sequencing (Fig-
ure 4C), and Pearson analysis showed 
high correlation between RNA-seq and 
qPCR fold change values (>0.99).
Figure 4. Gene expression analyses 
and validation. (A) Histogram of read 
counts per transcript per sample. With a 
cut-off of 2 reads, between 16,900 and 
17,600 transcripts could be identified 
across samples. (B) Relative expression 
of known molecular markers for cortical 
laminae. Layer 4 markers are enriched in 
samples originating from this layer; the 
same is true for Layer 2/3 marker expres-
sion in Layer 2/3 samples. (C) qPCR val-
idation of transcripts enriched in L2/3 or 
L4 according to RNA-seq. Fold changes 
follow expected expression patterns. As-
terisks indicate significant enrichment of 
targets in one layer compared to the oth-
er (two-sample unpaired t-test).  
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Figure 5. Sample variance in RNA-sequencing. (A) Cumulative plots of the coefficient of 
variance (CV) of individual experimental groups. Including only transcripts identified by 50 
reads or more, average CVs of <15% are found in ~85% of transcripts. (B) Principal compo-
nent analysis (PCA) showing sample clustering by layer, including only transcripts identified 
by at least 50 reads. Principal component (PC) 1 and 2 account for 88% of overall variance.
To assess the variance in transcript counts, we calculated the coefficient of variation (CV) for 
each transcript with a cut-off of 50 as the minimal read count separately for each group (Figure 
5A). This analysis showed that, on average, 85.93% of transcripts have a CV below 15%, sug-
gesting low variance across transcript counts for individual genes. Principal component analy-
sis (PCA) showed that samples cluster based on layer, and the first two components explained 
~88% variance the data (Figure 5B, Supplemental Figure 2B).
These quality control routines suggest that we have obtained RNA-sequencing data of high 
read quality, with individual bases being called confidently throughout the length of reads, 
which uniquely map to the mm10 reference genome at high rates (>90% average). The laminar 
origin of our samples could be identified through known molecular markers, confirming our 
samples are of high anatomical specificity. 
Protein mass spectrometry data validation and quality control
Peptides were assigned to protein groups based on shared peptide sequences, the majority of 
which consist mainly of unique peptide sequences (71%, Figure 6A). Razor peptides (i.e. pep-
tides that can be assigned to more than one protein but are assigned to the protein group with 
the most other peptides, i.e. Occam’s razor principle) on average made up 13% of the designat-
ed protein groups; non-unique peptides on average constituted 16%. When testing how much 
of the total and theoretically observable protein sequence length was identified by the analyses, 
we observe for most proteins a good coverage of the theoretically observable peptides (44% 
on average, Figure 6B). Complete sequence coverage is never achieved, likely because of the 
remaining tryptic peptides being too long or too short to be measured by mass spectrometry. 
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Since high numbers of peptide modifications and adducts can interfere with accurate protein 
quantification, we assessed the types of peptide modifications that we could observe on the 
identified peptides (Figure 6C and 6D). Reassuringly, the majority of peptides (98.33%) were 
found to be unmodified. For 0.96% of the peptides we found a modified form with an unanno-
tated mass shift, while 0.65% of peptides was modified and had a mass shift that could be anno-
tated to a known peptide modification (Figure 6C). In total we could identify 25 different types 
of peptide modifications (Figure 6D). Of these, the top three modifications were deamidation 
(38.94%), oxidation (15.53%) and loss of ammonia (15.48%), which are all common peptide 
modifications. Next, we addressed the data quality for individual samples, which showed that 
on average 23,489 unique amino acid sequences (ranging from 13,095 to 72,418) could be 
identified per sample (Figure 6E); the majority of these (>98%) could be assigned to regular 
protein groups, excluding reverse hits, contaminants or peptides identified only by modifica-
tion. Reverse hit rate (i.e. false discovery rate) or the number of proteins that could only be 
identified based on a modified peptide was never higher than 0.7%, suggesting high confidence 
of protein identification. Additionally, the number of potential contaminants was low for all 
samples, suggesting high sample purity (Figure 6F).
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Figure 6. Overview of protein groups, sequence coverage and peptide modifications. (A) 
Stack representation of designated protein groups with the mean contents of unique, razor and 
non-unique peptides represented in blue, yellow and red, respectively. (B) Sequence coverage 
of identified proteins was plotted as total protein sequence coverage against coverage of the-
oretically observable peptides (as determined by MaxQuant). (C) All identified peptides. (D) 
Identified peptide modifications with an annotated mass shift. (E) Submitted and identified 
MS spectra and uniquely identified amino acid sequences per sample. (F) Peptide and protein 
group identification confidence per sample. Colour coding corresponds to the experimental 
groups’ in Figure 1C.
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Figure 7. Quantification of protein groups across all samples. (A) Number of observa-
tions per protein group in the entire dataset. (B) Confidence of protein group identification 
across samples. (C) Protein content versus identified protein groups. For every protein group 
all measured iBAQ values are plotted in grey, with the median value in black. (D) Averag-
es and variances of peptides per protein group in each experimental group. (E) Box plot of 
LFQ intensity averages across samples within each group. (F) Box plot of protein copy num-
bers per cell (inferred as in [12]) averaged across samples within experimental groups. (G) 
Summed LFQ intensities averaged within experimental groups.  (H) Total mass of identi-
fied proteins per cell, averaged within experimental groups. The inferred protein copy num-
ber per cell was divided by Avogrado’s number (6.0221409 x 1023) and then multiplied by 
the protein mass in kilodaltons (kDa), yielding the total mass of identified proteins per cell. 
 
Of the designated protein groups (i.e. protein groups with a Posterior Error Probability (PEP, 
confidence of peptide identification) of <0.01, n = 6,245), over 3,000 could be reliably iden-
tified in all of our samples (Figure 7A and 7B); peptides in 4,676 protein groups could be 
identified with high confidence (PEP <0.0002). Of all identified proteins, 90% of the total 
protein content (as determined by intensity based absolute quantification [9]) was contained 
in the 979 most abundant proteins (Figure 7C). In this dataset we identified and quantified 
proteins over five orders of magnitude, suggesting high sensitivity even at low protein con-
centrations. Calculating the total mass of identified proteins per cell (by dividing inferred 
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protein copy numbers per cell by Avogrado’s number and multiplying by protein mass in 
kDa) showed that L2/3 cells on average contain 18.42 ±0.78 picograms of identified protein; 
this was 12.29 ±1.28 picograms in L4 cells (p = 0.0004, Student’s t-test) (Figure 7H). The 
number of identified proteins averaged per group across layers did not differ (p=0.6964, un-
paired Student’s t-test).  Since protein identification rates are likely to be independent from 
cortical layer identity, these results suggests that total protein levels per cell are lower in L4. 
To investigate how the two quantification methods (i.e. LFQ and proteomic ruler approach) 
correspond, we examined the correlation between LFQ intensities and protein copy num-
bers (Supplemental Figure 3). The two quantification methods were decently correlated 
(R2 ranged from 0.76 to 0.80), suggesting good consensus of protein abundance estimation. 
 
We then assessed the distributions of molecular mass (kDa) and amino acid sequence length 
of the proteins identified in our samples. On average, proteins were 71.65 ±82.77 kDa in mass 
(mean) (Figure 8A) and had a mean length of 643.63 ±745.27 amino acids (Figure 8B). To 
exclude any bias in protein abundance estimation based on protein length, we plotted mass or 
sequence length against LFQ intensities or estimated protein copy number [12]. This showed 
only weak, if any, correlations (R2 values <~0.005) between LFQ intensity or copy number and 
peptide mass or length, suggesting proteins of all sizes are equally well identified (Figure 8C, 
D, E, F).
Figure 8. Distributions of (A) molecular mass and (B) amino acid sequence length; smaller and 
shorter proteins are the most prevalent. When plotted against protein LFQ intensity (C, D) or 
protein copy number (inferred as in [12]) (E, F), weak (if any, see R2 values on figurines) cor-
relations are observed, suggesting that protein abundance estimation is not biased by peptide 
mass or length (also see Figure 6B).
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Next, we examined the variance between samples by calculating the coefficient of variation 
(CV) of inferred protein copy numbers [5] (Figure 9A). About 73% of proteins showed a CV 
of 45% or less, on average. We then employed principal component analysis (PCA), which 
showed that 72.5% of variance was explained by PC1 and 2, and that samples were clustered 
mostly by cortical layer (Figure 9B,C). These analyses were repeated for identified peptides for 
each protein group in individual samples, using different cut-offs of identified peptides (Figure 
7D). When no cut-off was used (i.e. including proteins identified by at least one peptide, see 
Figure 7D for the distribution across all groups), on average 73.88% of proteins showed a CV 
of 30% or less (Supplemental Figure 4A); With a cut-off of 10 identified peptides, a CV of 
15% or less was found for 70.74% of proteins (Supplemental Figure 4B). PCA using both of 
these cut-offs showed that samples cluster mostly around C column-derived samples. Principal 
components (PC) 1 and 2 explained 77.6% and 86.5% of variance, depending on the cut-off 
value used (Supplemental Figure 4C-F).
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Figure 9. Variance 
quantification of 
individual samples. 
(A) Cumulative plot 
of the coefficient of 
variation (CV) of the 
inferred protein copy 
numbers [5] per cell 
and per experimental 
group. On average, 
~73% of proteins 
show a CV of 45% 
or less. (B) Principal 
Component Analysis 
(PCA) based on in-
ferred protein copy 
numbers per cell. 
Principal Component 
(PC) 1 and 2 explain 
~73% of variance, 
and samples cluster 
mostly based on cor-
tical laminar origin. 
(C) Cumulative plot 
of percent variance 
explained by each 
PC. The first 5 PCs 
explain 85% of the 
variance.
Since our dataset 
contains several 
technical duplicates, 
we asked how well 
they correlate with 
the biological repli-
cates and compared 
identified peptides 
per protein group and 
protein copy num-
bers of biological and 
technical replicates 
(Figure 10). Biological samples and their direct technical replicates were highly correlated (R2 
≥ 0.89, Figure 10A-Ca,c), which was also found for the remaining pairwise comparisons (R2 
≥ 0.90) (Supplemental Figure 5, 6). These results suggest that samples are highly comparable
62
CHAPTER 2
Figure 10. Matrix of correlation coefficients of biological and technical replicates. Data 
from (A) all biological samples and their corresponding replicates combined across experi-
mental groups and cortical layers, (B) L2/3 (C) and L4. (a, b). Scatter plots showing peptides 
per protein group (a) or protein copy numbers (inferred copy numbers per cell [12], (b)) for 
biological samples (X axis) and their technical replicates (Y axis). (b, d) Histograms showing 
differences in identified peptides per protein group (b) or protein copy numbers (d) between 
biological and technical replicates. Note that across all samples, the variation between the bi-
ological sample and the technical replicas are small, with Pearson R2 values between 0.89-96.
in terms of peptide and protein counts, and that sequential nature of the mass spectroscopy does 
not systematically, or in statistically appreciably fashion, bias protein quantifications, at least 
in our samples.
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Discussion
The datasets presented here provide a transcript- and protein-wide view of experience-depen-
dent plasticity in the mouse barrel cortex. Since barrel cortex is heavily studied in the field of 
neuroscience (e.g. [1–3, 18–22]), especially in relation to plasticity, this resource should prove 
a valuable for researchers interested in the molecular and cellular underpinnings of EDP. Given 
the relatively high anatomical resolution at which samples were collected, the current dataset 
would also be beneficial in the understanding of molecular constituents of cortical laminar 
identity and function.
Researchers reusing our dataset should be aware that comparisons between control column C 
and spared columns (A/E, B/D) may have to be approached with caution, as this would involve 
two different columnar identities (whose molecular dissimilarities are currently unknown), 
each coming from cortices that have had different sensory experience.  However, direct com-
parisons between the C columns across experimental conditions (i.e control versus deprived) 
as well as within-animal across-column comparisons in deprived animals control for these 
confounding variables.
A combinatorial approach between proteomics and transcriptomics is a promising outlook that 
could help identify those molecular targets that are essential for reorganization of neural net-
works following sensory deprivation. Proteomics data can aid to broaden the scope of findings 
from transcriptomics studies as it can provide novel insights into post-transcriptional regulation 
of protein expression (of interest is RNA splicing which, given our sequencing depth, should be 
possible to investigate), the time course of protein expression (since proteins typically have a 
longer half-life than RNAs) and post-translational modifications that could orchestrate specific 
protein functions.
Only a few studies are available that focus on large-scale molecular changes in neural circuits 
following sensory deprivation [19, 20, 23]. As large-scale molecular techniques are becoming 
more available, studies employing them to investigate the molecular bases of plasticity are 
likely to follow suit. The phenotype of EDP in barrel cortex depends heavily on the experi-
mental approach used (e.g. enrichment vs. deprivation, single whisker experience vs. whole 
row deprivation, developmental time points [21]). The current dataset should prove useful to 
validate, expand and compare the findings of molecular studies employing different protocols. 
Moreover, comparing our dataset with those obtained from other brain regions (e.g. visual 
cortex, auditory cortex), would help to determine where previously observed differences in 
plasticity across different brain [22] regions might arise.
The current RNA-seq dataset might help address the molecular underpinnings of cortical 
experience-dependent plasticity. For example, it could be used (1) to identify genes whose 
transcription is modulated in an experience-dependent manner,  (2) to statistically map the 
transcriptional networks at laminar resolution,  (3) creating synergy with the single neuron 
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RNA-seq datasets [18, 24], to address the molecular diversity of the cortical networks, (4) 
combined with the proteomic analysis performed under comparable experimental conditions 
in the accompanying manuscript, to systematically study the transcriptional and translational 
regulation of the genome upon altered sensory experience, and finally (5) to identify and quan-
tify splice isoforms, given the sequencing depth of the current dataset. Since splicing and other 
posttranscriptional mechanisms govern which proteins are ultimately produced, combining the 
current transcriptomic dataset with a proteomics approach would also be of high importance.
The datasets presented here focus on isolated cortical columns and layers, which are neces-
sarily diverse samples containing neuronal and non-neuronal cell classes. In terms of expe-
rience-dependent plasticity, although most previous studies focus on excitatory projections, 
inhibitory cells and even non-neuronal cells have been implicated in plasticity [8, 25, 26].  This 
heterogeneity might be particularly important for L2/3, as also shown by the principal compo-
nent analysis (Figure 5B), given the relative diversity of cellular populations in supragranular 
layers and their heterogeneous connectivity patterns [27].
Taken together, we hope that this data will prove useful in discovering novel molecular targets 
responsible for cortical plasticity and will lead to targeted control of plasticity in health and 
disease. 
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Supplemental Material
L2/3 L4 
Mouse 
number 
Con- 
trol 
De- 
prived 
First order 
spared 
Second 
order 
spared 
Con- 
trol 
De- 
prived 
First 
order 
spared 
Second 
order 
spared 
21     XX    
37 XX    X    
38 XX        
                  
20   X XX   X X 
24  XX XX    X X 
36  XX X X  XX X X 
39  XX X X  XX  X 
 
Supplemental Table 1. Mass spectrometry sample origins. Colours correspond to those in
Figure 1C. Samples that were run once are marked X, technically duplicated samples are
marked XX. 
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Supplemental Figure 1. Duplication plots for all samples, produced using SeqMonk (Babra-
ham Bioinformatics).
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Supplemental Figure 2. Variance in RNA-sequencing data. (A) Cumulative plots of the 
coefficient of variance (CV) of experimental each group, including transcripts identified by at 
least one read. Average CVs of <25% are found in ~85% of transcripts. (B) Principal compo-
nent analysis (PCA) including transcripts identified by at least one read. The majority (88%) of 
overall variance is explained by Principal components (PC) 1 and 2.
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Supplemental Figure 3. Correlation between LFQ and protein copy numbers. Scatter 
plots of LFQ values (x axis) and inferred protein copy numbers [12] (y axis), showing a linear 
correlation between the two quantification methods (R2 > 0.75).
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Supplemental Figure 4. Variance quantification of individual samples. (A, B) Cumulative 
plots of the coefficient of variance (CV) in the number of identified peptides in each experi-
mental group. Including proteins with at least one identified peptide (A), CVs of 30% or less 
are found in ~74%. With an increased cut-off (10 peptides) ~70% of proteins show a CV of 
15% or less (C).  (C, D) Principal component analysis (PCA) using numbers of identified 
peptides per protein. With a cut-off of 1 identified peptide, ~78% of variance is explained by 
Principal Component (PC) 1 and 2 (B); this is ~87% when a cut-off of 10 identified peptides is 
used (D). (E, F) Cumulative plots of showing the percent variance explained by each PC. With 
a cutoff of 1 identified peptide (C) the first 5 PCs explain ~83% of the variance; using a cutoff 
of 10 peptides (F) this is ~91%.
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Supplemental Figure 5. Distribution of peptides per protein group in biological and technical 
replicates. Scatter plots of identified peptides per protein group from biological and technical 
replicates. Red-bordered graphs indicate pairwise comparisons between biological samples and 
their direct technical replicate; graphs with black borders contain the remaining comparisons. 
Overall, a strong linear correlation is observed in pairwise comparisons (R2 = 0.95 ±0.01), in 
particular between biological and technical replicate pairs (R2 ≥ 0.96 ±0.01). Scale bars cor-
respond to 100 peptides. Codes correspond to individual samples, with codes starting with A 
referring to L2/3 samples whereas codes starting with B belong to L4 samples.
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Supplemental Figure 6. Copy number distribution of biological and technical replicates. Log-
log plots showing protein copy numbers from biological and technical replicates. Pairwise 
comparisons between biological samples and their direct technical replicate are indicated by 
red borders; black borders indicate the remaining comparisons. As in Supplemental Figure 3, 
pairwise comparisons show high correlations between individual samples (average R2 = 0.90 
±0.01), which is highest for biological and technical replicate pairs (R2  = 0.93 ±0.03). Codes 
correspond to individual samples, with codes starting with A referring to L2/3 samples whereas 
codes starting with B belong to L4 samples.
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Abstract
Primary sensory areas of the mammalian neocortex are indispensable for interpretation of the 
sensory world, and for rapid adaptation to changes in the sensory environment or sensory organ 
use. Such adaptation is mediated through reorganization of sensory maps, also known as map 
plasticity. The barrel cortex is a widely-used model system to study experience-dependent map 
plasticity. Removal of a subset of whiskers alters somatosensory input that individual cortical 
columns receive, and leads to wide-scale changes in synaptic communication that underlie map 
reorganization. The cellular mechanisms of this map plasticity have been studied extensively. 
Long- and short-term changes in the efficacy of projections between cortical layer (L) IV (L4) 
and L2/3, as well as cross-columnar projections within L2/3 (see also Chapter 4), shrink rep-
resentations of deprived whiskers while allowing those of spared whiskers to expand. These 
changes are layerspecific and are presumably caused by and coupled to experience-dependent 
modulations on the molecular level, which are poorly understood. High-throughput methods 
now allow for mapping of molecular processes affected by sensory experience. Such tech-
niques have scarcely been applied before, and although having provided meaningful insights, 
the effects of sensory experience on individual cortical columns and layers remain elusive. 
To address these issues, here we have applied RNA-sequencing and mass spectrometry on 
samples derived from identified columns and layers of the juvenile mouse barrel cortex after 
12-14 days of single row whisker deprivation, known to induce large-scale reorganization of 
whisker representations. Whisker deprivation induced widespread transcriptional changes that 
were related to regulation of synaptic transmission. Differentially expressed transcripts were 
mostly found in pyramidal cells and interneurons, but we also show that non-neuronal cells 
change their transcription as a function of sensory experience. The results moreover suggest 
that whisker deprivation-induced synchronized sensory input increases the transcriptional pro-
file similarity of separate cortical columns. Comparisons between transcriptional and trans-
lational profiles nominated candidate molecules that might be strongly post-transcriptionally 
regulated. We lastly show the importance of research on molecular mechanisms of cortical 
plasticity, as molecules that are changed upon sensory deprivation are related to many neuro-
logical disorders.
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Introduction   
Sensory experience is a major driving force of cortical plasticity. Cortical sensory areas that 
process sensory information provide organisms the ability of sense, and are highly adaptable to 
alterations in sensory input, ensuring versatility in an organism’s ever-changing environment. 
The rodent barrel cortex, a subfield of the primary somatosensory cortex that processes so-
matosensory input originating from the animal’s mystacial pad, is a widely-used model system 
to study experience-dependent plasticity (EDP). 
A rodent’s whiskers are organized in five rows (A-E) and 4-8 arcs, comprising in total ~32 
whiskers on each side of the snout. In the barrel cortex, a one-to-one topographical represen-
tation of the whiskers can be found, comprising of individual cortical columns (also termed 
“barrel columns”), each of which is driven chiefly by its principal whisker to which it topo-
graphically corresponds. This organization provides the opportunity to easily modulate sensory 
input reaching neurons in select barrel columns: depriving individual whiskers while sparing 
their neighbours, or depriving all whiskers except a select few, introduces competition be-
tween barrel columns, ultimately leading to weakening of intracortical feed-forward excitatory 
projections in L4-L2/3 synapses in the deprived columns [1] through spike timing-dependent 
plasticity (STDP) [2]. Their counterparts in neighbouring spared columns, by contrast, are 
potentiated [3]. 
The effects of sensory experience are dependent on the developmental age and cortical layer 
under study: plasticity is found in supragranular layer 2/3 in neonates, juveniles and adults 
whereas L4 mostly loses its plastic nature after approximately the first postnatal week [4–7]. 
The experience-dependent, cortical column- and layer-specific alterations of synaptic strength 
are thought to underlie somatosensory map plasticity. Although barrel cortex EDP is well stud-
ied on the electrophysiological and structural level [1, 2, 6, 8–21], its molecular mechanisms 
remain largely elusive. Only few molecular studies are available, which either focussed on in-
dividual targets [22–26], or have used large-scale approaches (i.e. microarray, mass spectrom-
etry) [27–29]. Although providing valuable insights into general cellular processes involved 
in barrel cortex EDP, the genome- and proteome wide studies currently available lack high 
resolution on the anatomical level, since they analyze the barrel cortex in its entirety. In these 
studies, EDP was induced through deprivation or stimulation of all whiskers or by subjecting 
animals to an enriched environment, inducing preferentially homeostatic rather than Hebbian 
plasticity [30]. Only one study is currently available that used a proteomics approach to map 
experience-dependent changes on the protein level, and it, too, investigated the barrel cortex 
as a whole [29]. 
In the current study, we have isolated barrel cortical tissue at high anatomical resolution, iso-
lating L2/3 and L4 layers from individual mouse barrel columns after 11-12 days of single row 
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whisker plucking, a method that is well known to induce Hebbian experience-dependent plas-
ticity in the barrel cortex [1, 2]. We then employed RNA sequencing and mass spectrometry 
in order to elucidate how EDP is reflected in the molecular landscape of sensory deprived and 
spared cortical columns in a layer-specific manner. We were surprised to find that, contrary to 
what has been described at the electrophysiological level, experience-dependent changes in 
transcription (which could be linked to regulation of synaptic transmission) were more numer-
ous (but not greater) in L4 than in L2/3, and that column-specific changes were more robust in 
L4. These results reveal how cortical gene transcription and translation is modulated by sen-
sory experience, and suggest that molecular processes of separate cellular populations can be 
synchronized through neuronal activity.
Materials and Methods
Whisker deprivation, tissue sample collection, RNA isolation and RNA sequencing were per-
formed as described in detail in Chapter 2. Here, we briefly recapitulate the methods employed.
Whisker deprivation
All experiments were performed in accordance with the Animal Ethics Committee of the Rad-
boud University in Nijmegen, the Netherlands. Pregnant wild type mice (Charles River) were 
kept at a 12 hour light/dark cycle with access to food ad libitum. Cages were checked for birth 
daily. At P12 C-row whiskers were plucked under isoflurane anaesthesia while control animals 
were not plucked but anaesthetized and handled similarly. Animals across groups were litter-
mates and housed along with the mothers until tissue collection at P23-P26.  The deprived and 
control groups consist of 4 female pups each.
Sample collection
Tissue samples were collected from acutely prepared thalamocortical brain slices. In short, 
pups were deeply anaesthetized using isoflurane and perfused with ice-cold carbogenated slic-
ing medium before 400 µm thalamocortical slices [2] were prepared. After recovery in ACSF, 
L4 and L2/3 were isolated under a microscope using a pulled patch pipette; tissue from col-
umns A and B were pooled with tissue from columns E and D, respectively.  This sampling 
procedure resulted in 1st order (B-D) and 2nd order (A-E) neighbouring cortical columns being 
combined, increasing the material yield, ensuring that the data has single animal resolution. 
Furthermore, this sampling procedure respects the distance based anatomical scaling of the 
cross columnar projections, as neighbouring cortical columns have significantly more overlap-
ping projections than those columns separated by a third cortical column [31], and the sensory 
deprivation condition. Immediately after dissection, tissue samples were snap frozen in liquid 
nitrogen and stored at -80⁰C until further use.
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RNA isolation and quality control
Tissue samples originating from the same rows and layers were pooled within each animal. 
From control animals only the C column was used. RNA was isolated using the miRNeasy 
Mini kit (Qiagen #217004), DNAse treated (Thermo Scientific, #EN0521) and cleaned up 
using RNeasy MinElute kit (Qiagen #74204), all following the manufacturer’s instructions. 
Samples were then stored at -80 degrees Celsius until further processing.
 
RNA sample integrity was determined using Agilent Tapestation (High Sensitivity RNA Scre-
entape). Sample RINs ranged from 7.1 to 8.8. RT-PCR was then used to confirm RNA purity 
and integrity. From all cDNA samples a fragment of ~1000 kb could be amplified, suggesting 
that the RNA samples contained pure RNA of sufficient integrity. All RNA samples thus passed 
our quality control criteria and were subjected to RNA sequencing.
RNA sequencing
RNA sequencing was conducted at the Genomics Core Facility of the EMBL, Heidelberg, 
Germany. The cDNA library was generated using the non-stranded NEBNext Ultra RNA Li-
brary Preparation Kit for Illumina (New England Biolabs, catalogue #E7530), which includes 
oligo-dT bead selection of mRNA. For library enrichment, 13-14 PCR cycles were performed. 
Pooled libraries were sequenced on the Illumina NextSeq 500 instrument in a 75bp paired-end 
mode using high-output flow cells.
Transcriptomics data processing
After read quality control using FastQC (Babraham Bioinformatics), reads were mapped to 
the mm10 mouse reference genome using the STAR aligner [32]. Differential gene expression 
analysis was done using EdgeR v3.12.1 [33, 34], including only transcripts that displayed a 
count per million (CPM) of 1 in at least 4 samples. Comparisons were drawn between L4 and 
L2/3 of control C columns (2 fold change cutoff) or within layers (L2/3 vs L2/3, L4 vs L4) 
of control C columns, deprived C column, first order spared B/D columns and second order 
spared A/E columns (cutoff: 1.25 fold change).
Publicly available single-cell RNA-sequencing data
Single-cell RNA-sequencing data [35] was obtained from http://linnarssonlab.org/cortex/. 
Custom routines, written in MATLAB (Mathworks), were used to identify house-keeping 
genes whose transcription is not differentially expressed per cell type and laminar identity after 
normalizing transcript counts (to the total transcripts) per sample; the cell types included in the 
analysis were astrocytes, endothelial cells, interneurons, microglia, oligodendrocytes and py-
ramidal neurons. The result was a ranked order of so called house-keeping genes (HKG) from 
which the top 450 were used for analysis. For calculation of the cell enrichment index (CEI) 
the average copy number of each transcript within each cell class was divided by the total copy 
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number of the same transcript averaged across all cell classes. We then selected those tran-
scripts that showed an >10% enrichment in one cell type compared to others, which was used 
to identify differentially expressed transcripts (DETs) in each cell class.  The analyses were 
also repeated at higher thresholds which did not change the overall conclusions however it did 
reduce the number of targets that could be used for cellular identification.  
Mass spectrometry lysate preparation and protein digestion
Sample preparation and subsequent mass spectrometry were conducted at the Department of 
Molecular Biology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. 
Samples were prepared for mass spectrometry using the filter-aided sample preparation (FASP) 
method, as described before [4] (Figure 1B). Briefly, mouse brain tissues were homogenized in 
lysis buffer, ultrasonicated and clarified after which the proteins in the extract were precipitated 
using urea buffer and centrifuge-filtered. After washing and alkylation, the extracted proteins 
were digested using trypsin. The resulting peptides were then collected by centrifugation and 
desalted.
Mass spectrometry
Tryptic peptides were separated on an Easy-nLC 1000 (Thermo) using a 214 min gradient of 
acetonitrile (7% to 30%) followed by washes at 60% and 95% acetonitrile for 240 min of total 
data collection. Mass spectra were collected on a LTQ-Orbitrap Fusion Tribrid mass spectrom-
eter (Thermo) in data-dependent top-speed mode with dynamic exclusion set at 60 s. Precursor 
MS spectra were acquired at an m/z range of 400-1500 at a resolution of 120000 and a target 
value of 300000 ions per full scan in the Orbitrap. MS/MS spectra were acquired in HCD mode 
using 35% collision energy; fragmentation spectra were recorded in the ion trap.
Proteomics data processing
Raw data was analysed using MaxQuant version 1.5.1.0 [36] (match between-runs, label-free 
quantification and intensity based absolute quantification (iBAQ) were enabled). Dependent 
peptides were enabled to perform an unbiased search against modifications on the identified 
peptides. The RefSeq protein sequence database downloaded on 28-06-2016 was used to iden-
tify proteins. Identified proteins were filtered for reverse hits and common contaminants. To 
quantify protein expression and fold changes we used the Proteomic Ruler approach [37].
Gene ontology analysis
Webgestalt (www.webgestalt.org, 21-01-2017) was used to identify overrepresented gene on-
tologies. The background gene list consisted of all transcripts that were identified in our sam-
ples by at least one read. Ontologies were only considered if they contained at least 4 genes 
from the differentially expressed transcript list and displayed an false discovery rate (FDR) 
below 0.05.
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To assign functional clusters among molecules from combined analysis of transcripts and pro-
teins, we used the Database for Annotation, Visualization, and Integrated Discovery (DAVID; 
http://david.ncifcrf.gov, version 6.8) against the complete mus musculus background list (en-
richment scores and significance values were therefore not used) on “High stringency”.
Results 
Transcriptomic profiling of granular and supragranular layers of a canonical barrel cortical 
column
Given the functional differences of cortical laminae in both deprived and non-deprived sensory 
cortices, we first set out to investigate the transcriptome profiles of the granular L4 and supra-
granular L2/3 laminae of C barrel columns. L4 to L2/3 comparison resulted in a total of 5931 
differentially expressed transcripts (DETs). Using a 2-fold change cut-off, 762 transcripts were 
found differentially expressed, 488 (~64%) of which were enriched in L2/3 (Figure 1A, B). 
The laminar difference was robust, and remained when the cut-off was lowered to 1.5 (1779 
differentially expressed transcripts; 1090 or ~61% more abundant in L2/3, 689 or 39% upregu-
lated in L4) and only became less pronounced when transcripts with a fold change of 1.25 were 
included (3425 differentially expressed transcripts; 1918 or 56% upregulated in L2/3, 1507 or 
44% in L4). Maximal fold change was also reduced in L4 when using lower (i.e. 1.25, 1.5) 
cutoffs, but not at two-fold cutoffs (Figure 1C). These results suggest that, at least concern-
ing DETs displaying 1.5 fold changes or higher, the cellular populations of the two layers are 
comparable in their transcriptional activity, but the transcriptome of L2/3 is more diverse, as 
detailed below. Because cortical laminae are known to contain substantially different distribu-
tions of cell types [38], likely resulting in large differences in their transcriptomic profiles, we 
chose the most stringent (two-fold) cutoff for our further analyses of laminar differences (see 
Supplementary Table 1 for differentially expressed transcripts).
Similar amounts of RNA (~30 ng) were used from each sample for sequencing. Nonetheless, to 
further exclude any confounding effects that could lead to a skewed identification of transcripts 
across samples, we used the publicly available single-cell RNA sequencing dataset from exper-
imentally naive mouse somatosensory cortex collected by Zeisel et al [35] to select reference 
transcripts. From this dataset, we selected the top 450 transcripts that were expressed stably 
across all cell types in both layers (called house-keeping genes, HKGs; see Materials and 
Methods), and therefore did not display differential expression in our dataset. 
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Figure 1. (A) Relationship between read counts per million reads (CPM), fold changes and 
statistical significance according to edgeR differential gene expression analysis (no fold change 
cutoff applied). The color indicates significant difference (Red: FDR<0.05; Black:FDR>0.05). 
(B) Numbers of differentially expressed genes between L4 and L2/3 at varying fold change 
cut offs. (C) Range of fold changes of DETs more abundant in L2/3 or L4 when no cut off is 
applied. (D) Protein product classes of differentially expressed transcripts between L4 and L2/3 
according to Panther Database. See Supplementary Table 2 for transcripts in each category.
From these, 318 were identified by a sufficient amount of reads in our dataset. Between L4 and 
L2/3, 18 out of 318 reference transcripts were significantly different by more than two-fold, 
constituting only 2.36% of the differentially expressed genes (18 out of 762). We thus conclud-
ed that our previous observations could not be explained by imbalances in RNA input or biases 
in transcript identification between samples originating from different cortical layers, and that 
the L2/3 transcriptome indeed displays a greater variety than its granular counterpart.
With the widely-used online Panther Database, we determined for which protein classes the 762 
DETs code (Figure 1D). The three most represented protein classes were receptors (92/762 or 
12%), signaling molecules (83/762 or 11%; includes cytokines, growth factors and hormones) 
and transporters (71/762 or 9%; consisting mainly of voltage- and ligand-gated ion channels), 
indicating that cell-cell signaling is likely regulated differently between cortical layers. It may 
however also simply reflect the sizes of each protein class in total. We thus employed the 
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online tool Webgestalt to determine which gene ontology (GO) terms were significantly over-
represented. Gene ontologies entail three defined categories (cellular components, molecular 
functions or biological processes) to which gene products are attributed [39]. Gene ontology 
overrepresentation analyses determine whether differentially expressed gene sets can be linked 
to distinct GO terms and if their coregulation is significant (in which case the GO term is said 
to be overrepresented). Across all three categories, as many as 718 GO terms were overrepre-
sented, the top 12 of which are displayed in Figure 2; Figures 3 to 5 show the top 12 GO terms 
for each category separately.
Top overrepresented GO terms mostly are related to cell signaling (between or within cells), 
and developmental processes (Figure 2-5). “Proteinaceous extracellular matrix”, “Extracel-
lular space”, “Cell-cell signaling”, “Anatomical structure morphogenesis” and “Calcium ion 
binding”, for instance, contain transcripts that are translated into include extracellular matrix 
proteins, receptors, signaling molecules (including cytokines and growth factors) and intracel-
lular signal transducers. When we increased DET selection stringency further and only include 
transcripts with at least a four-fold change, again GO terms associated with extracellular space, 
tissue development and cellular differentiation were among the top representatives (See Sup-
plementary Table 4).
In line with our previous observation that most DETs originate from L2/3, transcripts asso-
ciated with GO terms are represented extensively by the supragranular layers (Figure 2, pie 
charts). This indicates that the bias in differential gene expression towards L2/3 originates 
from transcriptional regulation of cell signaling (both inter- and intracellular) and develop-
ment. Moreover, although it is commonly assumed that the neuronal circuitry is anatomically 
matured by ~P21, even after this age the transcriptomes both cortical layers seem to be heavily 
involved in developmental processes. 
Figure 2 (next page). Top 12 overrepresented GO terms of L4 vs L2/3 DETs, across all 
three ontologies. Circular plot shows the overlap of transcripts between GO terms (outer ring) 
and their fold change (inner ring - red indicates L4 enrichment, blue indicates L2/3 enrich-
ment). For clustering at the center, log read counts were used. Connected scatter plots display 
log read counts for each transcript belonging to each GO term, separately for L2/3- or L4-en-
riched transcripts; Associated pie charts display numbers of L2/3- or L4-enriched transcripts 
(see Supplementary Table 3 for transcripts in each category); Box plots indicate means and 
quartiles, bars represent maximal and minimal values, transcripts outside these boundaries are 
outliers. 
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Figure 3. Top 12 overrepresented GO terms of L4 vs L2/3 DETs within the ontology Bio-
logical Process. Circular plot shows the overlap of transcripts between GO terms (outer ring) 
and their fold change (inner ring - red indicates L4 enrichment, blue indicates L2/3 enrichment). 
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Figure 4. Top 12 overrepresented GO terms of L4 vs L2/3 DETs within the ontology Cel-
lular Component. Circular plot shows the overlap of transcripts between GO terms (outer 
ring) and their fold change (inner ring - red indicates L4 enrichment, blue indicates L2/3 en-
richment). 
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Figure 5. Top 12 overrepresented GO terms of L4 vs L2/3 DETs within the ontology Mo-
lecular Function. Circular plot shows the overlap of transcripts between GO terms (outer ring) 
and their fold change (inner ring - red indicates L4 enrichment, blue indicates L2/3 enrichment). 
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Cell type-enriched gene expression profiles of differentially expressed transcripts
Cortical layers are characterized by distinct distributions of cellular populations, each function-
ally relevant in sensory processing but with currently unknown transcriptomic laminar profiles. 
Given our previous finding that L2/3 displayed a higher number of DETs, we asked how they 
were distributed across cortical cellular populations. We used the single-cell transcriptomics 
data from [35], in which six cell types are distinguished, namely astrocytes, endothelial cells, 
interneurons, microglia, oligodendrocytes and pyramidal neurons to calculate a cell enrichment 
index (CEI) for each gene differentially expressed in our dataset (see Materials and Methods).
The highest amounts of DETs were preferentially expressed in pyramidal (202 DETs) and 
interneurons (176), followed by oligodendrocytes (91), endothelial cells (64), astrocytes (63) 
and microglia (38), totalling to 634 or 83.2% of DETs designated to one of the six cell types 
(Figure 6). Pyramidal and interneurons represent the largest class, in line with the observations 
of Zeisel and colleagues [35], who find that neurons contain more RNA than other cell types.
Laminar transcriptomic profiles of most cell types followed the overall trend described above 
and displayed higher transcript abundances in supragranular L2/3 layers. At least for interneu-
rons this follows previous work describing peaks in inhibitory cell density in L2/3 and L5a 
[40]. Oligodendrocytes contrasted with other cell types: the majority of their transcripts (71/91 
or 78%) was more abundant in L4, which could well be explained by the rarity of oligoden-
drocytes in superficial cortical layers [41]. Transcripts preferentially expressed by pyramidal 
neurons were distinct in that they were almost equally abundant between L4 and L2/3 (L4: 94, 
L2/3: 108 DETs), arguing that despite their different laminar locations, transcriptionally they 
are comparable.  
Differences in cell density could not always explain laminar enrichment of cell-type specif-
ic transcripts: transcripts enriched in endothelial cells were more abundant in L2/3, although 
neocortical blood vessels (from which endothelial cells presumably originate) do not display 
differences in density between L4 and L2/3 [42]. The same is true for microglia, which are 
not known to be distributed differentially between cortical layers [43]. As supported by Zeisel 
et al. (2015), who were able to identify distinct layer-specific cellular subpopulations based 
on their transcriptomic profile, these findings suggest that cortical layers do not only differ 
in the distribution of their cellular populations, but even within cell classes there are distinct 
laminar-specific transcriptomes. Because they also represent the largest number of DETs, the 
increased number of L2/3-enriched DETs likely originates mainly from interneurons and py-
ramidal neurons.
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Figure 6. Laminar 
profile of differentially 
expressed transcripts 
assigned to cell types 
based on previously 
published single-cell 
RNA-seq dataset (see 
Materials and Meth-
ods). The circular plot 
shows the distribution 
of transcripts over cell 
classes (outer ring) and 
their fold change (inner 
ring - red indicates L4 
enrichment, blue indi-
cates L2/3 enrichment). 
Connected scatter plots 
display log transcript 
counts for each tran-
script belonging to each 
cell class, separately for 
L2/3- or L4-enriched 
transcripts; pie charts 
display relative numbers 
of transcripts enriched 
in L2/3- or L4 (see Sup-
plementary Table 5 for 
transcripts in each cell 
type); Box plots indicate 
means and quartiles, 
bars represent maximal 
and minimal values, 
transcripts outside these 
boundaries are outliers.
Whisker deprivation induces differential gene expression in the barrel cortex
We then proceeded to investigate the experience-dependent changes in the transcriptome. Ju-
venile (P12) mice were subjected to extended (11-12 day) single-(C-)row whisker deprivation. 
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The control group consisted of similarly handled, but non-deprived, littermates.
To determine how sensory deprivation is reflected in each layer of mouse somatosensory cor-
tex, we identified DETs by comparing samples from the C-row deprived and non-deprived 
control animals, making intralaminar comparisons of the C barrel column across both groups. 
In total, we found 402 DETs in L2/3 and 724 in L4, with L2/3 fold changes displaying a smaller 
range and a tendency towards downregulation (Figure 7A-D). Although numbers of DETs, as 
expected, increased with decreasing cut offs (Figure 7C), we consistently found a substantially 
higher number of DETs in L4 (48.3 - 133% depending on the cutoff), which was surprising 
given the laminar transcriptional profiles described above. Because the S1 transcriptome was 
previously shown to adapt to long-term altered sensory experience, leaving only subtle changes 
in gene expression [28], we used a cutoff of 1.25 (combined with FDR < 0.05) in comparisons 
between experimental groups (See Supplementary Tables 6-12).
Between the control and deprived L2/3, 188 transcripts were differentially expressed, with 112 
downregulated (59.6%) and 76 (40.4%) upregulated transcripts in the deprived group. In L4, 
we found 356 DETs, of which 206 (57.9%) were upregulated upon whisker deprivation, leav-
ing 150 (42.1%) downregulated transcripts. Thus, although L2/3 receptive fields remain plastic 
throughout life while those L4 are largely stable by P12 [6], gene expression changes upon 
sensory deprivation follow the opposite trend. Between layers, transcripts code for similar 
classes of proteins, with slightly different distributions (Figure 7E, F). In L2/3, the three most 
represented protein classes were enzyme modulators (11%), transferases (10%) and receptors 
(9%); in L4 these were receptors (10%), hydrolases (10%) and cytoskeletal proteins (8%). The 
similarity in affected protein classes indicates that similar molecular players are changed in 
their expression; given the imbalance in number of DETs, cellular processes might however be 
affected distinctly in each layer.
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Figure 7. Relationship between read counts per million reads (CPM), fold changes and statis-
tical significance according to edgeR differential gene expression analysis in L2/3 (A) and L4 
(B) across control and deprived samples. Red transcripts are significantly different (FDR<0.05), 
black ones are not (FDR>0.05) (with no fold change cutoff applied). (C) Distribution of DETs 
and their respective up- or downregulation at various fold change cut offs. (D) Ranges of fold 
changes in DETs when no cutoff is applied. (E-F) Distribution of protein classes (according to 
the Panther Database) that identified DETs code for. See Supplementary Tables 13 and 14 for 
transcripts in each category.
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Experience-dependent transcriptional changes across the granular and supragranular layers
The observations thus far suggest that extended whisker deprivation induces lasting changes 
in the transcriptome, which are likely due to altered synaptic communication following reor-
ganization of the S1 sensory map, and could differ between cortical layers [4]. To learn which 
biological processes, molecular functions and cellular components these DETs represent, we 
screened for overrepresented GO terms for up- and downregulated transcripts identified in 
each layer (Figure 8, 9). The overrepresented GO terms were “Synaptic transmission” and 
“Transmission of nerve impulse” (excluding the general “System process” and “Single-organ-
ism process”) which were overrepresented in both layers, strongly linking the changes in the 
transcriptome to the altered sensory input and synaptic communication previously observed 
in neurons of sensory deprived barrel columns. Between layers, 104 transcripts were differen-
tially expressed in both layers and in the same direction. Because they could indicate which 
processes are affected generally by sensory deprivation, we subjected only these transcripts 
to GO enrichment analysis, which showed overrepresentation of synaptic transmission (13 
transcripts, FDR 8.76 x 10-3) and synaptic localization (14 transcripts, FDR 8.53 x 10-4), (see 
Supplementary Table 17) suggesting that transcriptional regulation of synaptic transmission 
is affected similarly in both layers. In line with this, a large overlap was found between tran-
scripts from L4 and L2/3 that were associated with the term “Synaptic transmission” (L2/3: 
20 transcripts, L4: 24; overlap: 15). Besides synaptic transmission, the term “Membrane” was 
overrepresented in both layers and in both contained the largest number of transcripts (L2/3: 
87, L4: 161). 
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Figure 8. Top overrepresented GO terms of control versus deprived DETs for L2/3. Circu-
lar plot shows the overlap of transcripts between GO terms (outer ring) and their fold change 
(inner ring - red indicates upregulation upon whisker deprivation, blue indicates downregula-
tion). Scatter plots display log2 fold changes for each transcript belonging to each GO term; 
Associated pie charts display numbers transcripts significantly change in L2/3, L4 or both 
(see Supplementary Table 15 for transcripts in each category); Box plots indicate means and 
quartiles, bars represent maximal and minimal values, transcripts outside these boundaries are 
outliers.
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Figure 9. Top overrepresented GO terms of control versus deprived DETs for L4. Circular 
plot shows the overlap of transcripts between GO terms (outer ring) and their fold change (in-
ner ring - red indicates upregulation upon whisker deprivation, blue indicates downregulation). 
Scatter plots display log2 fold changes for each transcript belonging to each GO term; Associ-
ated pie charts display numbers transcripts significantly change in L2/3, L4 or both (see Sup-
plementary Table 16 for transcripts in each category); Box plots indicate means and quartiles, 
bars represent maximal and minimal values, transcripts outside these boundaries are outliers.
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Protein classes coded for by transcripts in this GO term were largely similar between cortical 
layers, with receptors as the largest class in each layer (Figure 10), suggesting that cell-cell (in-
cluding non-synaptic) communication is overall affected by sensory deprivation. Several other 
overrepresented GO terms were specific for each layer (“Actin filament-based movement”, 
“Muscle adaptation” in L2/3; “G-protein coupled glutamate receptor signaling pathway” in 
L4), but were also sparsely populated and may therefore not be biologically relevant, at least 
not after sustained whisker deprivation. From these results we conclude that sustained sensory 
experience is reflected in the transcriptome of deprived barrel columns, specifically in modu-
lated expression of transcripts related to synaptic communication.
Figure 10. Protein classes of transcripts contained in the GO term ‘Membrane’, overrepresent-
ed across L2/3 and L4. See Supplementary Table 18 and 19 for transcripts in each category
Transcriptomes of granular layer display greater columnar specificity than supragranular lay-
ers
In response to whisker deprivation, neuronal responses in the deprived columns are diminished 
whereas those in spared neighbours are enhanced [30, 44]. Such column-specific differences in 
sensory-evoked responses could also be reflected in the transcriptome, which prompted us to 
investigate how the transcriptome of L2/3 and L4 in the deprived (C) barrel column compares 
to their 1st and 2nd order spared neighbours (i.e. B/D and A/E, respectively). Surprisingly, de-
prived columns were very similar to first order spared columns: in L2/3 no DETs were found 
at all and in L4 only 4 genes showed differential expression. Moreover, differential mRNA 
expression analysis between deprived and first and second order spared columns revealed sub-
stantially (~4-5.5 fold) larger numbers of DETs between columns in L4 compared to L2/3; The 
highest number of differences we found were in L4 between the deprived and second order 
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spared columns. Although differences became less extreme at higher cutoffs, the reduced co-
lumnar specificity in L2/3 compared to L4 was persistent at all fold change cutoffs tested (Ta-
ble 1). Similar to the comparison between cortical layers, cell-type specific transcripts selected 
from the single-cell RNA seq dataset from [35] did not reveal any bias that could explain the 
larger number of DETs in L4 compared to L2/3: using a fold change cutoff of 1.25, at most only 
9 out of 303 DETs (L4, deprived vs second order spared; 2.97%) were reference transcripts. 
These results thus suggest that sustained whisker deprivation induces transcriptional changes 
in the barrel cortex, the extent of which is greater and more column-specific in L4 compared 
to L2/3. Moreover, in stark contrast to electrophysiological findings, deprived and first-order 
spared columns are transcriptionally identical.
Fold change cutoff
Deprived vs first or-
der spared
Deprived vs second 
order spared
First order spared 
vs second order 
spared
L2/3 None 0 285 193
1.25 0 74 25
1.5 0 24 5
2 0 5 2
L4 None 12 1315 775
1.25 4 303 138
1.5 1 76 32
2 1 11 4
Table 1. Numbers of DETs across cortical columns and the distance between the deprived and 
spared whiskers’ cortical columns. In all animals C-row was deprived, hence B/D columns 
serve as 1st order spared columns, and A/E are 2nd order spared columns.
Cell type-specificity of experience-dependent changes in the transcriptome
Because distributions of cortical cell types can differ greatly between cortical layers, and dif-
ferent cell classes likely adjust their transcriptome differently in response to sensory experience 
(as proposed in Chapter 1), we used the single-cell transcriptomic dataset to determine the 
expression profile of experience-dependent DETs among different cell classes (see Materials 
and Methods for details).
Comparing DETs from the granular and supragranular layers, we found the transcripts in our 
mixed sample covered all six cell types identified; pyramidal neurons contained the largest 
number of cell-type specific transcripts, followed by interneurons, astrocytes, endothelial cells, 
while the least DETs were assigned to microglia and oligodendrocytes (Figure 11). This fol-
lows the general distribution of cell-type specific transcripts observed within the control col-
umn (compare Figure 6 and 11).
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Figure 11. Differentially 
expressed transcripts af-
ter whisker deprivation, 
assigned to cell types 
based on single-cell 
RNA-seq dataset [35]. 
The circular plot shows 
the distribution of tran-
scripts across cell classes 
(outer ring) and their fold 
change (inner ring - red 
indicates upregulation 
upon whisker deprivation, 
blue indicates downregu-
lation; scale is set between 
-1 and 1). Scatter plots 
display log2 fold chang-
es for each transcript be-
longing to every identified 
cell class; Associated pie 
charts display numbers of 
transcripts significantly 
upregulated in L2/3, L4 or 
both (see Supplementary 
Table 20 for transcripts in 
each category); Box plots 
indicate means and quar-
tiles, bars represent max-
imal and minimal values, 
transcripts outside these 
boundaries are outliers.
Overall fold changes did not differ between cell types (a maximum of two fold in both layers, 
with a few exceptions), and generally followed the overall pattern where in L2/3 downreg-
ulation was more prevalent and upregulation was observed more in L4. Transcripts related 
to astrocytes were distinct in that in L2/3 most transcripts were downregulated (9/12, 75%), 
whereas the opposite was true in L4 (5/19, 26.3%) resulting in bidirectional transcription pat-
tern across layers after whisker deprivation. Transcripts associated with pyramidal neurons 
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displayed a wider range of fold changes between layers (L2/3: -1.13  - 0.9; L4: -1.13 - 1.59 
log2(FC)) which was similar to microglial cells (L2/3: -0.79 - 0.56; L4: -1.06 - 1.07 log2(FC)) 
but not to other cell types. In L2/3, the transcripts with the largest fold changes were found 
mainly in pyramidal and interneurons, whereas in L4 such ‘hot spots’ were also observed in 
astrocytes, microglia and endothelial cells, suggesting that in L2/3 larger transcriptional chang-
es are more restricted to neurons than in L4.  This bias might be partially reversed with L4 
spiny-stellate neurons’ transcriptome identified, however the lack of single-cell RNAseq data 
prohibits this analysis.  Transcripts of all cell types were most uniquely expressed in L4, re-
flecting the larger overall amount of DETs identified in this layer. We conclude that long-term 
sensory deprivation mainly affects the transcriptomes of excitatory and inhibitory neurons but 
also their non-neuronal counterparts (including endothelial cells), and that laminar differences 
can be observed in experience-dependent, cell-type specific gene regulation.
Comparison of experience-dependent transcriptional and translational changes
Although mRNA transcripts are putatively translated into protein, it is well known that post-
transcriptional regulatory mechanisms can tightly control mRNA translation [45]. To inves-
tigate how transcriptomic profiles of spared and deprived barrel cortical correlate with those 
at the translational level, we employed mass spectrometry of tissues isolated in an identical 
manner as those subjected to RNA sequencing and after a similar period of sensory depriva-
tion (see Chapter 2 for methodology and quality control). We compared the relative change 
of the mRNA, quantified as fold changes in a logarithmic scale, to that of proteins encoded 
by the same transcripts obtained from corresponding samples (Figure 12). Using a 1.25 fold 
change (of mRNA) cut-off, molecules were clustered into 3 groups: 1) those changed in the 
same direction (up- or downregulated) in both transcription and translation (group A); 2) those 
changed in opposite directions (group B); 3) molecules changed in RNA abundance but not 
protein (group C). Molecules in each group were then used in a functional annotation analysis 
via the Database for Annotation, Visualization, and Integrated Discovery (DAVID). 
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Figure 12. Correlated changes across the transcriptome and proteome (or lack thereof). 
Upper right and lower left quartiles: transcripts and proteins that are co-modulated; Upper left 
and lower right quartiles: transcripts and proteins that are anticorrelated. See Supplementary 
Tables 21-23 for functional clusters.
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Across comparisons, we found that most targets were changed in the same direction in both 
datasets (160), but also a large number showed opposite changes (117) or were unchanged in 
the protein dataset (112). The genes that were modulated similarly in transcription and trans-
lation could be assigned to the largest number of functional clusters (i.e. 16), followed by 
the genes with opposite changes (10 functional clusters) and finally the genes that were only 
changed in transcription (8 functional clusters); most functional clusters were common across 
the three groups, Group A-C. All three groups contained genes that are related to synaptic func-
tion, (voltage-gated) ion channels, transcription, phosphorylation and signal transduction. This 
might be because some genes could be identified in more than one group across experimental 
conditions, suggesting that their direction of change in transcription or translation is dependent 
on the history of sensory input. Of particular interest are voltage-gated potassium and sodium 
channels, which are modulated in both the transcriptome and proteome and could powerfully 
shape neuronal spiking properties [46] (see Chapters 4-5). Overall, comparing transcriptional 
with translational profiles suggests that most DETs are similarly regulated at the protein level, 
but that there is also a large population of genes that are dissimilar between transcription and 
translation, which could point to a strong role for posttranscriptional control which, given the 
similarity of functional clusters, do not favor particular cellular processes over others (see Dis-
cussion).
Molecular correlates of altered sensory experience are also implicated in neurological disor-
ders
Experience-dependent plasticity is a complex process, involving processes that span multiple 
cell types (see above and Chapter 1).  Molecules involved in plasticity have been linked to 
various neurological disorders such as schizophrenia [47–49], autism [50], Alzheimer’s disease 
[51] and intellectual disability [52]. We therefore investigated the overlap between genes im-
plicated in brain disorders with the differentially transcribed targets after whisker deprivation 
using the Disease and Gene Annotations (DGA) [53], a database of genome-wide association 
(GWA) and population study results. Documented correlations between genes and disorders 
(e.g. protein or mRNA level alterations, single-nucleotide polymorphisms and mutations) were 
searched for DETs.  Neurological disorders with at least two transcripts/proteins associated 
with them were selected and finally negative results were filtered out, yielding an overview 
of molecules that were changed both in disease and during EDP in health. The differentially 
expressed targets (upon whisker deprivation) were related to ~15 common neurological disor-
ders, and coded for a variety of different protein classes (Figure 13).
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Figure 13 (previous page). Neurological disorders linked to DETs across cortical layers 
or upon whisker deprivation. Circular plot shows the distribution of transcripts across cell 
classes (outer ring) and their fold change (inner ring - red indicates upregulation, blue indicates 
downregulation). Pie charts indicate protein classes associated with transcripts identified in 
each comparison (see Supplementary Tables 24-26 for transcripts in each category).
Depression and migraine, for instance, were linked to transcripts identified in within-control 
column comparisons only, whereas links to other disorders such as schizophrenia, bipolar dis-
order and multiple sclerosis, were found in all comparisons (i.e across columns and layers; 
Figure 14); Substance dependence, Alzheimer’s disease and amyotrophic lateral sclerosis 
were also prominently represented disorders. Although some molecules were uniquely linked 
to a particular disorder, others were shared, including Grm1 (metabotropic glutamate receptor, 
shared in up to 5 disorders), Grm2 (found in 4 disorders), Ace (angiotensin-converting enzyme, 
linked to 8 disorders), Grik1 and Grik 3 (ionotropic glutamate receptors, 5 and 3 disorders, 
respectively).
Signaling molecules and receptors were among the most identified classes in the transcriptome 
in all comparisons. Similar protein classes were represented by the disorder-linked transcripts 
across comparisons, although they displayed rather distinct distributions due to the differences 
across layer and column. As noted in Chapter 1, comparisons between datasets and databases 
such as DGA are always limited by the contents of both. Studies on molecular correlations in 
diseases are not equally distributed, undoubtedly biasing the results presented herein. Never-
theless, these observations suggest that many neurological disorders have a basis in, or them-
selves influence, experience- dependent plasticity in the brain (or the cellular pathways utiliz-
ing the same molecules), and stress that a better understanding of the underlying mechanisms 
of plasticity in health will aid the understanding, treatment and perhaps prevention of disease.
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Figure 14. Differentially expressed transcripts associated with neurological disorders. 
Scatter plots display log read counts (in the case of control column) or log2 fold changes (in 
the case of control versus deprived) for each transcript belonging to each neurological disorder; 
Associated pie charts display numbers of transcripts significantly upregulated in L2/3,  L4 or 
both (see Supplementary Table 27 and 28 for transcripts in each category); Box plots indicate 
means and quartiles, bars represent maximal and minimal values, transcripts outside these 
boundaries are outliers.
Discussion
Here, we have generated transcriptome and proteome data and used bioinformatic methods 
for big datasets to systematically analyze the transcriptome and proteome, and showed how 
sustained single-whisker row deprivation affects the molecular landscape in the juvenile barrel 
cortex in a column- and layer-specific manner.  The principal findings are:
1) In the absence of whisker-deprivation, in the control animals’ C column, L2/3 and L4 
transcriptional profiles include 5931 transcripts that are differentially expressed.  Given 
the size of the transcriptome, approximately 1 in every 3 transcripts is differentially 
expressed across L2/3 and L4 (Figure 1).    
2) Most differentially regulated transcripts across layers have a differential transcription 
104
CHAPTER 3
within 2-folds: only a total of 762 transcripts (out of 5931) were differentially tran-
scribed across layers with a rate of >2-folds. As 64% of these transcripts are enriched 
in L2/3 (and 36% in L4), L2/3 can be considered transcriptionally more diverse than 
L4 (Figure 1).
3) GO analysis showed that differentially regulated transcripts are enriched for structural 
and functional protein classes (Figure 2).  Extracellular matrix/space, plasma mem-
brane, cellular signalling and calcium-dependent processes are among the most signifi-
cantly enriched primary gene ontology families when the two laminar transcriptomes 
are compared.  This might be a by-product of the delayed development of L2/3, in re-
spect to L4 (see below), however these systematic transcriptional differences associated 
with synaptic communication and neuronal anatomy (Figures 3-5) also argue that ex-
perience-dependent changes might alter the transcriptome in a laminar specific manner. 
4) The differential regulation of transcription across layers is not cell type-specific (Fig-
ure 6).  While most transcripts in identified cell-types have a (given the results above) 
predictable transcription profile, i.e. marked up-regulation in L2/3, most oligodendro-
cyte enriched transcripts are up-regulated in L4, likely reflecting their low abundance 
in superficial cortical layers.  
5) Gene expression in barrel cortex is altered upon whisker deprivation. In contrast to 
the above findings, most whisker deprivation-induced chnges are found in L4: 65% 
(724/1126) of the differentially transcribed transcripts originate in L4 whereas 35% (i.e. 
402/1126) were found in L2/3 (Figure 7). 
6) Whisker deprivation-induced changes in L4 primarily involved transcripts of receptors, 
cytoskeletal proteins and enzyme (modulators), and in L2/3, enzyme (modulators), re-
ceptors, and signaling molecules, in a descending ranked order (Figure 7).  Given their 
identified functions in synaptic transmission, cellular signalling, cell and membrane 
structure (Figure 8-9), these differentially regulated transcripts could be considered as 
primary targets of future functional studies searching for molecular switches of experi-
ence-dependent plasticity.     
7) Whisker deprivation-induced differential transcription is not cell-type specific but an 
overwhelming number of transcripts that are enriched in a cell type was regulated in a 
layer specific manner (Figure 11). Thus, transcriptionally, all cell types undergo expe-
rience-dependent plasticity but in a layer specific manner.
8) Experience-dependent transcriptional changes are also reflected in the proteome for a 
subset of the targets (~41%), while anti-correlated changes (~30%) and transcriptional 
changes that are not accompanied by significant translational changes (~19% of targets) 
suggest that post-transcriptional regulation might ultimately control the extent of plas-
ticity in the network (Figure 12; but also see below).
9) Identified molecules of experience-dependent plasticity are among the principal targets 
that are altered in major neurological disorders (Figure 13,14). 
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We were able to isolate the barrel cortical tissue at high anatomical resolution, for the first time 
allowing exploration of large-scale molecular changes within identified cortical columns and 
layers, both of which are known to behave distinctly upon whisker deprivation.  Transcripts 
that were differentially expressed upon whisker deprivation code for proteins that contribute 
various functions in intra- and interneuronal signalling, including synaptic proteins (Syn3, 
Cbln1, Doc2b, Trim9, Homer1), receptors (Grm1, Grm2, Grik1, Grik3, Ephb2, Hrh1, Ntsr1), 
gene expression regulators (Etv5, Cbep1, Xbp1) and secreted signaling molecules (or their pre-
cursors or producing enzymes) (Vgf, Agt, Ddc, Crh), suggesting that synaptic communication 
is modulated across several different levels upon whisker deprivation. 
Interestingly, the differential transcription across cortical columns due to whisker deprivation 
was more prominent in L4, contrary to how cortical columns and lamina behave electrophys-
iologically during map plasticity. Moreover, neighbouring deprived and spared columns were 
identical on the transcriptome level, although their neural responses are well known to be 
modulated differently [1, 15, 17]. These results were not due to a probable bias in RNA input 
or transcript identification as evidenced by comparable expression rates of reference transcripts 
across samples. A potential explanation for the dissimilarity between electrophysiological and 
transcriptomic findings lies in the relatively high number of cross-columnar projections found 
in L2/3, which mediate the expansion of spared whisker representations. As a result of coordi-
nated synaptic activation in L2/3, metabolic rates, intracellular signaling pathways and hence 
downstream gene regulation could also become more homogeneous. A similar effect has been 
described in the rat barrel cortex, after extended exposure to an enriched environment [28]. L4 
neurons on the other hand are mainly driven by thalamocortical projections and receive little 
thalamocortical input originating from surrounding whiskers’ barreloids [54]; although L4 py-
ramidal neurons could extend projections into neighbouring columns, cross-columnar commu-
nication is much slower and is less prevalent than in L2/3 [2, 5, 55]. These features could result 
a more distinct transcriptional profile across neighboring barrels in L4. 
We also investigated how transcripts from cortical laminae of identified C barrel columns differ 
from one another, and found that L2/3 displayed enhanced numbers of transcripts compared 
to L4. Transcripts in both layers were enriched for those that serve in intra- and intercellular 
communication and developmental processes. Transcripts contained in overrepresented GO 
terms were strongly represented by L2/3, which could be due to the “bottom-to-top” (from 
L6 to L1) manner in which the neocortex is formed. This could have strong implications for 
electrophysiological findings in acute slices, which are often performed in juvenile animals: 
although projections and synapses are mature, ongoing development of the surrounding tissues 
are likely to affect metabolic rates and expression rates for the proteins that are universally 
involved in neural development and cell maintenance, which in turn might indirectly influence 
the ion homeostasis and synaptic communication. 
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Publicly available single-cell RNA sequencing data [35] has helped us to estimate the contri-
butions of six different cell classes found in neocortex to the transcriptomic changes. Between 
L4 and L2/3, abundance of cell type-enriched DETs overall followed the known distributions 
of cell types in either layer with the exception of endothelial cells and microglia. This might 
indicate that cell type-enriched transcripts are a poor indicator for density of these cell classes, 
and suggests that between layers significant transcriptomic differences exist even within cell 
types, in agreement with the previous observations [35]. As expected, upon whisker depriva-
tion the majority of DETs were derived from interneurons and pyramidal cells. The contribu-
tion of non-neuronal cells to experience-dependent DETs was small (89/544 transcripts across 
layers; 16.4%), but should nevertheless not be dismissed, as non-neuronal cells are known to 
be involved in experience-dependent plasticity [56–64] and could be important (if not neces-
sarily crucial) in adapting and maintaining neural responses to sensory input. Cell type-specific 
DETs were not addressed in depth, but are obviously interesting targets for functional studies 
that could help further unravel how each cell type contributes to sensory map reorganization.
Transcriptomic changes upon extended modulation (28 days) of sensory experience have pre-
viously been investigated [28] and were found to be very small in number (29 DETs), likely 
reflecting the steady state of the cortical network after it has adapted to the novel environment 
the animals in that study were exposed to. Although the duration of whisker deprivation in 
our experiment was significantly shorter (12-14 days), it is sufficient to induce large-scale 
changes in somatosensory maps. In contrast to observations of Vallès and colleagues [28], we 
observed 188-356 DETs using similar fold change cutoffs. The discrepancy between these two 
set of observations could be the methodology; RNA sequencing offers greater specificity and 
sensitivity compared to microarray technology. Given the extent of the differences between the 
two studies, this is however unlikely to be the sole cause. A more likely source could be the 
differences in the sensory manipulation that were employed. Whisker deprivation introduces 
Hebbian plasticity and competition between cortical columns, a major driving force of cortical 
plasticity [44], whereas EDP upon enriched environment experience relies on non-Hebbian, 
homeostatic mechanisms [30, 65]. As plasticity mechanisms are likely to be a continuum in-
volving (somewhat) overlapping molecular pathways, these two forms of plasticity are proba-
bly associated with distinct transcriptional profiles. Finally, the superior anatomical resolution 
used in the current study could help to pinpoint DETs that would have gone unnoticed due to 
overshadowing of RNAs from surrounding tissues if the whole barrel cortex was used (as was 
the case in the study by Vallès et al.).
In the current experiments, we have studied the molecular changes at a time after whisker 
deprivation when the somatosensory map is known to have undergone reorganization. The 
transcriptome is known to be temporally responsive to sensory input [27], but still unknown 
are the molecular players that are required to allow map plasticity in the first place. Future 
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studies should therefore repeat the current protocol but at shorter time intervals, even starting 
within several hours after whisker deprivation as spike timing is known to be reversed acutely 
upon whisker trimming [2] which could already trigger large-scale molecular changes. The 
first three days following deprivation would also be of interest in relation to inhibitory neurons, 
as it was recently found that disinhibition precedes synaptic weakening [66]. Establishing the 
time course of molecular changes throughout the process of map plasticity will help determine 
what key processes and molecules govern the reorganization of sensory maps. One point of 
consideration is the developmental age at which to start whisker deprivation, as we found many 
development-related transcription even at P24; Such processes will only be more abundant at 
earlier ages, making it challenging to discern which changes might be more related to cortical 
developmental versus map plasticity. 
When interpreting the current data, it is important to keep in mind that the presence of mRNA 
in distal projections and local translation at the synapse could mean that a fraction of the data 
sampled in a cortical column might originate from its neighbouring cortical column. This means 
that although RNA was isolated from an identified column, at least in some cases transcription 
could still be regulated based on the sensory experience of neurons in the neighbouring col-
umn. In hippocampus, over 2,500 mRNAs were previously identified in dendrites [67], indi-
cating their likely involvement in plasticity in hippocampus but probably also cortex. Labeling 
dendritic or axonal mRNAs and proteins originating from individual columns and analyzing 
tissue from their neighbours could help determine to further elucidate where experience-depen-
dent transcriptional changes originate.
In the current study, we did not address in detail the possible effects of sensory experience on 
posttranscriptional regulation, the abundance of different splice variants and protein isoforms. 
The sequencing depth of our RNA sequencing dataset (50 million reads/sample) should allow 
for the identification and quantification of splice isoform abundances across the different sam-
ples, and could potentially be coupled to the abundances of different protein isoforms in our 
mass-spectrometry dataset. Activity-dependent mRNA splicing has been reported [68], and 
could have large implications on experience-dependent gene expression. Another posttranscrip-
tional regulatory mechanism that could powerfully control experience-dependent plasticity lies 
in microRNAs (miRNAs), small RNA molecules that can induce degradation or halt transla-
tion of specific mRNAs by binding to complementary sequences. Such post-transcriptional 
regulation is known to be important in various neurological functions [69] including synaptic 
plasticity [70], neuronal survival [71] and neuronal outgrowth and spine formation [72], and 
could also play important roles in EDP. As the pool of known miRNA target sequences contin-
ues to grow, the current dataset could be mined for targets of miRNA-mediated translational 
regulation. Likely targets for general posttranscriptional regulation would be those that display 
transcriptional but no (or opposite) translational changes, of which we have already identified 
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several. An important consideration here however is that a relatively high amount of molecules 
displayed changes only in transcript abundances but not in protein. This discrepancy might be 
functional (e.g. a readily translatable pool of these transcripts is made available, or they may 
require further extended sensory deprivation for translational changes to become apparent) but 
could also be technical, as it was technically challenging to obtain successful mass spectrome-
try runs (see Chapter 2).
Lastly, we showed that molecules that are subject to experience-dependent modulation are also 
commonly found to be dysregulated in their expression in neurological disorders, as we also 
proposed in Chapter 1 based on the meta-analysis of previously collected transcriptomic data. 
Functional studies based on the current dataset, particularly when performed in a cell type spe-
cific manner, will thus not only aid our basic understanding of EDP in health, but could pave 
the way for the discovery of novel disease biomarkers and the development and improvement 
of targeted therapies of EDP-related neurological disorders.
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Supplementary Tables
Supplementary Table 1. Transcripts that are differentially expressed across L4 and L2/3 in 
the Control (C) column
Gene Gene description FC (L4 vs 
L2/3)
FDR
Cnih3 cornichon family AMPA receptor auxiliary pro-tein 3 7.98
9.08E-
113
Gfap glial fibrillary acidic protein 0.14 8.87E-111
Pamr1 peptidase domain containing associated with muscle regeneration 1 3.31
7.03E-
101
Whrn Whirlin 5.80 1.33E-97
Grm2 glutamate receptor, metabotropic 2 3.74 1.73E-95
Mbp myelin basic protein 3.86 4.70E-88
Sel1l3 sel-1 suppressor of lin-12-like 3 (C. elegans) 2.21 4.53E-87
Scnn1a sodium channel, nonvoltage-gated 1 alpha 14.14 4.56E-86
Adora1 adenosine A1 receptor 2.37 3.32E-81
Cpne7 copine VII 0.28 8.11E-80
Hs3st4 heparan sulfate (glucosamine) 3-O-sulfotransfer-ase 4 8.83 1.66E-79
Tmem145 transmembrane protein 145 2.52 1.95E-79
Satb1 special AT-rich sequence binding protein 1 2.71 1.93E-77
Mb21d2 Mab-21 domain containing 2 2.32 9.88E-77
Cnp 2’,3’-cyclic nucleotide 3’ phosphodiesterase 2.74 3.22E-75
Camk2d calcium/calmodulin-dependent protein kinase II, delta 0.23 4.45E-72
Klhdc8b kelch domain containing 8B 0.36 8.22E-70
Lmo3 LIM domain only 3 4.16 1.06E-69
Kcnab3 potassium voltage-gated channel, shaker-related subfamily, beta member 3 6.12 7.01E-69
Cadps2 Ca2+-dependent activator protein for secretion 2 3.11 1.02E-68
Foxp1 forkhead box P1 2.47 1.98E-67
Mag myelin-associated glycoprotein 4.05 7.71E-67
Adarb2 adenosine deaminase, RNA-specific, B2 0.29 4.57E-66
Ntn5 netrin 5 2.72 4.81E-66
Grm4 glutamate receptor, metabotropic 4 2.73 3.87E-65
Plp1 proteolipid protein (myelin) 1 4.06 3.42E-64
Tmem132e transmembrane protein 132E 0.26 4.65E-64
Pcdh8 protocadherin 8 0.29 9.28E-64
Rcan2 regulator of calcineurin 2 2.27 1.09E-63
Hrk harakiri, BCL2 interacting protein (contains only BH3 domain) 0.25 3.80E-62
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Cldn11 claudin 11 3.51 5.86E-62
Gpr158 G protein-coupled receptor 158 2.14 1.25E-61
Rspo1 R-spondin 1 7.10 2.43E-61
Nrsn1 neurensin 1 2.04 4.19E-60
Cplx3 complexin 3 0.27 1.73E-59
Sorcs1 sortilin-related VPS10 domain containing recep-tor 1 2.13 3.29E-59
Tspan2 tetraspanin 2 3.42 3.79E-57
Mobp myelin-associated oligodendrocytic basic protein 5.09 1.09E-56
Arsj arylsulfatase J 0.08 1.15E-56
Gfra2 glial cell line derived neurotrophic factor family receptor alpha 2 4.15 3.08E-56
Myrf myelin regulatory factor 2.59 8.73E-56
Necab2 N-terminal EF-hand calcium binding protein 2 0.30 2.72E-55
Grik4 glutamate receptor, ionotropic, kainate 4 0.33 2.72E-55
Mog myelin oligodendrocyte glycoprotein 4.48 2.77E-55
Doc2b double C2, beta 0.25 5.33E-55
Mal myelin and lymphocyte protein, T cell differenti-ation protein 4.61 1.20E-54
Zmat4 zinc finger, matrin type 4 3.69 2.57E-54
Sowaha sosondowah ankyrin repeat domain family mem-ber A 0.35 1.02E-52
Plcxd2
phosphatidylinositol-specific phospholipase C, X 
domain containing 2 4.10 1.87E-52
Lrrc57 leucine rich repeat containing 57 2.04 1.99E-52
Nr2f2 nuclear receptor subfamily 2, group F, member 2 0.30 2.02E-52
Ccnd2 cyclin D2 0.40 3.54E-52
Sept4 septin 4 2.67 4.09E-52
Fam19a2 family with sequence similarity 19, member A2 2.12 8.17E-52
Fbxo32 F-box protein 32 4.26 4.41E-51
Trf transferrin 2.92 1.20E-50
Necab1 N-terminal EF-hand calcium binding protein 1 0.34 1.40E-50
Homer2 homer scaffolding protein 2 0.45 1.52E-50
Igsf11 immunoglobulin superfamily, member 11 0.42 2.28E-50
Rorb RAR-related orphan receptor beta 5.18 4.06E-50
Ccdc88c coiled-coil domain containing 88C 0.37 4.75E-50
Rgs12 regulator of G-protein signaling 12 0.47 2.26E-49
Ngb neuroglobin 0.15 8.99E-49
March4 membrane-associated ring finger (C3HC4) 4 0.45 2.48E-48
Grik3 glutamate receptor, ionotropic, kainate 3 3.15 5.44E-48
Syt10 synaptotagmin X 0.07 6.24E-48
Plb1 phospholipase B1 7.90 9.47E-48
Pak6 p21 protein (Cdc42/Rac)-activated kinase 6 0.42 1.08E-47
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Scube1 signal peptide, CUB domain, EGF-like 1 2.51 1.09E-47
Kirrel3 kin of IRRE like 3 (Drosophila) 0.41 2.47E-47
Fxyd6
FXYD domain-containing ion transport regulator 
6 0.25 3.04E-47
Kit KIT proto-oncogene receptor tyrosine kinase 0.44 2.25E-46
Osbpl5 oxysterol binding protein-like 5 2.46 2.67E-46
Met met proto-oncogene 0.15 3.15E-46
Fibcd1 fibrinogen C domain containing 1 0.16 9.80E-46
Cnr1 cannabinoid receptor 1 (brain) 0.36 1.69E-45
Rasal1 RAS protein activator like 1 (GAP1 like) 0.40 2.95E-45
Fam149a family with sequence similarity 149, member A 0.37 3.83E-45
Reln reelin 0.40 7.11E-45
Tmem88b transmembrane protein 88B 3.60 1.55E-44
Ccdc136 coiled-coil domain containing 136 2.14 3.59E-44
Palmd palmdelphin 0.34 5.08E-44
Chga chromogranin A 2.13 8.29E-44
Pld5 phospholipase D family, member 5 4.03 2.25E-43
Fa2h fatty acid 2-hydroxylase 3.69 2.38E-43
Nov nephroblastoma overexpressed gene 0.18 2.78E-43
Ermn ermin, ERM-like protein 4.45 3.13E-43
Neurl1a neuralized E3 ubiquitin protein ligase 1A 0.44 4.83E-43
Prox2 prospero homeobox 2 5.74 5.22E-43
Tnfaip8l3 tumor necrosis factor, alpha-induced protein 8-like 3 0.18 6.12E-43
Gpr37 G protein-coupled receptor 37 2.95 8.37E-43
Zcchc12 zinc finger, CCHC domain containing 12 0.39 1.62E-42
Plch2 phospholipase C, eta 2 2.31 1.68E-42
Dkkl1 dickkopf-like 1 8.07 2.23E-42
Cpne6 copine VI 0.36 2.89E-42
Kcns1 K+ voltage-gated channel, subfamily S, 1 2.98 3.29E-42
Kcnf1 potassium voltage-gated channel, subfamily F, member 1 0.43 6.97E-42
Dscaml1 DS cell adhesion molecule like 1 0.30 7.79E-42
Bok BCL2-related ovarian killer 3.07 1.36E-41
Gdpd5 glycerophosphodiester phosphodiesterase do-main containing 5 2.09 2.34E-41
Ly6h lymphocyte antigen 6 complex, locus H 0.44 1.05E-40
Hpcal4 hippocalcin-like 4 0.44 1.08E-40
Cdh4 cadherin 4 0.32 2.38E-40
Dcbld2 discoidin, CUB and LCCL domain containing 2 2.88 1.24E-39
Col23a1 collagen, type XXIII, alpha 1 0.23 1.92E-39
Lypd1 Ly6/Plaur domain containing 1 0.23 3.19E-39
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Rfx3
regulatory factor X, 3 (influences HLA class II 
expression) 0.43 3.19E-39
Egln3 egl-9 family hypoxia-inducible factor 3 0.26 3.50E-39
Kcnip2 Kv channel-interacting protein 2 2.14 3.66E-39
Htr3a 5-hydroxytryptamine (serotonin) receptor 3A 0.23 3.79E-39
Wfs1 wolframin ER transmembrane glycoprotein 0.28 4.25E-39
Ugt8a UDP galactosyltransferase 8A 3.06 1.16E-38
Marcksl1 MARCKS-like 1 0.44 2.33E-38
Plekhh1 pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 4.14 3.44E-38
Camk4 calcium/calmodulin-dependent protein kinase IV 2.09 3.62E-38
Pcdh19 protocadherin 19 0.34 2.62E-37
Peak1 pseudopodium-enriched atypical kinase 1 0.48 4.27E-37
Sp8 trans-acting transcription factor 8 0.23 5.11E-37
Asic4 acid-sensing (proton-gated) ion channel family member 4 0.45 9.21E-37
Bglap3 bone gamma-carboxyglutamate protein 3 25.30 1.33E-36
Chn2 chimerin 2 2.31 3.64E-36
Nkx6-2 NK6 homeobox 2 5.52 4.50E-36
Robo1 roundabout guidance receptor 1 0.44 6.93E-36
Vamp1 vesicle-associated membrane protein 1 2.35 2.10E-35
B3gat1 beta-1,3-glucuronyltransferase 1 (glucuronosyl-transferase P) 0.49 2.16E-35
Iqgap2 IQ motif containing GTPase activating protein 2 0.38 3.11E-35
Oxtr oxytocin receptor 0.36 1.08E-34
Arhgef28 Rho guanine nucleotide exchange factor (GEF) 28 0.50 1.58E-34
Trp53i11 transformation related protein 53 inducible pro-tein 11 0.24 1.99E-34
Xirp2 xin actin-binding repeat containing 2 4.60 2.29E-34
Wnt2b wingless-type MMTV integration site family, member 2B 3.87 3.65E-34
Timp2 tissue inhibitor of metalloproteinase 2 0.48 5.56E-34
Scn3b sodium channel, voltage-gated, type III, beta 0.37 5.77E-34
Gm20752 predicted gene, 20752 5.95 9.22E-34
Gdf10 growth differentiation factor 10 0.36 1.10E-33
Astn2 astrotactin 2 2.70 4.01E-33
Gjc2 gap junction protein, gamma 2 3.93 4.51E-33
Trpc6 transient receptor potential cation channel, sub-family C, member 6 0.19 4.90E-33
Cyp39a1 cytochrome P450, family 39, subfamily a, poly-peptide 1 4.36 7.78E-33
Scn1a sodium channel, voltage-gated, type I, alpha 2.06 8.44E-33
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Scml4 sex comb on midleg-like 4 (Drosophila) 0.19 9.95E-33
C2cd4c C2 calcium-dependent domain containing 4C 0.38 2.70E-32
Nell1 NEL-like 1 2.07 3.17E-32
Klhl13 kelch-like 13 0.48 3.28E-32
Ypel1 yippee-like 1 (Drosophila) 0.40 3.30E-32
Sdk2 sidekick cell adhesion molecule 2 0.30 4.44E-32
Dcdc2a doublecortin domain containing 2a 2.31 5.25E-32
Ipcef1 interaction protein for cytohesin exchange factors 1 2.05 5.47E-32
Sema3f sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F 2.82 5.69E-32
Shisa9 shisa family member 9 0.48 7.27E-32
Brinp3 bone morphogenetic protein/retinoic acid induc-
ible neural specific 3
2.31 7.36E-32
Myo16 myosin XVI 2.67 8.18E-32
Ndnf neuron-derived neurotrophic factor 0.19 8.94E-32
Hap1 huntingtin-associated protein 1 0.45 1.15E-31
Prkcg protein kinase C, gamma 0.28 1.39E-31
Trpm4 transient receptor potential cation channel, sub-family M, member 4 2.51 2.20E-31
C030013G03Rik RIKEN cDNA C030013G03 gene 11.57 2.64E-31
Fam160a1 family with sequence similarity 160, member A1 5.31 2.64E-31
Wnt9a wingless-type MMTV integration site family, member 9A 2.17 3.42E-31
Atp2b4 ATPase, Ca++ transporting, plasma membrane 4 0.20 4.20E-31
Sulf1 sulfatase 1 0.23 5.10E-31
Kcna3 potassium voltage-gated channel, shaker-related subfamily, member 3 0.35 6.05E-31
Plxdc1 plexin domain containing 1 2.45 9.77E-31
Usp27x ubiquitin specific peptidase 27, X chromosome 0.43 9.85E-31
Nbl1 neuroblastoma, suppression of tumorigenicity 1 0.44 1.46E-30
Arhgap6 Rho GTPase activating protein 6 0.23 1.46E-30
Bmp3 bone morphogenetic protein 3 0.25 5.65E-30
Hcn4 hyperpolarization-activated, cyclic nucleo-tide-gated K+ 4 0.31 9.34E-30
Adra1b adrenergic receptor, alpha 1b 0.45 9.77E-30
Psrc1 proline/serine-rich coiled-coil 1 2.10 6.46E-29
Il12a interleukin 12a 4.50 1.08E-28
Vat1l vesicle amine transport protein 1 like 0.36 1.10E-28
Krt77 keratin 77 0.24 2.20E-28
Ptpru protein tyrosine phosphatase, receptor type, U 0.36 3.00E-28
Pax6 paired box 6 0.40 3.20E-28
Dgkg diacylglycerol kinase, gamma 0.44 5.27E-28
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C1ql3 C1q-like 3 0.41 5.99E-28
Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3) 0.47 9.36E-28
Rin1 Ras and Rab interactor 1 0.48 1.26E-27
Grp gastrin releasing peptide 0.16 1.82E-27
Rgs8 regulator of G-protein signaling 8 0.25 2.50E-27
Gng7 guanine nucleotide binding protein (G protein), gamma 7 0.37 3.13E-27
Aifm3 apoptosis-inducing factor, mitochondrion-associ-ated 3 2.12 3.76E-27
Ramp3 receptor (calcitonin) activity modifying protein 3 0.40 4.34E-27
Fmo1 flavin containing monooxygenase 1 0.36 4.70E-27
Tnc tenascin C 0.19 1.08E-26
Ankrd63 ankyrin repeat domain 63 0.24 1.27E-26
Ptpro protein tyrosine phosphatase, receptor type, O 0.45 2.68E-26
Cacna1h calcium channel, voltage-dependent, T type, alpha 1H subunit 0.45 2.68E-26
Prr16 proline rich 16 2.76 3.27E-26
6330403A02Rik N/A 0.27 3.54E-26
Nrp2 neuropilin 2 0.33 4.38E-26
Ndst4 N-deacetylase/N-sulfotransferase (heparin glu-cosaminyl) 4 0.06 4.63E-26
Igfbp4 insulin-like growth factor binding protein 4 0.34 4.63E-26
B3gnt2 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucos-aminyltransferase 2 0.50 4.91E-26
Celf6 CUGBP, Elav-like family member 6 0.44 7.29E-26
Lrrc55 leucine rich repeat containing 55 2.79 7.42E-26
Il4ra interleukin 4 receptor, alpha 2.79 1.35E-25
B230216N24Rik RIKEN cDNA B230216N24 gene 0.22 1.42E-25
Gjb1 gap junction protein, beta 1 4.60 3.58E-25
Adamts2 a disintegrin-like and metallopeptidase (reproly-sin type) with thrombospondin type 1 motif, 2 0.24 3.69E-25
Tspan11 tetraspanin 11 2.80 4.63E-25
Opalin oligodendrocytic myelin paranodal and inner loop protein 4.39 4.81E-25
Zdhhc23 zinc finger, DHHC domain containing 23 0.43 4.97E-25
Gm14015 predicted gene 14015 11.77 5.49E-25
Adamts13 a disintegrin-like and metallopeptidase (reproly-sin type) with thrombospondin type 1 motif, 13 0.22 6.58E-25
Sgpp2 sphingosine-1-phosphate phosphotase 2 2.79 7.65E-25
Shisa6 shisa family member 6 2.98 1.01E-24
Penk preproenkephalin 0.32 1.19E-24
Id4 inhibitor of DNA binding 4 0.46 1.32E-24
Lpl lipoprotein lipase 0.40 2.13E-24
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Neurl1b neuralized E3 ubiquitin protein ligase 1B 0.49 2.50E-24
Fst follistatin 0.19 3.18E-24
S1pr5 sphingosine-1-phosphate receptor 5 2.55 4.46E-24
Pvalb parvalbumin 2.61 5.79E-24
Relt RELT tumor necrosis factor receptor 2.16 7.00E-24
AI504432 expressed sequence AI504432 0.45 8.20E-24
Asb11 ankyrin repeat and SOCS box-containing 11 3.52 1.25E-23
Actn2 actinin alpha 2 0.43 3.31E-23
Dgkb diacylglycerol kinase, beta 0.34 5.86E-23
Rcn1 reticulocalbin 1 0.48 6.76E-23
Tmem200b transmembrane protein 200B 3.51 7.31E-23
Grm1 glutamate receptor, metabotropic 1 0.47 8.02E-23
Zar1 zygote arrest 1 0.04 8.41E-23
Fmn1 formin 1 2.27 8.84E-23
6530403H02Rik RIKEN cDNA 6530403H02 gene 0.05 1.04E-22
Myh7b myosin, heavy chain 7B, cardiac muscle, beta 2.81 1.06E-22
Esr1 estrogen receptor 1 (alpha) 0.12 1.54E-22
Kndc1 kinase non-catalytic C-lobe domain (KIND) containing 1 2.04 1.75E-22
Syt17 synaptotagmin XVII 0.24 2.08E-22
Ovol2 ovo like zinc finger 2 4.14 2.17E-22
Aldh3b2 aldehyde dehydrogenase 3 family, member B2 0.22 2.74E-22
Lct lactase 0.21 2.82E-22
Sec14l5 SEC14-like lipid binding 5 4.66 3.68E-22
Ankrd6 ankyrin repeat domain 6 0.38 4.76E-22
Gm13629 predicted gene 13629 3.46 4.79E-22
Papss2 3’-phosphoadenosine 5’-phosphosulfate synthase 2 0.37 5.23E-22
Mcam melanoma cell adhesion molecule 2.49 6.69E-22
Thbs4 thrombospondin 4 0.08 7.02E-22
Boc
biregional cell adhesion molecule-related/
down-regulated by oncogenes (Cdon) binding 
protein
2.15 7.02E-22
Otof otoferlin 0.16 7.22E-22
Unc5b unc-5 netrin receptor B 2.29 1.32E-21
Rps6ka2 ribosomal protein S6 kinase, polypeptide 2 0.46 1.74E-21
S100a10 S100 calcium binding protein A10 (calpactin) 2.76 2.02E-21
Igsf9 immunoglobulin superfamily, member 9 2.04 2.20E-21
Mxra7 matrix-remodelling associated 7 2.02 2.53E-21
Chrm3 cholinergic receptor, muscarinic 3, cardiac 0.47 5.23E-21
Ppp1r14a protein phosphatase 1, regulatory (inhibitor) subunit 14A 3.59 1.01E-20
Coch cochlin 2.92 1.17E-20
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Rnf144b ring finger protein 144B 2.03 1.39E-20
Nxf7 nuclear RNA export factor 7 3.73 1.65E-20
Cdc42ep2 CDC42 effector protein (Rho GTPase binding) 2 2.06 1.80E-20
Galnt6 UDP-N-acetyl-alpha-D-galactosamine:polypep-tide N-acetylgalactosaminyltransferase 6 3.26 2.40E-20
Lrrtm4 leucine rich repeat transmembrane neuronal 4 0.39 2.52E-20
Mc4r melanocortin 4 receptor 0.08 2.62E-20
Tnnc1 troponin C, cardiac/slow skeletal 0.45 2.77E-20
Hapln2 hyaluronan and proteoglycan link protein 2 4.62 3.10E-20
Masp1 mannan-binding lectin serine peptidase 1 2.09 4.22E-20
Olfr316 olfactory receptor 316 14.52 5.39E-20
Plekhg3 pleckstrin homology domain containing, family G (with RhoGef domain) member 3 2.33 5.79E-20
Dsel dermatan sulfate epimerase-like 0.49 6.56E-20
Mir124a-1hg Mir124-1 host gene (non-protein coding) 2.14 7.31E-20
Gucy2g guanylate cyclase 2g 2.67 7.31E-20
Adamts4 a disintegrin-like and metallopeptidase (reproly-sin type) with thrombospondin type 1 motif, 4 2.32 9.53E-20
Krt73 keratin 73 0.12 1.00E-19
Hrh3 histamine receptor H3 2.54 1.06E-19
Gabrg3 gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3 0.35 1.26E-19
Gpc4 glypican 4 0.35 1.29E-19
Dll1 delta-like 1 (Drosophila) 0.44 1.43E-19
Myo5c myosin VC 2.11 1.66E-19
Cgref1 cell growth regulator with EF hand domain 1 0.44 1.74E-19
Emilin2 elastin microfibril interfacer 2 5.26 1.87E-19
Kcnh5 potassium voltage-gated channel, subfamily H (eag-related), member 5 2.35 2.13E-19
Smad3 SMAD family member 3 0.47 2.50E-19
Ndst3 N-deacetylase/N-sulfotransferase (heparan glu-cosaminyl) 3 0.48 2.97E-19
Zfp831 zinc finger protein 831 0.39 3.45E-19
Slit3 slit homolog 3 (Drosophila) 0.41 4.24E-19
Sec14l3 SEC14-like lipid binding 3 0.11 5.00E-19
Sstr4 somatostatin receptor 4 0.35 5.13E-19
Klhl4 kelch-like 4 0.49 7.34E-19
Glra3 glycine receptor, alpha 3 subunit 0.15 8.20E-19
Sh3bp4 SH3-domain binding protein 4 0.49 1.02E-18
Nos1 nitric oxide synthase 1, neuronal 0.27 1.19E-18
Nkpd1 NTPase, KAP family P-loop domain containing 1 0.26 1.30E-18
Rlbp1 retinaldehyde binding protein 1 0.49 1.51E-18
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Meis2 Meis homeobox 2 0.48 2.25E-18
Reep6 receptor accessory protein 6 0.45 2.45E-18
Ebf2 early B cell factor 2 0.14 3.06E-18
Gm12992 predicted gene 12992 2.75 3.75E-18
Dysf dysferlin 0.30 4.49E-18
6330416G13Rik N/A 2.22 4.58E-18
Tesc tescalcin 0.41 4.86E-18
Adamtsl5 ADAMTS-like 5 2.77 5.68E-18
Cybrd1 cytochrome b reductase 1 0.32 6.76E-18
Slc45a3 solute carrier family 45, member 3 5.96 6.99E-18
Baz1a bromodomain adjacent to zinc finger domain 1A 0.37 1.19E-17
P2rx4
purinergic receptor P2X, ligand-gated ion chan-
nel 4 2.06 1.83E-17
Pdlim2 PDZ and LIM domain 2 3.19 1.95E-17
Slc29a4 solute carrier family 29 (nucleoside transporters), member 4 0.32 2.57E-17
Cntnap5c contactin associated protein-like 5C 0.25 2.75E-17
Cartpt CART prepropeptide 6.59 3.66E-17
Ankrd34c ankyrin repeat domain 34C 2.29 3.91E-17
Scn9a sodium channel, voltage-gated, type IX, alpha 3.41 4.06E-17
Ntf3 neurotrophin 3 0.08 4.30E-17
5930438M14Rik RIKEN cDNA 5930438M14 gene 4.52 7.14E-17
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 0.32 7.23E-17
Lrrtm3 leucine rich repeat transmembrane neuronal 3 0.45 7.53E-17
Hes3 hairy and enhancer of split 3 (Drosophila) 10.80 7.70E-17
Prr5l proline rich 5 like 3.02 9.24E-17
Dok4 docking protein 4 0.49 1.07E-16
Hpse heparanase 5.39 1.08E-16
Socs3 suppressor of cytokine signaling 3 0.42 1.19E-16
Medag mesenteric estrogen dependent adipogenesis 2.35 1.19E-16
Mas1 MAS1 oncogene 0.28 1.27E-16
Filip1 filamin A interacting protein 1 0.37 1.61E-16
Sorcs3 sortilin-related VPS10 domain containing recep-tor 3 0.48 1.73E-16
Itih3 inter-alpha trypsin inhibitor, heavy chain 3 2.25 1.79E-16
Pdzrn4 PDZ domain containing RING finger 4 0.47 1.89E-16
Nipal4 NIPA-like domain containing 4 4.41 2.01E-16
Cdr2 cerebellar degeneration-related 2 2.89 2.06E-16
Anln anillin, actin binding protein 2.83 2.06E-16
Gsn gelsolin 2.05 2.24E-16
Rsph4a radial spoke head 4 homolog A (Chlamydomo-nas) 0.17 2.95E-16
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Kcng1 potassium voltage-gated channel, subfamily G, member 1 0.16 2.96E-16
Myh7 myosin, heavy polypeptide 7, cardiac muscle, beta 0.25 3.19E-16
Ccdc36 coiled-coil domain containing 36 0.23 4.79E-16
Tcerg1l transcription elongation regulator 1-like 0.35 5.62E-16
Gm15867 predicted gene 15867 2.86 5.94E-16
Prr18 proline rich 18 2.40 6.12E-16
Klhdc8a kelch domain containing 8A 3.15 6.62E-16
Podn podocan 0.34 6.91E-16
Adam33 a disintegrin and metallopeptidase domain 33 3.42 7.33E-16
Abracl ABRA C-terminal like 2.91 7.84E-16
Sertm1 serine rich and transmembrane domain contain-ing 1 0.49 8.79E-16
Greb1l growth regulation by estrogen in breast can-cer-like 0.45 9.16E-16
Lamc2 laminin, gamma 2 3.74 1.01E-15
Atp6v1c2 ATPase, H+ transporting, lysosomal V1 subunit C2 0.22 1.03E-15
Tmco5 transmembrane and coiled-coil domains 5 0.27 1.16E-15
Slc7a11 solute carrier family 7 (cationic amino acid trans-porter, y+ system), member 11 0.40 1.18E-15
Gpc6 glypican 6 0.47 1.24E-15
Lipg lipase, endothelial 0.33 1.31E-15
Gm4371 eukaryotic translation initiation factor 3, subunit I pseudogene 4.60 1.32E-15
Ptpn14 protein tyrosine phosphatase, non-receptor type 14 0.36 1.57E-15
Ryr3 ryanodine receptor 3 0.49 1.61E-15
Ocm oncomodulin 3.87 1.91E-15
Syt9 synaptotagmin IX 0.36 2.13E-15
S1pr3 sphingosine-1-phosphate receptor 3 2.03 2.89E-15
Grap2 GRB2-related adaptor protein 2 5.44 3.65E-15
Fndc9 fibronectin type III domain containing 9 0.39 4.12E-15
Gamt guanidinoacetate methyltransferase 2.12 4.26E-15
C130026L21Rik RIKEN cDNA C130026L21 gene 0.32 5.70E-15
Hs3st3b1 heparan sulfate (glucosamine) 3-O-sulfotransfer-ase 3B1 0.35 7.78E-15
Tac2 tachykinin 2 0.28 8.74E-15
Fgf3 fibroblast growth factor 3 0.10 1.03E-14
Epha3 Eph receptor A3 0.34 1.13E-14
Smoc2 SPARC related modular calcium binding 2 2.70 1.17E-14
Enc1 ectodermal-neural cortex 1 0.49 1.26E-14
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Amz1 archaelysin family metallopeptidase 1 0.44 1.33E-14
Tcfl5 transcription factor-like 5 (basic helix-loop-helix) 0.12 1.34E-14
A2m alpha-2-macroglobulin 0.26 1.52E-14
Trpc5
transient receptor potential cation channel, sub-
family C, member 5 0.47 1.78E-14
Epha6 Eph receptor A6 0.42 2.56E-14
Smoc1 SPARC related modular calcium binding 1 0.50 3.30E-14
Metrnl meteorin, glial cell differentiation regulator-like 0.49 3.31E-14
9630013A20Rik RIKEN cDNA 9630013A20 gene 2.28 3.89E-14
Wdfy4 WD repeat and FYVE domain containing 4 0.48 4.41E-14
Dtl denticleless E3 ubiquitin protein ligase 2.38 5.18E-14
Atp8b1 ATPase, class I, type 8B, member 1 3.26 5.71E-14
Cacng5
calcium channel, voltage-dependent, gamma 
subunit 5 0.50 6.16E-14
Tnni1 troponin I, skeletal, slow 1 3.88 6.17E-14
Rsph9 radial spoke head 9 homolog (Chlamydomonas) 0.46 6.89E-14
Il12rb1 interleukin 12 receptor, beta 1 3.34 9.58E-14
Lrrc38 leucine rich repeat containing 38 2.55 1.52E-13
Fgd3 FYVE, RhoGEF and PH domain containing 3 2.10 1.53E-13
A330102I10Rik RIKEN cDNA A330102I10 gene 2.07 1.57E-13
Trpc3
transient receptor potential cation channel, sub-
family C, member 3 2.14 1.67E-13
Hs3st2
heparan sulfate (glucosamine) 3-O-sulfotransfer-
ase 2 3.22 2.11E-13
Cnksr3 Cnksr family member 3 2.05 3.24E-13
Pcsk5 proprotein convertase subtilisin/kexin type 5 0.42 3.52E-13
Igtp interferon gamma induced GTPase 3.66 4.29E-13
Ccbe1 collagen and calcium binding EGF domains 1 0.46 4.74E-13
Chrm2 cholinergic receptor, muscarinic 2, cardiac 3.54 4.79E-13
Col6a3 collagen, type VI, alpha 3 0.33 5.67E-13
Tnn tenascin N 0.16 6.60E-13
Col6a5 collagen, type VI, alpha 5 0.18 6.77E-13
Hpgd hydroxyprostaglandin dehydrogenase 15 (NAD) 0.47 7.40E-13
Camk1g
calcium/calmodulin-dependent protein kinase I 
gamma 0.43 9.76E-13
Aspa aspartoacylase 2.80 9.95E-13
Rxfp1 relaxin/insulin-like family peptide receptor 1 0.30 1.10E-12
Dlx6os1 distal-less homeobox 6, opposite strand 1 0.48 1.11E-12
Socs2 suppressor of cytokine signaling 2 2.20 1.52E-12
Erbb3 erb-b2 receptor tyrosine kinase 3 2.16 1.55E-12
Dmkn dermokine 0.28 1.78E-12
Moxd1 monooxygenase, DBH-like 1 0.38 2.10E-12
Dnah10 dynein, axonemal, heavy chain 10 2.55 2.33E-12
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Aldh1a3 aldehyde dehydrogenase family 1, subfamily A3 0.14 3.33E-12
Adgrg2 adhesion G protein-coupled receptor G2 0.28 4.63E-12
Syt2 synaptotagmin II 2.37 4.71E-12
Fam19a1 family with sequence similarity 19, member A1 0.46 5.01E-12
Tbx22 T-box 22 0.12 6.52E-12
4930470P17Rik RIKEN cDNA 4930470P17 gene 0.30 8.93E-12
Wnt3
wingless-type MMTV integration site family, 
member 3 3.20 1.38E-11
Pdlim3 PDZ and LIM domain 3 4.87 1.50E-11
Myh1
myosin, heavy polypeptide 1, skeletal muscle, 
adult 0.32 1.77E-11
Qrfpr pyroglutamylated RFamide peptide receptor 0.26 1.83E-11
Cldn14 claudin 14 3.79 1.87E-11
Pcsk9 proprotein convertase subtilisin/kexin type 9 0.38 2.07E-11
Twist2 twist basic helix-loop-helix transcription factor 2 0.28 2.20E-11
Tle6 transducin-like enhancer of split 6 3.00 2.28E-11
Pvrl3 N/A 0.47 2.34E-11
Cdsn corneodesmosin 2.48 2.37E-11
Neurod6 neurogenic differentiation 6 2.55 2.66E-11
Trpc7
transient receptor potential cation channel, sub-
family C, member 7 0.29 2.66E-11
Pdpn podoplanin 0.50 2.76E-11
Angpt1 angiopoietin 1 0.45 3.45E-11
Kcnk13 potassium channel, subfamily K, member 13 0.36 3.94E-11
Gm10421 predicted gene 10421 0.31 5.60E-11
Nnat neuronatin 0.30 5.90E-11
Col14a1 collagen, type XIV, alpha 1 0.17 6.36E-11
Zfp54 zinc finger protein 54 3.65 6.90E-11
Tusc5 tumor suppressor candidate 5 4.67 7.40E-11
Plekhd1
pleckstrin homology domain containing, family 
D (with coiled-coil domains) member 1 0.36 7.79E-11
C920025E04Rik N/A 4.28 9.02E-11
1700016K19Rik RIKEN cDNA 1700016K19 gene 0.38 1.16E-10
Dusp4 dual specificity phosphatase 4 0.46 1.26E-10
Aspg asparaginase 0.27 1.45E-10
Dmrtb1
DMRT-like family B with proline-rich C-termi-
nal, 1 0.28 1.68E-10
Pde11a phosphodiesterase 11A 0.46 1.72E-10
Msln mesothelin 0.17 1.82E-10
Papln papilin, proteoglycan-like sulfated glycoprotein 0.40 1.89E-10
C1s1 complement component 1, s subcomponent 1 2.55 2.01E-10
Pnma1 paraneoplastic antigen MA1 0.49 2.23E-10
Cldn3 claudin 3 0.26 2.45E-10
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St18 suppression of tumorigenicity 18 2.56 3.11E-10
Teddm3 transmembrane epididymal family member 3 0.16 3.64E-10
Myoc myocilin 0.01 4.25E-10
AW551984 expressed sequence AW551984 0.26 4.67E-10
Gm16702 predicted gene, 16702 0.27 5.16E-10
Lrrc10b leucine rich repeat containing 10B 0.37 5.94E-10
Cpm carboxypeptidase M 2.18 6.00E-10
Tenm1 teneurin transmembrane protein 1 0.45 6.80E-10
C1ra complement component 1, r subcomponent A 2.13 6.83E-10
Ngf nerve growth factor 0.47 6.97E-10
Ctsk cathepsin K 0.49 7.47E-10
Hspb8 heat shock protein 8 0.47 9.96E-10
Matn2 matrilin 2 0.45 1.12E-09
Ttc22 tetratricopeptide repeat domain 22 0.39 1.21E-09
Cort cortistatin 0.48 1.23E-09
Lamb3 laminin, beta 3 0.29 1.26E-09
Vmn2r87 vomeronasal 2, receptor 87 2.05 1.27E-09
Fcgbp Fc fragment of IgG binding protein 0.27 1.39E-09
Tmem159 transmembrane protein 159 2.38 1.43E-09
Sspo SCO-spondin 3.05 1.45E-09
Zfp804b zinc finger protein 804B 0.16 1.73E-09
Nxph2 neurexophilin 2 0.34 2.06E-09
Nod2
nucleotide-binding oligomerization domain con-
taining 2 0.30 2.07E-09
Htr2c 5-hydroxytryptamine (serotonin) receptor 2C 0.36 2.10E-09
Cbln4 cerebellin 4 precursor protein 2.18 2.30E-09
Sptssb serine palmitoyltransferase, small subunit B 2.27 2.32E-09
Shisa3 shisa family member 3 5.16 2.43E-09
Fgf10 fibroblast growth factor 10 0.38 2.61E-09
A930012L18Rik RIKEN cDNA A930012L18 gene 2.37 3.73E-09
2010109I03Rik RIKEN cDNA 2010109I03 gene 4.14 3.74E-09
Jsrp1 junctional sarcoplasmic reticulum protein 1 0.49 4.09E-09
Six4 sine oculis-related homeobox 4 2.86 4.41E-09
Pthlh parathyroid hormone-like peptide 2.08 5.20E-09
Mdga1
MAM domain containing glycosylphosphatidyli-
nositol anchor 1 0.49 5.41E-09
Slco5a1
solute carrier organic anion transporter family, 
member 5A1 2.15 5.80E-09
5830416P10Rik N/A 0.28 5.92E-09
Onecut2 one cut domain, family member 2 3.78 6.11E-09
Slc16a10
solute carrier family 16 (monocarboxylic acid 
transporters), member 10 0.49 6.29E-09
Rerg RAS-like, estrogen-regulated, growth-inhibitor 2.03 6.30E-09
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Sgk2 serum/glucocorticoid regulated kinase 2 3.31 6.68E-09
Igfn1
immunoglobulin-like and fibronectin type III 
domain containing 1 0.46 7.09E-09
Cdh1 cadherin 1 0.01 7.30E-09
Abca6
ATP-binding cassette, sub-family A (ABC1), 
member 6 0.43 7.40E-09
Fbln1 fibulin 1 0.43 8.00E-09
Hsbp1l1 heat shock factor binding protein 1-like 1 2.38 8.40E-09
Nkx3-1 NK-3 transcription factor, locus 1 (Drosophila) 2.23 9.17E-09
AA387883 expressed sequence AA387883 0.34 9.32E-09
Col8a1 collagen, type VIII, alpha 1 4.81 9.72E-09
Lrrc43 leucine rich repeat containing 43 0.31 1.02E-08
Alpk2 alpha-kinase 2 3.74 1.04E-08
Samd9l sterile alpha motif domain containing 9-like 0.42 1.04E-08
Sec1 secretory blood group 1 2.26 1.06E-08
E130008D07Rik RIKEN cDNA E130008D07 gene 0.28 1.21E-08
Fbxl7 F-box and leucine-rich repeat protein 7 0.29 1.32E-08
Casr calcium-sensing receptor 4.03 1.43E-08
Palm3 paralemmin 3 0.42 1.58E-08
Atoh8 atonal bHLH transcription factor 8 0.23 2.22E-08
Cyp26b1
cytochrome P450, family 26, subfamily b, poly-
peptide 1 4.68 2.46E-08
Pcdhb8 protocadherin beta 8 2.20 2.46E-08
Frem1 Fras1 related extracellular matrix protein 1 0.49 2.74E-08
Zmynd10 zinc finger, MYND domain containing 10 0.41 3.07E-08
Upk1b uroplakin 1B 0.22 3.14E-08
Crhr2 corticotropin releasing hormone receptor 2 0.32 3.84E-08
Sla src-like adaptor 0.42 3.88E-08
Atoh7 atonal bHLH transcription factor 7 3.53 4.05E-08
H2-Bl histocompatibility 2, blastocyst 5.28 5.83E-08
Adam12
a disintegrin and metallopeptidase domain 12 
(meltrin alpha) 0.49 6.07E-08
Sycp2 synaptonemal complex protein 2 2.55 6.50E-08
Slc26a4 solute carrier family 26, member 4 0.27 6.80E-08
Klhl1 kelch-like 1 0.43 7.12E-08
Slc28a1
solute carrier family 28 (sodium-coupled nucleo-
side transporter), member 1 0.29 1.02E-07
Col22a1 collagen, type XXII, alpha 1 0.43 1.03E-07
Grm8 glutamate receptor, metabotropic 8 0.41 1.06E-07
Adgrf4 adhesion G protein-coupled receptor F4 2.29 1.10E-07
Slc13a4
solute carrier family 13 (sodium/sulfate symport-
ers), member 4 0.03 1.25E-07
Dkk2 dickkopf WNT signaling pathway inhibitor 2 0.34 1.32E-07
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B3gnt7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucos-
aminyltransferase 7 0.41 1.37E-07
Cd200r4 CD200 receptor 4 2.85 1.43E-07
Chia1 chitinase, acidic 1 0.32 1.68E-07
Magel2 melanoma antigen, family L, 2 0.30 1.74E-07
Endou endonuclease, polyU-specific 2.76 2.16E-07
Osmr oncostatin M receptor 0.45 2.40E-07
Prima1 proline rich membrane anchor 1 2.68 2.50E-07
Obscn
obscurin, cytoskeletal calmodulin and titin-inter-
acting RhoGEF 0.49 2.66E-07
A830011K09Rik RIKEN cDNA A830011K09 gene 2.13 3.18E-07
Vtcn1
V-set domain containing T cell activation inhibi-
tor 1 0.29 3.29E-07
Pth2r parathyroid hormone 2 receptor 2.19 3.32E-07
Plscr1 phospholipid scramblase 1 0.30 3.51E-07
C4b complement component 4B (Chido blood group) 0.20 3.68E-07
Myh2
myosin, heavy polypeptide 2, skeletal muscle, 
adult 0.41 3.92E-07
Tnnt2 troponin T2, cardiac 2.15 4.39E-07
Gm1653 predicted gene 1653 3.32 4.75E-07
Ace
angiotensin I converting enzyme (peptidyl-dipep-
tidase A) 1 0.44 5.02E-07
Unc13d unc-13 homolog D (C. elegans) 0.43 5.15E-07
Bace2 beta-site APP-cleaving enzyme 2 2.14 5.20E-07
Adgrd1 adhesion G protein-coupled receptor D1 0.49 5.88E-07
Fam196b family with sequence similarity 196, member B 0.35 6.09E-07
Tshr thyroid stimulating hormone receptor 0.24 6.48E-07
Ankfn1
ankyrin-repeat and fibronectin type III domain 
containing 1 2.39 6.80E-07
Tmem255b transmembrane protein 255B 0.48 7.27E-07
Wnt10b
wingless-type MMTV integration site family, 
member 10B 0.35 7.27E-07
4932411E22Rik N/A 2.10 7.62E-07
Insc inscuteable homolog (Drosophila) 2.86 8.28E-07
Ninj2 ninjurin 2 2.57 8.85E-07
Tmc3 transmembrane channel-like gene family 3 2.44 1.03E-06
Ecel1 endothelin converting enzyme-like 1 0.47 1.05E-06
Rxrg retinoid X receptor gamma 0.40 1.10E-06
Cd200r1 CD200 receptor 1 2.28 1.13E-06
Atp10b ATPase, class V, type 10B 2.14 1.15E-06
Aebp1 AE binding protein 1 0.12 1.15E-06
Ptgds prostaglandin D2 synthase (brain) 0.04 1.15E-06
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Slc23a3
solute carrier family 23 (nucleobase transport-
ers), member 3 0.40 1.23E-06
Fam83f family with sequence similarity 83, member F 3.70 1.26E-06
Ehf ets homologous factor 5.68 1.50E-06
Mpzl2 myelin protein zero-like 2 0.03 1.58E-06
Slco4c1
solute carrier organic anion transporter family, 
member 4C1 0.48 1.59E-06
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, 
member 1 0.23 1.68E-06
Dock5 dedicator of cytokinesis 5 2.00 2.15E-06
Samd3 sterile alpha motif domain containing 3 0.32 2.29E-06
Ldb2 LIM domain binding 2 0.48 2.40E-06
Ppp1r36 protein phosphatase 1, regulatory subunit 36 0.28 2.45E-06
Arsi arylsulfatase i 2.99 2.48E-06
Adamts16
a disintegrin-like and metallopeptidase (reproly-
sin type) with thrombospondin type 1 motif, 16 0.36 2.65E-06
Crb1
crumbs family member 1, photoreceptor morpho-
genesis associated 0.33 2.71E-06
Folr1 folate receptor 1 (adult) 0.39 3.23E-06
Vrk2 vaccinia related kinase 2 0.43 3.27E-06
Gipr gastric inhibitory polypeptide receptor 0.49 3.28E-06
Pla2g4e phospholipase A2, group IVE 2.40 3.53E-06
Nkd2 naked cuticle 2 homolog (Drosophila) 0.48 3.84E-06
Dnah7a dynein, axonemal, heavy chain 7A 0.43 3.91E-06
Itprip
inositol 1,4,5-triphosphate receptor interacting 
protein 0.48 4.51E-06
Pkp2 plakophilin 2 0.37 4.78E-06
Akr1c18 aldo-keto reductase family 1, member C18 2.23 4.78E-06
Dnase1l2 deoxyribonuclease 1-like 2 2.29 4.83E-06
Smco3
single-pass membrane protein with coiled-coil 
domains 3 2.23 4.83E-06
Ccno cyclin O 0.48 4.92E-06
Slc35d3 solute carrier family 35, member D3 0.39 5.09E-06
Inhbe inhibin beta-E 2.87 5.40E-06
Ltbp2
latent transforming growth factor beta binding 
protein 2 0.45 5.44E-06
Crabp2 cellular retinoic acid binding protein II 0.19 5.56E-06
Ctnna3 catenin (cadherin associated protein), alpha 3 0.41 6.08E-06
Trim72 tripartite motif-containing 72 2.77 6.74E-06
Fgf22 fibroblast growth factor 22 2.06 7.64E-06
Bicc1 BicC family RNA binding protein 1 0.47 7.95E-06
Efemp1
epidermal growth factor-containing fibulin-like 
extracellular matrix protein 1 0.39 8.32E-06
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Fgf23 fibroblast growth factor 23 2.49 9.13E-06
Abca8a
ATP-binding cassette, sub-family A (ABC1), 
member 8a 0.37 9.62E-06
Prss22 protease, serine 22 0.42 9.79E-06
2310065F04Rik RIKEN cDNA 2310065F04 gene 0.36 9.89E-06
Fndc8 fibronectin type III domain containing 8 2.22 9.89E-06
F2rl2 coagulation factor II (thrombin) receptor-like 2 0.36 1.08E-05
Cldn22 claudin 22 3.30 1.14E-05
Tbata thymus, brain and testes associated 2.48 1.17E-05
Nkain3 Na+/K+ transporting ATPase interacting 3 0.46 1.24E-05
Foxo6 forkhead box O6 0.36 1.54E-05
Plekhs1
pleckstrin homology domain containing, family 
S member 1 0.49 1.58E-05
Dusp2 dual specificity phosphatase 2 0.48 1.71E-05
Rfx2
regulatory factor X, 2 (influences HLA class II 
expression) 0.34 1.82E-05
Aldh1a2 aldehyde dehydrogenase family 1, subfamily A2 0.08 1.97E-05
Sncg synuclein, gamma 0.36 2.04E-05
Pgm5 phosphoglucomutase 5 0.48 2.12E-05
Omd osteomodulin 0.07 2.15E-05
Cdhr3 cadherin-related family member 3 2.69 2.17E-05
Adcy10 adenylate cyclase 10 0.42 2.22E-05
Fxyd2
FXYD domain-containing ion transport regulator 
2 0.48 2.27E-05
Paqr6 progestin and adipoQ receptor family member VI 2.33 2.32E-05
Gjb2 gap junction protein, beta 2 0.26 2.39E-05
Kcnj13
potassium inwardly-rectifying channel, subfami-
ly J, member 13 0.08 2.62E-05
Slc9a3
solute carrier family 9 (sodium/hydrogen ex-
changer), member 3 0.42 2.70E-05
Snora65 small nucleolar RNA, H/ACA box 65 2.02 2.86E-05
Gpr52 G protein-coupled receptor 52 0.41 2.93E-05
Fgfbp1 fibroblast growth factor binding protein 1 0.06 3.21E-05
Itga11 integrin alpha 11 0.39 3.25E-05
Usp51 ubiquitin specific protease 51 0.39 3.31E-05
Bmp7 bone morphogenetic protein 7 0.47 3.37E-05
Col6a4 collagen, type VI, alpha 4 0.34 3.43E-05
Serpind1
serine (or cysteine) peptidase inhibitor, clade D, 
member 1 0.19 3.46E-05
Cited1
Cbp/p300-interacting transactivator with Glu/
Asp-rich carboxy-terminal domain 1 2.07 3.55E-05
Mkrn2os makorin, ring finger protein 2, opposite strand 2.22 3.57E-05
Prelp proline arginine-rich end leucine-rich repeat 0.42 3.59E-05
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Gdf7 growth differentiation factor 7 0.37 3.66E-05
Mmp2 matrix metallopeptidase 2 0.48 3.75E-05
3930402G23Rik RIKEN cDNA 3930402G23 gene 0.48 3.81E-05
Slc22a6
solute carrier family 22 (organic anion transport-
er), member 6 0.07 4.00E-05
Gbp9 guanylate-binding protein 9 0.41 4.11E-05
Klk8 kallikrein related-peptidase 8 0.34 4.26E-05
0610040F04Rik RIKEN cDNA 0610040F04 gene 2.19 4.36E-05
Mypn myopalladin 2.02 4.58E-05
Piezo2
piezo-type mechanosensitive ion channel compo-
nent 2 0.37 5.69E-05
Fam167a family with sequence similarity 167, member A 0.41 6.07E-05
Kl klotho 0.30 6.29E-05
Drd4 dopamine receptor D4 0.39 6.78E-05
Lck lymphocyte protein tyrosine kinase 0.48 7.11E-05
Aox3 aldehyde oxidase 3 0.15 7.11E-05
Prtn3 proteinase 3 0.46 7.13E-05
Lbp lipopolysaccharide binding protein 0.07 7.23E-05
Ctxn3 cortexin 3 0.10 7.24E-05
Osr1 odd-skipped related 1 (Drosophila) 0.05 7.51E-05
Kazald1 Kazal-type serine peptidase inhibitor domain 1 2.39 7.56E-05
Krt80 keratin 80 0.20 7.97E-05
Fam83d family with sequence similarity 83, member D 2.15 8.31E-05
Capn6 calpain 6 2.07 9.79E-05
Ascl5 achaete-scute family bHLH transcription factor 5 0.44 1.05E-04
1700007P06Rik RIKEN cDNA 1700007P06 gene 2.10 1.11E-04
Myh3
myosin, heavy polypeptide 3, skeletal muscle, 
embryonic 0.38 1.25E-04
Thbd thrombomodulin 0.39 1.30E-04
Asgr1 asialoglycoprotein receptor 1 0.14 1.44E-04
Mlf1 myeloid leukemia factor 1 0.38 1.46E-04
Foxc2 forkhead box C2 0.13 1.46E-04
Bcl3 B cell leukemia/lymphoma 3 0.47 1.61E-04
Crispld2
cysteine-rich secretory protein LCCL domain 
containing 2 0.43 1.89E-04
Hhat hedgehog acyltransferase 2.03 1.89E-04
Fmod fibromodulin 0.13 1.97E-04
Adamts9
a disintegrin-like and metallopeptidase (reproly-
sin type) with thrombospondin type 1 motif, 9 0.47 1.97E-04
H2-Ab1 histocompatibility 2, class II antigen A, beta 1 0.24 2.06E-04
Egr2 early growth response 2 0.49 2.17E-04
Mrgprf MAS-related GPR, member F 0.09 2.36E-04
Edar ectodysplasin-A receptor 0.38 2.40E-04
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Eya2
EYA transcriptional coactivator and phosphatase 
2 0.23 2.44E-04
Tfap4 transcription factor AP4 2.03 2.49E-04
Snai3 snail family zinc finger 3 2.28 2.73E-04
Cfh complement component factor h 0.45 2.74E-04
Rph3al rabphilin 3A-like (without C2 domains) 0.41 2.75E-04
Lrg1 leucine-rich alpha-2-glycoprotein 1 0.45 2.85E-04
Slc22a12
solute carrier family 22 (organic anion/cation 
transporter), member 12 0.46 3.04E-04
Baiap3 BAI1-associated protein 3 0.30 3.09E-04
Msx1 msh homeobox 1 0.31 3.11E-04
Dcaf12l2 DDB1 and CUL4 associated factor 12-like 2 0.46 3.11E-04
Fam180a family with sequence similarity 180, member A 0.10 3.16E-04
Tecta tectorin alpha 0.42 3.20E-04
Wnt16
wingless-type MMTV integration site family, 
member 16 0.35 3.21E-04
1700024P16Rik RIKEN cDNA 1700024P16 gene 0.49 3.42E-04
Vit vitrin 0.46 3.59E-04
Slc6a12
solute carrier family 6 (neurotransmitter trans-
porter, betaine/GABA), member 12 0.16 3.61E-04
Agmat agmatine ureohydrolase (agmatinase) 0.50 3.87E-04
Sh3rf2 SH3 domain containing ring finger 2 0.41 3.95E-04
C730002L08Rik RIKEN cDNA C730002L08 gene 0.46 4.02E-04
Slc22a3
solute carrier family 22 (organic cation transport-
er), member 3 0.48 4.21E-04
Fgl2 fibrinogen-like protein 2 0.23 4.26E-04
Pou6f2 POU domain, class 6, transcription factor 2 3.84 4.60E-04
Serping1
serine (or cysteine) peptidase inhibitor, clade G, 
member 1 0.20 4.70E-04
Npff neuropeptide FF-amide peptide precursor 2.14 4.97E-04
1700003F12Rik RIKEN cDNA 1700003F12 gene 2.02 5.01E-04
Aim1l N/A 0.47 5.01E-04
Wif1 Wnt inhibitory factor 1 0.47 5.14E-04
Hcar1 hydrocarboxylic acid receptor 1 0.10 5.61E-04
Ankef1 ankyrin repeat and EF-hand domain containing 1 0.47 5.84E-04
Cd24a CD24a antigen 0.45 6.01E-04
Fibin fin bud initiation factor homolog (zebrafish) 0.38 6.12E-04
Cd163 CD163 antigen 0.41 6.18E-04
Loxl1 lysyl oxidase-like 1 0.41 6.25E-04
Slc6a13
solute carrier family 6 (neurotransmitter trans-
porter, GABA), member 13 0.15 7.79E-04
2310040G24Rik RIKEN cDNA 2310040G24 gene 2.01 8.01E-04
Clspn claspin 0.44 8.11E-04
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Ptch2 patched 2 0.41 8.21E-04
Wfikkn2
WAP, follistatin/kazal, immunoglobulin, kunitz 
and netrin domain containing 2 0.16 8.26E-04
Tnfsf9
tumor necrosis factor (ligand) superfamily, mem-
ber 9 0.35 8.79E-04
8430408G22Rik RIKEN cDNA 8430408G22 gene 2.74 8.81E-04
Tac1 tachykinin 1 0.45 9.37E-04
Rgs1 regulator of G-protein signaling 1 2.28 9.45E-04
Hcrtr2 hypocretin (orexin) receptor 2 0.39 9.50E-04
Gli1 GLI-Kruppel family member GLI1 3.02 1.07E-03
Fezf2 Fez family zinc finger 2 3.69 1.12E-03
Tagln transgelin 0.45 1.23E-03
Slc6a20a
solute carrier family 6 (neurotransmitter trans-
porter), member 20A 0.33 1.27E-03
Ptgfr prostaglandin F receptor 0.18 1.71E-03
Tfap2b transcription factor AP-2 beta 0.19 1.75E-03
Mmel1 membrane metallo-endopeptidase-like 1 2.05 1.78E-03
Igf2 insulin-like growth factor 2 0.25 1.96E-03
Prg4
proteoglycan 4 (megakaryocyte stimulating fac-
tor, articular superficial zone protein) 0.18 2.00E-03
Pdgfrl platelet-derived growth factor receptor-like 0.46 2.01E-03
Rtp1 receptor transporter protein 1 0.38 2.09E-03
Myo1h myosin 1H 0.41 2.12E-03
Wisp1 WNT1 inducible signaling pathway protein 1 0.48 2.33E-03
Rab37 RAB37, member RAS oncogene family 2.37 2.34E-03
Rcn3
reticulocalbin 3, EF-hand calcium binding do-
main 0.47 2.34E-03
A330070K13Rik RIKEN cDNA A330070K13 gene 2.13 2.55E-03
Col4a4 collagen, type IV, alpha 4 0.49 2.65E-03
Wnt6
wingless-type MMTV integration site family, 
member 6 0.34 2.66E-03
Slc9a2
solute carrier family 9 (sodium/hydrogen ex-
changer), member 2 0.36 3.13E-03
Col5a2 collagen, type V, alpha 2 0.42 3.19E-03
Pcolce procollagen C-endopeptidase enhancer protein 0.29 3.24E-03
Anxa1 annexin A1 0.22 3.33E-03
Svep1
sushi, von Willebrand factor type A, EGF and 
pentraxin domain containing 1 0.20 3.39E-03
Bmp6 bone morphogenetic protein 6 0.18 3.48E-03
Islr
immunoglobulin superfamily containing leu-
cine-rich repeat 0.28 3.51E-03
Col1a2 collagen, type I, alpha 2 0.33 3.57E-03
Emp1 epithelial membrane protein 1 0.26 3.81E-03
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Casp4 caspase 4, apoptosis-related cysteine peptidase 0.39 4.24E-03
Cd52 CD52 antigen 0.49 4.89E-03
Cyp1b1
cytochrome P450, family 1, subfamily b, poly-
peptide 1 0.38 5.43E-03
Itih2 inter-alpha trypsin inhibitor, heavy chain 2 0.23 5.58E-03
Dcn decorin 0.24 5.76E-03
Prrx2 paired related homeobox 2 0.47 6.16E-03
Colec12 collectin sub-family member 12 0.38 6.43E-03
Ogn osteoglycin 0.18 6.79E-03
Zic4 zinc finger protein of the cerebellum 4 0.29 6.86E-03
Myof myoferlin 0.42 7.10E-03
S100a11 S100 calcium binding protein A11 0.43 7.64E-03
Gpr182 G protein-coupled receptor 182 0.36 8.14E-03
Ch25h cholesterol 25-hydroxylase 0.39 8.26E-03
Stra6 stimulated by retinoic acid gene 6 0.31 8.31E-03
Cxcl1 chemokine (C-X-C motif) ligand 1 0.46 8.45E-03
Trabd2b TraB domain containing 2B 0.37 8.83E-03
Il1b interleukin 1 beta 0.32 9.30E-03
Col1a1 collagen, type I, alpha 1 0.29 1.07E-02
Foxd1 forkhead box D1 0.44 1.18E-02
Cstad
CSA-conditional, T cell activation-dependent 
protein 0.50 1.19E-02
Gpc3 glypican 3 0.49 1.20E-02
Dpp4 dipeptidylpeptidase 4 0.45 1.54E-02
Enpp1
ectonucleotide pyrophosphatase/phosphodiester-
ase 1 0.43 1.59E-02
Cd14 CD14 antigen 0.47 1.62E-02
H2-Aa histocompatibility 2, class II antigen A, alpha 0.22 1.73E-02
Clec3b C-type lectin domain family 3, member b 0.40 1.98E-02
Cped1
cadherin-like and PC-esterase domain containing 
1 0.37 2.11E-02
Thsd4 thrombospondin, type I, domain containing 4 0.45 2.74E-02
Mrc1 mannose receptor, C type 1 0.42 3.01E-02
Lilrb4a
leukocyte immunoglobulin-like receptor, sub-
family B, member 4A 0.45 3.32E-02
Lyz2 lysozyme 2 0.48 3.55E-02
Gprc5a
G protein-coupled receptor, family C, group 5, 
member A 0.29 3.60E-02
Zic1 zinc finger protein of the cerebellum 1 0.49 3.66E-02
F13a1 coagulation factor XIII, A1 subunit 0.36 3.72E-02
Cubn cubilin (intrinsic factor-cobalamin receptor) 0.42 3.83E-02
Bmp5 bone morphogenetic protein 5 0.40 3.89E-02
Alx4 aristaless-like homeobox 4 0.38 4.00E-02
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Clcf1 cardiotrophin-like cytokine factor 1 0.48 4.10E-02
H2-Eb1 histocompatibility 2, class II antigen E beta 0.48 4.24E-02
Lama1 laminin, alpha 1 0.47 4.32E-02
Cxcl10 chemokine (C-X-C motif) ligand 10 0.46 4.47E-02
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Supplementary Table 2. Protein classes of differentially expressed transcripts across L4 and 
L2/3 in the Control (C) column
Protein class Gene
Calcium-binding pro-
tein
Capn6, Prkcg, Sgk2, Rcn1, Nell1, Rps6ka2, S100a10, Smoc2, 
Cadps2, Klk8 (Kallikrein 1-related peptidase b8), Tnnc1, Plch2, 
Ltbp2, Ccbe1, Pvalb, Rcn3, Tesc, S100a11, Smoc1, Ocm, Klk8 
(Kallikrein-8), C1ra
Cell adhesion molecule Fcgbp, Boc, Cubn, Pcdh19, Dscaml1, Robo1, Cntnap5c, Asgr1, 
Ltbp2, Mypn, Sdk2, Tecta, Ccbe1, Mpzl2, Upk1b, Cdh1, Dcbld2, 
Tspan11, Cdh4, Pcdh8, Igfn1, Mcam, Magel2, Pcolce, Ctnna3, 
Igsf9, Sspo, Pcdhb8, Col8a1, Obscn, Cnr1, Mag, Celsr1, Nrp2, 
Tspan2, Cdhr3
Cell junction protein Myh7, Myh7b, Myo1h, Cldn14, Gjb1, Gjc2, Kirrel3, Myo16, 
Cldn11, Myh1, Myh3, Cldn22, Cldn3, Myo5c, Myh2, Gjb2
Chaperone Alpk2, Ccdc136, Sncg, Hspb8
Cytoskeletal protein Krt77, Emp1, Myh7, Lmo3, Mobp, Myh7b, Myo1h, Sept4, Gfap, 
Tnni1, Camk4, Tnnc1, Whrn, Pdlim3, Pkp2, Pdlim2, Sncg, Ar-
hgap6, Tnnt2, Dnah10, Krt80, Myo16, Marcksl1, Krt73, Myh1, 
Dnase1l2, Myh3, Rsph4a, Tagln, Actn2, Enc1, Ctnna3, Myo5c, 
Myh2, Dnah7a, Xirp2, Gsn, Ermn
Defense/immunity 
protein
Osmr, H2-Aa, Nell1, Boc, H2-Bl, Lbp, Dscaml1, Adgrd1, Adgrf4, 
Robo1, Asgr1, Mypn, Sdk2, Pnma1, Gipr, Crhr2, Mbp, Igfn1, 
A2m, H2-Eb1, H2-Ab1, Zcchc12, Crispld2, Igsf9, Pth2r, Wif1, 
C4b, Il12rb1, Obscn, Mag
Enzyme modulator Adamts2, Adamts16, Fxyd2, Myh7, Mobp, Myh7b, Myo1h, Sept4, 
Rapln, Cubn, Samd3, Rin1, Fst, Klk8, Arhgef28, Wfikkn2, Sel1l3, 
Plch2, Dock5, Itih3, Cntnap5c, Sh3rf2, Chn2, Myo16, Gbp9, 
Serpind1, Dcbld2, Myh1, Myh3, Thsd4, Ccno, Adamtsl5, Rgs1, 
Ccnd2, Plekhg3, Fgd3, Cnksr3, A2m, Klk8, Pcolce, Adamts9, 
Rgs8, Serpinf1, Adamts13, Dpp4, Rgs12, Casp4, Adamts4, Myo5c, 
Myh2, C1ra, Kndc1, Ccdc88c, Iqgap2, C4b, Itih2, Nrp2, Gng7, 
Serping1, Rasal1, AW551984
Extracellular matrix 
protein
Fcgbp, Adamts2, Adamts16, Colec12, Dcn, Lrrtm3, Papln, 
Cubn, Lamc2, Lrrc38, Rxfp1, Lrrtm4, Cntnap5c, Lrrc43, Ltbp2, 
Prelp, Tecta, Lamb3, Tshr, Ccbe1, Clec3b, Dcbld2, Mbp, Thsd4, 
Adamtsl5, Hapln2, Lama1, Podn, Fmod, Islr, Omd, Pcolce, Msln, 
Adamts9, Adamts13, Lrrc55, Adamts4, Sspo, Emilin2, Scube1, 
Ntn5, Col8a1, Ogn, Lrg1, Nrp2
Hydrolase Hpse, Arsj, Adamts2, Aebp1, Lpl, Kl, Capn6, Adamts16, Agmat, 
Masp1, Aspg, Loxl1, Pla2g4e, Papln, Boc, Bace2, Cubn, Pamr1, 
Mmel1, Ecel1, Atp8b1, Klk8, Plch2, Dscaml1, Prtn3, Robo1, 
Cntnap5c, Lct, Prg4, Mypn, Dnah10, Sdk2, Ctsk, Cnp, Ptpn14, 
Enpp1, Atp6v1c2, Dcbld2, Tesc, Cd163, Prss22, Thsd4, Igfn1, 
Adamtsl5, Atp2b4, Gdpd5, Sulf1, Ptpru, Sgpp2, Chia1, Klk8, 
Pcolce, Adamts9, Igsf9, Arsi, Adamts13, Dpp4, Casp4, Adamts4, 
Lipg, C1ra, Pde11a, Dnah7a, Lipg, Cpm, Obscn, Ptpro, Nrp2, 
Atp10b
Isomerase Ptgds, Pgm5
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Ligase Neurl1a, Neurl1b, March4, Gdpd5, Mog, Rnf144b
Lyase Gucy2g
Membrane traffic 
protein
Dysf, Otof, Doc2b, Cpne7, Rph3al, Rin1, Prr18, Sncg, Vamp1, 
Syt9, Cnih3, Syt2, Syt10, Myof, Hap1, Syt9, Cpne6, Ccdc88c, Mal
Nucleic acid binding Meis2, Esr1, Lmo3, Foxo6, Nod2, Plekhd1, Zfp831, Foxc2, Ehf, 
Tbx22, Foxp1, Rsph9, Satb1, Ascl5, Rxrg, Neurod6, Twist2, Ccno, 
Scml4, Atoh7, Cdr2, Osr1, Nkx6-2, Onecut2, Atoh8, Bicc1, Nkx3-
1, Nxf7, Sp8, Pax6, Prrx2, Msx1, Prox2, Fezf2, Nr2f2, Rorb, Alx4, 
Foxd1, Baz1a, Zmat4
Oxidoreductase Cyp39a1, Aldh3b2, Kcnab3, Rlbp1, Akr1c18, Loxl1, Cubn, Fmo1, 
Cntnap5c, Fa2h, Dcbld2, Cd163, Cyp1b1, Aifm3, Cybrd1, Cy-
p26b1, Aox3, Ch25h, Vat1l, Pcolce, Aldh1a3, Hpgd, Nrp2, Ald-
h1a2
Receptor Gpr182, Reep6, Mrc1, Grm2, Casr, Sorcs1, Dcn, Loxl1, Lrrtm3, 
Il4ra, Sstr4, Htr2c, Cubn, Ramp3, Lamc2, Mc4r, Vmn2r87, Un-
c5b, Grm8, Lrrc38, Klk8, Rxfp1, Ptgfr, Dscaml1, Chrm2, Adgrd1, 
Adgrf4, Grm4, Lrrtm4, Cntnap5c, Lrrc43, Chrm3, Prelp, Vit, 
Lamb3, Tshr, Relt, Gprc5a, Upk1b, Gipr, Crhr2, Qrfpr,  Dcbld2, 
Cd163, Tspan11, Coch, Hcrtr2, Trpm4, Mcam, Hrh3, Lama1, 
Adora1, Podn, Cnr1, Fmod, Myoc, Islr, Tenm1, Col6a3, Ptpru, 
Gpr52, Col6a5, Klk8, Omd, Pcolce, Ptch2, Gpr37, Lrrc55, Hcar1, 
Drd4, Col6a4, Pdgfrl, Mrgprf, Paqr6, C1ra, Ntn5, Pth2r, S1pr5, 
Matn2, Trpc, Adra1, Ogn, Oxtr, Wif1, Sorcs3, Grm1, Celsr1, Co-
l14a1, Lrg1, Nrp2, S1pr3, Tspan2
Signaling molecule Wnt2b, Fibcd1, Bmp3, Osmr, Tnc, Socs3, Dcn, Nell1, Lrrtm3, 
Ehf, Tac2, Tac1, Cubn, Nov, S100a10, Fgf22, Prg4, Klk8, Gdf7, 
Wnt16, Plch2, Wnt3, Sncg, Lrrtm4, Wnt10b, Cntnap5c, Cort, Ntf3, 
Ltbp2, Cbln4, Cxcl1, Ccbe1, Upk1b, Wisp1, Nxph2, Bmp6, Il12a, 
Marcksl1, Dcbld2, Homer2, Tspan11, Socs2, Bmp5, Inhbe, Fgf23, 
Cnih3, S100a11, Tac2, Cxcl10, Cnp, Penk, Podn, Plekhg3, Fgf3, 
Wnt6, Tenm1, Rcan2, A2m, Tnn, Angpt1, Ngf, Trf, Sema3f, Npff, 
Klk8, Chga, Pcolce, Wnt9a, Fgf10, Il1b, Fgl2, Bok, Bmp7, Clcf1, 
C1ra, Pthlh, Wif1, C4b, Il12rb1, Mag, Mlf1, Nrp2, Gdf10, Tspan2 
Storage protein Lpl, Lipg
Structural protein Krt77, Plp1, Gfap, Mbp, Krt80, Marcksl1, Krt73, Myoc, Mag
Transcription factor Esr1, Tcerg1l, Lmo3, Ldb2, Foxo6, Tle6, Nod2, Zfp831, Rfx3, 
Foxc2, Ehf, Tbx22, Id4, Foxp1, Pdlim3, Pdlim2, Satb1, Cited1, 
Ascl5, Rxrg, Neurod6, Twist2, Zmynd10, Smad3, Scml4, St18, 
Atoh7, Osr1, Nkx6-2, Onecut2, Atoh8, Nkx3-1, Sp8, Pax6, Prrx2, 
Six4, Msx1, Prox2, Nr2f2, Rorb, Alx4, Foxd1, Rfx2, Tfap2b, 
Zmat4  
Transfer/carrier pro-
tein
Ptgds, Prkcg, Sgk2, Cubn, Lbp, Rps6ka2, Sec14l5, Slc22a6, 
Cntnap5c, Sec14l3, Dcbld2, Slc22a3, Bicc1, Pcolce, Slc22a12, 
Plscr1, Nrp2 
Transferase Alpk2, Sla, Dgkb, B3gnt2, Prkcg, Sgk2, Rps6ka2, Camk4, Cam-
k2d, B3gat1, Grap2, Ankrd63, Camk2d, Papss2, Vrk2, B3gnt7, 
Galnt6, Pgm5, Hhat, Sec1, Camk1g, F13a1, Lck, Baz1a, Dgkg  
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Transmembrane 
receptor regulatory/
adaptor protein
Plekhs1
Transporter Reep6, Casr, Slc16a10, Grik4, Fxyd2, Kcnab3, Sorcs1, Slc6a12, 
Cacng5, Slc13a4, Slc23a3, Cubn, Slc6a13, Sec14l5, Vmn2r87, At-
p8b1, Hcn4, Slc22a6, Asic4, Cntnap5c, Sec14l3, Kcnh5, Slc7a11, 
Vit, Slco4c1, Trpc3, Scnn1a, Slc29a4, Mpzl2, Slc28a1, Cacna1h, 
Atp6v1c2, Dcbld2, Gpr158, Coch, Ngb, Scn3b, Trpm4, Trpc6, At-
p2b4, Slc22a3, Scn1a, Slc35d3, Col6a3, Grik3, Gabrg3, Col6a5, 
Glra3, Pcolce, Slc45a3, Ryr3, Slc22a12, Col6a4, Trpc5, Trpc7, 
Abca8a, Matn2, Trpc7, Htr3a, Sorcs3, Frem1, Cgref1, Slc6a20a, 
Col14a1, Abca6, P2rx4, Slco5a1, Nrp2, Gria3, Scn9a, Atp10b
134
CHAPTER 3
Supplementary Table 3.  Clustering of transcripts that are enriched in L4 and L2/3 of the 
Control (C) column by the associated Gene Ontology (GO) terms
GO term
Associated transcripts
L2/3 enriched L4 enriched
Protein-
aceous ex-
tracellular 
matrix
Smoc1, Wisp1, Frem1, Col4a4, Gpc3, Mmp2, 
Gpc6, Adamts9, Lama1, Ccbe1, Vit, Ltbp2, 
Matn2, Thsd4, Col22a1, Crispld2, Fbln1, Col5a2, 
Prelp, Tecta, Slit3, Papln, Reln, Loxl1, Efemp1, 
Adamts16, Wnt10b, Wnt16, Gpc4, Col6a4, Wnt6, 
Podn, Col1a2, Lamb3, Col1a1, Adamts2, Ser-
pinf1, Adamts13, Tnc, Ndnf, Nov, Ogn, Col14a1, 
Tnn, Fmod, Thbs4
Hpse, Emilin2, Co-
l8a1, Hapln2, Wnt2b, 
Wnt3, Coch, Adamt-
sl5, Smoc2, Kazald1, 
Adamts4, Wnt9a
Extracellular 
space
Wisp1, Metrnl, Adam12, Ctsk, Gpc3, Lyz2, Mmp2, 
Ngf, Gpc6, Adamts9, Lama1, Bmp7, Prtn3, Clcf1, 
Cd14, Cxcl1, Ccbe1, Ltbp2, Tac1, Cxcl10, Matn2, 
Angpt1, Cfh, Kit, Lrg1, Ace, Enpp1, Fbln1, 
S100a11, Col5a2, Prelp, Pcsk5, Slit3, Reln, Loxl1, 
Lpl, Bmp5, Thbd, Fgf10, Efemp1, Pcsk9, Gdf7, 
Gdf10, F13a1, Wnt10b, Wnt16, Gpc4, Igfbp4, 
Tnfsf9, Klk8, Wnt6, Podn, Dkk2, Lipg, Col1a2, 
Chia1, Il1b, Kl, Col1a1, Pcolce, Dmkn, Islr, A2m, 
Bmp3, Igf2, Adamts2, Dcn, Itih2, Sulf1, Serpinf1, 
Adamts13, Anxa1, C4b, Svep1, Tnc, Serping1, Fst, 
Serpind1, Bmp6, Nov, Ogn, Msln, Prg4, Col14a1, 
Grp, Fmod, Aebp1, Thbs4, Ptgds
Rspo1, Cartpt, Emi-
lin2, Col8a1, Il12a, 
Wnt2b, Pamr1, Wnt3, 
Trf, Coch, Inhbe, 
Sema3f, Il4ra, Cnp, 
C1s1, Scube1, Mcam, 
Fgf23, Cdsn, Adamts4, 
Cbln4, Cpm, Erbb3, 
Wnt9a, Npff, Chga, 
C1ra, Masp1, Mmel1, 
Gsn
Extracellular 
matrix
Smoc1, Wisp1, Frem1, Col4a4, Gpc3, Mmp2, 
Gpc6, Adamts9, Lama1, Bmp7, Prtn3, Ccbe1, Vit, 
Ltbp2, Matn2, Thsd4, Col22a1, Crispld2, Fbln1, 
Col5a2, Prelp, Tecta, Slit3, Papln, Reln, Loxl1, 
Lpl, Fgf10, Efemp1, Adamts16, Wnt10b, Wnt16, 
Gpc4, Col6a4, Wnt6, Podn, Col1a2, Plscr1, 
Lamb3, Col1a1, Pcolce, Adamts2, Dcn, Serpinf1, 
Adamts13, Tnc, Ndnf, Nov, Ogn, Col14a1, Tnn, 
Fmod, Aebp1, Thbs4
Hpse, Emilin2, Co-
l8a1, Hapln2, Wnt2b, 
Wnt3, Coch, Adamt-
sl5, Smoc2, Kazald1, 
Adamts4, Wnt9a
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Plasma mem-
brane part
Cacng5, Pdpn, Slc16a10, Gpc3, Slco4c1, Slc22a3, 
Nkd2, Lck, Shisa9, Fxyd2, Hpgd, Chrm3, Pgm5, 
Trpc5, Ecel1, Gria3, Grm1, Gpc6, Cd14, Ptpro, 
Tenm1, Slc22a12, Homer2, Cxcl10, Lrrtm3, Osmr, 
Cd24a, Kit, Dpp4, Dll1, Robo1, Neurl1a, Ace, 
Kcnf1, Enpp1, Prss22, Mrc1, Myof, Slc9a3, Cubn, 
Tesc, Grm8, Rasal1, Slc7a11, Hcrtr2, Lrrtm4, 
Thbd, Folr1, Drd4, F2rl2, Scn3b, Oxtr, Htr2c, 
Trabd2b, Kcnk13, Hs3st3b1, Gabrg3, Gpc4, Sstr4, 
Kcna3, Pcdh19, Grik4, Slc29a4, Cybrd1, Sl-
c6a20a, Cdh4, Celsr1, Kl, Plscr1, Dysf, Slc28a1, 
Pcdh8, Trpc7, Prkcg, Mas1, Adgrg2, Slc26a4, 
Nos1, Qrfpr, Gjb2, Cldn3, Rgs8, Tshr, Camk2d, 
Htr3a, Upk1b, Anxa1, Lct, Atp2b4, Trpc6, Kcng1, 
Otof, Glra3, Slc6a13, Slc22a6, Slc13a4
Scnn1a, Cnih3, Plb1, 
Whrn, Mal, Gjb1, Casr, 
Gjc2, Grm2, Chrm2, 
Cldn11, Tspan2, Scn9a, 
Il12rb1, Atp8b1, Grik3, 
Cadps2, Kcns1, Shisa6, 
Trf, Dcbld2, Cd200r4, 
Tspan11, S100a10, 
Grm4, Prima1, Gu-
cy2g, Scube1, Mcam, 
Adora1, Kcnh5, Rgs1, 
Cd200r1, Pcdhb8, 
Relt, Erbb3, Slco5a1, 
Kcnip2, Boc, Scn1a, 
S1pr3
System pro-
cess
Cacng5, B3gnt2, Ryr3, Egr2, Rlbp1, Rin1, Meis2, 
Sorcs3, Chrm3, Ecel1, Smad3, Ngf, Grm1, Rps-
6ka2, Ccbe1, Ptpro, Homer2, Tnnc1, Tac1, 
Angpt1, Kit, Dll1, Ace, Foxd1, Actn2, Pak6, 
Pcsk5, Tecta, Ctnna3, Myh2, Grm8, Gpr52, 
Ramp3, Reln, Ccnd2, Fgf10, Rtp1, Piezo2, 
Myh3, Pkp2, Foxo6, Scn3b, Cnr1, Oxtr, Htr2c, 
Adamts16, Wnt10b, Klk8, Penk, Col1a2, Myh1, 
Il1b, Stra6, Nr2f2, Dysf, Col1a1, Prkcg, Wfs1, 
Nos1, Gjb2, Myh7, Camk2d, Sulf1, Serpinf1, 
Anxa1, Atp2b4, Tfap2b, Bmp6, Nov, Col14a1, 
Otof, Aldh1a3, Foxc2, Syt10, Slc22a6
Scnn1a, Cartpt, Whrn, 
Nkx6-2, Rorb, Mag, 
Casr, Tnni1, Mbp, 
Chrm2, Scn9a, Atp8b1, 
Coch, Trim72, Grm4, 
Myrf, Hrh3, Trpm4, 
Mcam, Adora1, Dcd-
c2a, Rcan2, Nkx3-1, 
Tnnt2, Npff, Chga, 
Scn1a, Gsn, Dock5
Anatomical 
structure 
morphogen-
esis
B3gnt2, Pdpn, Arhgef28, Egr2, Frem1, Gpc3, 
Zic1, Peak1, Mmp2, Dusp2, Hpgd, Trpc5, Smad3, 
Ngf, Dusp4, Prrx2, Lama1, Bmp7, Bcl3, Id4, 
Ccbe1, Ptpro, Tenm1, Tnnc1, Cxcl10, Matn2, 
Cd24a, Angpt1, Nbl1, Kit, Dll1, Lrg1, Robo1, 
Unc13d, Foxd1, Actn2, Crispld2, Vrk2, Fbln1, 
Socs3, Col5a2, Prelp, Pcsk5, Kirrel3, Slit3, Reln, 
Pax6, Rasal1, Bmp5, Folr1, Fgf10, Efemp1, 
Alx4, Ankrd6, Edar, Gdf7, Cyp1b1, Pkp2, Ptpn14, 
Adamts16, Cpne6, Wnt10b, Wnt16, Rfx2, Klk8, 
Wnt6, Palmd, Nrp2, Crb1, Col1a2, Cdh4, Celsr1, 
Crhr2, Il1b, Msx1, Stra6, Sdk2, Rxfp1, Nr2f2, 
Lamb3, Pcdh8, Col1a1, Twist2, Slc26a4, Cldn3, 
Myh7, Igf2, Syt17, Tshr, Sp8, Dcn, Sulf1, Atoh8, 
Serpinf1, Anxa1, Tnc, Ndnf, Fst, Trpc6, Tfap2b, 
Crabp2, Bmp6, Nov, Ogn, Tnn, Aldh1a3, Fmod, 
Esr1, Foxc2, Aldh1a2, Thbs4
Hes3, Whrn, Hpse, 
Rorb, Col8a1, Cy-
p26b1, Xirp2, Ermn, 
Ovol2, Casr, Tnni1, 
Wnt2b, Onecut2, 
Fezf2, Atp8b1, Wnt3, 
Ugt8a, Gli1, Coch, 
Six4, Sema3f, Lrrc55, 
Il4ra, S100a10, Cnp, 
Astn2, Myo16, Sycp2, 
Lrrc38, Mcam, Cdsn, 
Foxp1, Plxdc1, Syt2, 
Dcdc2a, Unc5b, Fmn1, 
Nkx3-1, Tnnt2, Wnt9a, 
Ccdc136, Boc, Gamt, 
Cited1, Cdc42ep2, 
Gsn, Kndc1, Mypn, 
Dock5
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Regulation of 
multicellular 
organismal 
process
Smoc1, Egr2, Metrnl, Enc1, Gpc3, Meis2, Lck, 
Chrm3, Trpc5, Smad3, Ngf, Grm1, Lama1, Bmp7, 
Bcl3, Id4, Clcf1, Cd14, Cxcl1, Ccbe1, Ptpro, 
Hap1, Tnnc1, Tac1, Cxcl10, Lrrtm3, Cd24a, 
Angpt1, Nbl1, Kit, Dll1, Lrg1, Robo1, Neur-
l1a, Ace, Foxd1, Rfx3, Enpp1, Col5a2, Ctnna3, 
Ptch2, Slit3, Tesc, Reln, Pax6, Rasal1, Hcrtr2, 
Lpl, Bmp5, Lrrtm4, Thbd, Casp4, Fgf10, Efemp1, 
Pcsk9, Ankrd6, Gdf7, Cyp1b1, Pkp2, Foxo6, 
Scn3b, Cnr1, Oxtr, Htr2c, Gdf10, Cpne6, Wnt10b, 
Tnfsf9, Klk8, Wnt6, Lipg, Penk, Chia1, Cdh4, Cel-
sr1, Crhr2, Il1b, Msx1, Kl, Nr2f2, Col1a1, Twist2, 
Nos1, Myh7, Igf2, Syt17, Tshr, Camk2d, Dcn, 
Sulf1, Atoh8, Serpinf1, Anxa1, Atp2b4, Serping1, 
Ndnf, Fst, Trpc6, Crabp2, Bmp6, Nov, Ogn, Prg4, 
Col14a1, Gfap, Fmod, Esr1, Foxc2, Thbs4, Mc4r, 
Ptgds
Hes3, Rspo1, Cartpt, 
Slc45a3, Nkx6-2, Hpse, 
Rorb, Cyp26b1, Il12a, 
Fbxo32, Ovol2, Mag, 
Casr, Tnni1, Wnt2b, 
Fezf2, Fa2h, Chrm2, 
Adam33, Il12rb1, 
Wnt3, Gli1, Tle6, Trf, 
Six4, Sema3f, Il4ra, 
Myrf, S1pr5, Trpm4, 
Fgf23, Foxp1, Adora1, 
Syt2, Brinp3, Nkx3-1, 
Socs2, Erbb3, Tnnt2, 
Wnt9a, Npff, Chga, 
Boc, Gamt, Gdpd5, 
Cited1, Nell1, Kndc1, 
S1pr3, Dock5
Intrinsic 
component 
of plasma 
membrane
Cacng5, Slc16a10, Gpc3, Slco4c1, Slc22a3, 
Shisa9, Fxyd2, Chrm3, Trpc5, Ecel1, Gria3, 
Grm1, Gpc6, Cd14, Tenm1, Slc22a12, Osmr, 
Cd24a, Kcnf1, Enpp1, Prss22, Mrc1, Grm8, 
Rasal1, Slc7a11, Hcrtr2, Lrrtm4, Thbd, Folr1, 
Drd4, F2rl2, Scn3b, Oxtr, Htr2c, Trabd2b, 
Kcnk13, Hs3st3b1, Sstr4, Kcna3, Pcdh19, Grik4, 
Slc6a20a, Cdh4, Celsr1, Kl, Plscr1, Slc28a1, 
Pcdh8, Trpc7, Mas1, Slc26a4, Qrfpr, Tshr, Htr3a, 
Upk1b, Lct, Atp2b4, Trpc6, Kcng1, Glra3, 
Slc6a13, Slc22a6, Slc13a4
Scnn1a, Cnih3, Grm2, 
Chrm2, Cldn11, 
Tspan2, Scn9a, Il-
12rb1, Grik3, Kcns1, 
Shisa6, Dcbld2, 
Tspan11, Grm4, Pri-
ma1, Kcnh5, Pcdhb8, 
Relt, Slco5a1, Kcnip2, 
Boc, Scn1a, S1pr3
Cell-cell sig-
naling
Wisp1, Egr2, Gipr, Gpc3, Rin1, Nkd2, Shisa9, 
Sorcs3, Chrm3, Wif1, Smad3, Ngf, Bicc1, Grm1, 
Clcf1, Ptpro, Hap1, Tac1, Cd24a, Kit, Dll1, Neur-
l1a, Foxd1, Rfx3, Grm8, Rph3al, Gpr52, Reln, 
Hcrtr2, Folr1, Drd4, Fgf10, Ankrd6, C2cd4c, 
Ccdc88c, Pkp2, Syt9, Scn3b, Sncg, Cnr1, Oxtr, 
Htr2c, Trabd2b, Ptpru, Wnt10b, Wnt16, Sstr4, 
Tnfsf9, Wnt6, Dkk2, Pcdh19, Slc6a20a, Penk, 
Celsr1, Il1b, Nnat, Pcdh8, Col1a1, Prkcg, Cplx3, 
Gjb2, Doc2b, Syt17, Htr3a, Lypd1, Sulf1, At-
p6v1c2, Anxa1, Tnc, Tfap2b, Bmp6, Nov, Otof, 
Glra3, Slc6a13, Gfap, Mc4r, Syt10
Cnih3, Rspo1, Cartpt, 
Casr, Gjc2, Wnt2b, 
Grm2, Chrm2, Wnt3, 
Cadps2, Gli1, Shisa6, 
Grm4, Hrh3, Trpm4, 
Fgf23, Adora1, Syt2, 
Dcdc2a, Nkx3-1, Pc-
dhb8, Wnt9a, Npff
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G-protein 
coupled re-
ceptor signal-
ing pathway
Adgrd1, Gipr, Cort, Hpgd, Chrm3, Ecel1, Grm1, 
Cxcl1, Tenm1, Homer2, Tac1, Cxcl10, Dgkg, 
Actn2, Grm8, Rph3al, Gpr52, Ramp3, Hcrtr2, 
Drd4, Iqgap2, F2rl2, Cnr1, Oxtr, Htr2c, Gabrg3, 
Sstr4, Dgkb, Penk, Celsr1, Crhr2, Rxfp1, Tac2, 
Mas1, Adgrg2, Nos1, Qrfpr, Rgs8, Tshr, Htr3a, 
Anxa1, Atp2b4, Grp, Glra3, Esr1, Mc4r
Cartpt, Casr, Grm2, 
Chrm2, Grik3, Gpr37, 
Grm4, S1pr5, Hrh3, 
Tmem145, Adora1, 
Adgrf4, Rgs1, Akr1c18, 
Pth2r, Npff, Chga, 
Gpr158, Vmn2r87, 
S1pr3
Integral 
component 
of plasma 
membrane
Cacng5, Slc16a10, Gpc3, Slco4c1, Slc22a3, 
Shisa9, Fxyd2, Chrm3, Trpc5, Ecel1, Gria3, 
Grm1, Gpc6, Tenm1, Slc22a12, Osmr, Kcnf1, 
Enpp1, Mrc1, Grm8, Slc7a11, Hcrtr2, Lrrtm4, 
Thbd, Drd4, F2rl2, Scn3b, Oxtr, Htr2c, Trabd2b, 
Kcnk13, Hs3st3b1, Sstr4, Kcna3, Pcdh19, Grik4, 
Slc6a20a, Cdh4, Celsr1, Kl, Plscr1, Slc28a1, 
Pcdh8, Trpc7, Mas1, Slc26a4, Qrfpr, Tshr, Htr3a, 
Upk1b, Lct, Atp2b4, Trpc6, Kcng1, Glra3, 
Slc6a13, Slc22a6, Slc13a4
Scnn1a, Cnih3, Grm2, 
Chrm2, Cldn11, 
Tspan2, Scn9a, Il-
12rb1, Grik3, Kcns1, 
Shisa6, Dcbld2, 
Tspan11, Grm4, Kcnh5, 
Pcdhb8, Relt, Slco5a1, 
Kcnip2, Boc, Scn1a, 
S1pr3
Calcium ion 
binding
Smoc1, Ryr3, Rcn1, Nkd2, Rcn3, Ccbe1, Ltbp2, 
Tnnc1, Matn2, Cgref1, Hpcal4, Dll1, Dgkg, 
Actn2, Dnah7a, Enpp1, Fbln1, S100a11, Slit3, 
Cubn, Tesc, Rph3al, Thbd, Efemp1, C2cd4c, Syt9, 
Dgkb, Necab1, Pcdh19, Crb1, Cdh4, Celsr1, Ne-
cab2, Plscr1, Dysf, Pcdh8, Doc2b, Syt17, Sulf1, 
Anxa1, Svep1, Otof, Thbs4, Syt10
Casr, Ocm, Pamr1, 
S100a10, Astn2, 
Cdhr3, Smoc2, Pvalb, 
C1s1, Scube1, Syt2, 
Plch2, Pcdhb8, Kcnip2, 
C1ra, Masp1, Nell1, 
Gsn
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Supplementary Table 4. GO terms and associated differentially expressed transcripts using 
increased (4 fold) fold change cut off.
Description Transcripts FDR
Extracellular 
space
Bmp3, AeBP1, Bmp6, Serping1, C4b, Col14a1, Col8a1, Dcn, 
Fmod, Fst, Serpind1, Igf2, Il12a, Itih2, Anxa1, Nov, Ogn, 
Ptgds, Rspo1, Serpinf1, Adamts2, Thbs4, Tnc, Grp, Sulf1, 
Emilin2, Cartpt, Adamts13, Msln, Svep1, Prg4
2.00E-12
Proteinaceous 
extracellular 
matrix
Col14a1, Col8a1, Fmod, Hpse, Nov, Ogn, Serpinf1, Adamts2, 
Thbs4, Tnc, Emilin2, Adamts13, Tnn, Ndnf, Hapln2 1.44E-07
Extracellular 
matrix
AeBP1, Col14a1, Col8a1, Dcn, Fmod, Hpse, Nov, Ogn, Ser-
pinf1, Adamts2, Thbs4, Tnc, Emilin2, Adamts13, Tnn, Ndnf, 
Hapln2
2.97E-07
Regulation of 
multicellular 
organismal 
process
Ovol2, Camk2d, Syt17, Bmp6, Serping1, Casr, Col14a1, 
CraBP2, Dcn, Esr1, Myh7, Foxc2, Fmod, Fst, Gfap, Nkx6-2, 
Hes3, Hpse, Igf2, Il12a, Anxa1, Mag, Mc4r, Nov, Ogn, Ptgds, 
Rspo1, Serpinf1, Slc45a3, Thbs4, Trpc6, Tshr, Rorb, Cyp26b1, 
Sulf1, Cartpt, Atp2b4, Fbxo32, Ndnf, Atoh8, Prg4
2.43E-05
Regulation of 
developmental 
process
Ovol2, Lmo3, Syt17, Bmp6, Col14a1, CraBP2, Dcn, Esr1, 
Foxc2, Fmod, Fst, Gfap, Nkx6-2, Hes3, Hpse, Igf2, Il12a, 
Anxa1, Mag, Nov, Ogn, Serpinf1, Slc45a3, Tfap2b, Thbs4, 
Trpc6, Tshr, Rorb, Cyp26b1, Sulf1, Cartpt, Tcfl5, Dkkl1, Ndnf, 
Atoh8, Ermn
2.84E-04
Tissue devel-
opment
Ovol2, Camk2d, Bmp3, Bmp6, Casr, Col14a1, Col8a1, Dcn, 
Ebf2, Esr1, Eya2, Myh7, Foxc2, Fst, Hes3, Hpse, Anxa1, Nov, 
Aldh1a2, Tfap2b, Tnc, Upk1b, Cyp26b1, Sulf1, Xirp2, Ald-
h1a3, Atoh8, Prox2, Whrn, Hapln2
3.77E-04
Anatomical 
structure mor-
phogenesis
Ovol2, Syt17, Bmp6, Casr, Col8a1, CraBP2, Dcn, Esr1, 
Myh7, Foxc2, Fmod, Fst, Hes3, Hpse, Igf2, Anxa1, Nov, Ogn, 
Aldh1a2, Serpinf1, Tfap2b, Thbs4, Tnc, Trpc6, Tshr, Rorb, 
Cyp26b1, Sulf1, Xirp2, Sp8, Tnn, Aldh1a3, Ndnf, Atoh8, 
Whrn, Ermn
6.56E-04
Glycosamino-
glycan binding Dcn, Fmod, Serpind1, Nov, Ogn, Rspo1, Thbs4, Ndnf, Hapln2 1.01E-03
Retinoid bind-
ing CraBP2, Ptgds, Aldh1a2, Cyp26b1 1.01E-03
Isoprenoid 
binding CraBP2, Ptgds, Aldh1a2, Cyp26b1 1.43E-03
Endopepti-
dase inhibitor 
activity
Serping1, C4b, Serpind1, Itih2, Serpinf1, Tfap2b, Wfikkn2 1.57E-03
Peptidase in-
hibitor activity Serping1, C4b, Serpind1, Itih2, Serpinf1, Tfap2b, Wfikkn2 1.57E-03
Endopepti-
dase regulator 
activity
Serping1, C4b, Serpind1, Itih2, Serpinf1, Tfap2b, Wfikkn2 1.92E-03
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Regulation of 
cell differenti-
ation
Ovol2, Lmo3, Syt17, Bmp6, Col14a1, CraBP2, Fmod, Fst, 
Gfap, Nkx6-2, Hes3, Il12a, Anxa1, Mag, Nov, Ogn, Serpinf1, 
Slc45a3, Tfap2b, Trpc6, Rorb, Cyp26b1, Cartpt, Tcfl5, Dkkl1, 
Ndnf, Atoh8
2.11E-03
Growth factor 
activity Bmp3, Bmp6, Igf2, Il12a, Nov, Ogn, Thbs4 2.31E-03
Serine-type 
endopeptidase 
inhibitor ac-
tivity
Serping1, Serpind1, Itih2, Serpinf1, Wfikkn2 2.31E-03
Enzyme inhib-
itor activity
Serping1, C4b, Dcn, Serpind1, Itih2, Anxa1, Serpinf1, Tfap2b, 
Wfikkn2, Atp2b4
2.31E-03
Heparin bind-
ing Fmod, Serpind1, Nov, Ogn, Rspo1, Thbs4, Ndnf 2.31E-03
Retinoic acid 
metabolic 
process
CraBP2, Aldh1a2, Cyp26b1, Aldh1a3 2.61E-03
Transporter 
activity
Glra3, CraBP2, Slc6a13, Gjb1, Htr3a, Slc22a6, Ptgds, Scnn1a, 
Slc45a3, Nipal4, Trpc6, Kcng1, Slc13a4, Tnfaip8l3, Sec14l3, 
Atp2b4, Fxyd6, Ngb, Sec14l5, Atp6v1c2
2.84E-03
Nervous sys-
tem develop-
ment
Ovol2, Camk2d, Syt17, Bmp6, CraBP2, Fmod, Gfap, Gfra2, 
Nkx6-2, Hes3, Anxa1, Mag, Mal, MoBP, Ogn, Plp1, Aldh1a2, 
Serpinf1, Slc45a3, Tfap2b, Tnc, Trpc6, Tshr, Rorb, Sulf1, Tnn, 
Atp2b4, Aldh1a3, Ndnf, Atoh8, Prox2, Whrn, Hapln2
3.66E-03
Peptidase reg-
ulator activity Serping1, C4b, Serpind1, Itih2, Serpinf1, Tfap2b, Wfikkn2 5.07E-03
3-chloroal-
lyl aldehyde 
dehydrogenase 
activity
Aldh1a2, Aldh1a3, Aldh3b2 5.23E-03
Cellular hor-
mone metabol-
ic process
Bmp6, CraBP2, Esr1, Aldh1a2, Cyp26b1, Aldh1a3 5.68E-03
Regulation of 
multicellular 
organismal 
development
Ovol2, Syt17, Bmp6, Col14a1, CraBP2, Dcn, Esr1, Foxc2, 
Fmod, Fst, Gfap, Nkx6-2, Hes3, Hpse, Il12a, Anxa1, Mag, 
Ogn, Serpinf1, Slc45a3, Thbs4, Trpc6, Cyp26b1, Sulf1, 
Cartpt, Ndnf, Atoh8
5.68E-03
Response to 
endogenous 
stimulus
Lmo3, Bmp3, Glra3, Bmp6, Casr, Esr1, Foxc2, Fst, Igf2, 
Anxa1, Mc4r, Slc22a6, Ptgds, Serpinf1, Tfap2b, Tnc, Tshr, 
Rorb, Sulf1, Wfikkn2, Adamts13, Atp2b4, Fbxo32, Lypd1
5.68E-03
Positive reg-
ulation of 
multicellular 
organismal 
process
Ovol2, Camk2d, Syt17, Bmp6, Casr, CraBP2, Foxc2, Fst, 
Gfap, Nkx6-2, Hpse, Igf2, Il12a, Anxa1, Mag, Mc4r, Serpinf1, 
Trpc6, Tshr, Cyp26b1, Sulf1, Cartpt, Ndnf, Atoh8
5.68E-03
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Positive reg-
ulation of 
developmental 
process
Ovol2, Lmo3, Syt17, Bmp6, CraBP2, Dcn, Foxc2, Fst, Gfap, 
Nkx6-2, Hpse, Igf2, Il12a, Anxa1, Mag, Serpinf1, Trpc6, Tshr, 
Cyp26b1, Dkkl1, Ndnf, Atoh8
5.68E-03
Structural 
constituent of 
myelin sheath
Mal, MoBP, Plp1 6.86E-03
Sulfur com-
pound binding Fmod, Serpind1, Hpse, Nov, Ogn, Rspo1, Thbs4, Ndnf 6.86E-03
Regulation of 
hormone levels
Bmp6, Casr, CraBP2, Esr1, Anxa1, Mc4r, Nov, Aldh1a2, 
Tfap2b, Cyp26b1, Cartpt, Aldh1a3 6.95E-03
Cell develop-
ment
Ovol2, Camk2d, Syt17, Bmp3, Bmp6, Col14a1, CraBP2, 
Esr1, Foxc2, Fmod, Gfap, Nkx6-2, Hes3, Mag, Ogn, Plp1, 
Aldh1a2, Serpinf1, Slc45a3, Tnc, Trpc6, Tshr, Rorb, Sulf1, 
Wfikkn2, Tnn, Ndnf, Whrn, Hapln2
6.95E-03
Cellular re-
sponse to oxy-
gen-containing 
compound
Bmp6, Casr, Esr1, Foxc2, Igf2, Il12a, Anxa1, Aldh1a2, 
Serpinf1, Tnc, Trpc6, Rorb, Cyp26b1, Adamts13, Atp2b4, 
Fbxo32, Rgs8, Lypd1
6.95E-03
Epithelial cell 
proliferation
Ovol2, Bmp6, Col8a1, Esr1, Fst, Nov, Aldh1a2, Serpinf1, 
Thbs4, Sulf1, Atoh8 6.95E-03
Negative 
regulation of 
multicellular 
organismal 
process
Ovol2, Serping1, Dcn, Foxc2, Gfap, Nkx6-2, Il12a, Anxa1, 
Mag, Nov, Ptgds, Serpinf1, Thbs4, Trpc6, Rorb, Sulf1, Cartpt, 
Atp2b4, Prg4
6.95E-03
Cellular re-
sponse to lipid
Lmo3, Bmp6, Casr, Esr1, Il12a, Anxa1, Aldh1a2, Serpinf1, 
Tnc, Rorb, Cyp26b1, Adamts13, Fbxo32 6.95E-03
Pancreas de-
velopment Bmp6, Nkx6-2, Igf2, Anxa1, Aldh1a2, Msln 6.95E-03
Vascular 
wound healing Foxc2, Hpse, Ndnf 7.29E-03
Cellular 
response to 
retinoic acid
Aldh1a2, Serpinf1, Tnc, Rorb, Cyp26b1 7.29E-03
Animal organ 
morphogenesis
Ovol2, Bmp6, Col8a1, Esr1, Myh7, Foxc2, Fst, Igf2, Aldh1a2, 
Tfap2b, Tnc, Tshr, Rorb, Cyp26b1, Sulf1, Xirp2, Aldh1a3, 
Whrn
7.60E-03
Extracellular 
matrix organi-
zation
Col14a1, Foxc2, Fmod, Gfap, Hpse, Adamts2, Sulf1, Ndnf, 
Hapln2 7.95E-03
Extracellular 
structure or-
ganization
Col14a1, Foxc2, Fmod, Gfap, Hpse, Adamts2, Sulf1, Ndnf, 
Hapln2 7.95E-03
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System pro-
cess
Camk2d, Bmp6, Casr, Col14a1, Myh7, Foxc2, Nkx6-2, 
Anxa1, Mag, Nov, Slc22a6, Scnn1a, Serpinf1, Tfap2b, Rorb, 
Sulf1, Cartpt, Atp2b4, Syt10, Aldh1a3, Whrn, Otof
7.95E-03
Prostate gland 
development Esr1, Anxa1, Serpinf1, Tnc, Sulf1 8.37E-03
Epithelium 
development
Ovol2, Bmp6, Casr, Esr1, Foxc2, Fst, Hes3, Hpse, Anxa1, Al-
dh1a2, Tfap2b, Tnc, Upk1b, Cyp26b1, Sulf1, Aldh1a3, Atoh8, 
Whrn, Hapln2
8.37E-03
Response to 
retinoic acid Bmp6, Aldh1a2, Serpinf1, Tnc, Rorb, Cyp26b1 8.37E-03
Response to 
oxygen-con-
taining com-
pound
Glra3, Bmp6, Casr, Dcn, Esr1, Foxc2, Igf2, Il12a, Anxa1, 
Mc4r, Slc22a6, Aldh1a2, Serpinf1, Tnc, Trpc6, Rorb, Cy-
p26b1, Adamts13, Atp2b4, Fbxo32, Rgs8, Lypd1
1.57E-02
Circulatory 
system devel-
opment
Ovol2, Camk2d, Col14a1, Col8a1, Dcn, Myh7, Foxc2, Hpse, 
Nov, Aldh1a2, Serpinf1, Tfap2b, Thbs4, Sulf1, Xirp2, Pdlim3, 
Ndnf, Prox2
1.57E-02
Regulation of 
cell prolifera-
tion
Ovol2, Camk2d, Bmp6, Casr, Esr1, Gfap, Hpse, Igf2, Il12a, 
Anxa1, Nov, Ptgds, Rspo1, Aldh1a2, Serpinf1, Tfap2b, Thbs4, 
Tnc, Sulf1, Tcfl5, Atoh8, Prg4
1.59E-02
Cell prolifera-
tion
Ovol2, Camk2d, Bmp6, Casr, Col8a1, Esr1, Foxc2, Fst, Gfap, 
Hpse, Igf2, Il12a, Anxa1, Nov, Ptgds, Rspo1, Aldh1a2, Ser-
pinf1, Tfap2b, Thbs4, Tnc, Sulf1, Tcfl5, Atoh8, Prg4
1.59E-02
Positive reg-
ulation of 
response to 
stimulus
Camk2d, Lmo3, Bmp3, Hrk, Bmp6, Serping1, C4b, Casr, 
Dcn, Esr1, Eya2, Foxc2, Hpse, Igf2, Il12a, Anxa1, Mal, Nov, 
Rspo1, Thbs4, Sulf1, Tnfaip8l3, Cartpt, Aldh1a3, Atp6v1c2
1.75E-02
Regulation of 
muscle adap-
tation
Camk2d, Col14a1, Myh7, Atp2b4, Fbxo32 1.75E-02
Retinoic acid 
receptor sig-
naling path-
way
CraBP2, Aldh1a2, Cyp26b1, Aldh1a3 1.94E-02
Wound heal-
ing
Serping1, Dcn, Foxc2, Serpind1, Hpse, Anxa1, Nov, Tnc, 
Adamts13, Ndnf 2.02E-02
Urogenital 
system devel-
opment
Bmp6, Dcn, Esr1, Foxc2, Anxa1, Aldh1a2, Serpinf1, Tfap2b, 
Tnc, Sulf1 2.14E-02
Collagen tri-
mer Col14a1, Col8a1, Dcn, Col23a1, Emilin2 2.16E-02
Negative 
regulation of 
endopeptidase 
activity
Serping1, C4b, Serpind1, Itih2, Serpinf1, Tfap2b, Wfikkn2 2.45E-02
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Striated 
muscle tissue 
development
Camk2d, Col14a1, Dcn, Eya2, Myh7, Foxc2, Aldh1a2, Cy-
p26b1, Xirp2, Prox2 2.48E-02
Retinoid meta-
bolic process CraBP2, Aldh1a2, Cyp26b1, Aldh1a3 2.48E-02
Embryonic 
morphogenesis
Ovol2, Col8a1, CraBP2, Foxc2, Hes3, Aldh1a2, Tshr, Cy-
p26b1, Sulf1, Sp8, Aldh1a3, Atoh8, Whrn 2.48E-02
Positive reg-
ulation of cell 
differentiation
Ovol2, Lmo3, Syt17, Bmp6, CraBP2, Gfap, Nkx6-2, Il12a, 
Anxa1, Mag, Serpinf1, Trpc6, Cyp26b1, Dkkl1, Ndnf, Atoh8 2.60E-02
Negative regu-
lation of pepti-
dase activity
Serping1, C4b, Serpind1, Itih2, Serpinf1, Tfap2b, Wfikkn2 2.60E-02
Regulation of 
reproductive 
process
Esr1, Ptgds, Rspo1, Serpinf1, Sulf1, Plb1 2.74E-02
Monocar-
boxylic acid 
biosynthetic 
process
Anxa1, Plp1, Ptgds, Aldh1a2, Slc45a3, Cyp39a1, Aldh1a3 2.92E-02
Cell-cell sig-
naling
Syt17, Glra3, Bmp6, Casr, Slc6a13, Gfap, Htr3a, Anxa1, 
Mc4r, Nov, Rspo1, Tfap2b, Tnc, Sulf1, Cartpt, Syt10, At-
p6v1c2, Lypd1, Cnih3, Otof
2.92E-02
Cellular 
response to 
endogenous 
stimulus
Lmo3, Bmp3, Bmp6, Casr, Esr1, Foxc2, Fst, Igf2, Anxa1, 
Serpinf1, Tfap2b, Tnc, Tshr, Rorb, Sulf1, Wfikkn2, Atp2b4, 
Fbxo32
2.92E-02
Response to 
wounding
Serping1, Dcn, Foxc2, Gfap, Serpind1, Hpse, Anxa1, Nov, 
Tnc, Adamts13, Ndnf 2.92E-02
Response to 
acid chemical
Glra3, Bmp6, Slc22a6, Aldh1a2, Serpinf1, Tnc, Rorb, Cy-
p26b1, Atp2b4 2.92E-02
Response to 
lipid
Lmo3, Bmp6, Casr, Dcn, Esr1, Il12a, Anxa1, Ptgds, Aldh1a2, 
Serpinf1, Tnc, Rorb, Cyp26b1, Adamts13, Fbxo32 2.92E-02
Muscle tissue 
development
Camk2d, Col14a1, Dcn, Eya2, Myh7, Foxc2, Aldh1a2, Cy-
p26b1, Xirp2, Prox2 2.92E-02
Neuron differ-
entiation
Syt17, Bmp6, CraBP2, Fmod, Gfap, Nkx6-2, Hes3, Mag, Ogn, 
Plp1, Aldh1a2, Serpinf1, Tnc, Trpc6, Tshr, Rorb, Tnn, Ndnf, 
Prox2, Whrn
2.92E-02
Cellular 
response to 
chemical stim-
ulus
Lmo3, Bmp3, Bmp6, Casr, Dcn, Esr1, Foxc2, Fst, Igf2, Il12a, 
Anxa1, Nov, Aldh1a2, Serpinf1, Tfap2b, Thbs4, Tnc, Trpc6, 
Tshr, Rorb, Cyp26b1, Sulf1, Wfikkn2, Adamts13, Atp2b4, 
Fbxo32, Rgs8, Ndnf, Lypd1
2.92E-02
Growth Camk2d, Syt17, Bmp3, Bmp6, Col14a1, CraBP2, Esr1, Foxc2, Fmod, Igf2, Anxa1, Nov, Ogn, Tnc, Tshr, Tnn, Ndnf 2.92E-02
Sensory organ 
development
Bmp6, Col8a1, Foxc2, Aldh1a2, Serpinf1, Tfap2b, Tshr, Rorb, 
Cyp26b1, Atp2b4, Aldh1a3, Whrn 3.13E-02
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Collagen fibril 
organization
Col14a1, Foxc2, Fmod, Adamts2 3.13E-02
Regulation of 
retinoic acid 
receptor sig-
naling path-
way
CraBP2, Cyp26b1, Aldh1a3 3.13E-02
Hormone met-
abolic process Bmp6, CraBP2, Esr1, Aldh1a2, Cyp26b1, Aldh1a3 3.13E-02
Signal release Syt17, Bmp6, Casr, Anxa1, Mc4r, Nov, Tfap2b, Cartpt, Syt10, Otof 3.13E-02
Diterpenoid 
metabolic 
process
CraBP2, Aldh1a2, Cyp26b1, Aldh1a3 3.32E-02
Integrin bind-
ing Casr, Gfap, Nov, Thbs4, Tnn 3.34E-02
Negative 
regulation of 
developmental 
process
Ovol2, Dcn, Foxc2, Fst, Gfap, Nkx6-2, Anxa1, Mag, Nov, Ser-
pinf1, Thbs4, Trpc6, Rorb, Sulf1, Cartpt 3.34E-02
Developmental 
growth
Camk2d, Syt17, Col14a1, CraBP2, Esr1, Foxc2, Fmod, Igf2, 
Anxa1, Nov, Ogn, Tnc, Tshr 3.41E-02
Generation of 
neurons
Syt17, Bmp6, CraBP2, Fmod, Gfap, Nkx6-2, Hes3, Mag, Ogn, 
Plp1, Aldh1a2, Serpinf1, Slc45a3, Tnc, Trpc6, Tshr, Rorb, 
Tnn, Ndnf, Prox2, Whrn
3.46E-02
Angiogenesis 
involved in 
wound healing
Foxc2, Hpse, Ndnf 3.46E-02
Cardiac 
muscle tissue 
development
Camk2d, Col14a1, Myh7, Foxc2, Aldh1a2, Xirp2, Prox2 3.63E-02
Oxidoreduc-
tase activity, 
acting on the 
aldehyde or 
oxo group of 
donors
Aldh1a2, Aldh1a3, Aldh3b2, Aox3 3.65E-02
Organic acid 
biosynthetic 
process
Anxa1, Plp1, Ptgds, Aldh1a2, Slc45a3, Atp2b4, Cyp39a1, 
Aldh1a3 3.69E-02
Carboxylic 
acid biosyn-
thetic process
Anxa1, Plp1, Ptgds, Aldh1a2, Slc45a3, Atp2b4, Cyp39a1, 
Aldh1a3 3.69E-02
Cell adhesion
Arhgap6, Col14a1, Col8a1, Foxc2, Hpse, Igf2, Il12a, Anxa1, 
Mag, Mog, Nov, Thbs4, Tnc, Cyp26b1, Sulf1, Emilin2, Tnn, 
Msln, Cntnap5c, Svep1, Ndnf, Hapln2
3.69E-02
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Neurogenesis
Syt17, Bmp6, CraBP2, Fmod, Gfap, Nkx6-2, Hes3, Anxa1, 
Mag, Ogn, Plp1, Aldh1a2, Serpinf1, Slc45a3, Tnc, Trpc6, 
Tshr, Rorb, Tnn, Ndnf, Prox2, Whrn
3.85E-02
Biological ad-
hesion
Arhgap6, Col14a1, Col8a1, Foxc2, Hpse, Igf2, Il12a, Anxa1, 
Mag, Mog, Nov, Thbs4, Tnc, Cyp26b1, Sulf1, Emilin2, Tnn, 
Msln, Cntnap5c, Svep1, Ndnf, Hapln2
3.88E-02
Positive reg-
ulation of cell 
proliferation
Camk2d, Bmp6, Casr, Esr1, Gfap, Hpse, Igf2, Il12a, Anxa1, 
Aldh1a2, Tfap2b, Thbs4, Tnc, Sulf1 4.18E-02
Regulation of 
endothelial cell 
proliferation
Bmp6, Aldh1a2, Thbs4, Sulf1, Atoh8 4.19E-02
Regulation of 
system process
Camk2d, Bmp6, Casr, Col14a1, Myh7, Mag, Nov, Cartpt, 
Atp2b4, Fbxo32 4.19E-02
Response to 
organic sub-
stance
Lmo3, Bmp3, Glra3, Bmp6, Casr, Dcn, Esr1, Foxc2, Fst, 
Igf2, Il12a, Anxa1, Mc4r, Slc22a6, Ptgds, Aldh1a2, Serpinf1, 
Tfap2b, Thbs4, Tnc, Tshr, Rorb, Cyp26b1, Sulf1, Wfikkn2, 
Adamts13, Atp2b4, Fbxo32, Rgs8, Lypd1
4.19E-02
Peptide 
cross-linking Dcn, Anxa1, Ndnf 4.19E-02
Glial cell-de-
rived neuro-
trophic factor 
receptor sig-
naling path-
way
Gfra2, Sulf1 4.19E-02
Terpenoid 
metabolic 
process
CraBP2, Aldh1a2, Cyp26b1, Aldh1a3 4.19E-02
Angiogenesis Ovol2, Col8a1, Dcn, Foxc2, Hpse, Nov, Serpinf1, Thbs4, Sulf1, Ndnf 4.56E-02
Intracellular 
receptor sig-
naling path-
way
Lmo3, CraBP2, Esr1, Aldh1a2, Rorb, Cyp26b1, Aldh1a3 4.81E-02
Cardiac mus-
cle hypertro-
phy
Camk2d, Col14a1, Myh7, Atp2b4 4.81E-02
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Supplementary Table 5. Transcripts that are enriched in identified cell-types.
Cell type
Preferentially expressed transcripts
L2/3 L4
Astrocytes
Itih3, Id4, Rlbp1, Slc7a11, Hspb8, 
Pdpn, Pax6, Prelp, Fbln1, Ccno, 
Gpc4, Papss2, Nnat, Igf2, Efemp1, 
Ankef1, Unc13d, 3930402G23Rik, Vit, 
Zmynd10, Loxl1, Rfx2, Prrx2, Folr1, 
Cybrd1, Dnah7a, Pdgfrl, Islr, Celsr1, 
Col4a4, Hs3st3b1, Rtp1, Gfap, Clec3b, 
Gjb2, Mlf1, Gpr182, A2m, Aspg, Ser-
pinf1, AA387883, C4b, Lrrc43, Kl, 
Msx1, Ppp1r36, Bmp6, Aebp1, Rsph4a, 
Atoh8, Col6a5, Thbs4, Lbp, Slc13a4, 
Myoc
Bglap3, Cdhr3, Gli1, En-
dou, Sycp2, Paqr6, Dnah10, 
1700003F12Rik
Endothelial cells
B3gnt2, Sh3bp4, Obscn, Tagln, Zic1, 
Itprip, Lama1, Osmr, Pgm5, Thbd, 
Thsd4, Palmd, Nkd2, Rcn3, Dpp4, 
Ptpn14, Crispld2, Samd9l, Filip1, 
Tmem255b, Slc6a20a, Papln, Foxd1, 
Slc22a3, Cped1, S100a11, Emp1, Stra6, 
Pcolce, Alx4, Sh3rf2, Cubn, Bmp5, 
Ptch2, Piezo2, Dkk2, Crhr2, Fmod, 
Zic4, Serping1, Fbxl7, Plscr1, Ogn, 
Fgl2, Upk1b, Crabp2, Svep1, Anxa1, 
Krt80, Tfap2b, Foxc2, Sec14l3, Fgfbp1, 
Mpzl2
H2-Bl, Pdlim3, Col8a1, 
8430408G22Rik, Tmem200b, 
Ankfn1, Sgpp2, Smoc2, S1pr3, 
Rnf144b
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Interneurons
B3gat1, Timp2, Sorcs3, Homer2, 
Marcksl1, Shisa9, Ly6h, Rgs12, Kit, 
Hap1, Cacna1h, Grm1, March4, Reln, 
Camk1g, Rcn1, Dusp4, AI504432, 
Cnr1, Klhl13, Dgkg, Robo1, Dlx6os1, 
Adra1b, Igsf11, Ptpro, Cpne6, Asic4, 
Scn3b, Cacng5, Celf6, Tenm1, Usp27x, 
Trpc5, Necab1, Ankrd6, Ccbe1, Fa-
m149a, Epha6, Ace, Klhdc8b, Cort, 
Pdzrn4, Cgref1, Vat1l, Adam12, Penk, 
Zcchc12, Frem1, Dscaml1, Ltbp2, 
Pde11a, Cdh4, Pcdh19, Ngf, Rgs8, 
Pcdh8, Col5a2, Oxtr, Ecel1, Slc29a4, 
Tac1, Fmo1, Kcna3, Necab2, Adarb2, 
Camk2d, Fxyd6, Cpne7, Gabrg3, 
Fxyd2, Nr2f2, Tcerg1l, Epha3, Abca6, 
Nkain3, Moxd1, Nos1, Trp53i11, Syt9, 
Cyp1b1, Nov, Col6a4, Tmem132e, 
B3gnt7, Plekhd1, Wif1, Tac2, Fam167a, 
Bmp3, Htr2c, Dcaf12l2, Egln3, Slc9a2, 
Col6a3, Hcn4, Htr3a, Rxfp1, Fibin, 
Fibcd1, Fam196b, Tecta, Myh1, Rxrg, 
Hcrtr2, Trpc6, Slc35d3, Nxph2, Ndnf, 
Lamb3, Sp8, Cntnap5c, Nkpd1, Wnt16, 
Trpc7, Sncg, Tnfaip8l3, Gm16702, 
Baiap3, Magel2, Slc28a1, Scml4, Ngb, 
E130008D07Rik, Ccdc36, AW551984, 
Tshr, Col14a1, Krt73, Ptgfr, Zfp804b, 
Esr1, Slc6a12, Mc4r, Fgf3, Ndst4
Ehf, Hpse, Scn9a, Wnt2b, 
Pld5, Whrn, A330070K13Rik, 
Gm13629, Lrrc38, Snai3, 
Mmel1, Hhat, S100a10, 
Akr1c18, Fgf22, Zmat4, 
Tfap4, Shisa6, Plcxd2, Sl-
co5a1, Myh7b, Pthlh, Mypn, 
A330102I10Rik, Rerg, 
Cadps2, Pvalb, Hrh3, Fgd3, 
Myo16, Fmn1, Mxra7, Vamp1, 
Ccdc136, Sorcs1, Sel1l3, 
Rcan2, Fam19a2, Scn1a, 
Nrsn1
Microglia
Egr2, Cfh, Cd14, Igfbp4, Dusp2, Hpgd, 
Zdhhc23, Wdfy4, Mmp2, Mrc1, Lyz2, 
Colec12, Sla, Cxcl1, Cxcl10, Cd163, 
Col1a1, Cd52, Bcl3, Il1b, F13a1, 
Casp4, Ch25h, Tnfsf9, Itih2, Nod2, H2-
Aa, Aox3
Zfp54, Emilin2, C920025E04R-
ik, Cd200r4, Trim72, Rgs1, 
Cd200r1, Adam33, Il4ra, 
P2rx4
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Oligodendro-
cytes
Klhl4, Ctsk, Dll1, Kcnk13, Ascl5, Ct-
nna3, Adamts2, Abca8a, Gdf7, Ptgds, 
Eya2, Slc6a13, H2-Ab1, Serpind1, 
Fam180a, Aldh1a2, Wfikkn2, Slc22a6, 
Ctxn3, Mrgprf
Slc45a3, Casr, Nipal4, Cldn14, 
Sec14l5, Nkx6-2, Gjb1, Tnni1, 
Sgk2, Hapln2, Onecut2, Wnt3, 
Il12rb1, Opalin, Rab37, Sspo, 
Cyp39a1, Ninj2, Prima1, Insc, 
Ppp1r14a, Ermn, Plekhh1, 
Atp8b1, Galnt6, Gjc2, Pr-
r5l, Fbxo32, Pdlim2, Mog, 
Aspa, St18, Fa2h, Smco3, 
Mobp, Anln, Tmem88b, Mal, 
Tmem159, Fam83d, Atp10b, 
Mag, Gpr37, S1pr5, Cldn11, 
Tspan2, Ugt8a, 9630013A20R-
ik, Plekhg3, Mcam, Cpm, 
Trf, Bace2, Prr18, Plp1, 
Myrf, Erbb3, Mbp, Gamt, 
Unc5b, Adamts4, Dock5, 
6330416G13Rik, Masp1, Cd-
c42ep2, Sept4, Chn2, Cnksr3, 
Cnp, Gsn, Kndc1
Pyramidal neu-
rons
Enc1, Hpcal4, Gria3, Rin1, Neurl1a, 
Neurl1b, Smad3, Chrm3, Pvrl3, Kcnf1, 
Fam19a1, Igfn1, Meis2, Rfx3, C1ql3, 
Dsel, Slit3, Wisp1, Tnnc1, Rasal1, 
Sowaha, Tesc, Lpl, Greb1l, C730002L-
08Rik, Ypel1, Zfp831, Pnma1, Ramp3, 
Actn2, 6330403A02Rik, Prkcg, C2cd4c, 
Agmat, Jsrp1, Lrg1, Wfs1, Pcsk5, 
Slco4c1, Pcsk9, Klhl1, Grm8, Fndc9, 
Grik4, Gipr, 1700024P16Rik, Atp2b4, 
Sdk2, Mas1, Cstad, Lipg, Hrk, Ttc22, 
Ankrd63, Prss22, Lck, Slc9a3, Palm3, 
Myh2, Samd3, C130026L21Rik, 
Myh7, Aim1l, Slc23a3, F2rl2, Podn, 
Trabd2b, Wnt10b, Gpr52, Adcy10, 
Drd4, Gm10421, Sulf1, Itga11, Co-
l23a1, B230216N24Rik, Dmkn, Myh3, 
Otof, 2310065F04Rik, Lypd1, Krt77, 
Fst, Wnt6, Met, 4930470P17Rik, Crb1, 
5830416P10Rik, Adamts13, Fcgbp, 
Slc26a4, Aldh3b2, Twist2, Glra3, 
Atp6v1c2, Msln, Aldh1a3, Prg4, Ebf2, 
Syt10, Tnn, Arsj, Tcfl5, Asgr1, Tbx22, 
Cdh1, Zar1, Osr1
Hes3, Gm14015, 
C030013G03Rik, Grap2, Plb1, 
Gm20752, Shisa3, Dkkl1, 
Alpk2, Pou6f2, Cldn22, Inhbe, 
Ocm, Gm1653, 5930438M14R-
ik, Fam160a1, Hs3st4, Xirp2, 
Cyp26b1, Fezf2, Il12a, Cartpt, 
Rspo1, Tbata, Ovol2, Nxf7, 
Fgf23, Asb11, Lamc2, Arsi, 
Tle6, Tmc3, Six4, Hs3st2, Npff, 
Fndc8, 2310040G24Rik, Klh-
dc8a, 1700007P06Rik, Rorb, 
Snora65, Hsbp1l1, Gfra2, 
Sptssb, Lmo3, Cdsn, Sec1, Cit-
ed1, Gucy2g, Tnnt2, Kazald1, 
Bok, 4932411E22Rik, Pcdhb8, 
Nkx3-1, Pth2r, Ntn5, Prr16, 
Grm2, Pamr1, Sema3f, Grik3, 
C1ra, Lrrc55, Neurod6, Coch, 
Dtl, Vmn2r87, Kcns1, Tspan11, 
Ankrd34c, Grm4, Trpm4, Plx-
dc1, Dcdc2a, Myo5c, Medag, 
Pla2g4e, Trpc3, Psrc1, Kcnh5, 
Igsf9, Mb21d2, Brinp3, Wnt9a, 
Scube1, Foxp1, Boc, Gdpd5, 
Lrrc57, Adora1, Kcnip2, Ip-
cef1, Camk4
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Supplementary Table 6. Differentially expressed transcripts in L2/3 
Gene Gene discription FC (Control vs Deprived) FDR
Syn3 synapsin III 0.53 8.89E-08
Zdhhc14 zinc finger, DHHC domain containing 14 1.44 4.66E-07
Samd4 sterile alpha motif domain containing 4 1.58 8.18E-07
Enox1 ecto-NOX disulfide-thiol exchanger 1 1.61 8.18E-07
Obscn obscurin, cytoskeletal calmodulin and tit-in-interacting RhoGEF 0.45 4.24E-06
Galnt9 UDP-N-acetyl-alpha-D-galactosamine:poly-peptide N-acetylgalactosaminyltransferase 9 1.87 4.24E-06
Unc5d unc-5 netrin receptor D 0.70 1.25E-05
Car4 carbonic anhydrase 4 0.71 1.25E-05
Ubash3b ubiquitin associated and SH3 domain con-taining, B 1.43 4.00E-05
Tspan11 tetraspanin 11 0.58 4.00E-05
Ttr transthyretin 34.82 4.32E-05
Rhot2 ras homolog family member T2 1.26 4.82E-05
Myo1b myosin IB 0.80 4.82E-05
Ccdc184 coiled-coil domain containing 184 1.31 5.02E-05
Rgag4 retrotransposon gag domain containing 4 1.28 5.48E-05
Slco3a1 solute carrier organic anion transporter fami-ly, member 3a1 1.59 5.75E-05
Baiap2 brain-specific angiogenesis inhibitor 1-asso-ciated protein 2 1.27 6.24E-05
Iqgap2 IQ motif containing GTPase activating pro-tein 2 1.47 7.05E-05
Cobl cordon-bleu WH2 repeat 1.54 9.39E-05
Tnfrsf21 tumor necrosis factor receptor superfamily, member 21 1.32 9.52E-05
Slc9a9 solute carrier family 9 (sodium/hydrogen exchanger), member 9 0.68 1.13E-04
Srl sarcalumenin 0.67 1.14E-04
Erc2 ELKS/RAB6-interacting/CAST family mem-ber 2 0.79 1.40E-04
Gnb5 guanine nucleotide binding protein (G pro-tein), beta 5 1.31 1.49E-04
Col19a1 collagen, type XIX, alpha 1 0.71 1.63E-04
C130074G19Rik RIKEN cDNA C130074G19 gene 0.70 1.63E-04
Ccdc3 coiled-coil domain containing 3 0.51 1.63E-04
Nrep neuronal regeneration related protein 0.78 1.94E-04
Csmd2 CUB and Sushi multiple domains 2 1.28 2.27E-04
Spred3 sprouty-related, EVH1 domain containing 3 1.40 2.65E-04
Oscp1 organic solute carrier partner 1 0.80 3.90E-04
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Plxnc1 plexin C1 1.35 4.75E-04
Fat3 FAT atypical cadherin 3 0.72 5.09E-04
Slc7a4 solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 0.78 5.48E-04
Nrn1l neuritin 1-like 0.54 5.65E-04
Ephb2 Eph receptor B2 1.29 6.03E-04
B3galnt2 UDP-GalNAc:betaGlcNAc beta 1,3-galac-tosaminyltransferase, polypeptide 2 0.77 7.13E-04
Asb11 ankyrin repeat and SOCS box-containing 11 0.51 8.37E-04
Tmem132d transmembrane protein 132D 0.70 8.40E-04
Ankrd6 ankyrin repeat domain 6 1.56 8.59E-04
Slc25a17
solute carrier family 25 (mitochondrial carri-
er, peroxisomal membrane protein), member 
17 
0.79 9.88E-04
Tunar Tcl1 upstream neural differentiation associat-ed RNA 1.58 1.04E-03
Pth2r parathyroid hormone 2 receptor 0.48 1.48E-03
Pla2g4e phospholipase A2, group IVE 0.45 1.70E-03
3632451O06Rik RIKEN cDNA 3632451O06 gene 0.80 1.70E-03
Mdga1 MAM domain containing glycosylphosphati-dylinositol anchor 1 1.67 1.70E-03
Tmem200a transmembrane protein 200A 1.49 1.81E-03
Mybpc3 myosin binding protein C, cardiac 0.66 1.88E-03
Epb4.1l5 N/A 0.61 1.98E-03
Fnbp1l formin binding protein 1-like 1.35 1.98E-03
Synj2 synaptojanin 2 1.54 1.99E-03
Usp43 ubiquitin specific peptidase 43 0.54 2.52E-03
Pcdh8 protocadherin 8 1.35 2.55E-03
Ldb2 LIM domain binding 2 1.86 2.55E-03
Cd34 CD34 antigen 0.72 2.65E-03
Nim1k NIM1 serine/threonine protein kinase 0.80 2.65E-03
9230110C19Rik RIKEN cDNA 9230110C19 gene 1.49 2.67E-03
Tmem150c transmembrane protein 150C 1.36 2.83E-03
Mfsd4 N/A 0.66 2.83E-03
P3h3 prolyl 3-hydroxylase 3 1.29 3.22E-03
Etv5 ets variant 5 1.36 3.27E-03
Rasd2 RASD family, member 2 1.26 3.67E-03
Cbln1 cerebellin 1 precursor protein 0.58 3.88E-03
Celf6 CUGBP, Elav-like family member 6 1.36 3.90E-03
D430019H16Rik RIKEN cDNA D430019H16 gene 0.76 3.90E-03
Mast3 ENSMUSG00000031833 1.25 4.45E-03
Vgf VGF nerve growth factor inducible 1.29 4.51E-03
Tmem28 transmembrane protein 28 1.38 4.59E-03
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D130043K22Rik RIKEN cDNA D130043K22 gene 0.78 4.95E-03
Bok BCL2-related ovarian killer 0.71 5.13E-03
Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 1.31 5.51E-03
Amigo2 adhesion molecule with Ig like domain 2 0.53 5.53E-03
Egr3 early growth response 3 1.66 5.83E-03
5930412G12Rik RIKEN cDNA 5930412G12 gene 0.65 7.03E-03
Wnt9a wingless-type MMTV integration site family, member 9A 0.77 7.03E-03
Col22a1 collagen, type XXII, alpha 1 0.56 7.13E-03
Pla2g5 phospholipase A2, group V 1.52 7.26E-03
Ankrd34c ankyrin repeat domain 34C 0.67 7.33E-03
Crh corticotropin releasing hormone 1.47 7.40E-03
Anxa11 annexin A11 1.36 7.88E-03
Hspb6 heat shock protein, alpha-crystallin-related, B6 0.76 8.13E-03
Sbk1 SH3-binding kinase 1 1.32 8.58E-03
Fam171a1 family with sequence similarity 171, member A1 1.32 8.75E-03
Npas2 neuronal PAS domain protein 2 1.26 8.99E-03
Mical2 microtubule associated monooxygenase, cal-
ponin and LIM domain containing 2 
1.32 9.10E-03
St6galnac3
ST6 (alpha-N-acetyl-neuraminyl-2,3-be-
ta-galactosyl-1,3)-N-acetylgalactosaminide 
alpha-2,6-sialyltransferase 3 
0.70 9.79E-03
Agt angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 0.68 9.83E-03
Rsad1 radical S-adenosyl methionine domain con-taining 1 0.79 9.83E-03
Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 0.60 9.83E-03
Atad2 ATPase family, AAA domain containing 2 0.72 1.02E-02
Klhl40 kelch-like 40 0.60 1.02E-02
Hhatl hedgehog acyltransferase-like 0.74 1.02E-02
Fbxl4 F-box and leucine-rich repeat protein 4 0.69 1.04E-02
Myo16 myosin XVI 0.73 1.12E-02
Gpc4 glypican 4 0.66 1.12E-02
Mat2b methionine adenosyltransferase II, beta 0.79 1.12E-02
A930002C04Rik 0.33 1.12E-02
Cpne8 copine VIII 1.29 1.12E-02
Ripk2 receptor (TNFRSF)-interacting serine-thre-onine kinase 2 0.73 1.12E-02
Adam33 a disintegrin and metallopeptidase domain 33 0.58 1.18E-02
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Slc29a3 solute carrier family 29 (nucleoside trans-porters), member 3 0.80 1.20E-02
Fmnl1 formin-like 1 1.46 1.20E-02
Pvrl1 N/A 1.36 1.23E-02
C4a N/A 1.60 1.25E-02
Zbtb40 zinc finger and BTB domain containing 40 1.37 1.25E-02
Ddc dopa decarboxylase 0.63 1.30E-02
Vgll3 vestigial like family member 3 0.44 1.30E-02
Mapk12 mitogen-activated protein kinase 12 0.68 1.34E-02
Neu2 neuraminidase 2 0.75 1.40E-02
Pcsk9 proprotein convertase subtilisin/kexin type 9 0.61 1.42E-02
Dgkg diacylglycerol kinase, gamma 1.30 1.42E-02
Emb embigin 1.28 1.56E-02
Tmem245 transmembrane protein 245 0.71 1.56E-02
Cys1 cystin 1 1.48 1.57E-02
Sgsm1 small G protein signaling modulator 1 1.52 1.67E-02
Abca8b ATP-binding cassette, sub-family A (ABC1), member 8b 0.80 1.67E-02
Plekhg4 pleckstrin homology domain containing, family G (with RhoGef domain) member 4 1.61 1.67E-02
Grm2 glutamate receptor, metabotropic 2 0.80 1.69E-02
Fam13a family with sequence similarity 13, member A 0.79 1.72E-02
Wipf3 WAS/WASL interacting protein family, member 3 0.78 1.74E-02
9130019P16Rik RIKEN cDNA 9130019P16 gene 0.66 1.74E-02
Homer1 homer scaffolding protein 1 1.44 1.74E-02
Glb1l galactosidase, beta 1-like 0.76 1.94E-02
Efhc1 EF-hand domain (C-terminal) containing 1 0.53 1.95E-02
Ccnd1 cyclin D1 1.37 2.10E-02
Ciart circadian associated repressor of transcrip-tion 0.62 2.10E-02
Spata13 spermatogenesis associated 13 1.29 2.11E-02
Tcap titin-cap 0.65 2.29E-02
Slc35f4 solute carrier family 35, member F4 0.79 2.30E-02
Amn amnionless 0.64 2.33E-02
Zfp30 zinc finger protein 30 0.80 2.37E-02
Cpeb1 cytoplasmic polyadenylation element binding protein 1 0.77 2.37E-02
March10 membrane-associated ring finger (C3HC4) 10 0.60 2.37E-02
Strip2 striatin interacting protein 2 0.73 2.45E-02
Rims3 regulating synaptic membrane exocytosis 3 1.26 2.46E-02
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Hhipl1 hedgehog interacting protein-like 1 0.69 2.47E-02
Chst8 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 1.48 2.47E-02
Rps6ka2 ribosomal protein S6 kinase, polypeptide 2 1.31 2.48E-02
Hfe2 hemochromatosis type 2 (juvenile) 0.59 2.54E-02
Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 0.75 2.58E-02
Fam101b N/A 0.77 2.75E-02
Fndc8 fibronectin type III domain containing 8 1.82 2.79E-02
Ltbp2 latent transforming growth factor beta bind-ing protein 2 0.57 2.80E-02
Enc1 ectodermal-neural cortex 1 1.36 2.82E-02
Tnnc1 troponin C, cardiac/slow skeletal 0.75 2.88E-02
C2cd4c C2 calcium-dependent domain containing 4C 1.30 2.90E-02
Lmcd1 LIM and cysteine-rich domains 1 0.65 3.09E-02
Cfap52 cilia and flagella associated protein 52 0.43 3.10E-02
Dbp D site albumin promoter binding protein 0.64 3.15E-02
Fancm Fanconi anemia, complementation group M 0.76 3.21E-02
Hrh1 histamine receptor H1 1.27 3.23E-02
Zar1 zygote arrest 1 0.48 3.36E-02
Grm1 glutamate receptor, metabotropic 1 1.28 3.38E-02
Doc2b double C2, beta 1.31 3.40E-02
Tle2 transducin-like enhancer of split 2 1.26 3.45E-02
Sh3bgrl2 SH3 domain binding glutamic acid-rich pro-tein like 2 0.79 3.52E-02
Dgat2 diacylglycerol O-acyltransferase 2 0.80 3.56E-02
Klhl38 kelch-like 38 0.50 3.57E-02
Abcb1b ATP-binding cassette, sub-family B (MDR/TAP), member 1B 0.61 3.61E-02
Tcta T cell leukemia translocation altered gene 0.80 3.61E-02
Gm13629 N/A 0.65 3.68E-02
Brinp3 bone morphogenetic protein/retinoic acid 
inducible neural specific 3 
0.79 3.72E-02
Adgra1 adhesion G protein-coupled receptor A1 1.32 3.78E-02
Ndst3 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 1.29 3.78E-02
Gpr153 G protein-coupled receptor 153 0.76 3.84E-02
1700101I11Rik RIKEN cDNA 1700101I11 gene 0.59 3.84E-02
Spred1 sprouty protein with EVH-1 domain 1, relat-ed sequence 1.25 3.90E-02
Ntsr1 neurotensin receptor 1 0.58 3.97E-02
Zkscan16 zinc finger with KRAB and SCAN domains 16 0.68 4.00E-02
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Gm12992 predicted gene 12992 0.68 4.05E-02
Prss23 protease, serine 23 1.27 4.12E-02
Smad9 SMAD family member 9 0.74 4.12E-02
Ppil6 peptidylprolyl isomerase (cyclophilin)-like 6 0.73 4.17E-02
Erich1 glutamate rich 1 0.78 4.18E-02
Ccdc116 coiled-coil domain containing 116 0.66 4.24E-02
Trim17 tripartite motif-containing 17 1.32 4.29E-02
Slco1a4 solute carrier organic anion transporter fami-ly, member 1a4 0.70 4.32E-02
Capn6 calpain 6 0.54 4.46E-02
Nphp3 nephronophthisis 3 (adolescent) 0.77 4.55E-02
Hivep1 human immunodeficiency virus type I en-hancer binding protein 1 1.34 4.62E-02
Trem2 triggering receptor expressed on myeloid cells 2 0.78 4.66E-02
Efhc2 EF-hand domain (C-terminal) containing 2 0.58 4.74E-02
Fbxo32 F-box protein 32 0.73 4.85E-02
Cep131 centrosomal protein 131 0.78 4.86E-02
Qrfpr pyroglutamylated RFamide peptide receptor 1.78 4.86E-02
Cbln4 cerebellin 4 precursor protein 1.48 4.90E-02
Sun2 Sad1 and UNC84 domain containing 2 0.75 4.90E-02
Zfp810 zinc finger protein 810 0.74 4.94E-02
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Supplementary Table 7. Differentially expressed transcripts in L4 
Gene Gene description
FC (Con-
trol vs 
Deprived)
FDR
Unc5d unc-5 netrin receptor D 0.60 1.22E-12
Mgat5b mannoside acetylglucosaminyltransferase 5, isoenzyme B 1.39 1.63E-11
Zdhhc14 zinc finger, DHHC domain containing 14 1.51 1.78E-09
Slc9a9 solute carrier family 9 (sodium/hydrogen exchanger), member 9 0.59 1.78E-09
Enox1 ecto-NOX disulfide-thiol exchanger 1 1.70 7.54E-09
Tmem132d transmembrane protein 132D 0.59 7.54E-09
Fat3 FAT atypical cadherin 3 0.63 7.70E-09
Adgra1 adhesion G protein-coupled receptor A1 1.78 8.33E-09
Igsf3 immunoglobulin superfamily, member 3 1.44 8.33E-09
Galnt9 UDP-N-acetyl-alpha-D-galactosamine:poly-peptide N-acetylgalactosaminyltransferase 9 2.04 9.09E-09
Myo16 myosin XVI 0.58 1.00E-08
Orai2 ORAI calcium release-activated calcium modulator 2 0.76 1.97E-08
Sept6 septin 6 0.76 1.97E-08
Syn3 synapsin III 0.55 1.40E-07
Wnt2 wingless-type MMTV integration site family, member 2 2.56 1.40E-07
Gpr161 G protein-coupled receptor 161 2.10 1.40E-07
Snn stannin 0.76 4.00E-07
Usp2 ubiquitin specific peptidase 2 0.72 4.11E-07
Ube2e2 ubiquitin-conjugating enzyme E2E 2 1.27 5.02E-07
Ptprt protein tyrosine phosphatase, receptor type, T 0.73 5.02E-07
Adra1d adrenergic receptor, alpha 1d 1.39 7.38E-07
Mybpc3 myosin binding protein C, cardiac 0.56 7.38E-07
Mapk3 mitogen-activated protein kinase 3 1.27 7.46E-07
Evc2 Ellis van Creveld syndrome 2 1.73 7.96E-07
Ephb2 Eph receptor B2 1.38 8.18E-07
Brinp1 bone morphogenic protein/retinoic acid in-
ducible neural specific 1 
0.80 8.18E-07
Nr2f6 nuclear receptor subfamily 2, group F, mem-ber 6 1.27 9.90E-07
Rgs17 regulator of G-protein signaling 17 1.31 1.38E-06
Ldb2 LIM domain binding 2 2.38 1.53E-06
Slco3a1 solute carrier organic anion transporter fami-ly, member 3a1 1.66 1.84E-06
Sun1 Sad1 and UNC84 domain containing 1 0.76 1.92E-06
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Cys1 cystin 1 1.93 2.44E-06
Tmem150c transmembrane protein 150C 1.52 2.72E-06
Baiap2 brain-specific angiogenesis inhibitor 1-asso-ciated protein 2 1.29 3.93E-06
Rasd2 RASD family, member 2 1.35 5.14E-06
Nrip3 nuclear receptor interacting protein 3 1.27 5.56E-06
Emb embigin 1.45 7.63E-06
Egr3 early growth response 3 2.01 7.64E-06
Samd4 sterile alpha motif domain containing 4 1.50 9.08E-06
Pcdh8 protocadherin 8 1.48 1.01E-05
Gpr88 G-protein coupled receptor 88 1.27 1.01E-05
Kcnj3 potassium inwardly-rectifying channel, sub-family J, member 3 0.76 1.06E-05
Trim9 tripartite motif-containing 9 1.26 1.10E-05
Plxnd1 plexin D1 1.32 1.34E-05
Igfbp5 insulin-like growth factor binding protein 5 1.32 1.62E-05
Celf6 CUGBP, Elav-like family member 6 1.52 1.72E-05
Csmd2 CUB and Sushi multiple domains 2 1.31 1.87E-05
Ndst3 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 1.53 2.72E-05
Ankrd6 ankyrin repeat domain 6 1.68 3.03E-05
Ubash3b ubiquitin associated and SH3 domain con-taining, B 1.41 3.40E-05
Ccdc136 coiled-coil domain containing 136 1.32 3.40E-05
Rps6ka4 ribosomal protein S6 kinase, polypeptide 4 0.71 3.40E-05
Dpy19l3 dpy-19-like 3 (C. elegans) 1.37 3.40E-05
Rassf2 Ras association (RalGDS/AF-6) domain family member 2 1.26 3.64E-05
Ano3 anoctamin 3 0.77 4.48E-05
Brinp3 bone morphogenetic protein/retinoic acid 
inducible neural specific 3 
0.70 4.64E-05
Il17d interleukin 17D 1.27 5.24E-05
Rasl10a RAS-like, family 10, member A 1.37 5.99E-05
Sstr3 somatostatin receptor 3 0.79 5.99E-05
Zfyve28 zinc finger, FYVE domain containing 28 0.78 5.99E-05
Ccdc63 coiled-coil domain containing 63 3.01 6.63E-05
Strip2 striatin interacting protein 2 0.63 7.18E-05
Grb10 growth factor receptor bound protein 10 0.72 7.25E-05
Nptx1 neuronal pentraxin 1 1.31 7.35E-05
Sec14l1 SEC14-like lipid binding 1 0.78 7.35E-05
Nim1k NIM1 serine/threonine protein kinase 0.77 7.48E-05
Lrrn2 leucine rich repeat protein 2, neuronal 1.29 9.27E-05
Otud1 OTU domain containing 1 1.31 1.31E-04
156
CHAPTER 3
Osbpl10 oxysterol binding protein-like 10 1.27 1.31E-04
Gda guanine deaminase 0.77 1.31E-04
Hcn1 hyperpolarization-activated, cyclic nucleo-tide-gated K+ 1 1.31 1.31E-04
Synj2 synaptojanin 2 1.61 1.60E-04
Zfpm1 zinc finger protein, multitype 1 1.31 1.63E-04
Tmem200c transmembrane protein 200C 1.27 1.63E-04
Wipf3 WAS/WASL interacting protein family, member 3 0.71 1.63E-04
Rassf3 Ras association (RalGDS/AF-6) domain family member 3 0.79 2.07E-04
Mical2 microtubule associated monooxygenase, 
calponin and LIM domain containing 2 
1.41 2.07E-04
Sh3bgrl2 SH3 domain binding glutamic acid-rich pro-tein like 2 0.72 2.07E-04
Cobl cordon-bleu WH2 repeat 1.48 2.14E-04
Spred3 sprouty-related, EVH1 domain containing 3 1.38 2.20E-04
Tnfrsf21 tumor necrosis factor receptor superfamily, member 21 1.29 3.00E-04
Ociad2 OCIA domain containing 2 0.78 3.19E-04
Cdh22 cadherin 22 1.33 3.30E-04
Ptpn5 protein tyrosine phosphatase, non-receptor type 5 1.28 3.41E-04
Pcdhgc4 protocadherin gamma subfamily C, 4 1.28 5.00E-04
Spock3 sparc/osteonectin, cwcv and kazal-like do-mains proteoglycan 3 1.29 5.17E-04
Nell1 NEL-like 1 0.76 5.31E-04
Tmem151b transmembrane protein 151B 1.30 5.38E-04
Kcnd3 potassium voltage-gated channel, Shal-relat-ed family, member 3 1.27 5.38E-04
Pvrl1 N/A 1.45 5.53E-04
Plxnc1 plexin C1 1.33 5.79E-04
Etv5 ets variant 5 1.38 5.79E-04
Ppm1h protein phosphatase 1H (PP2C domain con-taining) 1.27 5.89E-04
Grik3 glutamate receptor, ionotropic, kainate 3 0.71 5.91E-04
Ttr transthyretin 15.89 6.00E-04
Mfsd4 N/A 0.65 6.03E-04
Numbl numb-like 1.27 6.68E-04
Ly6h lymphocyte antigen 6 complex, locus H 1.31 7.87E-04
Sowaha sosondowah ankyrin repeat domain family member A 1.34 8.00E-04
Nr1d1 nuclear receptor subfamily 1, group D, mem-ber 1 0.77 8.27E-04
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Bok BCL2-related ovarian killer 0.70 8.27E-04
Obscn obscurin, cytoskeletal calmodulin and tit-in-interacting RhoGEF 0.55 8.27E-04
Atp6ap1l ATPase, H+ transporting, lysosomal accesso-ry protein 1-like 0.70 8.27E-04
E130012A19Rik N/A 1.25 8.63E-04
Enc1 ectodermal-neural cortex 1 1.48 8.63E-04
Aff3 AF4/FMR2 family, member 3 1.34 8.63E-04
Grm2 glutamate receptor, metabotropic 2 0.76 8.78E-04
Neu2 neuraminidase 2 0.72 1.00E-03
Htr1b 5-hydroxytryptamine (serotonin) receptor 1B 2.37 1.01E-03
Bace2 beta-site APP-cleaving enzyme 2 0.54 1.02E-03
Jade1 jade family PHD finger 1 0.79 1.02E-03
Lgi2 leucine-rich repeat LGI family, member 2 0.74 1.08E-03
Plekhg4 pleckstrin homology domain containing, family G (with RhoGef domain) member 4 1.76 1.09E-03
Smad3 SMAD family member 3 1.42 1.13E-03
D030047H15Rik RIKEN cDNA D030047H15 gene 0.79 1.16E-03
Sbk1 SH3-binding kinase 1 1.37 1.18E-03
Lzts3 leucine zipper, putative tumor suppressor family member 3 1.27 1.20E-03
Diap2 N/A 0.77 1.29E-03
Fnbp1l formin binding protein 1-like 1.35 1.29E-03
Nrn1l neuritin 1-like 0.59 1.37E-03
Adam33 a disintegrin and metallopeptidase domain 33 0.54 1.37E-03
Tmem200a transmembrane protein 200A 1.46 1.40E-03
Tmem158 transmembrane protein 158 1.30 1.41E-03
Pla2g4e phospholipase A2, group IVE 0.47 1.41E-03
Omg oligodendrocyte myelin glycoprotein 0.79 1.45E-03
Gm266 predicted gene 266 1.76 1.48E-03
Gpr27 G protein-coupled receptor 27 1.28 1.50E-03
Pde1a phosphodiesterase 1A, calmodulin-dependent 1.48 1.51E-03
Cntnap5a contactin associated protein-like 5A 1.37 1.62E-03
Mdga1 MAM domain containing glycosylphosphati-dylinositol anchor 1 1.63 1.68E-03
Cep131 centrosomal protein 131 0.72 1.69E-03
Fancm Fanconi anemia, complementation group M 0.72 1.69E-03
Scai suppressor of cancer cell invasion 0.76 1.83E-03
St6galnac5
ST6 (alpha-N-acetyl-neuraminyl-2,3-be-
ta-galactosyl-1,3)-N-acetylgalactosaminide 
alpha-2,6-sialyltransferase 5 
1.42 1.85E-03
Rspo2 R-spondin 2 2.36 1.92E-03
Pcsk9 proprotein convertase subtilisin/kexin type 9 0.55 1.92E-03
158
CHAPTER 3
Rbm24 RNA binding motif protein 24 1.33 2.08E-03
Hs3st2 heparan sulfate (glucosamine) 3-O-sulfo-transferase 2 1.84 2.14E-03
Evc Ellis van Creveld gene syndrome 1.45 2.20E-03
D130043K22Rik RIKEN cDNA D130043K22 gene 0.77 2.27E-03
Iqgap2 IQ motif containing GTPase activating pro-tein 2 1.38 2.28E-03
Eef2k eukaryotic elongation factor-2 kinase 0.69 2.44E-03
Dcx doublecortin 0.72 2.55E-03
Sdk1 sidekick cell adhesion molecule 1 0.78 2.58E-03
Lmo7 LIM domain only 7 0.78 2.58E-03
Sft2d1 SFT2 domain containing 1 1.26 2.67E-03
B4galnt3 beta-1,4-N-acetyl-galactosaminyl transferase 3 2.06 2.68E-03
Baiap2l2 BAI1-associated protein 2-like 2 0.60 2.91E-03
Vgf VGF nerve growth factor inducible 1.29 2.92E-03
Bcl2 B cell leukemia/lymphoma 2 1.41 2.95E-03
Asb11 ankyrin repeat and SOCS box-containing 11 0.62 3.03E-03
Pxdc1 PX domain containing 1 1.59 3.04E-03
Mical1 microtubule associated monooxygenase, 
calponin and LIM domain containing 1 
1.43 3.05E-03
Hivep1 human immunodeficiency virus type I en-hancer binding protein 1 1.45 3.07E-03
Slc12a8 solute carrier family 12 (potassium/chloride transporters), member 8 0.51 3.08E-03
Cib2 calcium and integrin binding family member 2 1.26 3.12E-03
Thrb thyroid hormone receptor beta 1.30 3.38E-03
Cntnap5b contactin associated protein-like 5B 1.39 3.47E-03
C130074G19Rik RIKEN cDNA C130074G19 gene 0.76 3.61E-03
Lmo3 LIM domain only 3 0.74 3.65E-03
Ciart circadian associated repressor of transcrip-tion 0.59 3.71E-03
Homer1 homer scaffolding protein 1 1.50 3.73E-03
Gpr153 G protein-coupled receptor 153 0.72 3.73E-03
4930427A07Rik RIKEN cDNA 4930427A07 gene 0.57 3.89E-03
Hhatl hedgehog acyltransferase-like 0.74 3.90E-03
Adam23 a disintegrin and metallopeptidase domain 23 0.79 4.00E-03
Kcnf1 potassium voltage-gated channel, subfamily F, member 1 1.27 4.05E-03
Eogt EGF domain-specific O-linked N-acetylglu-cosamine (GlcNAc) transferase 0.79 4.10E-03
Serinc5 serine incorporator 5 0.78 4.29E-03
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Usp28 ubiquitin specific peptidase 28 0.80 4.34E-03
Gm2115 N/A 1.49 4.64E-03
Zbtb40 zinc finger and BTB domain containing 40 1.39 4.64E-03
Cd34 CD34 antigen 0.75 4.64E-03
Rims3 regulating synaptic membrane exocytosis 3 1.29 4.67E-03
Svil supervillin 0.61 4.69E-03
Lrrk2 leucine-rich repeat kinase 2 1.39 4.70E-03
Anxa11 annexin A11 1.34 4.97E-03
Shisa9 shisa family member 9 1.27 4.97E-03
Masp1 mannan-binding lectin serine peptidase 1 1.34 5.18E-03
Tgtp2 T cell specific GTPase 2 16.79 5.19E-03
Hebp2 heme binding protein 2 1.54 5.30E-03
Epb4.1l5 N/A 0.65 5.39E-03
Tunar Tcl1 upstream neural differentiation associat-ed RNA 1.49 5.42E-03
Cdh4 cadherin 4 1.38 5.45E-03
Spred1 sprouty protein with EVH-1 domain 1, relat-ed sequence 1.30 5.78E-03
E530011L22Rik N/A 0.67 5.84E-03
Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 1.53 5.85E-03
Gfod1 glucose-fructose oxidoreductase domain containing 1 1.25 6.09E-03
March1 membrane-associated ring finger (C3HC4) 1 1.27 6.23E-03
Cfap74 cilia and flagella associated protein 74 0.76 6.24E-03
Ankrd34b ankyrin repeat domain 34B 1.36 6.25E-03
Melk maternal embryonic leucine zipper kinase 0.48 6.40E-03
Ak4 adenylate kinase 4 1.32 6.47E-03
Fmnl1 formin-like 1 1.46 6.49E-03
Vdr vitamin D receptor 2.28 6.57E-03
Arhgap24 Rho GTPase activating protein 24 0.75 6.57E-03
Dgat2 diacylglycerol O-acyltransferase 2 0.78 6.57E-03
Arpc5 actin related protein 2/3 complex, subunit 5 1.26 6.57E-03
Ccnd2 cyclin D2 1.25 6.71E-03
Insm1 insulinoma-associated 1 1.44 7.06E-03
Gtf2ird1 general transcription factor II I repeat do-main-containing 1 0.79 7.26E-03
Klhl40 kelch-like 40 0.61 7.41E-03
Grik1 glutamate receptor, ionotropic, kainate 1 0.75 7.56E-03
Zfp160 zinc finger protein 160 0.80 7.57E-03
Cpne6 copine VI 1.32 7.71E-03
Sun2 Sad1 and UNC84 domain containing 2 0.72 7.83E-03
Maml3 mastermind like 3 (Drosophila) 1.71 7.88E-03
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Sema3f
sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 
3F 
1.36 7.94E-03
Stard4 StAR-related lipid transfer (START) domain containing 4 0.77 7.97E-03
Kif16b kinesin family member 16B 0.80 7.99E-03
Man1a mannosidase 1, alpha 1.37 8.10E-03
Ltbp2 latent transforming growth factor beta bind-ing protein 2 0.52 8.16E-03
Rnf217 ring finger protein 217 1.26 8.33E-03
Prss16 protease, serine 16 (thymus) 2.10 8.33E-03
Sgsm1 small G protein signaling modulator 1 1.53 8.34E-03
Slc26a8 solute carrier family 26, member 8 0.76 8.41E-03
Ddc dopa decarboxylase 0.66 8.41E-03
Dhodh dihydroorotate dehydrogenase 0.72 8.47E-03
Egr4 early growth response 4 1.31 8.47E-03
Dgkg diacylglycerol kinase, gamma 1.31 9.10E-03
Grp gastrin releasing peptide 1.87 9.15E-03
Gm3230 N/A 1.34 9.16E-03
Arhgap31 Rho GTPase activating protein 31 1.28 9.20E-03
St6galnac3
ST6 (alpha-N-acetyl-neuraminyl-2,3-be-
ta-galactosyl-1,3)-N-acetylgalactosaminide 
alpha-2,6-sialyltransferase 3 
0.72 9.25E-03
A630001G21Rik RIKEN cDNA A630001G21 gene 0.48 9.31E-03
Zfp46 zinc finger protein 46 0.79 9.38E-03
Nipal2 NIPA-like domain containing 2 0.74 1.00E-02
Armc4 armadillo repeat containing 4 0.53 1.04E-02
Srl sarcalumenin 0.75 1.06E-02
Abca8b ATP-binding cassette, sub-family A (ABC1), member 8b 0.80 1.08E-02
Myo5c myosin VC 0.75 1.08E-02
9230110C19Rik RIKEN cDNA 9230110C19 gene 1.41 1.10E-02
Parn poly(A)-specific ribonuclease (deadenylation nuclease) 0.79 1.12E-02
D430019H16Rik RIKEN cDNA D430019H16 gene 0.79 1.14E-02
Snx9 sorting nexin 9 1.27 1.19E-02
Ccdc62 coiled-coil domain containing 62 0.66 1.20E-02
Pde7b phosphodiesterase 7B 1.28 1.24E-02
9430041J12Rik RIKEN cDNA 9430041J12 gene 0.73 1.27E-02
Bex1 brain expressed X-linked 1 1.27 1.29E-02
Smad9 SMAD family member 9 0.73 1.30E-02
Tmtc4 transmembrane and tetratricopeptide repeat containing 4 1.32 1.39E-02
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Otub2 OTU domain, ubiquitin aldehyde binding 2 1.32 1.40E-02
Hhipl1 hedgehog interacting protein-like 1 0.68 1.44E-02
Zgrf1 zinc finger, GRF-type containing 1 0.71 1.45E-02
Tfap4 transcription factor AP4 0.53 1.46E-02
St8sia5 ST8 alpha-N-acetyl-neuraminide al-pha-2,8-sialyltransferase 5 1.29 1.47E-02
E130317F20Rik RIKEN cDNA E130317F20 gene 0.64 1.47E-02
Slco1a4 solute carrier organic anion transporter fami-ly, member 1a4 0.68 1.47E-02
Mthfd1l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like 0.68 1.51E-02
Sh3pxd2b SH3 and PX domains 2B 1.36 1.53E-02
Etv1 ets variant 1 1.42 1.58E-02
Piwil2 piwi-like RNA-mediated gene silencing 2 1.72 1.58E-02
Trim17 tripartite motif-containing 17 1.33 1.59E-02
Hmgb3 high mobility group box 3 0.74 1.59E-02
Fbxl7 F-box and leucine-rich repeat protein 7 2.16 1.59E-02
Tmem245 transmembrane protein 245 0.72 1.60E-02
Kcnj12 potassium inwardly-rectifying channel, sub-family J, member 12 1.32 1.64E-02
Actn3 actinin alpha 3 0.61 1.65E-02
Cdc25b cell division cycle 25B 0.76 1.74E-02
Hspa5 heat shock protein 5 1.48 1.79E-02
Sypl2 synaptophysin-like 2 1.43 1.80E-02
Prkg2 protein kinase, cGMP-dependent, type II 1.39 1.88E-02
Wdr78 WD repeat domain 78 1.43 1.91E-02
Caprin2 caprin family member 2 0.73 1.92E-02
Cemip cell migration inducing protein, hyaluronan binding 1.31 1.95E-02
Gm12992 predicted gene 12992 0.69 1.96E-02
Smim3 small integral membrane protein 3 0.73 1.96E-02
Zscan18 zinc finger and SCAN domain containing 18 0.80 1.96E-02
Lrfn2 leucine rich repeat and fibronectin type III domain containing 2 1.44 1.96E-02
Egfl7 EGF-like domain 7 0.80 1.98E-02
Cpeb1 cytoplasmic polyadenylation element binding protein 1 0.78 2.00E-02
Gm17769 N/A 0.50 2.01E-02
Pafah2 platelet-activating factor acetylhydrolase 2 0.77 2.08E-02
March10 membrane-associated ring finger (C3HC4) 10 0.62 2.13E-02
Ngb neuroglobin 1.60 2.18E-02
Grm1 glutamate receptor, metabotropic 1 1.29 2.19E-02
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Arhgef15 Rho guanine nucleotide exchange factor (GEF) 15 0.78 2.19E-02
Ntng1 netrin G1 1.30 2.23E-02
Mamld1 mastermind-like domain containing 1 1.26 2.23E-02
A930002C04Rik N/A 0.38 2.24E-02
Net1 neuroepithelial cell transforming gene 1 0.69 2.24E-02
Palmd palmdelphin 1.30 2.26E-02
4930470P17Rik RIKEN cDNA 4930470P17 gene 0.46 2.27E-02
Rab27a RAB27A, member RAS oncogene family 1.45 2.49E-02
Tnc tenascin C 1.68 2.49E-02
Lcorl ligand dependent nuclear receptor corepres-sor-like 0.78 2.49E-02
Spryd4 SPRY domain containing 4 1.26 2.57E-02
Dok2 docking protein 2 1.82 2.57E-02
Trpc5 transient receptor potential cation channel, subfamily C, member 5 1.38 2.57E-02
Mylk3 myosin light chain kinase 3 0.74 2.57E-02
Irs2 insulin receptor substrate 2 1.28 2.58E-02
Cbln4 cerebellin 4 precursor protein 1.49 2.62E-02
Ptprv N/A 0.51 2.62E-02
Lrrcc1 leucine rich repeat and coiled-coil domain containing 1 0.75 2.62E-02
Wdr76 WD repeat domain 76 0.70 2.71E-02
Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 1.56 2.78E-02
Tmem28 transmembrane protein 28 1.32 2.82E-02
Nsun7 NOL1/NOP2/Sun domain family, member 7 0.78 2.96E-02
Itga10 integrin, alpha 10 1.49 2.96E-02
Camk1g calcium/calmodulin-dependent protein ki-nase I gamma 1.43 3.02E-02
Wnt7a wingless-type MMTV integration site family, member 7A 1.50 3.03E-02
Adamts8
a disintegrin-like and metallopeptidase (re-
prolysin type) with thrombospondin type 1 
motif, 8 
1.34 3.09E-02
Pde10a phosphodiesterase 10A 1.57 3.11E-02
Adam8 a disintegrin and metallopeptidase domain 8 1.40 3.13E-02
Adck3 N/A 0.75 3.14E-02
Spred2 sprouty-related, EVH1 domain containing 2 1.34 3.14E-02
Creld2 cysteine-rich with EGF-like domains 2 1.42 3.16E-02
Efnb1 ephrin B1 1.39 3.16E-02
Tacc3 transforming, acidic coiled-coil containing protein 3 0.67 3.17E-02
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Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 1.81 3.18E-02
Gm6297 N/A 0.57 3.21E-02
Tmc4 transmembrane channel-like gene family 4 1.48 3.22E-02
Wrn Werner syndrome homolog (human) 0.79 3.27E-02
Tspan11 tetraspanin 11 0.74 3.36E-02
Tmem86a transmembrane protein 86A 0.78 3.39E-02
Angel1 angel homolog 1 0.71 3.42E-02
Layn layilin 1.71 3.42E-02
Ly75 lymphocyte antigen 75 0.64 3.42E-02
Chst8 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 1.42 3.46E-02
Echdc2 enoyl Coenzyme A hydratase domain con-taining 2 1.30 3.46E-02
Sesn1 sestrin 1 0.78 3.47E-02
Fam19a1 family with sequence similarity 19, member A1 1.40 3.47E-02
Vav3 vav 3 oncogene 1.47 3.47E-02
Xbp1 X-box binding protein 1 1.34 3.47E-02
AW551984 expressed sequence AW551984 2.07 3.56E-02
Zfp459 zinc finger protein 459 0.63 3.59E-02
Ap1s3 adaptor-related protein complex AP-1, sigma 3 1.50 3.70E-02
Plekha4
pleckstrin homology domain containing, 
family A (phosphoinositide binding specific) 
member 4 
0.67 3.81E-02
Doc2b double C2, beta 1.33 3.96E-02
Hyou1 hypoxia up-regulated 1 1.26 3.98E-02
Ksr2 kinase suppressor of ras 2 0.76 4.04E-02
Pcsk1 proprotein convertase subtilisin/kexin type 1 1.36 4.04E-02
Rab34 RAB34, member RAS oncogene family 0.80 4.07E-02
Kif26b kinesin family member 26B 1.40 4.07E-02
Rnf144b ring finger protein 144B 0.80 4.08E-02
Stk26 serine/threonine kinase 26 1.79 4.18E-02
Ldlr low density lipoprotein receptor 0.73 4.21E-02
Trim72 tripartite motif-containing 72 0.53 4.25E-02
Dusp4 dual specificity phosphatase 4 1.42 4.28E-02
Trmt13 tRNA methyltransferase 13 0.78 4.34E-02
C1ql1 complement component 1, q subcompo-nent-like 1 1.32 4.35E-02
Nfatc3 nuclear factor of activated T cells, cytoplas-mic, calcineurin dependent 3 0.79 4.38E-02
Met met proto-oncogene 1.49 4.39E-02
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Cdyl2 chromodomain protein, Y chromosome-like 2 1.52 4.40E-02
Lmcd1 LIM and cysteine-rich domains 1 0.68 4.44E-02
Manf mesencephalic astrocyte-derived neurotroph-ic factor 1.31 4.44E-02
Acot5 acyl-CoA thioesterase 5 1.30 4.46E-02
Siah3 seven in absentia homolog 3 (Drosophila) 1.46 4.48E-02
Cpne4 copine IV 1.28 4.49E-02
P4ha1
procollagen-proline, 2-oxoglutarate 4-di-
oxygenase (proline 4-hydroxylase), alpha 1 
polypeptide 
1.32 4.51E-02
Pparg peroxisome proliferator activated receptor gamma 0.79 4.56E-02
Olfm3 olfactomedin 3 1.28 4.63E-02
Slc23a3 solute carrier family 23 (nucleobase trans-porters), member 3 1.74 4.75E-02
Myoc myocilin 6.50 4.78E-02
Adamts17
a disintegrin-like and metallopeptidase (re-
prolysin type) with thrombospondin type 1 
motif, 17 
1.31 4.78E-02
2410127L17Rik N/A 1.27 4.81E-02
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Supplementary Table 8. Transcripts that are differentially expressed in L4 after whisker 
deprivation.  Comparisons between deprived versus first order spared columns.
Gene Gene description
FC (De-
prived vs 
First Order 
Spared)
FDR
Gpr88 G-protein coupled receptor 88 1.29 6.34E-05
Plxnd1 plexin D1 1.28 5.75E-03
Cxxc4 CXXC finger 4 1.30 3.91E-02
Melk maternal embryonic leucine zipper kinase 0.45 3.91E-02
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Supplementary Table 9. Transcripts that are differentially expressed in L2/3 after whisker 
deprivation.  Comparisons between deprived versus second order spared columns.
Gene Gene description
FC (De-
prived vs 
2nd Order 
Spared)
FDR
Dpysl2 dihydropyrimidinase-like 2 1.44 6.45E-20
Ntn5 netrin 5 1.60 8.09E-10
Aqp4 aquaporin 4 0.75 8.99E-08
Prdx1 peroxiredoxin 1 0.80 3.39E-06
Nptxr neuronal pentraxin receptor 0.76 6.94E-06
Rps26 ribosomal protein S26 0.74 7.85E-06
Grm4 glutamate receptor, metabotropic 4 1.36 1.85E-04
Efna3 ephrin A3 1.27 2.75E-04
Nefm neurofilament, medium polypeptide 1.41 8.81E-04
Gabrg1 gamma-aminobutyric acid (GABA) A recep-tor, subunit gamma 1 0.79 1.18E-03
Sec1 secretory blood group 1 2.03 1.52E-03
Mcc mutated in colorectal cancers 1.30 1.67E-03
Zbtb20 zinc finger and BTB domain containing 20 1.36 1.67E-03
Epha10 Eph receptor A10 1.32 2.39E-03
Plxdc1 plexin domain containing 1 1.41 3.22E-03
Kcnab3 potassium voltage-gated channel, shaker-re-lated subfamily, beta member 3 1.53 3.50E-03
Tspan17 tetraspanin 17 1.33 3.50E-03
Robo3 roundabout guidance receptor 3 1.30 3.50E-03
Zfp758 zinc finger protein 758 0.75 4.16E-03
Plagl1 pleiomorphic adenoma gene-like 1 0.77 4.35E-03
Cav1 caveolin 1, caveolae protein 0.66 4.46E-03
Tlr3 toll-like receptor 3 0.76 4.67E-03
Ptgfrn prostaglandin F2 receptor negative regulator 1.31 5.67E-03
Foxo1 forkhead box O1 0.76 5.73E-03
Pamr1 peptidase domain containing associated with muscle regeneration 1 1.26 6.39E-03
Id4 inhibitor of DNA binding 4 0.75 6.97E-03
Ptprv N/A 2.44 7.27E-03
Sema3f
sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 
3F 
1.43 7.34E-03
Gfap glial fibrillary acidic protein 0.73 1.13E-02
Ghr growth hormone receptor 0.77 1.15E-02
Slfn8 schlafen 8 0.53 1.17E-02
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Vwa5a von Willebrand factor A domain containing 5A 0.76 1.28E-02
Bmpr1b bone morphogenetic protein receptor, type 1B 0.80 1.28E-02
Scube1 signal peptide, CUB domain, EGF-like 1 1.27 1.28E-02
Rorb RAR-related orphan receptor beta 1.50 1.38E-02
Mag myelin-associated glycoprotein 1.35 1.38E-02
Ppp1r1b protein phosphatase 1, regulatory (inhibitor) subunit 1B 1.31 1.81E-02
Slc16a9 solute carrier family 16 (monocarboxylic acid transporters), member 9 0.56 1.84E-02
Cxcr5 chemokine (C-X-C motif) receptor 5 0.52 1.98E-02
Slc7a2 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 0.77 1.99E-02
Gulp1 GULP, engulfment adaptor PTB domain containing 1 0.67 2.17E-02
Trim12c tripartite motif-containing 12C 0.61 2.21E-02
Mgp matrix Gla protein 0.31 2.35E-02
1700125G02Rik RIKEN cDNA 1700125G02 gene 1.78 2.41E-02
Rims3 regulating synaptic membrane exocytosis 3 1.27 2.46E-02
Pcsk6 proprotein convertase subtilisin/kexin type 6 0.77 2.47E-02
Rpl37rt ribosomal protein L37 0.64 2.58E-02
Sept4 septin 4 1.26 2.77E-02
Timp3 tissue inhibitor of metalloproteinase 3 0.76 2.82E-02
Ddx58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 0.70 2.87E-02
1810041L15Rik RIKEN cDNA 1810041L15 gene 0.78 2.91E-02
Crip1 cysteine-rich protein 1 (intestinal) 0.37 2.91E-02
Ifit1
interferon-induced protein with tetratricopep-
tide repeats 1 0.53 2.92E-02
Wnt3 wingless-type MMTV integration site family, member 3 1.99 2.92E-02
Lmo3 LIM domain only 3 1.32 2.92E-02
Nmnat1 nicotinamide nucleotide adenylyltransferase 1 1.35 2.93E-02
Ifitm3 interferon induced transmembrane protein 3 0.53 2.94E-02
Adgrl4 adhesion G protein-coupled receptor L4 0.71 3.33E-02
Zfp521 zinc finger protein 521 0.79 3.57E-02
Pdgfd platelet-derived growth factor, D polypeptide 0.50 3.64E-02
Mycbpap MYCBP associated protein 1.91 3.68E-02
Blmh bleomycin hydrolase 1.37 3.74E-02
Six4 sine oculis-related homeobox 4 1.86 3.90E-02
Mgst1 microsomal glutathione S-transferase 1 0.65 3.97E-02
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Cartpt CART prepropeptide 2.05 4.13E-02
Astn2 astrotactin 2 1.31 4.24E-02
Ifit3
interferon-induced protein with tetratricopep-
tide repeats 3 0.57 4.28E-02
Vim vimentin 0.62 4.46E-02
Calcrl calcitonin receptor-like 0.68 4.59E-02
St8sia4 ST8 alpha-N-acetyl-neuraminide al-pha-2,8-sialyltransferase 4 0.73 4.63E-02
Sgpp2 sphingosine-1-phosphate phosphotase 2 1.41 4.63E-02
Gpx8 glutathione peroxidase 8 (putative) 0.68 4.63E-02
Necab1 N-terminal EF-hand calcium binding protein 1 0.80 4.80E-02
Pdgfc platelet-derived growth factor, C polypeptide 0.74 4.90E-02
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Supplementary Table 10. Transcripts that are differentially expressed in L4 after whisker 
deprivation.  Comparisons between deprived versus second order spared columns.
Gene Gene description
FC (Deprived 
vs Second 
Order Spared
FDR
Ntn5 netrin 5 1.64 2.81E-15
Dpysl2 dihydropyrimidinase-like 2 1.38 2.81E-15
Gabra5 gamma-aminobutyric acid (GABA) A recep-tor, subunit alpha 5 0.62 8.04E-14
Plxnd1 plexin D1 1.47 1.05E-10
Zbtb20 zinc finger and BTB domain containing 20 1.62 1.84E-09
Gpr88 G-protein coupled receptor 88 1.35 4.37E-09
Cpne4 copine IV 0.59 1.06E-07
Fam84a family with sequence similarity 84, member A 0.72 3.55E-07
Hdac9 histone deacetylase 9 0.67 3.56E-07
Dus3l dihydrouridine synthase 3-like (S. cerevisiae) 1.27 3.56E-07
Ccdc136 coiled-coil domain containing 136 1.39 3.56E-07
Chrd chordin 1.32 4.22E-07
Msi1 musashi RNA-binding protein 1 1.40 7.24E-07
Whrn whirlin 1.61 9.01E-07
Pcdh11x protocadherin 11 X-linked 0.61 1.02E-06
Rassf2 Ras association (RalGDS/AF-6) domain family member 2 1.30 1.56E-06
Tle2 transducin-like enhancer of split 2 1.49 2.20E-06
Gpr161 G protein-coupled receptor 161 1.97 2.51E-06
Tnc tenascin C 0.43 2.53E-06
Cntn4 contactin 4 0.70 2.69E-06
Rgs20 regulator of G-protein signaling 20 0.75 3.66E-06
Enpp2 ectonucleotide pyrophosphatase/phosphodi-esterase 2 0.72 4.84E-06
Rragd Ras-related GTP binding D 0.76 7.08E-06
Tmem145 transmembrane protein 145 1.30 8.00E-06
Hist3h2a histone cluster 3, H2a 1.39 8.32E-06
Tnnc1 troponin C, cardiac/slow skeletal 0.62 8.48E-06
Bax BCL2-associated X protein 1.26 1.03E-05
Ppp4r4 protein phosphatase 4, regulatory subunit 4 0.75 1.38E-05
Plb1 phospholipase B1 1.94 1.53E-05
Megf11 multiple EGF-like-domains 11 0.73 2.37E-05
Fam184b family with sequence similarity 184, member B 0.61 2.58E-05
Shroom2 shroom family member 2 0.79 2.92E-05
Gnal guanine nucleotide binding protein, alpha stimulating, olfactory type 0.79 3.09E-05
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Rab26 RAB26, member RAS oncogene family 1.71 3.11E-05
Sox4 SRY (sex determining region Y)-box 4 1.32 3.11E-05
Masp1 mannan-binding lectin serine peptidase 1 1.49 3.25E-05
Acvr1c activin A receptor, type IC 0.67 3.66E-05
Serpinb8 serine (or cysteine) peptidase inhibitor, clade B, member 8 0.62 3.66E-05
Jup junction plakoglobin 1.34 4.12E-05
Rasl10a RAS-like, family 10, member A 1.38 4.40E-05
Stard8 START domain containing 8 0.72 4.97E-05
Cdr1 cerebellar degeneration related antigen 1 0.51 6.92E-05
Scnn1a sodium channel, nonvoltage-gated 1 alpha 1.79 6.92E-05
Gda guanine deaminase 0.77 7.00E-05
Tssc4 tumor-suppressing subchromosomal transfer-able fragment 4 1.25 7.10E-05
Kcnb2 potassium voltage gated channel, Shab-relat-ed subfamily, member 2 0.69 7.69E-05
Kcnip4 Kv channel interacting protein 4 0.76 1.00E-04
Cntn6 contactin 6 0.77 1.27E-04
Nrp2 neuropilin 2 0.60 1.38E-04
Grik4 glutamate receptor, ionotropic, kainate 4 0.70 1.42E-04
Spats2l spermatogenesis associated, serine-rich 2-like 0.78 1.43E-04
Wipf3 WAS/WASL interacting protein family, member 3 0.71 1.49E-04
Wdr17 WD repeat domain 17 0.74 1.50E-04
Ptprt protein tyrosine phosphatase, receptor type, T 0.78 1.85E-04
Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3) 0.73 2.14E-04
C1ql3 C1q-like 3 0.68 2.14E-04
Efna3 ephrin A3 1.25 2.42E-04
C77370 expressed sequence C77370 0.78 2.56E-04
C2cd4c C2 calcium-dependent domain containing 4C 0.68 2.86E-04
Cort cortistatin 0.57 3.07E-04
Cpne5 copine V 0.73 3.49E-04
Klc4 kinesin light chain 4 1.26 3.49E-04
Irf2bp2 interferon regulatory factor 2 binding protein 2 1.32 3.73E-04
Dgkb diacylglycerol kinase, beta 0.62 3.74E-04
Dvl2 dishevelled segment polarity protein 2 1.27 3.88E-04
Timeless timeless circadian clock 1 1.44 3.95E-04
Grm4 glutamate receptor, metabotropic 4 1.30 4.34E-04
Ybx2 Y box protein 2 1.55 4.34E-04
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Cnr1 cannabinoid receptor 1 (brain) 0.73 4.34E-04
Mbp myelin basic protein 1.34 4.72E-04
Col19a1 collagen, type XIX, alpha 1 0.73 4.72E-04
Neto1 neuropilin (NRP) and tolloid (TLL)-like 1 0.78 4.96E-04
Sertm1 serine rich and transmembrane domain con-taining 1 0.68 5.09E-04
Fam101b N/A 0.71 5.69E-04
Mag myelin-associated glycoprotein 1.41 6.01E-04
Tmem196 transmembrane protein 196 0.63 7.31E-04
Ring1 ring finger protein 1 1.30 7.40E-04
Cnp 2’,3’-cyclic nucleotide 3’ phosphodiesterase 1.26 7.40E-04
Fzd3 frizzled class receptor 3 0.80 7.41E-04
B230216N24Rik RIKEN cDNA B230216N24 gene 0.54 8.47E-04
Psrc1 proline/serine-rich coiled-coil 1 1.31 9.61E-04
Ankrd63 ankyrin repeat domain 63 0.57 9.69E-04
AI504432 expressed sequence AI504432 0.72 1.16E-03
Anln anillin, actin binding protein 1.65 1.28E-03
Lamc2 laminin, gamma 2 1.90 1.34E-03
Thsd7a thrombospondin, type I, domain containing 7A 1.27 1.34E-03
Col9a3 collagen, type IX, alpha 3 1.25 1.37E-03
March4 membrane-associated ring finger (C3HC4) 4 0.79 1.49E-03
Diap2 N/A 0.77 1.49E-03
Plch2 phospholipase C, eta 2 1.28 1.54E-03
Il4ra interleukin 4 receptor, alpha 1.48 1.54E-03
Sema3f
sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 
3F 
1.42 1.59E-03
Herc6 hect domain and RLD 6 0.78 1.59E-03
Melk maternal embryonic leucine zipper kinase 0.45 1.61E-03
Atp2b4 ATPase, Ca++ transporting, plasma mem-brane 4 0.58 1.63E-03
Gm9899 predicted gene 9899 0.79 1.63E-03
Tprn taperin 1.29 1.68E-03
Hpcal4 hippocalcin-like 4 0.78 1.72E-03
Necab1 N-terminal EF-hand calcium binding protein 1 0.75 1.74E-03
Sec1 secretory blood group 1 1.72 1.78E-03
Bmp3 bone morphogenetic protein 3 0.61 1.85E-03
Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 1.27 1.85E-03
Trim17 tripartite motif-containing 17 1.40 1.91E-03
6330403A02Rik N/A 0.62 2.08E-03
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Adgra1 adhesion G protein-coupled receptor A1 1.41 2.08E-03
Igsf9 immunoglobulin superfamily, member 9 1.35 2.08E-03
Pkp2 plakophilin 2 0.41 2.14E-03
Gpr22 G protein-coupled receptor 22 0.78 2.14E-03
Lor loricrin 1.56 2.20E-03
Frzb frizzled-related protein 0.68 2.32E-03
Man2a1 mannosidase 2, alpha 1 0.79 2.45E-03
Neto2 neuropilin (NRP) and tolloid (TLL)-like 2 0.79 2.49E-03
Synpr synaptoporin 0.80 2.49E-03
Nxph3 neurexophilin 3 2.33 2.54E-03
Plagl1 pleiomorphic adenoma gene-like 1 0.78 2.69E-03
Ntrk3 neurotrophic tyrosine kinase, receptor, type 3 0.79 2.75E-03
Samd11 sterile alpha motif domain containing 11 2.14 2.75E-03
Sstr1 somatostatin receptor 1 0.79 2.77E-03
Sema6a sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A 1.28 2.80E-03
Sgk3 serum/glucocorticoid regulated kinase 3 0.78 3.07E-03
Col20a1 collagen, type XX, alpha 1 1.35 3.24E-03
Pgap1 post-GPI attachment to proteins 1 0.75 3.31E-03
Cacng3 calcium channel, voltage-dependent, gamma subunit 3 0.78 3.49E-03
Emx2os Emx2 opposite strand/antisense transcript (non-protein coding) 0.72 3.65E-03
Palmd palmdelphin 0.74 3.76E-03
Tpbg trophoblast glycoprotein 0.75 3.90E-03
Crip2 cysteine rich protein 2 0.79 3.94E-03
Shkbp1 Sh3kbp1 binding protein 1 1.25 4.17E-03
Olfr78 olfactory receptor 78 0.49 4.18E-03
Ccbe1 collagen and calcium binding EGF domains 1 0.66 4.28E-03
Zbtb7b zinc finger and BTB domain containing 7B 1.26 4.38E-03
Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 0.75 4.38E-03
Kcnv1 potassium channel, subfamily V, member 1 0.77 4.40E-03
Nov nephroblastoma overexpressed gene 0.64 4.47E-03
Tfeb transcription factor EB 1.34 4.64E-03
Csf2ra colony stimulating factor 2 receptor, alpha, 
low-affinity (granulocyte-macrophage) 
1.26 4.65E-03
Zfp831 zinc finger protein 831 0.68 4.78E-03
Chrm3 cholinergic receptor, muscarinic 3, cardiac 0.75 4.89E-03
Cdh7 cadherin 7, type 2 0.77 4.97E-03
Col11a2 collagen, type XI, alpha 2 1.25 5.02E-03
Sypl2 synaptophysin-like 2 1.48 5.44E-03
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Mical1 microtubule associated monooxygenase, 
calponin and LIM domain containing 1 
1.39 5.53E-03
Adamts3
a disintegrin-like and metallopeptidase (re-
prolysin type) with thrombospondin type 1 
motif, 3 
0.78 5.58E-03
Rasgrf2 RAS protein-specific guanine nucleotide-re-leasing factor 2 0.79 5.68E-03
Mas1 MAS1 oncogene 0.58 5.92E-03
Trpc6 transient receptor potential cation channel, subfamily C, member 6 0.61 6.06E-03
Tbx22 T-box 22 0.20 6.57E-03
6330416G13Rik N/A 1.38 6.76E-03
Cck cholecystokinin 0.79 6.92E-03
Sept4 septin 4 1.26 7.01E-03
Spon1 spondin 1, (f-spondin) extracellular matrix protein 1.35 7.12E-03
Zfp711 zinc finger protein 711 0.80 7.26E-03
Morf4l1-ps1 N/A 1.59 7.44E-03
Gm1821 N/A 1.30 7.45E-03
Ppox protoporphyrinogen oxidase 1.26 7.45E-03
Aldh3b2 aldehyde dehydrogenase 3 family, member B2 0.53 7.50E-03
Mobp myelin-associated oligodendrocytic basic protein 1.42 7.64E-03
Mir1249 microRNA 1249 1.86 7.65E-03
Iqgap2 IQ motif containing GTPase activating pro-tein 2 0.76 7.78E-03
B3gnt2 UDP-GlcNAc:betaGal beta-1,3-N-acetylglu-cosaminyltransferase 2 0.79 8.30E-03
Spata13 spermatogenesis associated 13 0.77 8.47E-03
Csgalnact1 chondroitin sulfate N-acetylgalactosaminyl-transferase 1 0.79 8.71E-03
Gsn gelsolin 1.35 8.84E-03
Tlr3 toll-like receptor 3 0.79 8.97E-03
Macrod1 MACRO domain containing 1 1.29 9.02E-03
Atm ataxia telangiectasia mutated 0.80 9.05E-03
Nhsl2 NHS-like 2 0.79 9.28E-03
Cchcr1 coiled-coil alpha-helical rod protein 1 1.53 9.83E-03
S100a6 S100 calcium binding protein A6 (calcyclin) 0.77 1.01E-02
Sema3a
sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 
3A 
0.80 1.04E-02
Gm10509 N/A 0.71 1.06E-02
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Ankfn1 ankyrin-repeat and fibronectin type III do-main containing 1 1.73 1.06E-02
Stk32b serine/threonine kinase 32B 0.55 1.07E-02
Gbp6 guanylate binding protein 6 2.26 1.10E-02
Adamts4
a disintegrin-like and metallopeptidase (re-
prolysin type) with thrombospondin type 1 
motif, 4 
1.36 1.10E-02
Kif27 kinesin family member 27 0.61 1.10E-02
Doc2b double C2, beta 0.74 1.11E-02
Relt RELT tumor necrosis factor receptor 1.29 1.14E-02
Bglap3 bone gamma-carboxyglutamate protein 3 1.86 1.15E-02
Lemd1 LEM domain containing 1 0.57 1.21E-02
Cdk18 cyclin-dependent kinase 18 1.44 1.26E-02
Lrrtm3 leucine rich repeat transmembrane neuronal 3 0.73 1.26E-02
Slc7a2 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 0.78 1.29E-02
Ptchd4 patched domain containing 4 0.74 1.29E-02
Ifi27 interferon, alpha-inducible protein 27 1.34 1.30E-02
Col26a1 collagen, type XXVI, alpha 1 1.29 1.31E-02
Efnb3 ephrin B3 1.28 1.32E-02
Dmgdh dimethylglycine dehydrogenase precursor 0.53 1.32E-02
Lhfpl2 lipoma HMGIC fusion partner-like 2 1.26 1.38E-02
Fam167a family with sequence similarity 167, member A 0.47 1.40E-02
Zdbf2 zinc finger, DBF-type containing 2 0.72 1.42E-02
Jun jun proto-oncogene 1.32 1.42E-02
Ndst3 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 0.77 1.42E-02
Plxnb3 plexin B3 1.25 1.42E-02
Acot5 acyl-CoA thioesterase 5 1.34 1.45E-02
Lrrc32 leucine rich repeat containing 32 0.72 1.45E-02
Mfap2 microfibrillar-associated protein 2 1.42 1.50E-02
Mafa v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) 1.67 1.50E-02
Fam149a family with sequence similarity 149, member A 0.79 1.52E-02
Pdzrn4 PDZ domain containing RING finger 4 0.73 1.57E-02
Gcnt4 glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase) 0.77 1.59E-02
Hrk harakiri, BCL2 interacting protein (contains only BH3 domain) 0.76 1.59E-02
Il1rapl1 interleukin 1 receptor accessory protein-like 1 0.75 1.63E-02
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Car12 carbonic anhydrase 12 0.63 1.65E-02
Mylk3 myosin light chain kinase 3 0.74 1.71E-02
Sec14l3 SEC14-like lipid binding 3 0.37 1.72E-02
Ndnf neuron-derived neurotrophic factor 0.62 1.73E-02
Jade3 jade family PHD finger 3 0.80 1.75E-02
Ankrd6 ankyrin repeat domain 6 0.73 1.77E-02
Ebf4 early B cell factor 4 1.28 1.84E-02
Klf8 Kruppel-like factor 8 0.77 1.86E-02
Pip5kl1 phosphatidylinositol-4-phosphate 5-ki-nase-like 1 1.62 1.87E-02
Snx8 sorting nexin 8 1.29 1.87E-02
Tmem245 transmembrane protein 245 0.74 1.87E-02
Igfbp4 insulin-like growth factor binding protein 4 0.73 1.97E-02
Ccdc80 coiled-coil domain containing 80 1.29 2.05E-02
Gjc2 gap junction protein, gamma 2 1.41 2.11E-02
Wasf2 WAS protein family, member 2 1.25 2.16E-02
Kcna3 potassium voltage-gated channel, shaker-re-lated subfamily, member 3 0.75 2.18E-02
Camk2d calcium/calmodulin-dependent protein ki-nase II, delta 0.78 2.19E-02
Zfp811 zinc finger protein 811 0.77 2.20E-02
Klhl4 kelch-like 4 0.78 2.20E-02
Efcab1 EF hand calcium binding domain 1 0.63 2.25E-02
Kcnmb4 potassium large conductance calcium-acti-vated channel, subfamily M, beta member 4 0.71 2.27E-02
Gpr37 G protein-coupled receptor 37 1.27 2.28E-02
Ilvbl ilvB (bacterial acetolactate synthase)-like 1.29 2.28E-02
Tcf19 transcription factor 19 1.30 2.31E-02
Ccdc63 coiled-coil domain containing 63 1.93 2.35E-02
Coro6 coronin 6 1.29 2.35E-02
Rpph1 ribonuclease P RNA component H1 0.17 2.39E-02
Hic2 hypermethylated in cancer 2 1.28 2.39E-02
Gm20939 predicted gene, 20939 0.71 2.39E-02
Met met proto-oncogene 0.67 2.40E-02
Tmem163 transmembrane protein 163 1.32 2.44E-02
Actn2 actinin alpha 2 0.77 2.45E-02
Adamts18
a disintegrin-like and metallopeptidase (re-
prolysin type) with thrombospondin type 1 
motif, 18 
0.61 2.47E-02
Moxd1 monooxygenase, DBH-like 1 0.65 2.47E-02
Ppp1r1b protein phosphatase 1, regulatory (inhibitor) subunit 1B 1.26 2.48E-02
Vat1l vesicle amine transport protein 1 like 0.76 2.48E-02
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Fndc9 fibronectin type III domain containing 9 0.69 2.59E-02
Rps6ka6 ribosomal protein S6 kinase polypeptide 6 0.73 2.63E-02
Gm13157 N/A 0.68 2.63E-02
Fam198b family with sequence similarity 198, member B 0.76 2.67E-02
Col16a1 collagen, type XVI, alpha 1 1.30 2.69E-02
Lipg lipase, endothelial 0.65 2.70E-02
Boc
biregional cell adhesion molecule-related/
down-regulated by oncogenes (Cdon) bind-
ing protein 
1.27 2.73E-02
Wfs1 Wolfram syndrome 1 homolog (human) 0.75 2.78E-02
Vangl2 vang-like 2 (van gogh, Drosophila) 1.27 2.80E-02
C1galt1 core 1 synthase, glycoprotein-N-acetylgalac-tosamine 3-beta-galactosyltransferase, 1 0.80 2.80E-02
Peg10 paternally expressed 10 0.78 2.83E-02
Fgf22 fibroblast growth factor 22 1.60 2.86E-02
Myh7b myosin, heavy chain 7B, cardiac muscle, beta 1.36 2.86E-02
Syn3 synapsin III 0.75 2.87E-02
Tbata thymus, brain and testes associated 1.70 2.87E-02
Tgm3 transglutaminase 3, E polypeptide 1.29 2.89E-02
Evc Ellis van Creveld gene syndrome 1.31 2.95E-02
Rprm reprimo, TP53 dependent G2 arrest mediator candidate 1.43 3.01E-02
Tspan15 tetraspanin 15 1.26 3.03E-02
Pip5k1b phosphatidylinositol-4-phosphate 5-kinase, type 1 beta 0.79 3.13E-02
Arg2 arginase type II 0.72 3.14E-02
Sorcs3 sortilin-related VPS10 domain containing receptor 3 0.77 3.14E-02
Stk36 serine/threonine kinase 36 1.29 3.15E-02
Ramp3 receptor (calcitonin) activity modifying protein 3 0.77 3.17E-02
Zfp958 zinc finger protein 958 0.79 3.21E-02
Otof otoferlin 0.58 3.21E-02
C030006K11Rik leucine rich repeat containing 24 1.28 3.29E-02
Echdc2 enoyl Coenzyme A hydratase domain con-taining 2 1.28 3.33E-02
Trip6 thyroid hormone receptor interactor 6 1.42 3.41E-02
Rorb RAR-related orphan receptor beta 1.36 3.49E-02
Zfpm2 zinc finger protein, multitype 2 0.74 3.49E-02
Mboat1 membrane bound O-acyltransferase domain containing 1 1.71 3.53E-02
Zfp748 zinc finger protein 748 0.80 3.56E-02
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Gpc6 glypican 6 0.76 3.57E-02
Dnaic2 dynein, axonemal, intermediate chain 2 1.59 3.63E-02
Evc2 Ellis van Creveld syndrome 2 1.31 3.68E-02
Thap3 THAP domain containing, apoptosis associ-ated protein 3 1.39 3.72E-02
Fgd2 FYVE, RhoGEF and PH domain containing 2 1.32 3.82E-02
Adamts17
a disintegrin-like and metallopeptidase (re-
prolysin type) with thrombospondin type 1 
motif, 17 
1.30 3.87E-02
Hfe2 hemochromatosis type 2 (juvenile) 0.63 3.98E-02
Plekhg3 pleckstrin homology domain containing, family G (with RhoGef domain) member 3 1.29 4.01E-02
Adam1a a disintegrin and metallopeptidase domain 1a 1.37 4.01E-02
2010001A14Rik RIKEN cDNA 2010001A14 gene 1.44 4.03E-02
Scn3b sodium channel, voltage-gated, type III, beta 0.79 4.04E-02
Penk preproenkephalin 0.73 4.05E-02
Sec14l5 SEC14-like lipid binding 5 1.51 4.07E-02
Nrsn2 neurensin 2 1.27 4.11E-02
Htr7 5-hydroxytryptamine (serotonin) receptor 7 0.79 4.13E-02
Kcnh7 potassium voltage-gated channel, subfamily H (eag-related), member 7 0.78 4.13E-02
Wnt10a wingless-type MMTV integration site family, member 10A 0.74 4.19E-02
Dmp1 dentin matrix protein 1 1.29 4.30E-02
2810468N07Rik RIKEN cDNA 2810468N07 gene 1.26 4.43E-02
Mamdc2 MAM domain containing 2 0.63 4.48E-02
Endou endonuclease, polyU-specific 1.65 4.53E-02
Zeb2os zinc finger E-box binding homeobox 2, op-posite strand 0.70 4.54E-02
Slit3 slit homolog 3 (Drosophila) 0.76 4.57E-02
Syt10 synaptotagmin X 0.58 4.71E-02
Zfp85 zinc finger protein 85 0.72 4.88E-02
Unc45b unc-45 myosin chaperone B 0.65 4.96E-02
Tle6 transducin-like enhancer of split 6 1.52 4.96E-02
Siah3 seven in absentia homolog 3 (Drosophila) 1.42 4.96E-02
2900055J20Rik RIKEN cDNA 2900055J20 gene 0.79 4.99E-02
Tshz2 teashirt zinc finger family member 2 1.42 5.00E-02
Lpin3 lipin 3 0.64 5.00E-02
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Supplementary Table 11. Transcripts that are differentially expressed in L2/3 after whisker 
deprivation.  Comparisons between first versus second order spared columns.
Gene Gene description
FC (First vs 
Second Order 
Spared)
FDR
Dpysl2 dihydropyrimidinase-like 2 1.44 3.35E-20
Rps26 ribosomal protein S26 0.73 1.28E-06
Efna3 ephrin A3 1.29 2.25E-04
Zbtb20 zinc finger and BTB domain containing 20 1.39 1.58E-03
Msi1 musashi RNA-binding protein 1 1.26 5.65E-03
Epha10 Eph receptor A10 1.29 9.95E-03
Mcc mutated in colorectal cancers 1.27 1.03E-02
Tlr3 toll-like receptor 3 0.78 2.40E-02
Rpl37rt ribosomal protein L37 0.63 2.47E-02
Litaf LPS-induced TN factor 0.77 2.47E-02
Mgp matrix Gla protein 0.30 2.47E-02
Chchd1 coiled-coil-helix-coiled-coil-helix domain containing 1 0.80 2.83E-02
Tmem210 transmembrane protein 210 1.46 2.88E-02
Cav1 caveolin 1, caveolae protein 0.70 3.05E-02
B2m beta-2 microglobulin 0.77 3.32E-02
Lyrm2 LYR motif containing 2 0.80 3.37E-02
Gstt1 glutathione S-transferase, theta 1 0.71 3.44E-02
Nefm neurofilament, medium polypeptide 1.29 3.57E-02
Kcng2 potassium voltage-gated channel, subfamily G, member 2 0.62 3.66E-02
Timp3 tissue inhibitor of metalloproteinase 3 0.76 4.17E-02
Ptprv N/A 2.14 4.20E-02
Foxo1 forkhead box O1 0.80 4.32E-02
Zfp433 zinc finger protein 433 0.58 4.40E-02
Epb4.1l4aos N/A 0.67 4.65E-02
Col11a1 collagen, type XI, alpha 1 1.29 4.93E-02
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Supplementary Table 12. Transcripts that are differentially expressed in L4 after whisker 
deprivation.  Comparisons between first versus second order spared columns.
Gene Gene description
FC (First vs 
Second Order 
Spared)
FDR
Dpysl2 dihydropyrimidinase-like 2 1.38 4.28E-15
Gabra5 gamma-aminobutyric acid (GABA) A re-ceptor, subunit alpha 5 0.62 6.13E-14
Cpne4 copine IV 0.57 3.49E-09
Ntn5 netrin 5 1.42 1.08E-06
Met met proto-oncogene 0.45 1.22E-06
Zbtb20 zinc finger and BTB domain containing 20 1.52 1.23E-06
Pcdh11x protocadherin 11 X-linked 0.61 1.50E-06
Msi1 musashi RNA-binding protein 1 1.39 2.46E-06
AI504432 expressed sequence AI504432 0.66 6.72E-05
Rhbdf1 rhomboid 5 homolog 1 1.30 8.25E-05
Zfp942 zinc finger protein 942 0.76 1.34E-04
Efna3 ephrin A3 1.28 1.34E-04
Cntn4 contactin 4 0.73 1.53E-04
Neto2 neuropilin (NRP) and tolloid (TLL)-like 2 0.74 1.67E-04
Gdpd5 glycerophosphodiester phosphodiesterase domain containing 5 1.31 2.04E-04
Doc2b double C2, beta 0.64 2.07E-04
Psd3 pleckstrin and Sec7 domain containing 3 0.80 2.24E-04
Kctd15 potassium channel tetramerisation domain containing 15 1.25 2.24E-04
Kcnip4 Kv channel interacting protein 4 0.76 2.24E-04
Necab1 N-terminal EF-hand calcium binding pro-tein 1 0.71 2.27E-04
Rgl2 ral guanine nucleotide dissociation stimula-tor-like 2 1.25 2.33E-04
Tmem145 transmembrane protein 145 1.26 2.44E-04
Hrk harakiri, BCL2 interacting protein (contains only BH3 domain) 0.66 2.56E-04
Klc4 kinesin light chain 4 1.28 2.56E-04
Sgk3 serum/glucocorticoid regulated kinase 3 0.73 2.95E-04
Mcc mutated in colorectal cancers 1.31 4.25E-04
Synpr synaptoporin 0.77 5.55E-04
Kcnmb4 potassium large conductance calcium-acti-vated channel, subfamily M, beta member 4 0.61 8.38E-04
Enpp2 ectonucleotide pyrophosphatase/phosphodi-esterase 2 0.77 9.20E-04
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Ndst3 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 0.70 9.33E-04
Hdac9 histone deacetylase 9 0.75 1.03E-03
Cdr1 cerebellar degeneration related antigen 1 0.56 1.30E-03
Neto1 neuropilin (NRP) and tolloid (TLL)-like 1 0.79 1.44E-03
Zfp932 zinc finger protein 932 0.78 1.74E-03
Iqgap2 IQ motif containing GTPase activating protein 2 0.72 2.48E-03
Mmp16 matrix metallopeptidase 16 0.80 2.58E-03
Plagl1 pleiomorphic adenoma gene-like 1 0.77 2.60E-03
Gpr22 G protein-coupled receptor 22 0.78 2.88E-03
Pde1a phosphodiesterase 1A, calmodulin-depen-dent 0.68 3.28E-03
Kcna3 potassium voltage-gated channel, shaker-re-lated subfamily, member 3 0.68 3.31E-03
Cntrob centrobin, centrosomal BRCA2 interacting protein 1.29 3.42E-03
Apoo apolipoprotein O 0.61 3.47E-03
Zfp800 zinc finger protein 800 0.79 3.72E-03
Dmpk dystrophia myotonica-protein kinase 1.26 3.72E-03
Stxbp2 syntaxin binding protein 2 1.29 4.22E-03
Grm4 glutamate receptor, metabotropic 4 1.26 4.25E-03
Tnnc1 troponin C, cardiac/slow skeletal 0.71 4.31E-03
Zfp958 zinc finger protein 958 0.72 4.44E-03
Scnn1a sodium channel, nonvoltage-gated 1 alpha 1.59 4.58E-03
Igsf9 immunoglobulin superfamily, member 9 1.34 4.98E-03
B230216N24R-
ik RIKEN cDNA B230216N24 gene 0.58 5.86E-03
Stk3 serine/threonine kinase 3 0.77 5.86E-03
Shkbp1 Sh3kbp1 binding protein 1 1.26 6.58E-03
Dgkb diacylglycerol kinase, beta 0.67 6.95E-03
Ankrd63 ankyrin repeat domain 63 0.61 7.28E-03
Chchd1 coiled-coil-helix-coiled-coil-helix domain containing 1 0.79 7.28E-03
Col11a2 collagen, type XI, alpha 2 1.26 8.34E-03
Il1rapl1 interleukin 1 receptor accessory protein-like 1 0.72 8.34E-03
Qtrt1 queuine tRNA-ribosyltransferase 1 1.26 8.62E-03
Atp2b4 ATPase, Ca++ transporting, plasma mem-brane 4 0.61 8.78E-03
Scn3b sodium channel, voltage-gated, type III, beta 0.74 8.81E-03
Matn2 matrilin 2 0.63 1.02E-02
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Rspo1 R-spondin 1 1.50 1.03E-02
Col19a1 collagen, type XIX, alpha 1 0.77 1.12E-02
Mvk mevalonate kinase 1.26 1.15E-02
Csf2ra colony stimulating factor 2 receptor, alpha, 
low-affinity (granulocyte-macrophage) 
1.25 1.18E-02
Foxj1 forkhead box J1 1.37 1.20E-02
Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3) 0.78 1.21E-02
Nhsl2 NHS-like 2 0.78 1.23E-02
Tmem196 transmembrane protein 196 0.68 1.25E-02
6330403A02Rik N/A 0.65 1.26E-02
Kcnb2 potassium voltage gated channel, Shab-re-lated subfamily, member 2 0.77 1.26E-02
Nov nephroblastoma overexpressed gene 0.65 1.28E-02
Whrn whirlin 1.32 1.43E-02
Cnr1 cannabinoid receptor 1 (brain) 0.78 1.46E-02
Adamts3
a disintegrin-like and metallopeptidase 
(reprolysin type) with thrombospondin type 
1 motif, 3 
0.79 1.58E-02
H2-DMa histocompatibility 2, class II, locus DMa 0.73 1.66E-02
Klhl13 kelch-like 13 0.80 1.70E-02
C2cd4c C2 calcium-dependent domain containing 4C 0.75 1.75E-02
Trip10 thyroid hormone receptor interactor 10 1.37 1.75E-02
Col5a1 collagen, type V, alpha 1 1.39 1.80E-02
Cldn1 claudin 1 0.45 1.86E-02
C1ql3 C1q-like 3 0.76 1.88E-02
C1galt1 core 1 synthase, glycoprotein-N-acetylga-lactosamine 3-beta-galactosyltransferase, 1 0.78 1.97E-02
Mir1249 microRNA 1249 1.80 2.09E-02
Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 0.77 2.11E-02
Prss12 protease, serine 12 neurotrypsin (motopsin) 0.70 2.11E-02
Kcns1 K+ voltage-gated channel, subfamily S, 1 1.30 2.17E-02
Lypd1 Ly6/Plaur domain containing 1 0.67 2.19E-02
Pcdh19 protocadherin 19 0.75 2.27E-02
Grin1os N/A 1.36 2.28E-02
Itga4 integrin alpha 4 0.76 2.29E-02
Dsel dermatan sulfate epimerase-like 0.77 2.29E-02
Igfbp4 insulin-like growth factor binding protein 4 0.72 2.29E-02
Vat1l vesicle amine transport protein 1 like 0.74 2.31E-02
Ccdc63 coiled-coil domain containing 63 2.00 2.31E-02
Bmp3 bone morphogenetic protein 3 0.67 2.38E-02
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Zfp811 zinc finger protein 811 0.76 2.40E-02
Grm1 glutamate receptor, metabotropic 1 0.78 2.41E-02
Nrp2 neuropilin 2 0.71 2.44E-02
Spata13 spermatogenesis associated 13 0.78 2.68E-02
Col26a1 collagen, type XXVI, alpha 1 1.28 2.71E-02
Rarb retinoic acid receptor, beta 0.77 2.83E-02
Camk2d calcium/calmodulin-dependent protein kinase II, delta 0.77 2.83E-02
Ypel1 yippee-like 1 (Drosophila) 0.78 3.02E-02
Sema3f
sema domain, immunoglobulin domain (Ig), 
short basic domain, secreted, (semaphorin) 
3F 
1.31 3.03E-02
Zfp930 zinc finger protein 930 0.77 3.10E-02
Il4ra interleukin 4 receptor, alpha 1.35 3.11E-02
Prkcg protein kinase C, gamma 0.72 3.14E-02
Ankrd6 ankyrin repeat domain 6 0.73 3.32E-02
Tspan15 tetraspanin 15 1.27 3.37E-02
Sertm1 serine rich and transmembrane domain containing 1 0.76 3.43E-02
Ttc16 tetratricopeptide repeat domain 16 1.81 3.47E-02
Hic2 hypermethylated in cancer 2 1.28 3.47E-02
Fgf10 fibroblast growth factor 10 0.60 3.53E-02
Ccbl1 N/A 1.27 3.63E-02
Casp8ap2 caspase 8 associated protein 2 0.80 3.63E-02
Mical1 microtubule associated monooxygenase, 
calponin and LIM domain containing 1 
1.31 3.82E-02
Kifc5b kinesin family member C5B 1.33 3.82E-02
D330050I16Rik N/A 0.48 3.82E-02
Sec14l3 SEC14-like lipid binding 3 0.40 3.84E-02
Cort cortistatin 0.69 4.02E-02
Morf4l1-ps1 N/A 1.49 4.05E-02
Tmem232 transmembrane protein 232 0.62 4.07E-02
Tax1bp3 Tax1 (human T cell leukemia virus type I) binding protein 3 1.37 4.31E-02
Stk36 serine/threonine kinase 36 1.29 4.35E-02
Moxd1 monooxygenase, DBH-like 1 0.66 4.35E-02
Lrguk leucine-rich repeats and guanylate kinase domain containing 0.54 4.42E-02
Cdh9 cadherin 9 0.64 4.65E-02
2210408I21Rik RIKEN cDNA 2210408I21 gene 0.79 4.68E-02
Lypd6b LY6/PLAUR domain containing 6B 0.75 4.68E-02
Gprin3 GPRIN family member 3 0.67 4.68E-02
Palmd palmdelphin 0.79 4.85E-02
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Ptpro protein tyrosine phosphatase, receptor type, O 0.80 4.93E-02
Trp53i11 transformation related protein 53 inducible protein 11 0.71 4.94E-02
1700125G02Rik RIKEN cDNA 1700125G02 gene 1.56 4.94E-02
Pdzrn4 PDZ domain containing RING finger 4 0.75 4.96E-02
Col16a1 collagen, type XVI, alpha 1 1.28 5.00E-02
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Supplementary Table 13. Protein classes of differentially expressed transcripts in L2/3 
after whisker deprivation.  Comparisons between control and deprived columns.
Protein class Gene
Calcium-binding protein Capn6, Rps6ka2, Tnnc1, Ltbp2, Srl, Mast3, Slc25a17
Cell adhesion molecule Ltbp2, Tspan11, Pcdh8, Obscn
Cell junction protein Myo16, Myo1b
Chaperone Hspb6
Cytoskeletal protein Sun2, Mical2, Tcap, Fnbp1l, Tnnc1, Wipf3, Myo16, 
Lmcd1, Myo1b, Enc1, Syn3, Fmnl1
Defense/immunity protein Adgra1, Trem2, Pth2r, Obscn
Enzyme modulator Asap2, Rims3, Rhot2, Plekhg4, Gnb5, Ccnd1, Fnbp1l, 
Spata13, Fasd2, Myo16, Srl, Myo1b, Agt, Sgsm1, Erc2, 
Iqgap2
Extracellular matrix protein P3h3, Ltbp2
Hydrolase Usp43, Capn6, Gnb5, Pla2g4e, Atad2, Sgsm1, Synj2, 
Pla2g5, Neu2, Obscn, Glb1l
Isomerase Ppil6
Ligase Usp43
Lyase Car4, Ddc
Membrane traffic protein Doc2b, Srl, Erc2, Cpne8, Syn3
Nucleic acid binding Asap2, Usp43, Etv5, Fancm, Hivep1, Slc25a17, Enox1, 
Cpeb1, Dbp
Oxidoreductase Cyp39a1, Enox1
Receptor Grm2, Tnfrsf21, Adgra1, Unc5d, Ntsr1, Spred3, Qrfpr, 
Tspan11, Hrh1, Baiap2, Spred1, Pth2r, Grm1
Signaling molecule Cbln1, Plekhg4, Homer1, Fnbp1l, Spata13, Crh, Etv5, 
Ltbp2, Cbln4, Tspan11, Wnt9a, Bok, Neu2
Structural protein Lmcd1
Transcription factor Tle2, Zbtb40, Ldb2, Vgll3, Etv5, Npas2, Hivep1, 
Zfp810, Smad9, Dbp
Transfer/carrier protein Ttr, Rps6ka2, Mast3, Slc25a17
Transferase Sbk1, Rps6ka2, Mapk12, B3galnt2, Dgat2, Tanc1, 
Mast3, Hhatl, Chst8, Ripk2, Nim1k, Agt, Dgkg, Galnt9
Transmembrane receptor regu-
latory/adaptor protein
Emb
Transporter Ttr, Abca8b, Slco3a1, Slc29a3, Slc7a4, Slco1a4, 
Slc25a17
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Supplementary Table 14. Protein classes of differentially expressed transcripts in L4 after 
whisker deprivation.  Comparisons between control and deprived columns.
Protein class Gene
Calcium-binding protein Egfl7, Nell1, Gda, Ltbp2, Rps6ka4, Srl, Sdk1, Cib2
Cell adhesion molecule Ltbp2, Tspan11, Cdh4, Pcdh8, Cntnap5b, Armc4, Obscn, 
Sdk1, Celsr1, Cdh22, Cntnap5a
Cell junction protein Myo16, Myo5c
Chaperone Ccdc136, Man1a, Eef2k
Cytoskeletal protein Sun1, Sun2, Actn3, Lmo3, Diap2, Mical2, Lmo7, Wdr78, 
Arpc5, Fnbp1l, Mical1, Wipf3, Myo16, Kif26b, Sept6, 
Lmcd1, Svil, Kif16b, Enc1, Mapk3, Armc4, Myo5c, Syn3, 
Fmnl1
Defense/immunity protein Ociad2, Nell1, Adgra1, Obscn, Sdk1
Enzyme modulator Gm266, Rims3, Vav3, Adamts17, Plekhg4, Rassf2, Ras-
l10a, Net1, Fnbp1l, Rasd2, Myo16, Sept6, Srl, Ppm1h, 
Rgs17, Sgsm1, Ccnd2, Cntnap5b, Myo5c, Iqgap2, Rassf3, 
Adamts8, Cntnap5a, Aw551984
Extracellular matrix protein Lgi2, Adamts17, Lrfn2, Lrrn2, Ltbp2, Lrrcc1, Cntnap5b, 
Omg, Ldlr, Net1, Ntng1, Adamts8, Cntnap5a
Hydrolase Adamts17, Ptpn5, Masp1, Pla2g4e, Thrb, Bace2, Cd-
c25b, Otud1, Pde7b, Ptprv, Otub2, Nrip3, Zgrf1, Ppm1h, 
Atp6ap1l, Sgsm1, Ptprt, Synj2, Cntnap5b, Gda, Neu2, 
Cib2, Pafah2, Pde10a, Obscn, Sdk1, Adamts8, Prss16, 
Cntnap5a, Pde1a
Isomerase Cdyl2, Echdc2
Ligase Cdyl2, Mthfd1l, Echdc2, Siah3, March1, Rnf144b, 
Rnf217, Ube2e2
Lyase Cdyl2, Echdc2, Ddc
Membrane traffic protein Doc2b, Sypl2, Srl, Cpne4, Ap1s3, Zfyve28, Cpne6, Syn3, 
Stard4
Nucleic acid binding Cemip, Lcorl, Lmo3, Gda, Parn, Etv5, Pparg, Otud1, 
Wrn, Zgrf1, Fancm, Vdr, Etv1, Hivep1, Thrb, Nr2f6, 
Nr1d1, Angel1, Hmgb3, Enox1, Jade1, Cpeb1, Zfpm1, 
Rbm24
Oxidoreductase Cyp27b1, Cdyl2, Echdc2, Gfod1, Sesn1, Dhodh, Cnt-
nap5b, Enox1, P4ha1, Cntnap5a
Receptor Lgi2, Grm2, Htr1b, Tnfrsf21, Baiap2l2, Lrfn2, Adgra1, 
Lrrn2, Unc5d, Spred3, Lrrcc1, Tspan11, Sstr3, Ptprt, 
Myoc, Baiap2, Cntnap5b, Spred2, Gpr161, Ly75, Spred1, 
Olfm3, Gpr27, Omg, Ldlr, Net1, Gpr88, Grm1, Celsr1, 
Ntng1, Adra1d, Cntnap5a
Signaling molecule Tnc, Vav3, Plekhg4, Bcl2, Wnt7a, Nell1, Homer1, Fnbp1l, 
Etv5, Ltbp2, Cbln4, Tspan11, Etv1, Efnb1, Il17d, Cnt-
nap5b, Sema3f, Armc4, Hmgb3, Wnt2, Bok, Neu2, Numbl, 
Cntnap5a
Storage protein Armc4
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Structural protein Lmcd1, Myoc, Olfm3
Transcription factor Gtf2ird1, Zbtb40, Ldb2, Lmo3, Nfatc3, Etv5, Pparg, Aff3, 
Maml3, Zfp459, Nrip3, Smad3, Vdr, Etv1, Hivep1, Thrb, 
Nr2f6, Nr1d1, Hmgb3, Jade1, Smad9, Zfpm1
Transfer/carrier protein Gda, Ttr, Sec14l1, Rps6ka4, Sdk1, Cntnap5b, Cntnap5a, 
Stard4
Transferase Sbk1, Ksr2, Melk, Cdyl2, Eef2k, Tmtc4, Mylk3, Lrrk2, 
Echdc2, Rps6ka4, Dgat2, Mapk3, Sdk1, Ak4, Hhatl, 
Chst8, Eogt, Mgat5b, Mapk3, Camk1g, Nim1k, Dgkg, 
B4galnt3, Galnt9
Transmembrane receptor reg-
ulatory/adaptor protein
Emb, Serinc5, Grb10
Transporter Grik1, Hcn1, Gda, Slc23a3, Ttr, Sec14l1, Abca8b, 
Slc7a11, Slco3a1, Ngb, Caprin2, Atp6ap1l, Cntnap5b, 
Grik3, Slco1a4, Trpc5, Cntnap5a
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Supplementary Table 15. GO terms of differentially expressed transcripts in L2/3. Compari-
sons between control and deprived columns.
GO term
Associated transcripts
Modulated in L2/3 only Modulated in L2/3 and L4
Synaptic trans-
mission
Agt, Ntsr1, Crh, Cbln1, Hrh1
Ddc, Syn3, Cpeb1, Vgf, Grm1, Doc2b, 
Etv5, Baiap2, Rims3, Grm2, Pvrl1, 
Ephb2, Pcdh8, Rasd2, Egr3
System process
Agt, Tnnc1, Ntsr1, Tanc1, 
Amn, Fbxo32, Crh, Cbln1, 
Nphp3, Tcap, Rps6ka2, Hrh1
Ddc, Cd34, Lmcd1, Syn3, Cpeb1, Vgf, 
Grm1, Doc2b, Etv5, Baiap2, Homer1, 
Rims3, Grm2, Pvrl1, Ephb2, Pcdh8, 
Rasd2, Egr3, Mybpc3
Transmission of 
nerve impulse
Agt, Ntsr1, Crh, Cbln1, Hrh1
Ddc, Syn3, Cpeb1, Vgf, Grm1, Doc2b, 
Etv5, Baiap2, Rims3, Grm2, Pvrl1, 
Ephb2, Pcdh8, Rasd2, Egr3
Multicellular 
organismal sig-
naling
Agt, Ntsr1, Crh, Cbln1, Hrh1
Ddc, Syn3, Cpeb1, Vgf, Grm1, Doc2b, 
Etv5, Baiap2, Rims3, Grm2, Pvrl1, 
Ephb2, Pcdh8, Rasd2, Egr3
Cell-cell signal-
ing
Agt, Ntsr1, Crh, Cbln1, Hrh1
Ddc, Cd34, Syn3, Cpeb1, Vgf, Grm1, 
Doc2b, Etv5, Baiap2, Rims3, Grm2, 
Pvrl1, Ephb2, Pcdh8, Rasd2, Egr3
Neurological 
system process
Agt, Ntsr1, Tanc1, Crh, Cbln1, 
Nphp3, Rps6ka2, Hrh1
Ddc, Syn3, Cpeb1, Vgf, Grm1, Doc2b, 
Etv5, Baiap2, Rims3, Grm2, Pvrl1, 
Ephb2, Pcdh8, Rasd2, Egr3
Actin fila-
ment-based 
movement
Tnnc1, Myo1b
Epb4.1l5, Fnbp1l, Sun2
Membrane
Abcb1b, Slc35f4, Ntsr1, Pth2r, 
Car4, Gpc4, Slc7a4, Spata13, 
Tanc1, Slc25a17, Tspan11, 
Amn, B3galnt2, Amigo2, 
Rhot2, Asap2, Cyp39a1, 
Gnb5, Slc29a3, Qrfpr, Cbln1, 
Myo1b, Pla2g5, Trem2, Tcta, 
Ccnd1, 3632451O06Rik, 
C130074G19Rik, Erc2, Hfe2, 
Oscp1, Tmem28, Nrn1l, Hrh1
Tspan11, Amn, B3galnt2, Amigo2, 
Rhot2, Asap2, Cyp39a1, Gnb5, 
Slc29a3, Qrfpr, Cbln1, Myo1b, Pla2g5, 
Trem2, Tcta, Ccnd1, 3632451O06Rik, 
C130074G19Rik, Erc2, Hfe2, Oscp1, 
Tmem28, Nrn1l, Hrh1, Epb4.1l5, Chst8, 
Tnfrsf21, Cd34, Cobl, Syn3, St6galnac3, 
Pla2g4e, Tmem200a, Tmem245, Plxnc1, 
Mdga1, Spred3, Cpeb1, Fnbp1l, Vgf, 
Fmnl1, D130043K22Rik, Abca8b, Bok, 
Hhatl, Dgkg, Grm1, Hhipl1, Mfsd4, 
Doc2b, Baiap2, Slco1a4, Slco3a1, Ho-
mer1, Synj2, Enox1, Adam33, Zdhhc14, 
Dgat2, Galnt9, Spred1, Sun2, Grm2, 
Gpr153, Pvrl1, Ephb2, Pcdh8, Rasd2, 
Tmem150c, Slc9a9, Fat3, Unc5d, 
Tmem132d, Emb, Cys1, Ndst3, Myo16
Muscle adapta-
tion Agt, Fbxo32, Tcap
Lmcd1
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Supplementary Table 16. GO terms of differentially expressed transcripts in L4. Compari-
sons between control and deprived columns.
GO term
Associated transcripts
Modulated in L4 only Modulated in L2/3 and L4
Membrane
Adam23, Adam8, Adra1d, Ano3, 
Ap1s3, Arhgap24, B4galnt3, Bace2, 
Baiap2l2, Bcl2, Camk1g, Ccdc136, 
Ccdc62, Ccnd2, Cdh4, Celsr1, Cnt-
nap5a, Cntnap5b, Cpne6, Cyp27b1, 
Dhodh, Dpy19l3, Efnb1, Evc, Evc2, 
Gpr161, Gpr27, Gpr88, Grik1, Grik3, 
Hcn1, Hs3st2, Hspa5, Htr1b, Igsf3, 
Irs2, Itga10, Kcnd3, Kcnf1, Kcnj12, 
Kcnj3, Kif16b, Ksr2, Layn, Ldlr, 
Lmo7, Lrfn2, Lrrk2, Ly6h, Ly75, 
Man1a, Mapk3, March1, Melk, Met, 
Mgat5b, Nfatc3, Nipal2, Ntng1, 
Ociad2, Omg, Orai2, Palmd, Pcdh-
gc4, Pde10a, Plekha4, Plxnd1, Ptpn5, 
Ptprt, Rab27a, Rasl10a, Rassf3, 
Rgs17, Rnf144b, Rnf217, Scai, Sdk1, 
Sema3f, Serinc5, Shisa9, Slc12a8, 
Slc23a3, Slc26a8, Slc7a11, Smad3, 
Snn, Snx9, Spred2, Sstr3, St6galnac5, 
St8sia5, Sun1, Svil, Sypl2, Tmc4, 
Tmem151b, Tmem158, Tmem86a, 
Tmtc4, Trim72, Trpc5, Vav3, Vdr, 
Zfyve28
Abca8b, Adam33, Baiap2, 
Bok, C130074G19Rik, Cd34, 
Chst8, Cobl, Cpeb1, Cys1, 
D130043K22Rik, Dgat2, Dgkg, 
Doc2b, Emb, Enox1, Epb4.1l5, 
Ephb2, Fat3, Fmnl1, Fnbp1l, Gal-
nt9, Gpr153, Grm1, Grm2, Hhatl, 
Hhipl1, Homer1, Mdga1, Mfsd4, 
Myo16, Ndst3, Nrn1l, Pcdh8, 
Pla2g4e, Plxnc1, Pvrl1, Rasd2, 
Slc9a9, Slco1a4, Slco3a1, Spred1, 
Spred3, St6galnac3, Sun2, Syn3, 
Synj2, Tmem132d, Tmem150c, 
Tmem200a, Tmem245, Tmem28, 
Tnfrsf21, Tspan11, Unc5d, Vgf, 
Zdhhc14
Single organ-
ism signaling
Adam23, Adam8, Adra1d, Arhgap24, 
Arhgap31, Arhgef15, Baiap2l2, Bcl2, 
Bex1, Caprin2, Celsr1, Cib2, Cnt-
nap5a, Cntnap5b, Cyp27b1, Dcx, 
Dok2, Evc, Evc2, Gpr161, Gpr27, 
Gpr88, Grb10, Grik1, Grik3, Grp, 
Hspa5, Htr1b, Igfbp5, Irs2, Itga10, 
Kif16b, Ksr2, Lrrk2, Maml3, Mapk3, 
Met, Net1, Nr1d1, Nr2f6, Numbl, 
Omg, Pde10a, Pde1a, Pde7b, Plxnd1, 
Pparg, Ptprt, Ptprv, Rab27a, Rab34, 
Rasl10a, Rassf2, Rassf3, Rgs17, Rps-
6ka4, Rspo2, Scai, Serinc5, Shisa9, 
Smad3, Spock3, Spred2, Sstr3, Tfap4, 
Thrb, Tnc, Trim9, Usp28, Vav3, Vdr, 
Wnt2, Wnt7a, Xbp1, Zfyve28
Adam33, Ankrd6, Asb11, Baiap2, 
Bok, Cd34, Cpeb1, Ddc, Dgkg, 
Doc2b, Egr3, Ephb2, Etv5, Gpr153, 
Grm1, Grm2, Homer1, Iqgap2, 
Lmcd1, Obscn, Pcdh8, Pcsk9, Plx-
nc1, Pvrl1, Rasd2, Rims3, Sgsm1, 
Smad9, Spred1, Spred3, Syn3, 
Tnfrsf21, Unc5d, Vgf
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3Cell commu-
nication
Adam23, Adam8, Adra1d, Arhgap24, 
Arhgap31, Arhgef15, Baiap2l2, Bcl2, 
Bex1, Caprin2, Celsr1, Cib2, Cnt-
nap5a, Cntnap5b, Cyp27b1, Dcx, 
Dok2, Evc, Evc2, Gpr161, Gpr27, 
Gpr88, Grb10, Grik1, Grik3, Grp, 
Hspa5, Htr1b, Igfbp5, Irs2, Itga10, 
Kif16b, Ksr2, Lrrk2, Maml3, Mapk3, 
Met, Net1, Nr1d1, Nr2f6, Numbl, 
Omg, Pde10a, Pde1a, Pde7b, Plx-
nd1, Pparg, Ptprt, Ptprv, Rab27a, 
Rab34, Rasl10a, Rassf2, Rassf3, 
Rgs17, Rps6ka4, Rspo2, Scai, Ser-
inc5, Sh3pxd2b, Shisa9, Smad3, Snx9, 
Spock3, Spred2, Sstr3, Tfap4, Thrb, 
Tnc, Trim9, Usp28, Vav3, Vdr, Wnt2, 
Wnt7a, Wrn, Xbp1, Zfyve28
Adam33, Ankrd6, Asb11, Baiap2, 
Bok, Cd34, Cpeb1, Ddc, Dgkg, 
Doc2b, Egr3, Ephb2, Etv5, Gpr153, 
Grm1, Grm2, Homer1, Iqgap2, 
Lmcd1, Obscn, Pcdh8, Pcsk9, Plx-
nc1, Pvrl1, Rasd2, Rims3, Sgsm1, 
Smad9, Spred1, Spred3, Syn3, 
Tnfrsf21, Unc5d, Vgf
Single-organ-
ism process
Actn3, Adam23, Adam8, Adra1d, 
Aff3, Arhgap24, Arhgap31, Arhgef15, 
AW551984, Baiap2l2, Bcl2, Bex1, 
Caprin2, Cdc25b, Cdh4, Celsr1, 
Cib2, Cntnap5a, Cntnap5b, Cyp27b1, 
Dcx, Diap2, Dok2, Efnb1, Egfl7, 
Etv1, Evc, Evc2, Gpr161, Gpr27, 
Gpr88, Grb10, Grik1, Grik3, Grp, 
Gtf2ird1, Hcn1, Hmgb3, Hs3st2, 
Hspa5, Htr1b, Igfbp5, Insm1, Irs2, 
Itga10, Kif16b, Kif26b, Ksr2, Ldlr, 
Lrrk2, Maml3, Manf, Mapk3, Masp1, 
Met, Mylk3, Nell1, Net1, Nfatc3, 
Nptx1, Nr1d1, Nr2f6, Ntng1, Numbl, 
Olfm3, Omg, Pde10a, Pde1a, Pde7b, 
Piwil2, Plxnd1, Pparg, Ptprt, Ptprv, 
Rab27a, Rab34, Rasl10a, Rassf2, 
Rassf3, Rbm24, Rgs17, Rps6ka4, 
Rspo2, Scai, Sema3f, Serinc5, 
Sh3pxd2b, Shisa9, Slc26a8, Slc7a11, 
Smad3, Spock3, Spred2, Sstr3, Svil, 
Tacc3, Tfap4, Thrb, Tnc, Trim72, 
Trim9, Usp2, Usp28, Vav3, Vdr, Wnt2, 
Wnt7a, Wrn, Xbp1, Zfpm1, Zfyve28
Adam33, Ankrd6, Asb11, Baiap2, 
Bok, Cd34, Cobl, Cpeb1, 
D130043K22Rik, Ddc, Dgat2, 
Dgkg, Doc2b, Egr3, Enc1, Enox1, 
Epb4.1l5, Ephb2, Etv5, Fancm, 
Fat3, Gpr153, Grm1, Grm2, 
Homer1, Iqgap2, Ldb2, Lmcd1, 
Mdga1, Mybpc3, Neu2, Nrn1l, Ob-
scn, Pcdh8, Pcsk9, Plxnc1, Pvrl1, 
Rasd2, Rims3, Sgsm1, Smad9, 
Spred1, Spred3, Syn3, Tnfrsf21, 
Unc5d, Vgf
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Signaling
Adam23, Adam8, Adra1d, Arhgap24, 
Arhgap31, Arhgef15, Baiap2l2, Bcl2, 
Bex1, Caprin2, Celsr1, Cib2, Cnt-
nap5a, Cntnap5b, Cyp27b1, Dcx, 
Dok2, Evc, Evc2, Gpr161, Gpr27, 
Gpr88, Grb10, Grik1, Grik3, Grp, 
Hspa5, Htr1b, Igfbp5, Irs2, Itga10, 
Kif16b, Ksr2, Lrrk2, Maml3, Mapk3, 
Met, Net1, Nr1d1, Nr2f6, Numbl, 
Omg, Pde10a, Pde1a, Pde7b, Plxnd1, 
Pparg, Ptprt, Ptprv, Rab27a, Rab34, 
Rasl10a, Rassf2, Rassf3, Rgs17, Rps-
6ka4, Rspo2, Scai, Serinc5, Shisa9, 
Smad3, Spock3, Spred2, Sstr3, Tfap4, 
Thrb, Tnc, Trim9, Usp28, Vav3, Vdr, 
Wnt2, Wnt7a, Xbp1, Zfyve28
Adam33, Ankrd6, Asb11, Baiap2, 
Bok, Cd34, Cpeb1, Ddc, Dgkg, 
Doc2b, Egr3, Ephb2, Etv5, Gpr153, 
Grm1, Grm2, Homer1, Iqgap2, 
Lmcd1, Obscn, Pcdh8, Pcsk9, Plx-
nc1, Pvrl1, Rasd2, Rims3, Sgsm1, 
Smad9, Spred1, Spred3, Syn3, 
Tnfrsf21, Unc5d, Vgf
Tissue devel-
opment
Ankrd6, Cobl, Dgat2, Epb4.1l5, 
Etv5, Homer1, Ldb2, Mybpc3, Neu2, 
Pcdh8, Pvrl1, Smad9
Adam8, AW551984, Bcl2, Celsr1, 
Cyp27b1, Efnb1, Igfbp5, Kif16b, 
Kif26b, Lrrk2, Mapk3, Met, Mylk3, 
Nell1, Nfatc3, Plxnd1, Pparg, 
Rbm24, Rspo2, Sema3f, Sh3pxd2b, 
Smad3, Svil, Thrb, Tnc, Usp2, Vdr, 
Wnt2, Wnt7a, Xbp1, Zfpm1
Synaptic 
transmission
Arhgef15, Celsr1, Grik1, Grik3, 
Htr1b, Shisa9
Baiap2, Cpeb1, Ddc, Doc2b, Egr3, 
Ephb2, Etv5, Grm1, Grm2, Pcdh8, 
Pvrl1, Rasd2, Rims3
Transmis-
sion of nerve 
impulse
Arhgef15, Celsr1, Grik1, Grik3, 
Htr1b, Omg, Serinc5, Shisa9, Trim9, 
Wnt7a, Xbp1
Baiap2, Cpeb1, Ddc, Doc2b, 
Egr3, Ephb2, Etv5, Grm1, Grm2, 
Pcdh8, Pvrl1, Rasd2, Rims3, Syn3, 
Vgf,  
Cell-cell sig-
naling
Arhgef15, Celsr1, Grik1, Grik3, 
Htr1b, Irs2, Met, Ptprv, Shisa9, Tnc, 
Trim9, Wnt2, Wnt7a, Xbp1
Baiap2, Cd34, Cpeb1, Ddc, Doc2b, 
Egr3, Ephb2, Etv5, Grm1, Grm2, 
Pcdh8, Pvrl1, Rasd2, Rims3, Syn3, 
Vgf
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Signal trans-
duction
Adam23, Adam8, Adra1d, Arhgap24, 
Arhgap31, Arhgef15, Baiap2l2, Bcl2, 
Bex1, Caprin2, Celsr1, Cib2, Cntna-
p5a, Cntnap5b, Cyp27b1, Dcx, Dok2, 
Evc, Evc2, Gpr161, Gpr27, Gpr88, 
Grb10, Grik1, Grik3, Grp, Hspa5, 
Htr1b, Igfbp5, Irs2, Itga10, Kif16b, 
Ksr2, Lrrk2, Maml3, Mapk3, Met, 
Net1, Nr1d1, Nr2f6, Numbl, Pde10a, 
Pde1a, Pde7b, Plxnd1, Pparg, Pt-
prt, Ptprv, Rab27a, Rab34, Rasl10a, 
Rassf2, Rassf3, Rgs17, Rps6ka4, 
Rspo2, Scai, Smad3, Spock3, Spred2, 
Sstr3, Tfap4, Thrb, Tnc, Usp28, Vav3, 
Vdr, Wnt2, Wnt7a, Xbp1, Zfyve28
Adam33, Ankrd6, Asb11, Baiap2, 
Bok, Dgkg, Ephb2, Gpr153, Grm1, 
Grm2, Homer1, Iqgap2, Lmcd1, 
Obscn, Pcsk9, Plxnc1, Rasd2, 
Sgsm1, Smad9, Spred1, Spred3, 
Tnfrsf21, Unc5d
G-protein 
coupled glu-
tamate recep-
tor signaling 
pathway
Grik3
Grm1, Grm2, Homer1
Multicellular 
organismal 
signaling
Arhgef15, Baiap2, Cpeb1, Ddc, 
Doc2b, Egr3, Ephb2, Etv5, Grm1, 
Grm2, Pcdh8, Pvrl1, Rasd2, Rims3, 
Syn3, Vgf, Celsr1, Grik1, Grik3, 
Htr1b, Omg, Serinc5, Shisa9, Trim9, 
Wnt7a, Xbp1
Baiap2, Cpeb1, Ddc, Doc2b, Egr3, 
Ephb2, Etv5, Grm1, Grm2, Pcdh8, 
Pvrl1, Rasd2, Rims3, Syn3, Vgf
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Supplementary Table 17. GO terms associated with differentially expressed transcripts co-
modulated in L2/3 and L4 upon whisker deprivation.
Description Transcripts FDR
Neuron part
Grm2, Baiap2, Cobl, Cpeb1, Ddc, Doc2b, Enc1, 
Ephb2, Grm1, Pcdh8, Synj2, Brinp3, Nrn1l, Rims3, 
Homer1, Syn3, Samd4, Tnfrsf21 8.53E-04
Synapse
Grm2, Baiap2, Cpeb1, Ddc, Doc2b, Emb, Ephb2, 
Grm1, Pcdh8, Cbln4, Rims3, Homer1, Syn3, Samd4 8.53E-04
Chemical synaptic 
transmission
Etv5, Grm2, Baiap2, Cpeb1, Doc2b, Egr3, Ephb2, 
Grm1, Pcdh8, Rims3, Syn3, Vgf, Rasd2 8.76E-03
Anterograde 
trans-synaptic 
signaling
Etv5, Grm2, Baiap2, Cpeb1, Doc2b, Egr3, Ephb2, 
Grm1, Pcdh8, Rims3, Syn3, Vgf, Rasd2 8.76E-03
Synaptic signaling
Etv5, Grm2, Baiap2, Cpeb1, Doc2b, Egr3, Ephb2, 
Grm1, Pcdh8, Rims3, Syn3, Vgf, Rasd2 8.76E-03
Trans-synaptic 
signaling
Etv5, Grm2, Baiap2, Cpeb1, Doc2b, Egr3, Ephb2, 
Grm1, Pcdh8, Rims3, Syn3, Vgf, Rasd2 8.76E-03
Neuron projection
Grm2, Baiap2, Cobl, Cpeb1, Ddc, Ephb2, Grm1, 
Pcdh8, Synj2, Brinp3, Nrn1l, Homer1, Samd4, Tn-
frsf21 7.35E-03
Intrinsic compo-
nent of plasma 
membrane
Grm2, Slco3a1, Cd34, Emb, Ephb2, Grm1, Pcdh8, 
Tmem150c, Nrn1l, Tmem245, Slco1a4, Plxnc1, 
Tspan11, Tnfrsf21 1.68E-02
Integral compo-
nent of plasma 
membrane
Grm2, Slco3a1, Cd34, Emb, Ephb2, Grm1, Pcdh8, 
Tmem150c, Tmem245, Slco1a4, Plxnc1, Tspan11, 
Tnfrsf21 2.63E-02
Axon
Grm2, Cobl, Ddc, Ephb2, Synj2, Nrn1l, Homer1, 
Tnfrsf21 2.63E-02
Synapse part
Grm2, Baiap2, Cpeb1, Ddc, Doc2b, Grm1, Pcdh8, 
Rims3, Homer1, Syn3 2.63E-02
Somatodendritic 
compartment
Grm2, Baiap2, Cobl, Ddc, Enc1, Ephb2, Grm1, 
Pcdh8, Brinp3, Samd4 3.39E-02
Cell projection
Grm2, Baiap2, Cep131, Cobl, Cpeb1, Cys1, Ddc, 
Ephb2, Grm1, Pcdh8, Synj2, Brinp3, Nrn1l, Homer1, 
Iqgap2, Samd4, Tnfrsf21 4.21E-02
Plasma membrane 
part
Grm2, Slco3a1, Spred1, Cd34, Cpeb1, Cys1, Emb, 
Ephb2, Grm1, Pcdh8, Tmem150c, Nrn1l, Tmem245, 
Homer1, Slco1a4, Plxnc1, Tspan11, Tnfrsf21 4.21E-02
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Supplementary Table 18. Control vs deprived column, L2/3 protein classes of within the 
GO term ‘Membrane’.
Protein class Gene
Calcium-binding protein Slc25a17
Cell adhesion molecule Tspan11, Pcdh8
Cell junction protein Myo16, Myo1b
Cytoskeletal protein Sun2, Fnbp1l, Myo16, Myo1b, Syn3, Fmnl1
Defense/immunity protein Trem2, Pth2r
Enzyme modulator Asap2, Rhot2, Gnb5, Ccnd1, Fnbp1l, Spata13, 
Rasd2, Myo16, Myo1b, Erc2
Hydrolase Gnb5, Pla2g4e, Synj2, Pla2g5
Lyase Car4
Membrane traffic protein Doc2b, Erc2, Syn3
Nucleic acid binding Asap2, Slc25a17, Enox1, Cpeb1
Oxidoreductase Cyp39a1, Enox1
Receptor Grm2, Tnfrsf21, Unc5d, Ntsr1, Spred3, Qrfpr, 
Tspan11, Hrh1, Baiap2, Spred1, Pth2r, Grm1
Signaling molecule Cbln1, Homer1, Fnbp1l, Spata13, Tspan11, 
Bok
Transfer/carrier protein Slc25a17
Transferase B3galnt2, Dgat2, Tanc1, Hhatl, Chst8, Dgkg, 
Galnt9
Transmembrane receptor regulatory/
adaptor protein
Emb
Transporter Abca8b, Slco3a1, Slc29a3, Slc7a4, Slco1a4, 
Slc25a17
 
194
CHAPTER 3
Supplementary Table 19. Control vs deprived column, L4 protein classes of within the 
GO term ‘Membrane’.
Protein class Gene
Calcium-binding protein Sdk1
Cell adhesion molecule Tspan11, Cdh4, Pcdh8, Cntnap5b, Sdk1, Cel-
sr1, Cntnap5a
Cell junction protein Myo16
Chaperone Ccdc136, Man1a
Cytoskeletal protein Sun1, Sun2, Lmo7, Fnbp1l, Myo16, Svil, 
Kif16b, Mapk3, Syn3, Fmnl1
Defense/immunity protein Ociad2, Sdk1
Enzyme modulator Vav3, Rasl10a, Fnbp1l, Rasd2, Myo16, Rgs17, 
Ccnd2, Cntnap5b, Rassf3, Cntnap5a
Extracellular matrix protein Lrfn2, Cntnap5b, Ldlr, Omg, Ntng1, Cntnap5a
Hydrolase Ptpn5, Pla2g4e, Bace2, Ptprt, Synj2, Cnt-
nap5b, Pde10a, Sdk1, Cntnap5a
Ligase March1, Rnf144b, Rnf217
Membrane traffic protein Doc2b, Sypl2, Ap1s3, Zfyve28, Cpne6, Syn3
Nucleic acid binding Vdr, Enox1, Cpeb1
Oxidoreductase Cyp27b1, Dhodh, Cntnap5b, Enox1, Cntnap5a
Receptor Grm2, Htr1b, Tnfrsf21, Baiap2l2, Lrfn2, 
Unc5d, Spred3, Tspan11, Sstr3, Ptprt, Baiap2, 
Cntnap5b, Spred2, Ly75, Gpr161, Spred1, 
Gpr27, Ldlr, Omg, Gpr88, Grm1, Celsr1, 
Ntng1, Adra1d, Cntnap5a
Signaling molecule Vav3, Bcl2, Homer1, Fnbp1l, Tspan11, Efnb1, 
Cntnap5b, Sema3f, Bok, Cntnap5a
Transcription factor Nfatc3, Smad3, Vdr
Transfer/carrier protein Sdk1, Cntnap5b, Cntnap5a
Transferase Ksr2, Melk, Tmtc4, Lrrk2, Dgat2, Mapk3, 
Sdk1, Hhatl, Chst8, Mgat5b, Mapk3, Camk1g, 
Dgkg, B4gaint3, Gaint9
Transmembrane receptor regulatory/
adaptor protein
Emb, Serinc5
Transporter Grik1, hcn1, Slc23a3, Abca8b, Slc7a11, Sl-
co3a1, Trpc5, Cntnap5a
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Supplementary Table 20. Control versus deprived, cell type-specific differentially expressed 
transcripts
Cell type
Preferentially expressed transcripts
Modulated in L2/3 Modulated in L4 Modulated in 
both
Astrocytes
5930412G12Rik, 
Agt, C4a, Ccdc3, 
Efhc1, Gpc4, 
Hrh1, Nphp3, 
Pla2g5, Ppil6
Armc4, Celsr1, D030047H15R-
ik, Dpy19l3, Echdc2, Evc, 
Gm266, Htr1b, Igfbp5, Myoc, 
Sh3pxd2b, Slc7a11, Smim3, 
Sypl2, Tnc, Wdr78, Wnt7a
Epb4.1l5, Hhatl, 
Ttr
Endothelial cells
Amigo2, Car4, 
Ccnd1, Fam101b, 
Myo1b, Prss23
Adamts8, Arhgap31, Arhgef15, 
Egfl7, Eogt, Fbxl7, Itga10, 
Layn, Ly75, Mical1, Palmd, 
Rnf144b, Svil, Tgtp2
C130074G19Rik, 
Cd34, Obscn, 
Slco1a4, 
Interneurons
3632451O06R-
ik, Amn, Capn6, 
Col19a1, Crh, 
Erich1, Fbxl4, 
Gm13629, 
Hspb6, Klhl38, 
Qrfpr, Rgag4, 
Rhot2, Rps6ka2, 
Slc25a17, Slc35f4, 
Tcta, Tle2, Vgll3, 
Zfp30, Zkscan16
Adam8, Adamts17, Aff3, Ank-
rd34b, Arhgap24, AW551984, 
Baiap2l2, Bex1, C1ql1, Cam-
k1g, Ccdc136, Ccnd2, Cdh4, 
Cdyl2, Cib2, Cpne4, Cpne6, 
Cyp27b1, Dhodh, Dusp4, 
E130317F20Rik, E530011L-
22Rik, Gm2115, Gpr27, Grb10, 
Grik1, Gtf2ird1, Hcn1, Hebp2, 
Hmgb3, Hspa5, Igsf3, Il17d, 
Irs2, Kcnd3, Kcnj12, Kif26b, 
Lgi2, Ly6h, Maml3, Mamld1, 
Manf, Mapk3, Mgat5b, Ngb, 
Nipal2, Nr2f6, Nrip3, Olfm3, 
Parn, Pcdhgc4, Pcsk1, Pde10a, 
Ppm1h, Ptprt, Rab27a, Rgs17, 
Scai, Sdk1, Sec14l1, Shisa9, 
Siah3, Spock3, Spryd4, St6gal-
nac5, St8sia5, Tacc3, Tfap4, 
Tmtc4, Trpc5, Usp28, Vdr, 
Xbp1, Zfp160, Zscan18
9230110C19Rik, 
Abca8b, Ankrd6, 
Celf6, Dgkg, 
Doc2b, Enox1, 
Ephb2, Grm1, 
Hhipl1, Ltbp2, 
Myo16, Ndst3, 
Pcdh8, Plxnc1, 
Pvrl1, Rims3, 
Samd4, Sbk1, 
Sh3bgrl2, Smad9, 
Spred3, Strip2, 
Tmem150c, Tme-
m200a, Tnfrsf21, 
Trim17, Ubash3b, 
Vgf
Microglia
Abcb1b, Ripk2, 
Trem2
A630001G21Rik, Dok2, Melk, 
Prss16, Ptprv, Pxdc1, Sft2d1, 
Tmem86a, Trim72, Vav3
Adam33, Iqgap2, 
Slc9a9, Sun2
Oligodendro-
cytes
9130019P16Rik, 
Cyp39a1, Fbxo32, 
Slc29a3, Spata13
Bace2, Ccdc62, Etv1, Insm1, 
Lcorl, Ldlr, Masp1, Nfatc3, 
Omg, Serinc5
Chst8, Ddc, St-
6galnac3
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Pyramidal neu-
rons
1700101I11Rik, 
Ankrd34c, Asap2, 
Atad2, B3galnt2, 
C2cd4c, Cbln1, 
Ccdc116, Cpne8, 
Efhc2, Erc2, 
Fam13a, Fndc8, 
Glb1l, Hfe2, 
Mapk12, Mast3, 
Mat2b, Npas2, 
Ntsr1, Oscp1, 
Pth2r, Rsad1, 
Slc7a4, Tcap, 
Tnnc1, Usp43, 
Wnt9a, Zar1
2410127L17Rik, 4930470P17R-
ik, 9430041J12Rik, Acot5, 
Actn3, Adck3, Adra1d, Ak4, 
Angel1, Ano3, Ap1s3, Atp6ap1l, 
B4galnt3, Brinp1, Caprin2, 
Ccdc63, Cdh22, Cntnap5a, 
Creld2, Diap2, E130012A19R-
ik, Eef2k, Efnb1, Egr4, Evc2, 
Fam19a1, Gda, Gm17769, 
Gm3230, Gpr88, Grik3, Hs3st2, 
Kcnf1, Kcnj3, Ksr2, Lmo3, 
Lmo7, Lrfn2, Lrrk2, Lzts3, 
March1, Met, Mylk3, Myo5c, 
Nptx1, Nr1d1, Nsun7, Ntng1, 
Numbl, Ociad2, Orai2, Osb-
pl10, Otub2, Otud1, Pafah2, 
Pde1a, Pde7b, Plekha4, Pparg, 
Prkg2, Ptpn5, Rasl10a, Rassf3, 
Rbm24, Rspo2, Sema3f, Sept6, 
Sesn1, Slc12a8, Slc23a3, 
Smad3, Snn, Sowaha, Spred2, 
Sstr3, Stard4, Sun1, Tmc4, 
Tmem158, Tmem200c, Trim9, 
Ube2e2, Usp2, Wdr76, Wnt2, 
Zfp459, Zfp46, Zfpm1, Zfyve28
Anxa11, Asb11, 
Baiap2, Bok, 
Brinp3, Cobl, 
Cpeb1, Csmd2, 
D130043K22Rik, 
Dgat2, Egr3, 
Emb, Enc1, Etv5, 
Fat3, Fmnl1, 
Fnbp1l, Gal-
nt9, Gm12992, 
Gpr153, Grm2, 
Homer1, Klhl40, 
Lmcd1, Mfsd4, 
Mical2, Mybpc3, 
Neu2, Nrn1l, 
Pcsk9, Pla2g4e, 
Plekhg4, Spred1, 
Srl, Tmem132d, 
Tmem245, 
Tspan11, Wipf3, 
Zdhhc14
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Supplementary Table 21. Genes that are comodulated in transcription and translation.
Term # Genes
Cell junction 15
Shroom2, Grik3, Psd3, Gria3, Pcdh8, Rims3, Kctd8, Synpr, 
Chrm3, Lrrtm3, Syn3, Stard8, Emb, Lrrk2, Lrfn2
Voltage-gated 
channel 5 Kcnd3, Scn3b, Cacng3, Kcnj3, Kcnip4
Integral com-
ponent of mem-
brane 60
Scn3b, Wfs1, Grik3, Otub2, Cntnap5a, Tmem145, Atp2b4, Un-
c5d, Brinp3, Islr2, Kcnd3, Pgap1, Scai, Ccdc136, Ptprt, Pcdh8, 
Cacng3, Grm1, Tmem245, Slc7a11, Tmem132d, Grm4, Chrm3, 
Sstr1, Igsf3, Lrrk2, Trp53i11, Adgra1, Kcnmb4, Plxnc1, Enpp2, 
Ifitm3, Sypl2, Kcnj3, Csmd2, Sec14l1, Sorcs3, Cdh7, Synpr, Lr-
rtm3, Cnr1, Dhodh, Msi1, D130043k22rik, Emb, Plxnd1, Il1rapl1, 
Hhatl, Lrfn2, Plp2, Ptpn5, Fzd3, Gria3, Tpbg, Thsd7a, Ntrk3, 
Slc6a7, Slc7a2, Rhot2, Mgst1
Ion transport 9
Kcnmb4, Kcnd3, Atp2b4, Scn3b, Grik3, Gria3, Cacng3, Kcnj3, 
Kcnip4
Potassium ion 
transport 4 Kcnmb4, Kcnd3, Kcnj3, Kcnip4
Extracellular 
matrix 6 Crip2, Fbln5, Tnc, Col12a1, Col1a1, Spon1
Protein phos-
phatase 4 Ubash3b, Ptpn5, Ppm1h, Ptprt
Potassium ion 
transport 4 Kcnmb4, Kcnd3, Kcnj3, Kcnip4
GTPase activity 4 Gnal, Rhot2, Rragd, Lrrk2
Nucleotide-bind-
ing 15
Pip5k1b, Prkg2, Rragd, Stk3, Ntrk3, Mast3, Gnal, Hyou1, Dgkb, 
Atp2b4, Syn3, Mapk3, Rhot2, Lrrk2, Ube2e2
Transferase 10
Ntrk3, Mast3, Dgkb, Mapk3, Pip5k1b, Prkg2, Lrrk2, Ube2e2, 
Stk3, Mgst1
Protein phos-
phorylation 6 Ntrk3, Mast3, Mapk3, Prkg2, Lrrk2, Stk3
Oxidation-re-
duction process 7 Vat1l, P4ha1, Dhodh, Mical1, Nqo1, Gfod1, Mgst1
Immunity 3 Hmgb2, Ifitm3, Sec14l1
G-protein cou-
pled receptor 
activity 7 Grm4, Chrm3, Sstr1, Cnr1, Fzd3, Grm1, Adgra1
Regulation of 
transcription, 
DNA-templated 4 Rgs20, Hmgb2, Scai, Irf2bp2
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Supplementary Table 22. Genes that are anticorrelated in transcription and translation.
Term # Genes
Cell junction 13
Sh3pxd2b, Lzts3, Rgs17, Neto1, Rims3, Jup, Cbln4, Grm2, Shisa9, 
Tmem163, Stard8, Olfm3, Sv2c
Inactivation of 
MAPK activ-
ity 4 Cav1, Spred2, Spred3, Spred1
Motor protein 4 Myo1b, Myh11, Myo16, Klc4
Ion transport 4 Kcnmb4, Atp2b4, Kcnb2, Kcna3
Nucleotide 
binding 13
Sept4, Myo1b, Pde10a, Lars2, Ak4, Atp2b4, Ksr2, Rps6ka2, Dgkg, 
Msi1, Myh11, Myo16, Mvk
Kinase 5 Ksr2, Rps6ka2, Dgkg, Mvk, Ak4
Transmem-
brane helix 37
Orai2, Kcnmb4, Cav1, Kcna3, Astn2, Sypl2, Csmd2, Neto1, Hrh1, 
Shisa9, Atp2b4, Fat3, Msi1, Ilvbl, Plxnd1, Sv2c, Il1rapl1, Apoo, 
Mrc1, Kcnb2, Adam23, Sun2, Ccdc136, Ptprt, Gdpd5, Tmem200c, 
Sun1, Grm1, Tmem245, Tmem132d, Thsd7a, Slc6a9, Slc25a13, 
Grm2, Tmem163, Bax, Adgra1
Oxidation-re-
duction pro-
cess 4 Sh3pxd2b, Mical1, Ppox, Dus3l
G-protein cou-
pled receptor 
activity 4 Hrh1, Grm2, Grm1, Adgra1
Transcription 
regulation 3 Hmgb3, Lmcd1, Rorb
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Supplementary Table 23. Genes that are modulated in transcription but not translation.
Term # Genes
Cell junction 16
Psd3, Prkcg, Gria3, Homer1, Rims3, Neto1, Cbln4, Slc17a8, Synpr, 
Grm2, Chrm2, Trim9, Pkp2, Svil, Syn3, Erc2
Ion channel 7 Hcn1, Kcnab3, Kcnb2, Kcna3, Kcnh7, Gria3, Kcnip4
Nucleo-
tide-binding 13
Hcn1, Sept4, Prkcg, Prkg2, Mthfd1l, Ephb2, Atp2b4, Syn3, Dgkg, 
Camk2d, Myo16, Hspa5, Sept6
Integral 
component of 
membrane 39
Cav1, Kcnab3, Enpp2, Aqp4, Kcna3, Dpy19l3, Sypl2, Cdh4, Cntna-
p5a, Neto1, Ephb2, Cntnap5b, Snn, Synpr, Atp2b4, Opalin, Unc5d, 
D130043k22rik, Ghr, Hcn1, Mag, Kcnb2, Efnb1, Vangl2, Scai, Sun2, 
Gria3, Tmem132d, Pcdh19, Slc17a8, Grm4, Nptxr, Grm2, Chrm2, 
Cd34, Kcnh7, Ptgfrn, Adgra1, Fam171a1
Kinase 5 Dgkg, Camk2d, Prkcg, Prkg2, Ephb2
Cell division 3 Sept4, Anxa11, Sept6
G-protein 
coupled recep-
tor signaling 
pathway 5 Grm4, Grm2, Chrm2, Gnb5, Adgra1
Transducer 4 Grm4, Grm2, Chrm2, Gnb5
Transcription, 
DNA-templat-
ed 4 Klf8, Ppp1r1b, Scai, Lmcd1
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Supplementary Table 24. Protein classes of disorder-related differentially expressed tran-
scripts between Control C column L2/3 and L4
Protein class Gene
Calcium-binding protein Cadps2
Cell adhesion molecule Mcam, Ctnna3, Cnr1, Mag
Chaperone Hspb8
Cytoskeletal protein Gfap, Ctnna3, Gsn, Ermn
Defense/immunity protein Mbl2, Crhr2, A2m, C4b, Mag, Cd8a
Enzyme modulator A2m, Adamts13, Dpp4, Casp4, C4b
Extracellular matrix protein Lrrtm3, Hapln2, Adamts13
Hydrolase Hpse, Bace2, Mmel1, Cnp, Cd163, Adamts13, 
Dpp4, Casp4 
Membrane traffic protein Cnih3
Nucleic acid binding Esr1
Oxidoreductase Fmo1, Cd163, Aldh1a2
Receptor Grm2, Lrrtm3, Il4r, Htr2c, Mc4r, Grm8, 
Chrm2, Crhr2, Cd163, Mcam, Hrh3, Adora1, 
Cnr1, Drd4, Grm1
Signaling molecule Lrrtm3, Cort, Il12a, Homer2, Cnih3, Cxcl10, 
Cnp, A2m, Chga, Il1b, C4b, Mag
Structural protein Gfap, Mag
Transcription factor Esr1
Transferase B3gat1
Transporter Grik4, Cacna1h, Grik3, Gabrg3, Htr3a, Gria3
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Supplementary Table 25. Protein classes of disorder-related differentially expressed tran-
scripts between control versus deprived L2/3 
Protein class Gene
Cell adhesion molecule Pcdh8
Cytoskeletal protein Syn3
Defense/immunity protein Trem2
Enzyme modulator Rims3, Plekhg4, Agt
Lyase Ddc
Membrane traffic protein Syn3
Nucleic acid binding Dbp
Receptor Grm2, Baiap2, Grm1
Signaling molecule Plekhg4, Homer1, Crh
Transcription factor Dbp
Transfer/carrier protein Ttr
Transferase Agt
Transporter Ttr, Slco3a1
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Supplementary Table 26. Protein classes of disorder-related differentially expressed tran-
scripts between control versus deprived L4 
Protein class Gene
Cell adhesion molecule Pcdh8
Cytoskeletal protein Mical1, Mapk3, Syn3
Enzyme modulator Rims3, Plekhg4, Rgs17
Extracellular matrix protein Lgi2, Omg, Ldlr, Ntng1
Hydrolase Ptpn5, Bace2
Ligase Mthfd1l
Lyase Ddc
Membrane traffic protein Syn3
Nucleic acid binding Pparg, Nr1d1
Oxidoreductase Cyp27b1
Receptor Lgi2, Grm2, Htr1b, Baiap2, Spred2, Omg, Ldlr, 
Grm1, Ntng1
Signaling molecule Plekhg4, Homer1, Wnt2
Transcription factor Pparg, Smad3, Nr1d1
Transfer/carrier protein Ttr
Transferase Lrrk2, Mapk3
Transporter Grik1, Ttr, Slc7a11, Slco3a1, Grik3, Slc6a2
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Supplementary Table 27. Control Column, L2/3 vs L4 disorder-related differentially ex-
pressed transcripts.
Disorder
Associated transcripts
L2/3 enriched L4 enriched
Alzheimer’s dis-
ease
Lrrtm3, Cnr1, Cfh, Hspb8, Ace, 
Cort, Mmp2, Il1b, Htr2c, Gfap, 
Ctnna3, Drd4, Casp4, A2m, 
Esr1
Hpse, Cartpt, Chrm2, Mmel1, Grm2, 
Bace2, Gsn, Chga
Amyotrophic 
lateral sclerosis
Gria3, Grm1, Igfbp4, Fmo1, 
Igf2
Fbxo32, Grm2, Chga
Autism
Egr2, Cacna1h, Celf6, Grm8, 
Dpp4, Drd4, Met, C4b
Cadps2
Bipolar disorder
Mdga1, Egr2, Grm1, Ace, 
Grik4, Il1b, Htr2c, Gfap, Drd4, 
Esr1
Chrm2, Cnp
Dementia
Ace, Il1b, Htr2c, Gfap, 
Adamts13, Esr1
Cartpt
Depression Cnr1, Ace, Gfap, Crhr2, Esr1 Chrm2, Grik3, Erbb3
Down syndrome
Kit, Cfh, Adam12, Mmp2, Gfap, 
Esr1
Bace2, Gsn
Migraine Cnr1, Ace, Htr2c, Drd4, Esr1 Hrh3
Multiple sclerosis
Cnr1, Cd14, Ace, Kcna3, 
Cxcl10, Cd163, Il1b, Gfap, 
A2m, Anxa1, Cd8a
Il12a, Mmel1, Mcam, Cnp
Parkinson’s dis-
ease
Cnr1, Cfh, Cd14, Igf2, Il1b, 
Gfap, Esr1
Cd200r1
Schizophrenia
B3gat1, Gria3, Homer2, 
Mdga1, Egr2, Grm1, Cnr1, Ace, 
Adam12, Grik4, Fxyd6, Il1b, 
Htr2c, Gfap, Htr3a, Drd4, Met, 
Aldh1a2, Esr1, Mc4r, Ctxn3
Hapln2, Cnih3, Ermn, Gfra2, Mag, 
Grm2, Grik3, Erbb3, Cnp, Adora1, 
Chga
Substance depen-
dence
Cnr1, Grm8, Fmo1, Gabrg3, 
Il1b, Drd4
Chrm2, Grik3
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Supplementary Table 28. Control versus Deprived, Disorder-related transcripts
Disorder
Associated transcripts
Modulated in L2/3 Modulated in L4 Modulated in both
Alzheimer’s 
disease
Amyotrophic 
lateral sclero-
sis
Fbxo32
Igfbp5, Met, Smad3 Grm1, Grm2, Vgf
Autism Efhc2
Htr1b, Mapk3, Met, 
Wnt2
Baiap2, Celf6, 
Bipolar disor-
der
Grik1, Hspa5, Nr1d1, 
Ntng1, Xbp1
Egr3, Grm1, Mdga1, 
Syn3, Vgf
Dementia Agt, Trem2 Lrrk2 Syn3, Ttr
Depression Grik3, Htr1b Grm2, Ttr
Down syn-
drome
Bace2, Grik1, Mthfd1l, 
Spred2
Epilepsy
Crh, Dbp, Efhc1, 
Efhc2
Grik1, Lgi2, Mical1 Grm1
Multiple scle-
rosis Agt, C4a, Trem2
Cyp27b1, Slc7a11 Cd34, Syn3
Panic disorder Crh Tmem132
Shizophrenia
Dcx, Egr4, Grik1, 
Grik3, Hspa5, Htr1b, 
Kcnj3, Met, Ntng1, 
Omg, Ptpn5, Xbp1
Csmd2, Egr3, Grm1, 
Grm2, Homer1, Mdga1, 
Pcdh8, Rims3, Syn3
Spinocerebel-
lar ataxia
Kcnd3 Grm1, Plekhg4, 
Substance 
dependence
Grik1, Grik3, Htr1b, 
Mapk3, Rgs17
Ddc, Homer1, Slco3a1
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Abstract 
Topographical representations in the somatosensory cortex exhibit plasticity throughout an 
animal’s life, allowing for adaptation of cortical sensory processing to ever-changing sen-
sory input. Feed-forward excitatory synapses originating from cortical layer (L) 4 in the 
barrel cortex have been shown to powerfully shape neural responses in the upper layers of 
the cortex in an experience-dependent manner.  Recent large-scale molecular mapping exper-
iments described in the previous chapters have shown that upper layers of the barrel cortex, a 
prominent locus for cross-columnar connectivity, undergo large-scale changes upon whisker 
deprivation, which are coupled across neighbouring cortical columns. These observations 
suggest that cross-columnar projections might undergo synaptic plasticity, thus potentially 
help explain the correlated nature of the molecular changes across neighbouring deprived and 
spared cortical columns.  To directly observe whether sustained whisker deprivation induces 
synaptic plasticity across this synapse, I employed whole-cell recordings in L2/3 excitatory 
neurons. After whisker deprivation, population excitability of the deprived-to-spared column 
projections was not altered, moreover synaptic efficacy remained unchanged upon ex vivo 
induction of long-term potentiation across the same synapse. The speed of communication 
between the deprived and spared columns, however, is categorically increased across all 
stimulation thresholds and was further enhanced following long-term potentiation protocols.  
These results suggest that whisker deprivation causes plasticity across the cross-columnar 
L2/3 projections however the plasticity is not expressed as a reduction in synaptic weights.  
The plastic changes in the speed of communication is likely to be caused by disinhibition 
previously observed in the deprived whisker’s cortical column. Taken together, the current 
results nominate L2/3 cross-columnar projections and intrinsic spiking properties as loci 
of experience-dependent plasticity in barrel cortex.  Future studies that repeat these experi-
ments after blocking inhibitory transmission while recording from neuronal populations in 
the deprived whisker’s L2/3 will shed light onto the mechanisms of the plasticity in speed of 
cross-columnar communication. 
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Introduction
Sensory areas of the mammalian neocortex process information gathered by the peripheral 
sensory organs. In sensory cortices, neurons that preferentially respond to a given stimulus are 
positioned in close proximity of one another, forming sensory maps representing the periph-
eral organ (reviewed in Chapter 1). Sensory maps are modulated by experience, coordinating 
circuit formation during postnatal development and ensuring functional adaptation to changing 
sensory input in adulthood. The molecular, cellular, synaptic and network mechanisms under-
lying sensory map reorganization are not yet fully understood.
Over the last two and a half decades, the barrel cortex subfield of the rodent primary somato-
sensory cortex (S1) has emerged as (one of) the leading animal models of experience-depen-
dent plasticity (EDP). Neurons in each barrel cortical column are mainly responsive to a single 
whisker, named principal whisker. Whisker deprivation leads to extensive reorganization of 
somatosensory maps [1], expanding spared whiskers’ representations while deprived whiskers’ 
representations shrink. The synaptic mechanisms of these changes have previously been de-
scribed. Upon whisker deprivation, feed-forward excitatory projections originating from cor-
tical layer IV (L4) and targeting L2/3 are depressed [2]; meanwhile corresponding synapses 
in the spared whiskers’ column are potentiated [3]. These changes in synaptic strength are ex-
pressed through spike-timing dependent plasticity [4, 5] and require coordinated changes in ion-
otropic N-methyl-D-aspartate (NMDA) and metabotropic glutamate (mGluR1) signalling [3]. 
Although L4-L2/3 projections are predominantly restricted to a single barrel cortical column, 
neurons in the upper layers of the cortex do not obey the columnar boundaries. These cross-co-
lumnar projections are thought to be important for integration of sensory input across whiskers 
[6], and are modulated both physiologically and structurally upon whisker deprivation [7–9]. 
Synaptic plasticity across cross-columnar projections could therefore explain how deprived col-
umns lose their responsiveness to the stimulation of deprived (principal) whiskers, and could pro-
vide a circuit mechanism for the receptive field remapping observed after whisker deprivation. 
Here, I thus studied L2/3 cross-columnar projections onto pyramidal neurons in acute slices of 
whisker deprived rats and control littermates.  I found that whisker deprivation did not alter the 
EPSP amplitude in spared L2/3 neurons after presynaptic L2/3 population stimulation in the 
deprived column. Deprived-to-spared synapses could be potentiated using an ex vivo long-term 
potentiation (LTP) protocol, however the amount of potentiation was comparable across the 
deprived and control animals. In spared columns, neurons displayed increased spike thresholds 
coupled with reduced spike counts, plausibly as a result of homeostatic plasticity that limits 
the increased excitability in spared whisker’s cortical column (see Discussion). Interestingly, 
speed of communication (i.e. rising speed of EPSPs) across the cross-columnar projections 
originating from the deprived column was increased across all stimulus intensities studied. 
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Together these results suggest that deprived-to-spared projections express experience depen-
dent plasticity although plasticity is not expressed as a change in synaptic strengths.  Rather 
a unique form of plasticity that alters the speed of communication across the cross-columnar 
projections was observed (see Discussion).  These observations might help to address the ori-
gin of correlated molecular changes across the spared and deprived L2/3 as increased speed of 
communication across cross-columnar projections will result in neurons in the neighbouring 
columns’ L2/3 to be driven by the same input in the sensory periphery independent from their 
original preferred whiskers.  
Materials and Methods
Animals 
All procedures were approved by the Animal Ethics Committee of the Radboud University, 
Nijmegen, the Netherlands, and were in accordance with the Dutch legislation. Long Evans 
rats were housed in standard cages with access to food and water ad libitum. Four female rats 
were used to obtain maximally four nests of newborn rats per female. Newborn rats were then 
used in between postnatal day (P) 22-33.
Whisker deprivation 
Whisker plucking started on P12 and was maintained for 10 – 21 days, during which any whis-
ker regrowth was removed every two days. Animals were anesthetized using isoflurane prior to 
plucking. After anesthesia, C‐row whiskers on the right side of the animals’ face were plucked. 
Control animals were similarly handled and anesthetized but whiskers were not plucked.
Slice preparation 
Acute brain slices were prepared fresh before experiments. Slicing medium (Choline- Chlo-
ride 108 mM; KCl 3 mM; NaHCO3 26 mM; 6 MgSO4; NaHPO4 1.25 mM; D- glucose 25 
mM; Na-pyruvate 3 mM; CaCl2 2 mM) was ice cold and carbogenated (95% O2/5% CO2) 
for >30 minutes prior to brain slice preparation. Animals were anesthetized using isoflurane, 
after which perfusion of the brain was performed by clamping the aorta caudally from the di-
aphragm and pumping slicing medium into the left atrium of the heart, while the right atrium 
was cut. This caused the slicing medium to flow to the brain as directly as possible. Perfusion 
was maintained for approximately one minute, after which the brain was quickly dissected 
from the skull. After removing the cerebellum, the brain was cut at a 50 ‐ 55° angle from the 
midsaggital plane in slices of 400 μm using a VT1000S vibratome (Leica Microsystems). From 
anaesthesia to brain slices, the procedure typically took 8 to 10 minutes. Slices were placed in 
carbogenated artificial cerebrospinal fluid (ACSF; NaCl 120 mM; KCl 3.5 mM; MgSO4 1.3 
mM; CaCl2 2.5 mM; D‐glucose 10 mM; NaHCO3 25 mM; NaHPO4 1.25 mM) which was 
kept at 37°C. After 30 minutes, heating of ACSF was stopped and its temperature was allowed 
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to drop to room temperature where it was kept. 
Electrophysiology 
Slice recordings were performed at room temperature in carbogenated ACSF. Only slices in 
which C‐barrel and B/D columns could be identified were used. To stimulate L2/3 neurons 
in C‐columns, a bipolar Tungsten electrode (Frederick 23 Haer & Co) was placed in layer 2/3 
vertically above the C barrel, approximately 100 μm from the border with the B/D column 
(Figure 1). A recording electrode was placed in layer 2/3 of the B/D column, horizontally 200 
μm away from the tips of the stimulation electrode (100 μm into the neighboring column). 
Whole‐cell current‐clamp recordings of L2/3 neurons in B/D columns were then conducted 
using an EPC10 amplifier (HEKA). Capillaries (Sutter GC150‐15F; ID 0.5 mm; OD 1.0 mm) 
were pulled to prepare electrodes with an impedance of 8MΩ using a PP2000 pipette puller 
(Sutter). During all experiments, pipettes contained the same intracellular solution (K‐Gluco-
nate 130 mM; KCl 5 mM; HEPES 10 mM; MgCl2 2.5 mM; Mg‐ATP 4 mM; Na‐GTP 0.4 mM; 
Na‐phosphocreatine 10 mM; EGTA 0.6 mM). Series resistance (Rs) was monitored using hy-
perpolarizing pulses of 5 pA with a duration of 10 ms. Cells were excluded from the dataset if 
Vm >‐60 mV, if Rs >350 MΩ and if Vm or Rs varied more than 20% during the experiments. If 
necessary, Vm was kept stable at ~ -75 mV using (typically hyperpolarizing) current injection.
Identification of pyramidal neurons 
In all experiments the cell type of recorded neurons was classified based on pyramidal soma 
shape and the cell’s spiking pattern during incremental step current injections (10 incremental 
steps of 40 pA, starting at 40 pA). Only cells displaying an adaptive spiking pattern (a feature 
of excitatory pyramidal neurons [10]) were included in subsequent analyses.
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Figure 1. Experimental design. Rat pups were randomly assigned to one of two groups.  Con-
trol rats (panels on the left) had all of their whiskers intact.  Whisker deprived animals (right 
panels) had their C-row whiskers deprived unilaterally for 10-22 days starting from P12. Acute 
thalamocortical slices were prepared from P22-33 animals. A bipolar electrode was placed in 
L2/3 of the deprived C column while whole-cell recordings were made from pyramidal neu-
rons in the L2/3 of the neighboring spared B or D column.
Measurement of population excitability
Current was injected through the bipolar stimulation electrode in the C-barrel column. Current 
amplitude was set at the lowest intensity needed to evoke EPSPs of 2 - 3 mV in the postsynap-
tic B/D column neurons, after which amplitude of the current injection was increased by steps 
of 10%. Incremental steps were continued until stimulation intensity reached 1.4x the starting 
amplitude.  
LTP induction ex vivo
Baseline synaptic strength was determined by presenting 30 stimuli with an interstimulus in-
terval of 15 sec, at the previously set stimulation amplitude. LTP was subsequently induced by 
theta-burst stimulation (TBS) in L2/3 of the C‐barrel column (1 train = 5 bursts of 5 pulses at 
100 Hz, 200 ms inter‐burst interval; 10 trains were presented with 15 second intervals), coin-
ciding with postsynaptic depolarization sustained with somatic 400 pA current injection in the 
spared (B/D) columns. Slope and amplitude of EPSPs were determined using the Patchmaster 
software (HEKA). For each cell, EPSP slope and amplitude was normalized to the baseline, 
after averaging baseline responses over a period of 1 minute prior to the LTP induction. The 
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normalized values were then averaged across cells for population/group analyses. Percentual 
changes following TBS for each phase (initial/mid/late) were determined as 100 x ([relative 
EPSP slope post‐TBS]/[relative EPSP slope pre‐TBS]) or 100 x ([relative EPSP amplitude 
post‐TBS]/[relative EPSP amplitude pre‐TBS]). To determine differences between groups, in-
dependent two‐sample t‐tests were used. Paired two‐sample t‐tests were used to determine 
differences within groups (pre‐TBS vs. post‐TBS).
Quantification of action potential parameters 
Quantifications were performed using custom written routines in MATLAB (Mathworks). The 
spike threshold was inferred from the peak of the second derivative of the membrane potential. 
Latency of action potentials were calculated with respect to the onset of stimulus.  
Results 
Input/output-relationships of cross-columnar L2/3 – L2/3 projections    
Population excitability was assessed using an input/output curve where the presynaptic popu-
lation stimulation intensity was varied and the evoked postsynaptic EPSP response quantified; 
to do so I recorded EPSP amplitudes of L2/3 neurons in spared B/D-barrel columns evoked by 
incremental field stimulation of L2/3 neurons in the adjacent deprived C-barrel column (see 
Figure 1). 
The mean evoked EPSP amplitude increased with increasing stimulus intensity in both groups; 
at maximal stimulation intensity reached approximately 8 mV in both groups (control: 7.84 
±0.18 mV, n=15; deprived: 8.08 ± 0.25 mV, n=21). Across the 5 stimulus intensity levels, scal-
ing the stimulus intensity by 40% increased the EPSP amplitude by a factor of ~3 (average con-
trol: 332.9%; average deprived: 263.7%).  Overall, EPSP amplitudes of control and deprived 
groups were similar, and no difference could be determined between groups at any stimulation 
intensity (p-value 0.72, two sample Kolmogorov-Smirnov test) (see Figure 2A, B). 
Similarly, the mean absolute EPSP amplitude of the two groups across stimulation intensities 
were comparable (p>0.94; independent two-sample t-test). To ensure that the lack of a system-
atic change across the groups is not because of the variance within each observation condition, 
EPSPs were also normalized to the maximum EPSP obtained in each cell.  Normalized EPSP 
comparisons across groups and stimulus conditions were similar to the raw EPSP amplitude 
comparisons, as such that whisker deprivation did not influence the evoked EPSP size; stimulus 
intensity scaled the evoked responses similarly across both conditions (Figure 2C; normalized 
responses to 1.0 - 1.4x stimulation intensities, control: 31.1 ±4.95 - 46.1 ±6.35 – 67 ±8.67 - 84.4 
±10.7 – 100 ±11.4%, deprived: 36.8 ±6.06 - 50.5 ±8.54 - 65.9 ±9.09 – 79 ±9.47 – 97 ±10.8%). 
These results argue that amplitude of the evoked responses across the cross-columnar projec-
tions between deprived and spared columns is not altered after sustained whisker deprivation. 
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Whisker deprivation does not alter synaptic efficacy
Observations outlined above indirectly indicate that whisker deprivation does not significantly 
alter synaptic strengths, at least after the whisker deprivation protocol described herein.  An-
other way to measure the change in synaptic strengths due to altered sensory experience is the 
induction of long-term potentiation (LTP) or long-term depression (LTD).  It has been shown 
that sensory deprivation induces synaptic depression and potentiation in vivo in the whisker 
deprived and spared columns, respectively [2–4].  Because induction of LTD in vivo increases 
the amount of LTP that can be induced experimentally across the same synapse ex vivo ([2–4]), 
I conducted LTP experiments in cross-columnar projections between deprived (presynaptic) 
and spared (postsynaptic) neurons. To induce LTP ex vivo, theta-burst stimulation (TBS) of 
L2/3 neuronal populations in C-columns was paired with postsynaptic depolarization of the 
L2/3 neurons of adjacent spared (B/D) columns (Figure 3A). Post-TBS measurements were 
divided into initial (0 – 7 minutes post-TBS), mid (30 – 37 minutes post-TBS) and late (42 – 49 
minutes post-TBS) stages to address how EPSP amplitude or slope behave over time following 
tetanic stimulation.
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Figure 2. Excitability of cross-columnar projections. (A) Input/output curves obtained from 
incremental field stimulation of L2/3 neurons in C‐barrel columns, paired with cross‐columnar 
L2/3 single cell recording. Connected circles: mean EPSP amplitudes per group. Individual 
circles: absolute EPSP amplitudes per cell. (B) Example recordings of two cells from each 
experimental group. Insets: mean traces (3 sweeps per trace) per stimulation intensity for each 
cell. (C) EPSP amplitudes normalized to mean maximal amplitude in control animals. All error 
bars are standard error of the mean (s.e.m.)
As expected, absolute EPSP amplitude in slices from control and deprived animals were com-
parable prior to LTP induction (control: 3.97 ±1.08 mV; deprived: 3.86 ±1.49 mV; p>0.89; 
independent two-sample t-test) (Figure 3B).
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Figure 3. EPSP amplitude in control and deprived animals following TBS. (A) A represen-
tative LTP experiment. Inset: Mean EPSP traces sampled from 15’ prior to (black) and 30’ after 
TBS (blue). TBS induces a clear, long-lasting increase of EPSP amplitude while Vm and Rs 
(bottom) are stable throughout the experiment. Vertical lines indicate TBS duration. (B) Mean 
EPSP amplitude pre-TBS. (C)  EPSP amplitude normalized to mean baseline value, averaged 
across cells. (D) Average EPSP amplitudes for initial, medial and late stages, normalized to 
baseline values. All error bars are s.e.m.
Upon tetanic stimulation evoked-EPSP amplitudes increased compared to the baseline in both 
groups (control: mean relative initial increase 25%, p=0.008; deprived: mean relative initial 
increase 41%; p=4.41 x 10-5; paired t-test). After TBS, evoked EPSP amplitudes across the 
groups remained comparable with the exception that during the mid-phase interval, recordings 
from deprived animals had a slightly larger potentiation (control: mean increase 33 ±4%; de-
prived: mean increase 46 ±3%; p= 0.046; independent two-sample t-test) (see Figure 3C). This 
suggests that EPSP amplitudes can be enhanced through tetanization in deprived and control 
groups similarly, with slight (~10%) and short lasting (<10 min) enhancement in projections 
originating from the deprived cortical column.  Combined with the observations on the popula-
tion excitability measures, these results argue that whisker deprivation does not alter synaptic 
efficacy across the cross-columnar projections originating from the deprived cortical column.
TBS results in faster EPSP rise in deprived whisker’s cross-columnar projections
In feed-forward L4-L2/3 excitatory projections, for the quantification of synaptic potentiation 
and depression, EPSP amplitude and slope are used interchangeably.  This is mostly because 
pre- and postsynaptic neurons are heavily interconnected as they are sampled from the same 
cortical column after vertically aligning the center of the bipolar stimulation electrode to the 
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relative horizontal position of the neuron to be patched.  In cross-columnar experiments, how-
ever, the relative position of the pre- and postsynaptic populations are not always experimen-
tally observable, moreover the density of the synaptic connections are typically not known. 
Therefore a change (or lack thereof) in EPSP amplitude after sensory deprivation does not nec-
essarily predict how the integration of the synaptic input might be differentially regulated by 
sensory experience.  Thus, I quantified the EPSP slope before and after TBS in control animals 
and animals who received sustained whisker deprivation.  
Figure 4. EPSP slope in control and deprived animals following theta-burst stimulation 
(TBS). (A) EPSP amplitude averaged across cells before TBS. (B) TBS resulted in sustained 
long-term facilitation of the slope of monosynaptic EPSP.  (C) Average EPSP amplitudes for 
initial, mid and late stages, normalized to baseline values. All error bars are s.e.m.
Absolute monosynaptic EPSP slope in deprived animals was higher than that of control ani-
mals even before TBS (control: 0.415 ±0.16 mV/ms; deprived: 0.731 ±0.56 mV/ms); although 
this difference did not reach statistical significance (see Figure 4A; p=0.25; independent 
two-sample t-test) it could be potentially explained by the reduced inhibition in L2/3 of the 
spared whisker’s cortical column [11].  TBS induced strong facilitation of EPSP slope in de-
prived-to-spared cross-columnar projections which gradually increased post-TBS (Figure 4C). 
The TBS induced enhancement had a rapid onset (initial: 57.7 ±13.8% compared to baseline, 
p=5.09 x 10-5) and was sustained for the rest of the experiment (mid: 65.6 ±9.7%, p=8.65 x 
10-9; late: 81.7 ±8.3%, p=8.13 x 10-11).  TBS did not change the EPSP slope between the spared 
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cortical columns in the control animals, although it induced short-lasting, short-term excitabil-
ity change (initial: 14.9 ±12.2%, p=0.038, paired t-test), which gradually decayed and returned 
to the pre-TBS, baseline levels (mid: 0.7 ±9.3% increase, p=0.99; late:  6.7 ±4.6% increase, 
p=0.22).  Combined with the observations on the EPSP amplitude, these results suggest that 
whisker deprivation alters the “speed” of communication between the deprived-and-spared 
cortical columns via the cross columnar connections, rather than controlling the weight of 
synaptic connections.   
Whisker deprivation reduces neuronal excitability and spike frequencies in the spared column
EPSP amplitude in cross-columnar projections was unaffected by whisker deprivation, how-
ever intracellular information transfer by the postsynaptic neurons might still undergo expe-
rience-dependent changes.  Therefore, I performed whole-cell current clamp recordings and 
quantified the action potential (spike) threshold, latency and timing with ramp-and-hold stim-
ulation (10 incremental steps of 40 pA, 500 ms; Figure 5 and Table 1). 
Group analysis (using two-way ANOVA for all metrics) showed that sustained somatic cur-
rent injection resulted in significantly less spiking in deprived animals compared to controls 
(F=32.09, P<0.001). Note that independent from the deprivation condition, all neurons were 
in a spared column, and thus had their own principal whiskers intact prior to recordings.  The 
difference was not because of delayed spike latency or increased inter-spike interval (ISI, see 
Table 1), but could be explained (at least in part) by the early cessation of late spiking in the 
deprived animals. Latency to the last action potential was earlier in deprived animals (F=17.37, 
p<0.001), which resulted in shorter spiking window (i.e. Latency
LastAP
-LatencyFirstAP; F=22.83, 
p<0.001; whisker deprivation condition x stimulus amplitude interaction, p=0.03).  Accord-
ingly, neurons in the deprived animals did not maintain their spiking as long as comparable 
neurons in the control animals did, resulting in reduced compression ratio, described as the du-
ration of spiking window / current injection duration (F=22.81, p<0.001; whisker deprivation 
condition x stimulus amplitude, p=0.03). 
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Figure 5. Spike characteristics upon incremental current injections in control and de-
prived animals. All recordings are made in L2/3 excitatory neurons in the spared whiskers’ 
cortical column. Asterisks indicate significant differences based on two-way ANOVA compari-
sons (see Table 1). Line graphs: error bars are s.e.m. Box plots: bars indicate interquartile inter-
vals, error bars span across 2.7 sigma (i.e. 99.3% coverage for the entire distribution); outliers 
are marked individually. In each group, 32 cells were recorded.
Although minimal, maximal and mean ISI were comparable across groups (see Table 1), in-
terspike interval adaptation (calculated as (ISIlast - ISIfirst) / ISIfirst ) was significantly less after 
whisker deprivation (F=20.82, p<0.001), which is in agreement with the reduced AP count 
and shorter spiking window detailed above.  These observations suggest that excitability of 
the L2/3 neurons in the spared whisker’s cortical column was reduced which is also supported 
by the increased action potential thresholds in deprived animals (F=20.82, p<0.001).  These 
results suggest that spared (B/D) column neurons of deprived animals are less excitable than 
those in control animals, and their spike trains are shorter and contain fewer action potentials, 
in particular at lower current injections.
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Faster rate of depolarization in the spared whisker’s column after whisker deprivation 
The results thus far argue that sensory deprivation does not alter the synaptic efficacy but re-
duces the excitability of the post-synaptic neuron. Reduction of the postsynaptic excitability 
might thus be expected to impair the speed of membrane depolarization, also known as EPSP 
slope, upon synaptic activation.  Ex vivo LTP induction experiments, however, showed that 
after whisker deprivation the EPSP slope was dramatically faster. 
Table 1 - Statistical comparisons performed for the data in Figure 5
Metric Main effect (whisker depriva-
tion, i.e. control vs deprived)
Interaction (whisker depriva-
tion x stimulus intensity)
 F Fcritical p F Fcritical p
AP threshold, first AP 18.68 3.86 1.8 x 10-5 0.87 1.89 0.55
AP threshold, mean 25.66 3.86 5.39 x 10-7 1.09 1.89 0.37
AP count 32.09 3.86 2.22 x 10-8 0.97 1.89 0.46
ISI, minimal 0.02 3.86 0.88 1.27 1.89 0.26
ISI, mean 0.08 3.86 0.77 1.30 1.89 0.24
ISI adaptation 7.70 3.86 0.006 0.80 1.89 0.61
AP latency, first AP 0.27 3.86 0.60 0.65 1.89 0.75
AP latency, last AP 17.37 3.86 3.5 x 10-5 1.83 1.89 0.06
Spiking window 22.83 3.86 2.19 x 10-6 2.11 1.89 0.03
Spiking window / cur-
rent injection duration 
22.81 3.86 2.21 x 10-6 2.11 1.89 0.03
Considering that the EPSP slope further rose upon TBS stimulation, I reasoned that EPSP 
slope might be modulated by prior (sensory / synaptic) experience, and express plasticity inde-
pendently from the changes in synaptic efficacy. I thus investigated the slope of evoked EPSPs 
in spared neurons upon incremental field stimulation of their deprived neighbours. On average, 
slopes ranged from 0.04 ±0.05 mV/ms at 1.0x stimulation intensity to 0.22 ±0.24 mV/ms at 
1.4x intensity in control animals (Figure 6). In deprived animals, EPSP slopes were roughly 
twice as fast (p=0.018, two sample Kolmogorov-Smirnov test), i.e. 0.09 ±0.13 mV/ms and 0.47 
±0.45 mV/ms, respectively. These results show that although cross-columnar projections have 
comparable synaptic efficacy independent from the sensory deprivation history (Figure 2), 
speed of depolarization upon is facilitated in the deprived cortical column (Figure 6). Thus, the 
plasticity across the cross-columnar projections are expressed in the temporal domain rather an 
absolute change in synaptic weights (also see Discussion).
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Figure 6. Speed of depolarization across cross-columnar projections. (A) Example traces 
of evoked EPSPs. Traces are aligned either at the stimulus artefact or at EPSP onset. For clar-
ity, the stimulus artefact is truncated for pairs 1 and 2. EPSPs rising fase is typically faster in 
deprived animals. (B) Input/output‐curves obtained from incremental field stimulation of L2/3 
neurons in C‐barrel columns, paired with cross‐columnar L2/3 single cell recording. In spared 
columns, EPSP slope is significantly enhanced (p=0.018, two sample Kolmogorov-Smirnov 
test). Connected circles: mean EPSP slopes per group. Individual circles: absolute EPSP slopes 
per cell. (C) EPSP slopes normalized to mean maximal slope in control animals. All error bars 
are s.e.m.
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Discussion 
Identifying the neural circuits and cellular and molecular mechanisms of experience-de-
pendent plasticity is a cardinal goal of Neuroscience.  Here, using a combination of sensory 
deprivation, whole-cell current clamp recordings and a synaptic plasticity induction protocol, 
I experimentally addressed whether sensory experience controls the way two neighboring 
cortical columns communicate with each other.  The results showed that sustained (10-21 
days long) whisker deprivation during a period of somatosensory cortical development where 
cross-columnar projections readily undergo rapid reorganization [1, 12] does not alter syn-
aptic efficacy although it facilitates the speed of communication from the deprived-to-spared 
cortical column.  Interestingly excitability of the L2/3 excitatory neurons in the spared whis-
kers’ cortical column is reduced after deprivation of a surround whisker. 
 
The role of sensory input in shaping the organization of the somatosensory cortex has been 
known for several decades (see e.g [13–18]).  Detailed characterization of the intracortical 
projections originating from the main thalamic recipient cortical layer (L4) have shown that 
feed-forward projections onto L2/3 are a major locus of synaptic plasticity [2–4], but cellu-
lar mechanisms of cross-columnar L2/3 projections are unknown. To our knowledge, results 
described herein are the first to address how whisker deprivation affects L2/3 cross‐columnar 
deprived-to-spared synapses.  
 
In vivo induction of LTD can be identified ex vivo by an enhancement of LTP induction [2, 
19]. Cross-columnar L2/3 theta-burst stimulation induced a marked increase in EPSP slope 
in spared columns of deprived but not control animals, indicating an in vivo experience-de-
pendent depression of L2/3 cross-columnar synapses. In contrast, EPSP amplitude was not 
altered as LTP could be induced with similar efficacy in both experimental groups. Intrinsic 
spiking properties of neurons are also modulated by sensory experience [7] and as such can 
be tuned in parallel with synaptic strength to accommodate sensory cortical circuits to altered 
sensory input. We found that pyramidal neurons in L2/3 of spared barrel columns had higher 
spike thresholds, which was paired with a lower spike count.
Previous work [2] showed that enhancement of spared whisker responses relies on potentiation 
of L4-L2/3 synapses of spared columns. Our results suggest that in spared columns, strength-
ening of L4-L2/3 projections is paired with a reduced L2/3 spike frequency, which could be a 
homeostatic response to a relative increase of sensory input from spared whiskers. In deprived 
columns, L4-L2/3 projections are depressed, which our results suggest is accompanied by an 
LTD-like depression of L2/3 cross-columnar excitatory synapses. LTP facilitation in deprived 
animals was mainly observed in the EPSP slope, and only modestly in EPSP amplitude, sug-
gesting that synaptic strength was not reduced by whisker deprivation (as was confirmed by 
input-output experiments) but instead might affect action potential generation or propagation 
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in deprived L2/3 excitatory neurons. If our current results are any indication, action potential 
characteristics are also likely to be distinct in deprived compared to spared columns; our results 
do not predict any change in spike threshold as this would likely result in increased EPSP am-
plitudes in input-output experiments. Other parameters, such as spike count or latency could 
however be modulated upon whisker deprivation.
Enhanced EPSP slope could also be explained by the effects of whisker deprivation on local 
circuitry of individual barrel columns. Local recurrent excitation in L2/3 is reduced in whisker 
deprived columns [9, 20] but a greater reduction is found in recurrent inhibitory circuits, like-
ly a reflecting homeostatic response to reduced sensory input [21]. Such disinhibition could 
favor spike-timing towards LTP induction, which would explain enhanced induction of LTP 
in cross-columnar projections in deprived animals in our experiments, and would also explain 
how fewer action potentials in spared columns could still drive neighbouring deprived columns. 
In vivo, such effects have been described: whisker deprivation-induced disinhibition in L2/3 
allows for LTP induction through spared whisker deflections, which is could not be achieved 
when all whiskers were intact [22]. Importantly however, in our experiments we focused on the 
opposite synapse and directly stimulated L2/3 in slices, ignoring input from thalamus or L4.
Whisker deprivation introduces a reversal of the relative spike timing between L4 and L2/3 
[4], likely favoring LTP induction in spared-to-deprived synapses and LTD in deprived-to-
spared synapses. If deprived-to-spared synapses are depressed in vivo, as our results suggest, 
a prediction one might make is that spared-to-deprived synapses should undergo potentiation. 
To investigate whether the plasticity of the cross-columnar connections is bidirectional, the 
protocols described here can be reversed: spared barrel columns are stimulated in L2/3 while 
simultaneously evoked responses of neurons in L2/3 of an adjacent deprived column are re-
corded.  In closing, the results described introduces reciprocal cross-columnar projections be-
tween neighboring cortical columns as a locus of experience-dependent plasticity. 
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Chapter 5
Experience-dependent plasticity is a multi-scale, 
systems-level reorganization of the nervous system
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Abstract
Early stages of information processing in the nervous system take place along the primary 
sensory pathways where information is encoded topographically to generate internal represen-
tations of the world that surrounds us.  These sensory representations, also known as sensory 
maps, are products of spatiotemporally correlated activation of synaptically coupled networks. 
Sensory experience powerfully shapes sensory maps both during development as well as in 
adulthood.  This experience-dependent plasticity is believed to define where and how informa-
tion is processed in the nervous system.  Despite the critical contribution of sensory maps to 
sensory perception and brain function, neural circuits and mechanisms responsible for experi-
ence-dependent changes in sensory representations are not well understood.  With this thesis, 
I set out to address this question experimentally. By systematically mapping the transcriptome 
and proteome in a cortical column- and layer-specific manner in the barrel cortex of control 
animals and animals that underwent prolonged whisker deprivation, I detailed the molecular 
changes correlated with the animals’ sensory history. To bridge these findings with the circuit 
level observations regarding the synaptic basis of experience-dependent plasticity, I performed 
whole-cell patch clamp recordings, cellular/population excitability measurements and induced 
synaptic plasticity ex vivo.  Here I review these findings on the molecular, synaptic and circuit 
level organization of the barrel cortex during experience-dependent plasticity, and propose that 
plasticity should ideally be studied as a “coupled system” across the scales of the biological 
circuit organization; while short-term homeostatic changes in network excitability upon sen-
sory deprivation trigger the molecular changes that alter circuit organization in the long-term, 
the cellular diversity helps express distinct forms of plasticity in parallel. I elaborate on this 
viewpoint using a specific example based on experimental observations and show that plastic 
changes in a single molecule could alter spike-timing in a cell-type specific manner to bidirec-
tionally control experience-dependent plasticity. 
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Introduction
The critical contribution of experience-dependent plasticity (EDP) of sensory representations 
in brain function is apparent already during early postnatal brain development, a period during 
which long- and short-range projections are formed and subsequently modified in a use-de-
pendent manner. Neurite outgrowth, required for the information flow throughout the brain, is 
initiated during embryonic development but continues well after birth [1, 2]. 
Postnatal critical developmental periods are experimentally observed upon perturbation of 
sensory input, which in turn leads to malformation of cortical representations and impair be-
havioural performance. The classical experiments of Hubel and Wiesel on ocular dominance 
plasticity conducted more than 50 years ago showed  that the closure of one eye for a short 
period of time early in postnatal development leads to long-lasting aberrant neuronal responses 
in the deprived primary visual cortex throughout the rest of life [3, 4]. Critical developmental 
periods are not limited to visual areas [5–7]. In the tactile system, eliminating peripheral so-
matosensory input through whisker follicle lesioning, severance of the infraorbital nerve (ION) 
or disruption of the thalamocortical communication before postnatal (P) day 4 results in the 
absence of “barrels” [8–10]; [11] which are topographical representations of whiskers in the 
primary somatosensory cortex [12, 13]). When whiskers are removed from their follicles with-
out damaging the ascending neuronal projections (which is an important distinction from the 
aforementioned methods above; also see Chapter 1) the L4 barrel patterning remains intact, 
but the spared whiskers’ representations are enlarged to drive cortical neurons whose principal 
whiskers are now deprived [14]. Later during development, i.e. ~P10-P14, sensory deprivation 
through whisker clipping disrupts L2/3 receptive fields while leaving those in L4 unaffected 
[15, 16]. 
The observations above can be attributed to malformation of neurites and synapses brought 
about by a lack of peripheral sensory input. In the case of ocular dominance plasticity, a major 
reduction was found in the number of thalamocortical axonal afferents reaching neurons cor-
responding to the deprived eye [17].  Ocular dominance plasticity is correlated with spine loss 
in L2/3 pyramidal neurons [18] and with enhanced dendritic patterning away from deprived 
ocular dominance columns in L4 [19]. In the somatosensory cortex, arrival of thalamocortical 
axons in L4 and lower L3 takes place between P0 and P4 [20, 21].  L4 axons start extending 
into L2/3 around P8, and branch within and across cortical columns before cross-columnar 
projections prune by ~P16, resulting in the stereotypical intra-columnar projection pattern that 
will be maintained throughout life [22]. Whisker deprivation in neonates and juveniles showed 
that sensory neurons’ projections are formed in a use-dependent manner. Sensory deprivation 
strongly reduces filopodium motility in L4 and L2/3 (but increase it in L5) and prune L2/3 
dendritic branches [17, 23, 24]. The impact of sensory experience on the cortical circuit forma-
tion implies that it is an important determinant for animals’ sensory performance later in life. 
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Animals that receive sensory deprivation during critical developmental periods indeed display 
reduced performances in behavioural paradigms: cats remain form-blind throughout life after 
visual deprivation [3]; rats perform poorly in behavioural tasks that require whisker input after 
P0-P3 whisker deprivation [25] or when thalamocortical communication is perturbed geneti-
cally [9, 10]; de-whiskered rats show increased orientation to visual stimuli [26]. Thus, sensory 
experience during early postnatal development not only is involved in juvenile and adult sen-
sory map plasticity, but is in fact required to developmentally establish behaviourally relevant 
circuits in the brain. 
This epoch of rapid synaptic and circuit development is the period during which I manipulated 
the animals’ sensory experience (see Chapter 2 for details).  By bilaterally depriving C-row 
whiskers starting from P12 for a period of 2-3 weeks, I aimed to take advantage of the develop-
mental plasticity and shape sensory representations in the barrel cortex.  The onset of whisker 
deprivation was selected in a way that maturation of thalamocortical projections was complete 
[27, 28] although neurons across the upper layers of the barrel cortex still responded to whisker 
deprivation with a change in their receptive fields (see e.g.  [14, 16, 29–40]).  
Experience-dependent changes in the transcriptome
Sensory experience can lead to detectable changes in the barrel cortex in a matter of minutes 
[37].  Change in the flow of information across columns and layers [37], aided in the intermedi-
ate term by homeostatic scaling [41], could help trigger sensory map reorganization, however, 
such long-term changes in synaptic organization and circuit formation require experience-de-
pendent molecular changes.  
As reviewed in Chapter 1, transcriptional regulation by sensory experience can be triggered 
with transient exposure to enriched environment (EEE). Originally shown by Vallès and col-
leagues [42], immediately after EEE, the vast majority of differentially expressed transcripts 
are upregulated by sensory experience. If animals are returned to their home cage for a period 
of 4 hours after EEE, downregulated genes become more prevalent.  This directional switch 
of gene transcription is likely to reflect the lack of (enriched) somatosensory input in animals’ 
home cage, causing a relative reduction in sensory input, synaptic transmission and metabolic 
rate, thus obviating upregulation of transcripts that are more relevant when computational de-
mands of the somatosensory cortical circuit are high. If this is the case, one would predict that 
longer EEE should result in sustained transcript up- or downregulation until the network has 
accommodated to the enhanced sensory input. This was confirmed in a follow-up study which 
showed that after 28 days of exposure to EEE, only 29 genes are differentially transcribed [43], 
likely reflecting a ‘steady-state’ for the transcriptome upon sustained change in the sensory 
drive.  
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Experiments outlined in Chapter 2 introduce a different protocol that is commonly used in the 
electrophysiological literature (see e.g. [35, 37, 44]) to study synaptic and circuit mechanisms 
of experience-dependent plasticity; unlike in the EEE protocol, altered sensory experience is 
ensured by depriving a row of whiskers for a period of around two weeks.  One common 
observation across the two types of plasticity induction protocols is that gene ontology (GO) 
analysis performed in Chapter 1 on the EEE and Chapter 3 on the whisker deprivation (WD) 
expression data identify regulation of synaptic transmission as one of the most significantly 
enriched GO term. Gene products derived from transcripts in this group include both intracel-
lular and secreted proteins that have been shown to regulate cytoskeletal remodelling, synaptic 
signalling, neuronal outgrowth and synaptic strength [45–47]. The upregulation of these tran-
scripts are suggestive of changes in sensory representations upon EEE and WD.  Prior electro-
physiological experiments indicate the direction of this change: sharpened receptive fields and 
sensory representations after EEE [48] and an expansion of the spared whisker’s representation 
as well as a shift in principal whisker for neurons in the deprived whisker’s cortical column 
after WD [35, 37, 44]. Although intrinsic properties are subject to change upon EEE, at least 
in hippocampus [49], only one ion channel was found to be differentially expressed in barrel 
cortex, suggesting that regulation of their transcript levels may require prolonged durations of 
altered sensory input or is more sensitive to other sensory manipulations; alternatively they are 
modulated primarily on the protein level during the time course of the EEE [50, 51]. In support 
of the former interpretation, after ~2 week WD transcripts that regulate synaptic transmission 
were among the most differentially (compared to non-whisker deprived controls) regulated 
gene ontology classes both in L4 and L2/3 (see Chapter 3).  Because these transcripts are also 
closely related to those in transmission of nerve impulses (action potentials), it is not surprising 
that WD strongly modulates the transcription of the molecular machinery critical for the initi-
ation and transmission of action potentials (APs).  Experiments in Chapter 4 experimentally 
confirm this observation using electrophysiological recordings and detail what specific features 
of APs are modulated upon WD.  Future work that will systematically alter the differentially 
regulated transcripts (using, e.g., siRNAs, CRISPR/Cas9) to control APs in the intact brain 
might help to develop novel methods to control sensory representations.  
Altered sensory experience could induce a wide range of cellular processes, requiring regula-
tion of specific genes downstream of synaptic transmission. A major group of differentially ex-
pressed genes are thus involved in transcriptional regulation, including immediate early genes 
like Fos, Egr1, Jun and JunB, which have been shown previously to be synaptic activity-induc-
ible and linked to plasticity [52–54]. Enhanced expression rates of transcription factors could 
point to distinct regulatory networks in which EEE induces upregulation (or downregulation) 
of specific transcription factors that in turn govern the expression of downstream genes; the 
proteins derived from them could then regulate e.g. synaptic signalling, intrinsic electrophysi-
ological properties, intercellular signalling and cytoskeleton organisation. Indeed, as shown in 
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Chapter 3, transcription factors are among the protein classes modulated by WD. Considering 
that expression of some of these genes are cell type-specific [55], controlling their regulation 
might help express distinct forms of plasticity in parallel.
 
Besides those processes that are expected to be modulated in response to sensory experience, 
such as those in cell-cell signaling, G-protein coupled glutamate signalling pathway, tran-
scripts that encode membrane proteins, or those that control actin filament-based movement 
in the cell, data from EEE and WD also nominate less obvious candidates.  One of these is 
apoptosis, controlled cell death. Although apoptosis would naturally occur during the course 
of altered sensory experience, perhaps a more plausible explanation for their differential reg-
ulation is the multi-faceted nature of protein functions.  Extracellular stimuli that can induce 
neuronal apoptosis have also been linked to neuronal plasticity in particular in hippocampus 
[56–60]. Examples of these, brain-derived neurotrophic factor (BDNF), basic fibroblast growth 
factor (bFGF) and glutamate, are all potent regulators of synaptic plasticity also in the neocor-
tex [61]. Differentially expressed genes identified after EEE and WD, including Sgk1, Rock1, 
Bdnf, Stat1 and Jun, are involved both in neuronal plasticity and apoptosis [61–65]. Moreover, 
many genes, e.g. tp53, that control the cell-cycle and apoptosis are transcriptional regulators 
[66, 67].  Thus, contribution of any given differentially expressed transcript to expression of 
plasticity needs to be understood in the context of other correlated changes in the transcriptome 
and proteome to map out the specific molecular events that lead to activity dependent changes 
in the network. 
Sustaining increased neuronal activity leads to heightened energy consumption and thus ele-
vates oxygen consumption [68]. Increased metabolic rate and subsequent hypoxia could also 
elevate reactive oxygen species that could lead to oxidative stress and ultimately neuronal 
death [69]. These processes might also occur, to some degree, in the barrel cortex during al-
tered sensory experience as shown by the enrichment in GO terms like the nucleotide binding 
(many of which entail ATP-binding proteins, which suggests increased energy consumption), 
response to oxidative stress and blood vessel morphogenesis (see Chapter 1).  These changes 
are likely to be a result of increased metabolic rates and the need for changes in vasculature 
to accommodate the changing metabolic needs of the cellular populations during sustained 
altered sensory experience.  Bioinformatic analysis performed in Chapter 1 proposes specific 
molecular pathways that link synaptic activation to the activity-dependent plasticity of the neu-
rovasculature via releasable factors.  Targeted modulation of the nodes in this pathway might 
provide novel solutions for controlling the neurovasculature, potentially contributing novel 
therapies for the treatment of stroke and aging-related vascular changes.  
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Experience-dependent changes in the proteome
Transcriptomic approaches provide valuable insights into the cellular processes that underlie 
circuit reorganization following sensory experience, yet a range of post-transcriptional regu-
latory mechanisms govern RNA translation into protein [70].  As proposed in Chapter 3, the 
post-transcriptional regulation could shape the molecular landscape in unique ways that could 
not be predicted by the transcriptome alone. The difference between the transcriptome and 
proteome, at least in the experimental design outlined in Chapter 2, could potentially be ex-
plained by the different turnover rates of mRNA and proteins (see Chapter 3 for a comparative 
insight).  Therefore here I discuss the change in the proteome upon altered sensory experience, 
rather than critically discussing the differential regulation of the transcriptome and proteome 
upon WD.    
The original systematic observations on the proteins that are modulated by somatosensory ex-
perience were made by Butko and colleagues [71] who studied the barrel cortex synaptoneuro-
somes after daily whisker brushing or trimming for a period of 30 days starting from postnatal 
day 4. Although isolation of the synaptoneurosomes exclude the proteins in non-synaptic cel-
lular compartments and non-neuronal cell types, identifying changes at the level of the synapse 
should provide unique insights on the proteins that are involved in cellular communication. 
Even at this subcellular resolution, however, the vast majority (>95%) of identified proteins did 
not show any change in abundance between trimmed or deprived animals. This suggests that 
only a small population of synaptic proteins is affected when comparing enhanced and reduced 
sensory input, at least in the protocol used by Butko et al [71].  Because a large portion of the 
proteome consists of structural proteins [72], any changes in them might have been too subtle 
to pick up at the subcellular resolution. Experiments in Chapter 2 overcome this limitation and 
isolate the tissue in cortical column and laminar resolution to quantify up to 6000 protein class-
es/sample (on average ~5000 proteins, with over 3000 identified in all samples).  Among these 
~25% of the protein groups are differentially regulated by more than two-fold upon whisker 
deprivation, which suggests that the extent of changes in the proteome is much broader than 
appreciated before. It is important to note, however, that because my experiments include all 
cell classes and all compartments of the neurons, the anatomical localization of the enriched 
proteins is currently unknown. 
The proteins differentially expressed after whisker deprivation are commonly involved in syn-
aptic processes, comprising receptors and ion channels involved with synaptic communication, 
or modulate initiation and propagation of action potentials.  Among the cytosolic proteins, the 
most commonly differentially regulated proteins often serve in protein activation cascades or 
in energy utilization. Action potential generation and neuronal firing properties are a product of 
the distribution of ion channels found on neuronal membranes [73] and have been previously 
shown to change following sensory experience [74]. At the synapse, ion channels (neurotrans-
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mitter receptors as well as voltage-gated channels) govern synaptic strength and are indispens-
able for regulation of plasticity [75].  Thus the outlined differential protein profile is not sur-
prising, however it provides specific protein targets that regulate the synaptic strength. These 
in turn could underlie receptive field plasticity as observed following full whisker deprivation 
[76]. Downregulation upon whisker deprivation of proteins involved in glutamate signaling 
fits well with the reduced synaptic activity in the deprived barrel cortex, and may be an active 
process considering the enhanced abundance of the proteasome machinery in the same syn-
apses [71]. Protein degradation has previously been implicated in synaptic plasticity [77], and 
serves to clear the synapse of unused protein complexes (such as neurotransmitter receptors 
and structural proteins) and make place for others. Protein degradation works in tandem with 
local synaptic translation, which might account for the vast majority of the differently abundant 
proteins at deprived and stimulated synapses in the Butko database: of the 250 proteins, 229 are 
produced from RNAs that were identified in a transcriptomics study of hippocampal neurites 
[78]. Although these results suggest that somatic translation and subsequent synaptic localiza-
tion might have a minor role in constituting experience-dependent synaptic plasticity, after pro-
longed whisker deprivation, I have found significant differential translation across key motor 
proteins, transcriptional regulators, kinases and nucleotide-binding proteins which suggest that 
local and somatic translation might work in parallel (Chapter 3).  While local translation might 
ensure that those synapses whose activity is regulated upon altered sensory experience undergo 
specific plastic changes, differential regulation of somatic translation might be involved with 
(or a product of) cellular homeostasis.   
Synapses of experience-dependent plasticity in the barrel cortex
Molecular changes in single neurons cannot be translated into network reorganization un-
less synaptically coupled neurons undergo correlated, or otherwise complementary, changes. 
Therefore, functional plasticity in the central nervous system is characterized by changes in 
synaptic strength and intrinsic (integrative) properties of the neurons involved. Types of corti-
cal plasticity have been reviewed elsewhere [79–81]; thus here I focus on the Hebbian forms of 
plasticity that involves correlated changes across pre- and postsynaptic neurons. 
Long-term potentiation (LTP) and long-term depression (LTD) are considered being the major 
cellular correlate of learning and memory, and are characterized by an increase or decrease in 
synaptic efficacy, respectively. The interplay between ionotropic glutamate receptors, specif-
ically α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-Methyl-D-as-
partic acid (NMDA) receptor activation have been shown to mediate induction of LTP during 
in vitro tetanus stimulation protocols, whereas activation of the metabotropic glutamate recep-
tor is known to induce LTD [82–85].  A significant subset of the molecules involved with the 
localization, activation and recycling of these receptors are differentially transcribed or trans-
lated upon whisker deprivation although the exact receptor subunit, alternative splice variants 
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or the rate of differential regulation vary based on the sensory history, that is, whether the 
neurons were located in a deprived or spared cortical column (Chapter 3).   
Intracellularly, supralinear versus sublinear Ca2+ signalling underlie the generation of LTP and 
LTD, respectively [80]. Activation of glutamate receptors following synaptic communication, 
in concert with voltage-gated Ca2+ channels in the postsynaptic neuron are thought to form the 
basis of aforementioned Ca2+ signalling in vivo. Because Ca2+ acts as a second messenger and 
is involved in activation of kinases, many of which are differentially regulated upon whisker 
deprivation (see Chapter 3), controlling synaptic plasticity via Ca2+-dependent processes re-
quire temporal regulation of the intracellular Ca2+ concentration.  This could be achieved by 
modulating Ca2+ channels in the membrane, Ca2+ buffers in the cytosol and localization of the 
Ca2+ stores in the respective synapse.  The transcriptome and proteome described herein point 
to specific molecules, like Homer1 for the regulation of localization of the smooth endoplasmic 
reticulum in the postsynaptic density [86], or the Calcium Voltage-Gated Channel Auxiliary 
Subunit Gamma 3 for regulation of synaptic Ca2+ channels [87] that could powerfully shape 
synaptic plasticity, plausibly in a bidirectional manner during whisker deprivation.  
 
Most studies in the barrel cortex focus on the feed-forward excitatory projections from L4 
onto L2/3 as the primary target of experience-dependent changes in synaptic communication 
(see e.g. [30, 35, 37, 38]).  Upon whisker stimulation, responses to the principal whisker are 
initially driven by feed-forward excitation from thalamus to L4 from there to the L2/3 within 
the same column, as precisely timed inhibition and excitation shape the timing of synaptic 
communication [88–90].  Multi-whisker receptive field organization of L4 neurons suggest that 
subcortical nuclei might already be subject to plasticity following altered sensory experience 
which is experimentally confirmed in thalamocortical axonal projections [91].  L4 neuronal 
projections primarily target the supragranular L2/3, which in turn projects to the subgranular 
L5a/b and L6, while making cross-columnar projections to neighboring columns. Pyramidal 
neurons in L5a/b and L6 project to other cortical areas and subcortical nuclei, but also project 
upwards to the granular and supragranular layers of the neighboring columns [90]. Given this 
connectivity schema, L2/3 is considered to be not only a convergence point of intracortical 
projections, but also one of the two layers (along with L5) that primarily ensure cross-colum-
nar communication. Considering that the synaptic activity could drive the transcriptional and 
translational changes only if the information flow along the cortical pathways would converge, 
experience-dependent plasticity of cross-columnar projections might be critically involved 
in large-scale reorganization of the sensory representations in an activity dependent manner. 
Therefore, in Chapter 4, I examined the plasticity across the cross-columnar projections be-
tween the spared and deprived L2/3. These experiments showed that prolonged whisker depri-
vation alters the speed of communication, rather than modulating the synaptic strengths while 
controlling the excitability of neurons in an experience-dependent manner. Thus, the plastic 
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changes of the cross-laminar projections could couple the neural activity across neighbouring 
cortical columns, allowing correlated changes to be expressed at the molecular levels across 
anatomically independent cortical circuits.
   
Expressing parallel forms of plasticity in local networks
As outlined above, observations across the transcriptome, proteome and the synaptic commu-
nication causally link different levels of biological circuit organization from molecules to an-
atomically distinct, functionally coupled circuits.  If the molecules involved in translating the 
adaptive changes in circuit communication to transcriptional and translational regulation were 
to act in a cell-type specific manner, it would be possible to express distinct forms of plasticity 
simultaneously in local networks.    
A significant portion of the molecular players that could fulfil these requirements are likely to 
be found in the axonal initial segment (AIS).  A neuron’s spiking properties and control over 
its excitability are major factors in determining its output and hence its contribution to neural 
networks. The axon initial segment (AIS) displays low action potential (AP) threshold and as 
such has since long been identified as the locus from which the AP originates [92]. Various ion 
channels are found at the AIS, many of which are regulated in an experience-dependent manner 
after whisker deprivation (see Chapter 3) and each of which have functionally significant roles 
with respect to neuronal excitability and spiking properties [93]. For instance, Kv1 channels can 
determine the shape of axonal APs [94], and were recently found to be redistributed in the AIS 
of auditory neurons as a result of cochlea removal, leading to enhanced neuronal excitability 
[95]. In parvalbumin-expressing (PV+) fast-spiking (FS) interneurons, Kv1.1 containing potas-
sium channels in the AIS contribute to a delayed spiking pattern and can control excitability of 
these cells [96]; the gene encoding Kv1.1 (KCNA1) was recently shown to be under transcrip-
tional control of the activity-dependent transcription factor Er81 [55].
In recent years it has become clear that the AIS is not only the origin of axonal APs, but also 
a site of activity-dependent structural plasticity [97], its length and location subject to change 
in response to altered neuronal activity: for instance, when avian brainstem auditory neurons 
are deprived of auditory input, the AIS increases in length, leading to an enhanced neuronal 
excitability [98]. In contrast, increasing the excitatory drive in hippocampal neurons does not 
change the AIS length but instead causes it to reversibly shift away from the soma, while reduc-
ing the excitability of these neurons [99]. Depriving auditory neurons from their synaptic input 
also leads to a redistribution of Kv channels (among which is Kv1.1), showing that Kv1 chan-
nel composition of the AIS is altered in an experience dependent manner [95]. Er81 transcrip-
tion is downstream to glutamatergic receptor activation, requires elevated intracellular calcium 
concentration [100], and activity-dependent relocation of AIS can be blocked by Ca2+-channels 
[99], all of which are molecular players that are differentially regulated by whisker deprivation 
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as described above (see Chapter 3). 
One prediction based on the calcium-dependence of Er81, and its transcriptional control over 
Kv1.1 would be a homeostatic mechanism that would rearrange ion channel composition of 
the AIS and as such modulate neuronal excitability and spiking properties.  This is expected 
to be regulated (at least in part) by changes in calcium levels, which subsequently alter Er81 
transcription and Kv1.1 expression. The relation between AIS location, length and ion channel 
composition and Er81 expression could be readily examined by immunohistochemical means 
[101]. Consequences of AIS plasticity on neuronal excitability have also been proposed depend 
on neuron morphology [102] which displays large variety between neuronal cell types, sug-
gesting that mechanisms underlying AIS plasticity could have cell-type specific effects on neu-
ronal excitability. ER81 regulation of Kv1.1 expression might be cell type- and species-specific 
as it was shown in chickens that neuronal Kv1.1 expression and Kv1-currents were markedly 
reduced following sensory deprivation although the neuronal excitability was increased [95]. 
This is contrary to the observed upregulation of Er81 (and presumably Kv1.1) upon reduction 
of synaptic input to mouse PV+ FS neurons in mice [55] and suggests that complementary 
mechanisms regulate neuronal activity, Kv-channel expression and its distribution in AIS. 
Immunohistochemical analysis of Er81 expression showed that Er81 is not restricted to PV+, 
but also is found in somatostatin (SST)-positive neurons as well as pyramidal cells [55]. This 
raises the intriguing possibility that the Er81-mediated tuning of intrinsic properties and spike 
timing is not restricted to PV+ FS interneurons. Given that Er81 is a transcription factor, its 
activity-dependent modulation would ultimately alter the expression of its downstream targets, 
as is the case for Kv1.1 [55, 100]. Given that pyramidal neurons (PNs), besides PV+ FS cells, 
contain detectable levels of Er81, another potential mechanism by which Er81 could contribute 
to neural network function is through Chandelier cells.  Because Chandelier cells target the AIS 
of PNs, they were traditionally viewed as suitably positioned to determine the output of their 
postsynaptic partners through inhibition at the axon [103]. Intriguingly however they have also 
been shown to possess the ability to have a depolarizing and even excitatory functions due to 
the high chloride content in the AIS of the PNs they target, which in turn is attributed to the low 
abundance at the AIS of the potassium chloride cotransporter 2 (KCC2) [104]. Since KCC2 is 
also a downstream target of Er81 [100], by orchestrating the abundance of KCC2 at the AIS 
of postsynaptic pyramidal neurons Er81 could fine-tune the reversal potential of GABAergic 
inputs at AIS of PNs in an activity dependent (and potentially context-dependent) manner. 
Inhibition has long been known to play an important role in shaping the temporal pattern of ex-
citation in local networks. As originally shown in sensory neurons, sensory stimulation evokes 
precisely timed excitatory and inhibitory drives onto cortical excitatory neurons, with inhibi-
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tion usually being stronger and slightly delayed compared to excitation, which allows a short 
window of opportunity during which the excitatory drives can summate and drive spiking 
activity [105, 106]. Given that a few simultaneously activated excitatory neurons could induce 
strong and widespread inhibition on the neural network [107], the strength of the local inhibi-
tion originating from feedforward excitatory drive and the onset latency of inhibitory spiking 
have powerful computational features.  Stimulus-evoked inhibition that is strong, widespread 
and tightly coupled with excitation (which would be predicted upon Er81 transcriptional sup-
pression) would serve many functions, including controlling precise timing of response [105, 
106], preventing runaway excitation [107], sharpen stimulus selectivity [108], and overall in-
creasing the sparseness of sensory response [109]. Because increased synaptic activity reduces 
Er81 transcription, and shortens the delay to the 1st action potential from the PV+ interneurons 
[55] in the L2/3 of the barrel cortex, the net effect of the Er81 mediated changes in PV+ spike 
timing is expected to enhance the coupling between local excitation and inhibition, improving 
stimulus representations in the superficial layers i.e. where my transcriptomic, proteomic and 
synaptic mapping experiments took place (Chapters 2,3,4).          
Experiments in the barrel cortex showed that synaptic plasticity is expressed through spike-tim-
ing dependent plasticity (STDP), as opposed to rate or covariance based plasticity induction 
methods [37] and gated by inhibition [44]. This poses an interesting potential role for the 
Er81-mediated delayed firing pattern since the presence or absence of the delayed spiking 
will allow PV+ interneurons to contribute differentially to the sharpening of receptive fields 
and modulation of STDP in the network, in particular between PNs (Figure 1).  Because, in 
addition to delayed firing pattern, Er81+ FS interneurons are also less excitable (likely due to 
an increased Kv1.1 subunit incorporation at the AIS), and their maximum firing frequency is 
lower than Er81- cells [55], the contribution of the PV+ interneurons to map plasticity might be 
determined by their Er81 expression levels; Er81- cells potentially produce stronger inhibitory 
output as opposed to Er81+ cells and could be recruited to shrink receptive fields (Figure 1B, 
1C) while the delayed firing pattern found in Er81+ cells may contribute to map plasticity by 
allowing for STDP to occur between excitatory neurons (Figure 1B, 1D). Future studies will 
need to identify the pre- and postsynaptic partners of each subclass of PV+ interneuron in order 
to elucidate how they contribute to EDP. A rather simplified prediction would be, because Er81- 
cells tend to receive higher amounts of inhibitory inputs, possibly from SST+ interneurons, 
which preferentially inhibit other interneuronal subclasses [110], in circuit motifs that involve 
presynaptic SST+ cells, postsynaptic PV+ Er81- interneurons would contribute to fine stimu-
lus representations (Figure 1C).  Accordingly, presynaptic pyramidal neurons that drive PV+ 
Er81+ interneurons would drive the plasticity of sensory representations, creating subcircuit 
formations that fine-tune stimulus representation versus plasticity (Figure 1D).
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Figure 1. A model of parallel circuit computations for expression of plasticity and shaping 
stimulus representations. Proposed functional network effects of differential Er81 expression 
in PV+ FS interneurons. (A – B) In response to enhanced or reduced neuronal activity, Er81 
expression in PV+ FS interneurons within a neural network is down- or upregulated, respec-
tively, resulting in a continuum of Er81 expression levels within the population of PV+ FS 
interneurons. Accordingly, Kv1.1 expression and its distribution at the AIS of these cells are 
attenuated, resulting in an extension or reduction of the latency to the first spike (B, middle) 
[55]. (B – D) The presynaptic partners and levels of Er81 expression could dictate the func-
tional roles displayed by PV+ FS  cells within the neural network. B, left: PV+ FS interneurons 
displaying lower levels of Er81 expression are characterized by more numerous inhibitory 
inputs, likely originating from SST+ interneurons. Their reduced spike latency and heightened 
excitability would allow them to quickly inhibit postsynaptic excitatory neurons and hence 
sharpen sensory receptive fields before being silenced by their SST+ presynaptic partners (C). 
B, right: Conversely, PV+ FS interneurons that express Er81 at higher levels would receive a 
stronger excitatory drive; their delayed firing pattern would provide a broader time window 
during which synapses between excitatory neurons could be potentiated. When Er81 expres-
sion levels and spike latency are reduced as a result of increased neuronal activity, synaptic 
depression would be favoured (D). In this figure, Er81 expression in cell types other than PV+ 
FS interneurons is omitted but could nonetheless contribute to network function and plasticity 
through similar mechanisms. 
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Conclusions  
This thesis was aimed to systematically address the mechanisms of plasticity using the whisker 
representations in the barrel cortex as a model system.  The single-row whisker deprivation pro-
tocol ensured the availability of appropriate within-animal comparisons, a critical requirement 
for molecular analysis.  The onset and duration of the whisker deprivation provided a unique 
time window when intracortical projections from L4 onto L2/3 as well as cross-columnar L2/3 
projections develop without confounding the data with changes in the thalamocortical circuitry. 
Electrophysiological experiments showed the functional consequences of molecular changes 
and decoupled the changes in synaptic communication from synaptic strength.  Finally, various 
bioinformatic analyses mapped out the critical molecular pathways that could help shape the 
future in the field of experience-dependent cortical plasticity.  I hope the outlined approach for 
the study of brain plasticity, and the public availability of the transcriptomic and proteomic 
datasets will help to unravel the mechanisms of plasticity from molecules to behaviour. Despite 
the rich history of the field, our path to mechanistic understanding of brain plasticity has only 
just begun to open.
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Summary 
A major challenge of Neuroscience is to determine how the brain makes sense of its environment. 
Key to this fundamental question is to understand the inner workings of the (primary) sensory areas 
of the neocortex, which receive and process information gathered at the periphery. Together, the 
visual, auditory, gustatory and somatosensory cortices of the mammalian neocortex grant the ani-
mal the sense of sight, hearing, taste and touch, making them of the utmost importance for survival. 
Sensory neurons represent the sensory periphery locally such that each neuron preferentially rep-
resents a select range of stimuli or stimulus features. These so-called receptive fields are found 
throughout all sensory areas.  From orientation selectivity and ocular dominance in the visual 
cortex , to sound frequency and loudness selectivity in auditory cortex as well as touch selectivity 
in somatosensory cortex, receptive fields ensure parallel encoding of high-dimensional sensory 
stimuli. Neurons in sensory cortices that are situated closely to each other often have similar re-
ceptive fields, together forming a cortical representation of the sensory organ. For instance, ori-
entation columns in visual cortex are formed as neighbouring neurons throughout the layers of 
the cortex all respond most strongly to a given orientation of the visual stimulus; in the rodent 
auditory cortex frequency maps can be distinguished where local neuronal populations are tuned 
to a range of sound frequencies. The cortical organization into such sensory maps benefits speed 
and energy costs of neuronal communication, allowing for efficient processing of sensory input.
Because the sensory world is often highly dynamic, sensory cortices must be able to cope 
with frequent contextual and physical changes in stimulus. For example, as a plane flies 
through a thick cloud, changes in the contrast and availability of the stimulus (i.e. the im-
age of the plane as reflected onto the retina of an observer on the ground) vary dramatically 
although the perception of the observer remains constant.  Experience-dependent plasticity 
(EDP) is the process by which neuronal communication is adapted to sustained changes in 
incoming information. EDP is observed in all sensory areas and can be triggered by, among 
others, preferential organ use, sensory deprivation or perceptual learning.  EDP is expressed 
throughout an animal’s life, but it relies on distinct mechanisms depending on the species, 
developmental age, sensory area and cortical layer under study. Despite these differences, a 
common observation across all sensory maps studied has been that cortical representations of 
(parts of) sensory organs that are more extensively used (perhaps due to a greater behavioural 
relevance) are generally expanded whereas those of unused/under-used organs shrink, a pro-
cess known as map plasticity. Such reorganization of sensory maps ensures that animals learn 
from their previous sensory experience and can thus adapt to the ever-changing sensory world.
One brain region where EDP can be readily induced, and studied throughout the entire life 
span, is the rodent barrel cortex, a subfield of the primary somatosensory cortex (S1). It is 
comprised of “barrel” columns (named after barrel-like structures found in layer IV), each 
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of which topographically corresponds to a specific whisker found on the animal’s contra-
lateral snout. Sensory information originating from whisker follicles passes through nuclei 
with similar topographic representations in the brainstem (known as barrellettes, and thala-
mus (barrelloids), after which it reaches layer IV (L4) of the barrel cortex. From there, the 
majority of excitatory projections ascend to layer II/III (L2/3), and are largely constrained 
to the boundaries of their column of origin. Neurons residing in each column are strong-
ly driven by deflections of the topographically corresponding (“principal”) whisker; When 
neighbouring whiskers are deflected, whisker deflection-evoked firing rates decrease while 
the latency of the evoked responses increases. Thus, neurons can be driven by synaptic part-
ners in neighbouring columns, as horizontal projections originating from L2/3 and L5 en-
able intercolumnar communication. Its topographical organization makes barrel cortex ide-
ally suited for studies of EDP, as sensory experience of neurons in select barrel columns 
can be modulated through deprivation (i.e. clipping or plucking) or stimulation of individ-
ual whiskers, which can be done with ease and relatively little discomfort for the animal.
Barrel cortex EDP is commonly studied using electrophysiology, therefore it is well known that 
responses of individual neurons change upon altered whisker experience.  The molecular mech-
anisms that enable barrel cortical map plasticity are still largely unknown. Previous studies have 
shown that targeted modulation of select molecular targets could act to control the cellular re-
sponse change upon altered sensory experience. Although studies on single molecules are indis-
pensable for understanding the molecular mechanisms of EDP, large-scale transcriptome- and 
proteome-wide techniques are required to systematically map the molecular pathways of brain 
plasticity. On this front, too, only few studies are available. In the current thesis, I have thus aimed 
to obtain large-scale molecular datasets with high anatomical resolution in order to investigate 
how sustained whisker deprivation (12-14 days) alters transcription and translation in the cor-
responding cortical cellular population. Additionally, I have used electrophysiological means to 
investigate how sensory experience affects the principal neural pathways of cortical plasticity.
Chapter 1 provides a general overview of experience-dependent map reorganization in the 
barrel cortex, and its known molecular correlates. Performing meta-analysis on publicly 
available transcriptomic data, this chapter also shows that EDP is a systems-level response 
that involves all the major cell classes, ranging from neurons and glia to endothelial cells, 
in the brain.  Using molecular pathway analysis, the chapter bridges the different cell class-
es, and proposes how experience-dependent change in synaptic communication could drive 
plasticity in the cerebrovasculature via releasable factors. Lastly, focusing on the function of 
differentially transcribed genes and translated mRNAs, the chapter argues that synaptic dys-
function in various neurological disorders recruits molecules similar to those controlled by 
experience, thus supporting an important role for synaptic plasticity in health and disease.
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The phenotype of EDP in barrel cortex (and other brain regions) depends on the cortical 
layer and column studied, however the current literature on the large-scale molecular cor-
relates of EDP commonly ignores both. I have thus isolated brain tissue from control and 
deprived mouse barrel cortex in a column- and layer-dependent manner, which were then used 
in RNA sequencing and protein mass spectrometry analyses. The methodology of obtaining 
these tissues as well as quality control of the obtained datasets are described in Chapter 2.
In Chapter 3, I describe the transcriptional profile of the granular (L4) and supragranular 
(L2/3) cortical layers of C-row barrel columns, and then show how 12 days of sensory depri-
vation affects the molecular make-up of deprived barrel columns. In stark contrast to what 
one would predict based on electrophysiological findings, the results show that most differ-
ential gene expression takes place in L4 rather than in the electrophysiologically more plastic 
L2/3, and that neighbouring deprived and spared columns are transcriptionally near-identical.
Molecular changes upon sensory deprivation would ultimately serve to modulate synaptic 
strength and neuronal communication, leading to reorganization of sensory maps. Physiologi-
cal plasticity of cross-columnar projections could help orchestrate the changes across multiple 
cortical columns, thus potentially explaining the correlated nature of the molecular changes 
across neighbouring deprived and spared cortical columns (Chapter 3). To address whether 
cross-columnar projections undergo physiologically identifiable changes upon altered sensory 
experience, in Chapter 4 I perform whole-cell patch clamp recordings. The results show that 
sustained whisker deprivation, the protocol used in Chapters 2-3, induces experience-depen-
dent reorganization of cross-columnar projections. Unlike the previous observations on the na-
ture of synaptic plasticity in intra-columnar projections, whisker deprivation does not signifi-
cantly modulate synaptic strength; it rather controls the speed of communication.  Moreover, 
sensory experience modifies single-neuron excitability such that whisker deprivation increases 
spike threshold while reducing rate of evoked spiking across the cross-columnar projections. 
In Chapter 5, I bring these observations together and propose that brain plastici-
ty is a systems-level response that involves coupled changes across molecular, syn-
aptic and cellular networks. Thus, a mechanistic understanding of brain plastici-
ty will require targeting molecular interactions in single cells, in cortical layer and 
column resolution, while the observation of plastic changes in neuronal responses will need 
to be studied in respect to the other cellular classes and the synaptic partners in the network.
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Samenvatting
Een grote uitdaging binnen de neurowetenschap is om vast te stellen hoe het 
brein zijn omgeving begrijpt. Hiertoe vormt een begrip van de werking van de (pri-
maire) sensorische gebieden in de neocortex, die informatie uit de periferie ontvan-
gen en verwerken, een sleutelrol. De visuele, auditieve, gustatieve en somatosen-
sorische cortices van het zoogdierenbrein zorgen er samen voor dat het dier kan zien, 
horen, proeven en voelen. Dit maakt hen van het uiterste belang om te kunnen overleven.  
 
Sensorische neuronen vertegenwoordigen lokaal de sensorische periferie: elke neuron reageert 
met een zekere voorkeur op een specifiek bereik aan stimuli of op bepaalde stimuluseigen-
schappen. Deze zogenaamde ‘receptieve velden’ zijn in alle sensorische gebieden te vinden. 
Van oriëntatieselectiviteit en oculaire dominantie in de visuele cortex, tot selectiviteit voor ge-
luidsvolume en –frequentie in de auditieve cortex en tastselectiviteit in de somatosensorische 
cortex, receptieve velden zorgen voor de parallele codering van sensorische stimuli van hoge 
dimensionaliteit. Neuronen in sensorische cortices die zich dicht bij elkaar bevinden hebben 
vaak soortgelijke receptieve velden, waardoor ze samen een representatie van (een deel van) 
een zintuig vormen in de cortex. In de visuele cortex worden bijvoorbeeld orientatiekolommen 
gevormd doordat groepen neuronen in elke laag van de cortex het sterkst reageren op de oriën-
tatie van een visuele stimulus; In de auditieve cortex zijn frequentiekaarten te onderscheiden 
waarin lokale neuronale populaties zijn afgestemd op een reeks geluidsfrequenties. Door de or-
ganisatie van zulke ‘sensorische kaarten’ kan neuronale communicatie op hoge snelheid en met 
laag energiegebruik plaatsvinden, waardoor sensorische input efficiënt wordt verwerkt.  
Omdat de wereld van zintuiglijke prikkels vaak zeer dynamisch is moeten sensorische corti-
ces kunnen omgaan met veelvuldige veranderingen in de context en aard van binnenkomende 
stimuli. Als, bijvoorbeeld, een vliegtuig door een dikke wolk vliegt, verandert het contrast 
en de aanwezigheid van de stimulus (dat wil zeggen, het beeld van het vliegtuig dat door het 
netvlies van de waarnemer op de grond wordt opgevangen) zeer sterk, terwijl de waarneming 
ervan voor de waarnemer min of meer constant blijft. Ervaringsafhankelijke plasticiteit (EAP) 
is het proces waarbij neuronale communicatie wordt aangepast aan de hand van volhardende 
veranderingen in binnenkomende informatie. EAP is waar te nemen in alle sensorische geb-
ieden en kan worden geïnduceerd door, onder anderen, voorkeursgebruik van bepaalde zin- 
tuigen, onthouding van sensorische prikkels en perceptueel leren. EAP vindt plaats gedurende 
het hele leven van een dier, maar is afhankelijk van specifieke mechanismes die verschillen 
per diersoort, ontwikkelingsfase, het sensorsiche gebied en de corticale laag. Ondanks deze 
verschillen kan worden gesteld dat corticale representaties van (delen van) zintuigen die rela- 
tief veel worden gebruikt (bijvoorbeeld doordat ze relevanter zijn voor de gedragingen van het 
dier) over het algemeen genomen worden uitgebreid, terwijl die van minder- of niet-gebruikte 
zintuigen juist krimpen. Dit proces staat bekend als ‘kaartplasticiteit’. Doordat sensorische 
kaarten kunnen worden gereorganiseerd kunnen dieren leren van voorgaande zintuiglijke er-
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varingen, om zich op die manier aan een zeer veranderlijke wereld te kunnen aanpassen.  
 
Een breinregio waar EAP met gemak kan worden geïnduceerd en over de gehele levens-
duur kan worden bestudeerd is de barrel cortex van knaagdieren, een subveld van de pri-
maire somatosensorische cortex (S1). Het bestaat uit zogenaamde “barrel” kolommen (ge- 
noemd naar de structuren in corticale laag IV die lijken op tonnen, ofwel barrels), waarvan 
elke topografisch correspondeert met een specifieke snorhaar op de tegenoverliggende snuit 
van het knaagdier. Sensorische informatie komt binnen via de haarfollikels van de snorha-
ren en passeert verschillende kernen in het brein die een soorgelijke topografische organi-
satie kennen (barrelettes in de hersenstam; barreloids in de thalamus) alvorens te arriveren 
in laag IV (L4) van de barrel cortex. Van hieruit verspreiden de meerderheid van de acti-
verende uitlopers (projecties) zich naar laag II/III (L2/3), waarbij ze de grenzen van hun ko-
lom over het algemeen niet overschrijden. Neuronen binnen elke kolom reageren sterk op 
verbuigingen van de topografisch corresponderende (‘hoofd-’)snorhaar. Echter, als naast-
gelegen snorharen worden gebogen, verminderen de neuronale responsen, terwijl de vertra 
ging in de responsen oploopt. Neuronen in één kolom kunnen dus worden aangedreven door 
neuronen in naburige kolommen: horizontale projecties in L2/3 en L5 verzorgen deze com-
municatie tussen kolommen. De topografische organisatie van de barrel cortex maakt deze 
breinregio uitermate geschikt om EAP te bestuderen, aangezien de sensorische ervaring van 
neuronen in vooraf bekende barrel kolommen kan worden gemoduleerd door middel van 
verwijdering (dat wil zeggen, knippen of plukken) of stimulatie van individuele snorharen. 
Beide kunnen met gemak, en relatief weinig ongerief voor het dier, worden toegepast.   
 
EAP in de barrel cortex wordt doorgaans bestudeerd doormiddel van elektrofysiologische 
technieken, waardoor het bekend is dat individuele neuronen hun responsen aanpassen aan de 
mate van het gebruik van de snorharen. De moleculaire mechanismen die kaartplasticiteit in de 
barrel cortex mogelijk maken zijn echter nog grotendeels onbekend. Voorgaande studies heb-
ben aangetoond dat de aanpassingen van de neuronale responsen zouden kunnen worden aan- 
gestuurd door modulatie van specifieke moleculen. Hoewel studies gericht op individuele 
moleculen uiteindelijk onmisbaar zijn om de moleculaire mechanismen van EAP te begrijpen, 
zijn grootschalige transcriptoom- en proteoomtechnieken nodig om de moleculaire mecha-
nismen van breinplasticiteit systematisch in kaart te brengen. Ook op dit gebied zijn maar 
weinig studies voorhanden. In dit proefschrift heb ik daarom gepoogd om grootschalige data-
sets van hoge anatomische resolutie te vergaren om inzicht te krijgen in de veranderingen die 
plaatsvinden in transcriptie en translatie in corticale cellulaire populaties na langdurige (12-
14 daagse) snorhaarverwijdering. Tevens heb ik elektrofysiologische technieken benut om te 
onderzoeken hoe sensorische ervaring de hoofdroutes van corticale plasticiteit beïnvloed.  
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Hoofdstuk 1 geeft een algemeen overzicht van ervaringsafhankelijke kaartreorganisa-
tie in de barrel cortex en de hierbij bekende moleculaire correlaten. Doormiddel van me-
ta-analyse van openbare transcriptoom-data toont dit hoofdstuk aan dat EAP een respons is 
op het niveau van meerdere systemen en dat het alle grote celtypes van het brein aangaat, 
van neuronen en gliacellen tot endotheelcellen. Aan de hand van analyses van moleculaire 
routes overbrugt dit hoofstuk de verschillende celtypes, en stelt dat ervaringsafhankelij- 
ke veranderingen in synaptische communicatie de plasticiteit van het bloedvatenstelsel 
van het brein zou kunnen aansturen middels uitgescheiden signaalmoleculen. Als laatste 
wordt ingegaan op de functie van de differentieel getranscribeerde genen en getranslateerde 
mRNAs, waarbij wordt gepleit dat ervaringsafhankelijke plasticiteit en verstoorde synap-
tische communicatie in neurologische afwijkingen op gelijksoortige moleculen berust, wat 
wijst op een belangrijke rol voor synaptische plasticiteit in zowel gezondheid als ziekte.  
 
Het fenotype van EAP in de barrel cortex (en andere breinregio’s) hangt af van de cortica-
le laag en kolom die wordt bestudeerd, echter worden beide door de huidige grootschalige 
onderzoeken naar moleculare correlaten genegeerd. Daarom heb ik individuele kolommen 
en lagen verzameld van de barrel cortex van muizen die wel of geen snorhaarverwijdering 
hebben ondergaan, waarna de weefsels zijn geanalyseerd doormiddel van RNA-sequencing 
en eiwit-massaspectrometrie. De methode voor het verkrijgen van deze weefsels alsmede 
de kwaliteitscontrole van de verkregen datasets worden beschreven in Hoofdstuk 2.   
 
In Hoofdstuk 3 beschrijf ik het transcriptionele profiel van de granulaire (L4) en supra-
granulaire (L2/3) corticale lagen van de C-rij barrel kolom, en toon daarna aan hoe de mo-
leculaire samenstelling van de barrel kolommen wordt beïnvloedt na 12-14 dagen lang 
aangehouden verwijdering van hun hoofdsnorhaar. In sterk contrast met de verwachtin 
gen op basis van voorgaande elektrofysiologische bevindingen tonen de resultaten aan dat 
de meeste veranderingen in genexpressie plaats vinden in L4 in plaats van de, elektrofy-
siologisch gezien meer plastische, L2/3, en dat naburige kolommen (waarvan één met 
en één zonder intacte hoofdsnorhaar) op transcriptioneel niveau bijna identiek zijn.  
 
Moleculaire veranderingen als gevolg van zintuiglijke onthouding zouden uiteindelijk de sy- 
naptische sterkte en neuronale communicatie kunnen moduleren, wat vervolgens de reorgani-
satie van sensorische kaarten als gevolg zou kunnen hebben. Plasticiteit van kolom-overbrug-
gende projecties zou de aanpassingen van neuronale responsen van meerdere kolommen kun-
nen verzorgen, wat de gelijksoortige moleculaire veranderingen in naburige kolommen met en 
zonder hoofdsnorhaar (Hoofdstuk 3) zou kunnen verklaren. Om te onderzoeken of projecties 
tussen kolommen fysiologisch meetbare veranderingen ondergaan als gevolg van veranderde 
sensorische ervaring, gebruik ik in Hoofdstuk 4 patch-clamp-metingen. De resultaten tonen 
aan dat langdurige snorhaarverwijdering, welke ook is toegepast in Hoofdstukken 2 en 3, er-
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varingsafhankelijke reorganisatie induceert van projecties tussen kolommen. In tegenstelling 
tot voorgaande observaties aangaande de aard van synaptische plasticiteit van projecties binnen 
de corticale kolom, verandert snorhaarverwijdering de synaptische sterkte van kolom-over-
bruggende projecties niet; in plaats daarvan verandert het de communicatiesnelheid. Boven- 
dien beïnvloedt snorhaarverwijdering de exciteerbaarheid van individuele neu-
ronen: de drempelwaarde voor het vuren van een actiepotentiaal wordt ver-
hoogd terwijl het aantal opgewekte actiepotentialen wordt verlaagd.  
 
In Hoofdstuk 5 breng ik deze observaties samen en stel dat breinplasticiteit een respons 
is op het niveau van meerdere systemen dat gekoppelde veranderingen aangaat over mo-
leculaire, synaptische en cellulaire netwerken. Daarom zal het verkrijgen van een mecha-
nistisch begrip van breinplasticiteit vervolgonderzoek vereisen dat zich richt op molecu-
laire interacties in individuele cellen, en dat uitgevoerd wordt in specifieke corticale lagen 
en kolommen. Bovendien zullen plastische veranderingen in neuronale responsen moeten 
worden bestudeerd in relatie tot andere celtypes en synaptische partners in het netwerk. 
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Dankwoord 
Man man man, dit was me het ritje wel! Onderzoek doen is hartstikke leuk, maar nooit makke-
lijk en het bestaat uit het nemen van vele hordes, wat het aan de ene kant spannend maakt maar 
tegelijkertijd ontmoedigend kan zijn. Gelukkig was er een hele hoop mensen die me in de loop 
van de jaren hebben geholpen, begeleid en gesteund.
Tansu, your positive attitude, support, enthusiasm and trust in your students, including me, is 
legendary. From the beginning of my Master’s internship to the end of my PhD (and beyond!), 
whenever results seem grim, you always manage to find some ray of light in the dark pit that 
science sometimes can become. Thank you so much for all the uplifting talks, pleasant discus-
sions (about science, career and otherwise), patience, hard work and early-morning tea/dart 
ceremonies.
Paul, onze expertises liggen zo nu en dan ver van elkaar af, wat ik soms lastig vond. Maar 
tegelijkertijd wist je me juist daardoor vragen te stellen die me ertoe zetten om de data ook 
eens vanuit een andere hoek te bekijken. Dankjewel voor alle feedback, uitleg en discussies die 
hebben geholpen m’n PhD-project tot een goed einde te brengen.
Armaz, unfortunately our paths went separate ways in the middle of my PhD project. Although 
you couldn’t be there to see it finished, I got to work with you for quite some time. Your enthu-
siasm and fresh ideas were always much appreciated, and I would like to express my gratitude 
for all the things you taught me on the molecular front, without which my thesis could not have 
obtained its current state. 
De meeste van m’n werkzaamheden heb ik uitgevoerd op de afdeling Neurofysiologie. Ik vind 
het tof dat ik heb mogen helpen om het eerste begin van deze afdeling (waar ik ook na m’n 
promotie mag blijven werken) op te zetten. Debbie, Frouwke, Ron en Wim, jullie waren er ook 
vanaf het begin af aan bij, en ik voel me trots dat ik samen met jullie lange tijd de kerngroep 
van de afdeling heb mogen vormen. Debbie, bij jou kan ik altijd terecht met vragen over één of 
ander (oud of nieuw) protocol of gewoon voor een lekker babbeltje, en je staat altijd voor ieder-
een klaar. Dankjewel dat je m’n paranimf wil zijn! Frouwke, dankjewel voor de gezelligheid 
die je met je meebracht, en alle hulp die je me hebt kunnen bieden met je brede kennis op het 
gebied van immunohistochemie. Ron, ik stond laatst bij de tramhalte, stond er een man met z’n 
handen in z’n zakken... Nou ja, je weet hoe ongepast die grap verder is dus ik maak hem verder 
niet af. Dankjewel voor al je hulp voor en tijdens m’n PhD-werk, je bent echt de go-to-guy 
voor allerlei praktische zaken, contacten en flauwe grappen (waar ik erg van houd). Wat tof dat 
je de fotografie wilt verzorgen! Wim, jouw uitgebreide kennis en begeleiding hebben destijds 
m’n Master-stage tot een goed einde gebracht, maar ook daarna stond je deur altijd open voor 
een praatje, hetzij wetenschappelijk van aard, hetzij over compleet andere dingen (Game of 
Thrones, Japan, thee, bier, ... ). Bij je nieuwe functie hoort ook een nieuwe werkplek, maar 
desondanks weet ik zeker dat we elkaar (gelukkig!) nog in de wandelgangen zullen spreken.
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Of course my time at Neurophysiology wouldn’t have been the same without the good compa-
ny, pleasant talks, scientific discussions and cooperations and tea ceremonies I got (and get) to 
have with Bernhard, Angélica, Fleur, Rémi, Ashutosh, Gea, Xuan, Urszula and Yiping. Many 
thanks to you all, with special thanks to Yutaro and his wife Amanda for their help with the 
RNA-seq analsysis and data interpretation! Eric, dankjewel voor de fijne gesprekken, goede 
adviezen en fijne samenwerking, ik ben blij dat ik kantoor en labruimte nog even met je mag 
delen.
Samenwerking is ook binnen de wetenschap van belang. Toen de afdeling Neurofysiologie 
nog piepjong was werden er al gezamelijke werkbesprekingen georganiseerd met de afdeling 
Moleculaire Dierfysiologie. Gevolg was dat ik van tijd tot tijd ook een luisterend oor vond aan 
de overkant van de straat. Bedankt, Gerard, Sharon, Astrid, Eric, Nick, en de rest van de 6e 
verdieping op het RIMLS voor jullie interesse en nuttige feedback. Ook dank aan de leden van 
de afdeling Neuroinformatica, met wie ik ook vaak gedachten heb mogen uitwisselen. Jeffrey, 
ook met jouw afdeling heb ik veel en met veel plezier samengewerkt, hartelijk dank daarvoor 
en voor het openstellen van je lab, ook aan alle leden van je gezellige groep: Amanda, Martha, 
Peter, Ilse, Shaha, Charlotte, Mireille, Joanna. Michiel, zonder jou en je team, Rik, Pascal en 
Marijke, had dit proefschrift het zonder de proteomics moeten stellen. Hartelijk dank aan jullie 
voor de samenwerking.
Hoewel onze groepen doorgaans in verschillende wetenschappelijke gebieden werkzaam zijn 
heeft dat de leden van de afdeling Organismale Dierfysiologie nooit weerhouden om zich open 
te stellen naar leden van andere afdelingen. Al vanaf het begin af aan waren we altijd welkom 
voor een praatje bij het koffiezet-/tostiapparaat tijdens de pauze of voor een biertje (maar vaker 
meer dan één) op de vrijdagavond. Deze zet ik ook nu nog met alle plezier voort. Dankjulliewel 
Gert, Jan, Jeroen, Remi, Stefan, Peter, Juriaan, Marnix, Daisy, Tom, Liesbeth, Thamar en Wim!
Laurens, dankjewel dat je me wilt bijstaan als para-/bronimf, en bedankt voor alle goede 
gesprekken, gedeelde biertjes en feestjes. Ik ben blij dat we hier, ook na ons PhD-werk, zo af 
en toe nog tijd voor kunnen vinden. Nog even doorbijten bro, en dan mag ik jou bijstaan als 
je jouw boekje gaat verdedigen. Many thanks also to Chao and AliReza, my PhD-buddies at 
Neurophysiology, even a quick talk with either of you could really help to get clarity, see things 
from a different perspective or just make me laugh. Chao, I hope your beer brewing is going 
well; we should exchange beers some time! I’ve come to miss your sarcasm around the depart-
ment since you’re living in Germany. AliReza, you’re extremely busy as a recently married 
man with a job that keeps you on the road many a time while finishing writing up your thesis. 
Don’t worry, you’ll get there! As we say: de aanhouder wint J Thanks also to Piray, for good 
company and conversations we’ve shared while enjoying good beer, en ook jij bedankt, Teun, 
voor de gezelligheid zowel tijdens als na je stage. Aron, Nikkie, wat prijs ik mezelf gelukkig 
dat jullie er waren toen ik nog maar net begon. Met veel wijsheid en geduld hebben jullie me 
meer dan eens vooruit geholpen. Ik kon altijd bij jullie terecht met vragen of gewoon voor een 
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babbeltje, en denk mede dankzij jullie nog vaak met plezier terug aan de FENS in Milaan. 
Dankjulliewel!
Al m’n werkzaamheden had ik niet kunnen doen zonder alle goede hulp die ik heb gehad van 
de medewerkers van het CDL: Bianca, Maikel, Debbie, Stefanie, Mike, Kitty, Henk, Iris, Jan-
neke, en Nicole, dankjullie wel voor jullie hulp!
Een dankwoord zou natuurlijk niet compleet zijn zonder de studenten te noemen die ik heb 
mogen (mede)begeleiden: Lucas D., Anja, Heleen, Cisil, Jesse, Jolien, Lisa, Lucas L., Manou-
kia, Wiebke, Maaike, bedankt dat ik jullie heb mogen begeleiden. Speciale dank aan David en 
Ghihad voor hun hulp bij het verzamelen van de weefsels voor de RNA-seq en mass spec. Veel 
succes allemaal met de rest van jullie studies en verdere loopbaan! Niccoló, you started as a 
student of mine, now I’m thrilled that you get to stay at our department as a PhD student for a 
little longer, you’re going to do great J
Het volgende intermezzo gaat niet zozeer collega’s, vrienden of familieleden aan, maar wil 
ik hier desalniettemin toch even vermelden: veel dank aan Al Food afhaalcentrum voor alle 
pizza’s die jullie voor me hebben gebakken na de lange werkdagen. Bedankt, Grolsch, voor de 
nodige mentale ondersteuning. Verder wil ik ook Hatebreed, Amon Amarth, Finntroll en Lamb 
of God bedanken voor hun inspirerende woorden naar, tijdens en vanuit m’n werk, die me er 
op meerdere momenten absoluut doorheen hebben gesleept. “It’s our struggles that define us, 
and the hardships we endure!”
Er ging geen verjaardag of ander feestje in onze familie voorbij of er werd door allerlei ooms, 
tantes, neven en nichten gevraagd waar ik eigenlijk precies mee bezig was, hoe dat dan in z’n 
werk ging, of het moeilijk was (“Ja L ”), of ik al bijna klaar was (“Nee L ”) en of ik al verdere 
plannen had. Er was dus veel interesse in de voortgang van m’n werkzaamheden. Hoewel het 
niet altijd makkelijk was om één en ander in niet-wetenschappelijke taal uit te leggen vond ik 
het altijd onmeunig mooi dat er zoveel interesse was in m’n werk, en daarvoor wil ik de fa- 
milies Kole, Oude Ophuis, Wessels en Van Oerle allemaal hartelijk bedanken. In het bijzonder 
dank aan Bert, Desirée, Tanja, Kevin en Jeroen maar ook Thea en Frits, wat fijn om zulke lieve 
schoonfamilie te hebben!
Dan zijn er nog m’n vrienden die ik al sinds de middelbare school of zelfs ruim daarvoor al ken. 
Hoe had ik ooit deze tijd door kunnen komen zonder jullie om op terug te vallen? Joost, Oliv-
ier, Qilong, Tim, Dirk, Maurits-Jan, Melvin, Chris, Pim, Rik, en Tom, ook jullie hebben altijd 
interesse en steun getoond voor het werk wat ik doe. Maar bovenal is en blijft het altijd heerlijk 
om als vanouds met jullie te praten (en te buizen). “Homies for life, later!” (oh ja, ‘Born To Be 
Alive’ is van Patrick Hernandez en niet van The Village People). Extra kudo’s voor Olivier, de 
voorkant van dit boekje ziet er dankzij hem prachtig uit! Dank ook aan Mariëlle, Joris, Steph-
anie, Dennis, Quincy, Annemarie, Barrie, Leonie, Hugo, Lotte, Dimitris, Milan, Johan, Sandra 
en Tom voor alle interesse, warmte en gezelligheid.
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Lieve pap en mam, ik ben jullie heel erg dankbaar voor de manier waarop jullie mij (en Floor) 
hebben opgevoed en vind dat jullie daar trots op mogen zijn. Jullie hebben ons altijd gesteund 
in ons leven, zij het op het gebied van opleiding, werk, relaties of anderzijds. Ik heb er altijd 
graag de treinreis voor over om jullie weer even te zien en spreken. Hetzelfde geldt natuurlijk 
voor mijn lieve zus Floor en haar vriend Merijn, en mijn kleine neefjes Thijmen en Lennart! 
Jullie hebben allemaal altijd interesse getoond en me steun gegeven, jullie zijn me allemaal 
heel erg dierbaar en ik hou van jullie.
Lieve Chantal,  je hebt wel eens gezegd dat je vind dat ik alles de afgelopen jaren toch echt 
helemaal zelf heb gedaan. Wat mij betreft is niets minder waar, want je liefde, vertrouwen, je 
blijdschap bij positief nieuws en opbeurende en motiverende woorden bij tegenslagen zijn on-
misbaar geweest in de afgelopen jaren (en de lieve zorgen tijdens het schrijven van dit boekje, 
niet te vergeten!). Wat me ook te wachten staat in de toekomst, ik weet dat ik het aankan als je 
naast me staat. Dankjewel lieverd, ik hou van je.
Koen
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Curriculum Vitae 
Koen Kole werd geboren op 7 april 1988 te Oldenzaal. Hij groeide op in Oldenzaal en 
voltooide in 2005 de Havo aan het Thijcollege in dezelfde stad. In dat jaar begon hij ook met 
de studie Biologie en Medisch Laboratoriumonderzoek aan de Saxion Hogeschool te En-
schede, waar hij de propedeuse behaalde. In 2006 begon hij aan de opleiding Lerarenopleiding 
Tweede Graad Biologie aan de Christelijke Hogeschool Windesheim te Zwolle. Deze opleiding 
werd in 2010 gevolgd door de Masteropleiding Medische Beiologie aan de Radboud Universi-
teit te Nijmegen. Tijdens de Masterfase heeft hij tijdens twee stages onderzoek verricht.
Zijn eerste stage liep Koen bij de afdeling Molecular Biology in het toenmalige Nijmegen Cen-
tre for Molecular Life Sciences (nu Radboud Institute for Medical Life Sciences) onder bege-
leiding van Dr. Colin Logie. Tijdens deze stage werkte hij aan de bouw van een in vitro model 
voor genregulatie en histonmodificatie. 
Tijdens zijn tweede stage werd hij op de afdeling Neurophysiology begeleid door Dr. Wim 
Scheenen en Prof. Dr. Tansu Celikel, met wie hij doormiddel van elektrosfysiologische tech-
nieken onderzoek deed naar neuronale plasticiteit in de barrel cortex van ratten.
In maart 2013 behaalde hij zijn diploma, en zette zijn onderzoek in de barrel cortex voort als 
promovendus op dezelfde afdeling. De resultaten van dit onderzoek staan in dit proefshrift 
beschreven en zijn gepresenteerd op internationale wetenschappelijke bijeenkomsten (het 
negende en tiende FENS Forum te Milaan in 2014 en te Kopenhagen in 2016). Verder zijn de 
resultaten van dit onderzoek gepubliceerd in diverse internationale wetenschappelijke tijd-
schriften. Sinds april 2017 is Koen werkzaam als postdoctoraal medewerker op de afdeling 
Neurophysiology in Nijmegen.
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Donders Graduate School for Cognitive Neuroscience
For a successful research Institute, it is vital to train the next generation of young scientists. 
To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour established the 
Donders Graduate School for Cognitive Neuroscience (DGCN), which was officially rec-
ognised as a national graduate school in 2009. The Graduate School covers training at both 
Master’s and PhD level and provides an excellent educational context fully aligned with the 
research programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in biology, 
physics, psycholinguistics, psychology, behavioral science, medicine and related disciplines. 
Selective admission and assessment centers guarantee the enrolment of the best and most 
motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni show 
a continuation in academia with postdoc positions at top institutes worldwide, e.g. Stanford 
University, University of Oxford, University of Cambridge, UCL London, MPI Leipzig, Ha-
nyang University in South Korea, NTNU Norway, University of Illinois, North Western Uni-
versity, Northeastern University in Boston, ETH Zürich, University of Vienna etc.
Positions outside academia spread among the following sectors: 
- specialists in a medical environment, mainly in genetics, geriatrics, psychiatry and neurolo-
gy,
- specialists in a psychological environment, e.g. as specialist in neuropsychology, psychologi-
cal diagnostics or therapy, 
- higher education as coordinators or lecturers. 
A smaller percentage enters business as research consultants, analysts or head of research and 
development. Fewer graduates stay in a research environment as lab coordinators, technical 
support or policy advisors. Upcoming possibilities are positions in the IT sector and manage-
ment position in pharmaceutical industry. In general, the PhDs graduates almost invariably 
continue with high-quality positions that play an important role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/
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